id	sid	tid	token	lemma	pos
aji-147	1	1	_	_	PUNCT
aji-147	2	1	_	_	PUNCT
aji-147	3	1	_	_	PUNCT
aji-147	4	1	_	_	PUNCT
aji-147	5	1	_	_	PUNCT
aji-147	6	1	_	_	PUNCT
aji-147	7	1	_	_	PUNCT
aji-147	8	1	_	_	PUNCT
aji-147	9	1	_	_	PUNCT
aji-147	10	1	_	_	PUNCT
aji-147	11	1	_	_	PUNCT
aji-147	12	1	_	_	PUNCT
aji-147	13	1	_	_	PUNCT
aji-147	14	1	_	_	PUNCT
aji-147	15	1	_	_	PUNCT
aji-147	16	1	_	_	PUNCT
aji-147	17	1	_	_	PUNCT
aji-147	18	1	_	_	PUNCT
aji-147	19	1	_	_	PUNCT
aji-147	20	1	_	_	PUNCT
aji-147	21	1	_	_	PUNCT
aji-147	22	1	_	_	PUNCT
aji-147	23	1	_	_	PUNCT
aji-147	24	1	_	_	PUNCT
aji-147	25	1	_	_	PUNCT
aji-147	26	1	_	_	PUNCT
aji-147	27	1	_	_	PUNCT
aji-147	28	1	_	_	PUNCT
aji-147	29	1	_	_	PUNCT
aji-147	30	1	_	_	PUNCT
aji-147	31	1	_	_	PUNCT
aji-147	32	1	_	_	PUNCT
aji-147	33	1	_	_	PUNCT
aji-147	34	1	_	_	PUNCT
aji-147	35	1	_	_	PUNCT
aji-147	36	1	_	_	PUNCT
aji-147	37	1	_	_	PUNCT
aji-147	38	1	_	_	PUNCT
aji-147	39	1	_	_	PUNCT
aji-147	40	1	_	_	PUNCT
aji-147	41	1	_	_	PUNCT
aji-147	42	1	_	_	PUNCT
aji-147	43	1	_	_	PUNCT
aji-147	44	1	_	_	PUNCT
aji-147	45	1	_	_	PUNCT
aji-147	46	1	_	_	PUNCT
aji-147	47	1	_	_	PUNCT
aji-147	48	1	_	_	PUNCT
aji-147	49	1	_	_	PUNCT
aji-147	50	1	_	_	PUNCT
aji-147	51	1	_	_	PUNCT
aji-147	52	1	_	_	PUNCT
aji-147	53	1	_	_	PUNCT
aji-147	54	1	_	_	PUNCT
aji-147	55	1	_	_	PUNCT
aji-147	56	1	_	_	PUNCT
aji-147	57	1	_	_	PUNCT
aji-147	58	1	_	_	PUNCT
aji-147	59	1	_	_	PUNCT
aji-147	60	1	_	_	PUNCT
aji-147	61	1	_	_	PUNCT
aji-147	62	1	_	_	PUNCT
aji-147	63	1	_	_	PUNCT
aji-147	64	1	_	_	PUNCT
aji-147	65	1	_	_	PUNCT
aji-147	66	1	_	_	PUNCT
aji-147	67	1	_	_	PUNCT
aji-147	68	1	_	_	PUNCT
aji-147	69	1	_	_	PUNCT
aji-147	70	1	_	_	PUNCT
aji-147	71	1	_	_	PUNCT
aji-147	72	1	_	_	PUNCT
aji-147	73	1	_	_	PUNCT
aji-147	74	1	_	_	PUNCT
aji-147	75	1	_	_	PUNCT
aji-147	76	1	_	_	PUNCT
aji-147	77	1	_	_	PUNCT
aji-147	78	1	_	_	PUNCT
aji-147	79	1	_	_	PUNCT
aji-147	80	1	_	_	PUNCT
aji-147	81	1	_	_	PUNCT
aji-147	82	1	_	_	PUNCT
aji-147	83	1	_	_	PUNCT
aji-147	84	1	_	_	PUNCT
aji-147	85	1	_	_	PUNCT
aji-147	86	1	_	_	PUNCT
aji-147	87	1	_	_	PUNCT
aji-147	88	1	_	_	PUNCT
aji-147	89	1	_	_	PUNCT
aji-147	90	1	_	_	PUNCT
aji-147	91	1	_	_	PUNCT
aji-147	92	1	_	_	PUNCT
aji-147	93	1	_	_	PUNCT
aji-147	94	1	_	_	PUNCT
aji-147	95	1	_	_	PUNCT
aji-147	96	1	_	_	PUNCT
aji-147	97	1	_	_	PUNCT
aji-147	98	1	_	_	PUNCT
aji-147	99	1	_	_	PUNCT
aji-147	100	1	_	_	PUNCT
aji-147	101	1	_	_	PUNCT
aji-147	102	1	*	*	PUNCT
aji-147	102	2	corresponding	correspond	VERB
aji-147	102	3	author	author	NOUN
aji-147	102	4	:	:	PUNCT
aji-147	102	5	e	e	NOUN
aji-147	102	6	-	-	NOUN
aji-147	102	7	mail	mail	NOUN
aji-147	102	8	:	:	PUNCT
aji-147	102	9	arvindkumarshukla@pusan.ac.kr	arvindkumarshukla@pusan.ac.kr	X
aji-147	102	10	;	;	PUNCT
aji-147	102	11	arvindkumarshuklapnu@gmail.com	arvindkumarshuklapnu@gmail.com	NOUN
aji-147	102	12	cite	cite	VERB
aji-147	102	13	as	as	ADP
aji-147	102	14	:	:	PUNCT
aji-147	102	15	shukla	shukla	NOUN
aji-147	102	16	,	,	PUNCT
aji-147	102	17	sandhya	sandhya	PROPN
aji-147	102	18	,	,	PUNCT
aji-147	102	19	arvind	arvind	PROPN
aji-147	102	20	kumar	kumar	PROPN
aji-147	102	21	shukla	shukla	PROPN
aji-147	102	22	,	,	PUNCT
aji-147	102	23	navin	navin	PROPN
aji-147	102	24	ray	ray	PROPN
aji-147	102	25	,	,	PUNCT
aji-147	102	26	adarsha	adarsha	PROPN
aji-147	102	27	mahendra	mahendra	PROPN
aji-147	102	28	upadhyay	upadhyay	PROPN
aji-147	102	29	,	,	PUNCT
aji-147	102	30	giovanna	giovanna	PROPN
aji-147	102	31	mirone	mirone	PROPN
aji-147	102	32	,	,	PUNCT
aji-147	102	33	and	and	CCONJ
aji-147	102	34	raj	raj	PROPN
aji-147	102	35	kumar	kumar	PROPN
aji-147	102	36	mongre	mongre	PROPN
aji-147	102	37	.	.	PUNCT
aji-147	103	1	2024	2024	NUM
aji-147	103	2	.	.	PUNCT
aji-147	104	1	“	"	PUNCT
aji-147	104	2	long	long	ADV
aji-147	104	3	-	-	PUNCT
aji-147	104	4	lasting	last	VERB
aji-147	104	5	response	response	NOUN
aji-147	104	6	of	of	ADP
aji-147	104	7	human	human	ADJ
aji-147	104	8	circulating	circulating	PROPN
aji-147	104	9	t	t	PROPN
aji-147	104	10	-	-	PUNCT
aji-147	104	11	follicular	follicular	ADJ
aji-147	104	12	helper	helper	NOUN
aji-147	104	13	cells	cell	NOUN
aji-147	104	14	(	(	PUNCT
aji-147	104	15	ctfh	ctfh	NOUN
aji-147	104	16	)	)	PUNCT
aji-147	104	17	to	to	PART
aji-147	104	18	post	post	VERB
aji-147	104	19	sars	sar	NOUN
aji-147	104	20	-	-	PUNCT
aji-147	104	21	cov-2	cov-2	NOUN
aji-147	104	22	mrna	mrna	PROPN
aji-147	104	23	immunization	immunization	NOUN
aji-147	104	24	”	"	PUNCT
aji-147	104	25	.	.	PUNCT
aji-147	105	1	asian	asian	ADJ
aji-147	105	2	journal	journal	NOUN
aji-147	105	3	of	of	ADP
aji-147	105	4	immunology	immunology	NOUN
aji-147	105	5	7	7	NUM
aji-147	105	6	(	(	PUNCT
aji-147	105	7	1):228	1):228	NUM
aji-147	105	8	-	-	SYM
aji-147	105	9	46	46	NUM
aji-147	105	10	.	.	PUNCT
aji-147	106	1	https://journalaji.com/index.php/aji/article/view/147	https://journalaji.com/index.php/aji/article/view/147	NUM
aji-147	106	2	.	.	PUNCT
aji-147	106	3	asian	asian	ADJ
aji-147	106	4	journal	journal	PROPN
aji-147	106	5	of	of	ADP
aji-147	106	6	immunology	immunology	NOUN
aji-147	106	7	volume	volume	NOUN
aji-147	106	8	7	7	NUM
aji-147	106	9	,	,	PUNCT
aji-147	106	10	issue	issue	NOUN
aji-147	106	11	1	1	NUM
aji-147	106	12	,	,	PUNCT
aji-147	106	13	page	page	NOUN
aji-147	106	14	228	228	NUM
aji-147	106	15	-	-	SYM
aji-147	106	16	246	246	NUM
aji-147	106	17	,	,	PUNCT
aji-147	106	18	2024	2024	NUM
aji-147	106	19	;	;	PUNCT
aji-147	106	20	article	article	NOUN
aji-147	106	21	no.aji.125387	no.aji.125387	PROPN
aji-147	106	22	long	long	ADV
aji-147	106	23	-	-	PUNCT
aji-147	106	24	lasting	last	VERB
aji-147	106	25	response	response	NOUN
aji-147	106	26	of	of	ADP
aji-147	106	27	human	human	ADJ
aji-147	106	28	circulating	circulating	PROPN
aji-147	106	29	t	t	PROPN
aji-147	106	30	-	-	PUNCT
aji-147	106	31	follicular	follicular	ADJ
aji-147	106	32	helper	helper	NOUN
aji-147	106	33	cells	cell	NOUN
aji-147	106	34	(	(	PUNCT
aji-147	106	35	ctfh	ctfh	NOUN
aji-147	106	36	)	)	PUNCT
aji-147	106	37	to	to	PART
aji-147	106	38	post	post	VERB
aji-147	106	39	sars	sar	NOUN
aji-147	106	40	-	-	PUNCT
aji-147	106	41	cov-2	cov-2	NOUN
aji-147	106	42	mrna	mrna	PROPN
aji-147	106	43	immunization	immunization	PROPN
aji-147	106	44	sandhya	sandhya	PROPN
aji-147	106	45	shukla	shukla	PROPN
aji-147	106	46	a	a	PROPN
aji-147	106	47	,	,	PUNCT
aji-147	106	48	arvind	arvind	PROPN
aji-147	106	49	kumar	kumar	PROPN
aji-147	106	50	shukla	shukla	PROPN
aji-147	106	51	b	b	PROPN
aji-147	106	52	*	*	PROPN
aji-147	106	53	,	,	PUNCT
aji-147	106	54	navin	navin	PROPN
aji-147	106	55	ray	ray	PROPN
aji-147	106	56	c	c	PROPN
aji-147	106	57	,	,	PUNCT
aji-147	106	58	adarsha	adarsha	PROPN
aji-147	106	59	mahendra	mahendra	PROPN
aji-147	106	60	upadhyay	upadhyay	PROPN
aji-147	106	61	d	d	PROPN
aji-147	106	62	,	,	PUNCT
aji-147	106	63	giovanna	giovanna	PROPN
aji-147	106	64	mirone	mirone	PROPN
aji-147	106	65	e	e	PROPN
aji-147	106	66	and	and	CCONJ
aji-147	106	67	raj	raj	PROPN
aji-147	106	68	kumar	kumar	PROPN
aji-147	106	69	mongre	mongre	PROPN
aji-147	106	70	f	f	PROPN
aji-147	106	71	a	a	DET
aji-147	106	72	department	department	NOUN
aji-147	106	73	of	of	ADP
aji-147	106	74	pharmacology	pharmacology	NOUN
aji-147	106	75	,	,	PUNCT
aji-147	106	76	bharati	bharati	PROPN
aji-147	106	77	vidyapeeth	vidyapeeth	PROPN
aji-147	106	78	deemed	deem	VERB
aji-147	106	79	university	university	PROPN
aji-147	106	80	medical	medical	ADJ
aji-147	106	81	college	college	NOUN
aji-147	106	82	,	,	PUNCT
aji-147	106	83	pune-411043	pune-411043	NOUN
aji-147	106	84	,	,	PUNCT
aji-147	106	85	india	india	PROPN
aji-147	106	86	.	.	PUNCT
aji-147	107	1	b	b	X
aji-147	107	2	school	school	NOUN
aji-147	107	3	of	of	ADP
aji-147	107	4	biomedical	biomedical	ADJ
aji-147	107	5	convergence	convergence	NOUN
aji-147	107	6	engineering	engineering	NOUN
aji-147	107	7	,	,	PUNCT
aji-147	107	8	pusan	pusan	PROPN
aji-147	107	9	national	national	PROPN
aji-147	107	10	university	university	PROPN
aji-147	107	11	,	,	PUNCT
aji-147	107	12	yangsan-50612	yangsan-50612	NOUN
aji-147	107	13	,	,	PUNCT
aji-147	107	14	south	south	PROPN
aji-147	107	15	korea	korea	PROPN
aji-147	107	16	.	.	PUNCT
aji-147	108	1	c	c	PROPN
aji-147	108	2	laboratory	laboratory	NOUN
aji-147	108	3	of	of	ADP
aji-147	108	4	mucosal	mucosal	NOUN
aji-147	108	5	exposome	exposome	NOUN
aji-147	108	6	and	and	CCONJ
aji-147	108	7	biomodulation	biomodulation	NOUN
aji-147	108	8	,	,	PUNCT
aji-147	108	9	department	department	NOUN
aji-147	108	10	of	of	ADP
aji-147	108	11	integrative	integrative	ADJ
aji-147	108	12	biomedical	biomedical	ADJ
aji-147	108	13	sciences	science	NOUN
aji-147	108	14	,	,	PUNCT
aji-147	108	15	pusan	pusan	PROPN
aji-147	108	16	national	national	PROPN
aji-147	108	17	university	university	PROPN
aji-147	108	18	,	,	PUNCT
aji-147	108	19	yangsan-50612	yangsan-50612	NOUN
aji-147	108	20	,	,	PUNCT
aji-147	108	21	south	south	PROPN
aji-147	108	22	korea	korea	PROPN
aji-147	108	23	.	.	PUNCT
aji-147	109	1	d	d	DET
aji-147	109	2	department	department	NOUN
aji-147	109	3	of	of	ADP
aji-147	109	4	gastrointestinal	gastrointestinal	ADJ
aji-147	109	5	surgery	surgery	NOUN
aji-147	109	6	,	,	PUNCT
aji-147	109	7	school	school	NOUN
aji-147	109	8	of	of	ADP
aji-147	109	9	overseas	overseas	ADJ
aji-147	109	10	education	education	NOUN
aji-147	109	11	,	,	PUNCT
aji-147	109	12	guizhou	guizhou	PROPN
aji-147	109	13	medical	medical	PROPN
aji-147	109	14	university	university	PROPN
aji-147	109	15	,	,	PUNCT
aji-147	109	16	guiyang	guiyang	NOUN
aji-147	109	17	,	,	PUNCT
aji-147	109	18	guizhou-550025	guizhou-550025	NOUN
aji-147	109	19	,	,	PUNCT
aji-147	109	20	china	china	PROPN
aji-147	109	21	.	.	PUNCT
aji-147	110	1	e	e	PROPN
aji-147	110	2	department	department	PROPN
aji-147	110	3	of	of	ADP
aji-147	110	4	scienze	scienze	PROPN
aji-147	110	5	e	e	PROPN
aji-147	110	6	tecnologie	tecnologie	PROPN
aji-147	110	7	ambientali	ambientali	PROPN
aji-147	110	8	,	,	PUNCT
aji-147	110	9	biologiche	biologiche	NOUN
aji-147	110	10	e	e	PROPN
aji-147	110	11	farmaceutiche	farmaceutiche	NOUN
aji-147	110	12	,	,	PUNCT
aji-147	110	13	university	university	PROPN
aji-147	110	14	of	of	ADP
aji-147	110	15	campania	campania	PROPN
aji-147	110	16	luigi	luigi	PROPN
aji-147	110	17	vanvitelli	vanvitelli	PROPN
aji-147	110	18	;	;	PUNCT
aji-147	110	19	via	via	ADP
aji-147	110	20	vivaldi	vivaldi	PROPN
aji-147	110	21	43	43	NUM
aji-147	110	22	,	,	PUNCT
aji-147	110	23	caserta-81100	caserta-81100	PROPN
aji-147	110	24	,	,	PUNCT
aji-147	110	25	italy	italy	PROPN
aji-147	110	26	.	.	PUNCT
aji-147	111	1	f	f	PROPN
aji-147	111	2	department	department	PROPN
aji-147	111	3	of	of	ADP
aji-147	111	4	surgery	surgery	NOUN
aji-147	111	5	,	,	PUNCT
aji-147	111	6	boston	boston	PROPN
aji-147	111	7	children	children	PROPN
aji-147	111	8	's	's	PART
aji-147	111	9	hospital	hospital	NOUN
aji-147	111	10	,	,	PUNCT
aji-147	111	11	harvard	harvard	PROPN
aji-147	111	12	medical	medical	PROPN
aji-147	111	13	school	school	PROPN
aji-147	111	14	,	,	PUNCT
aji-147	111	15	harvard	harvard	PROPN
aji-147	111	16	university	university	PROPN
aji-147	111	17	,	,	PUNCT
aji-147	111	18	300	300	NUM
aji-147	111	19	longwood	longwood	PROPN
aji-147	111	20	ave	ave	PROPN
aji-147	111	21	,	,	PUNCT
aji-147	111	22	boston	boston	PROPN
aji-147	111	23	,	,	PUNCT
aji-147	111	24	ma	ma	PROPN
aji-147	111	25	02115	02115	PROPN
aji-147	111	26	,	,	PUNCT
aji-147	111	27	usa	usa	PROPN
aji-147	111	28	.	.	PROPN
aji-147	111	29	authors	author	NOUN
aji-147	111	30	’	’	PART
aji-147	111	31	contributions	contribution	NOUN
aji-147	111	32	this	this	DET
aji-147	111	33	work	work	NOUN
aji-147	111	34	was	be	AUX
aji-147	111	35	carried	carry	VERB
aji-147	111	36	out	out	ADP
aji-147	111	37	in	in	ADP
aji-147	111	38	collaboration	collaboration	NOUN
aji-147	111	39	among	among	ADP
aji-147	111	40	all	all	DET
aji-147	111	41	authors	author	NOUN
aji-147	111	42	.	.	PUNCT
aji-147	112	1	all	all	DET
aji-147	112	2	authors	author	NOUN
aji-147	112	3	read	read	VERB
aji-147	112	4	and	and	CCONJ
aji-147	112	5	approved	approve	VERB
aji-147	112	6	the	the	DET
aji-147	112	7	final	final	ADJ
aji-147	112	8	manuscript	manuscript	NOUN
aji-147	112	9	.	.	PUNCT
aji-147	113	1	article	article	NOUN
aji-147	113	2	information	information	PROPN
aji-147	113	3	doi	doi	PROPN
aji-147	113	4	:	:	PUNCT
aji-147	113	5	https://doi.org/10.9734/aji/2024/v7i1147	https://doi.org/10.9734/aji/2024/v7i1147	NOUN
aji-147	113	6	open	open	ADJ
aji-147	113	7	peer	peer	NOUN
aji-147	113	8	review	review	NOUN
aji-147	113	9	history	history	NOUN
aji-147	113	10	:	:	PUNCT
aji-147	113	11	this	this	DET
aji-147	113	12	journal	journal	NOUN
aji-147	113	13	follows	follow	VERB
aji-147	113	14	the	the	DET
aji-147	113	15	advanced	advance	VERB
aji-147	113	16	open	open	ADJ
aji-147	113	17	peer	peer	NOUN
aji-147	113	18	review	review	NOUN
aji-147	113	19	policy	policy	NOUN
aji-147	113	20	.	.	PUNCT
aji-147	114	1	identity	identity	NOUN
aji-147	114	2	of	of	ADP
aji-147	114	3	the	the	DET
aji-147	114	4	reviewers	reviewer	NOUN
aji-147	114	5	,	,	PUNCT
aji-147	114	6	editor(s	editor(s	NOUN
aji-147	114	7	)	)	PUNCT
aji-147	114	8	and	and	CCONJ
aji-147	114	9	additional	additional	ADJ
aji-147	114	10	reviewers	reviewer	NOUN
aji-147	114	11	,	,	PUNCT
aji-147	114	12	peer	peer	NOUN
aji-147	114	13	review	review	NOUN
aji-147	114	14	comments	comment	NOUN
aji-147	114	15	,	,	PUNCT
aji-147	114	16	different	different	ADJ
aji-147	114	17	versions	version	NOUN
aji-147	114	18	of	of	ADP
aji-147	114	19	the	the	DET
aji-147	114	20	manuscript	manuscript	NOUN
aji-147	114	21	,	,	PUNCT
aji-147	114	22	comments	comment	NOUN
aji-147	114	23	of	of	ADP
aji-147	114	24	the	the	DET
aji-147	114	25	editors	editor	NOUN
aji-147	114	26	,	,	PUNCT
aji-147	114	27	etc	etc	X
aji-147	114	28	.	.	X
aji-147	114	29	are	be	AUX
aji-147	114	30	available	available	ADJ
aji-147	114	31	here	here	ADV
aji-147	114	32	:	:	PUNCT
aji-147	114	33	https://www.sdiarticle5.com/review-history/125387	https://www.sdiarticle5.com/review-history/125387	PROPN
aji-147	114	34	received	receive	VERB
aji-147	114	35	:	:	PUNCT
aji-147	114	36	04/09/2024	04/09/2024	NUM
aji-147	114	37	accepted	accept	VERB
aji-147	114	38	:	:	PUNCT
aji-147	114	39	06/11/2024	06/11/2024	NUM
aji-147	114	40	published	publish	VERB
aji-147	114	41	:	:	PUNCT
aji-147	114	42	13/11/2024	13/11/2024	NUM
aji-147	114	43	review	review	NOUN
aji-147	114	44	article	article	NOUN
aji-147	114	45	https://doi.org/10.9734/aji/2024/v7i1147	https://doi.org/10.9734/aji/2024/v7i1147	PROPN
aji-147	114	46	https://www.sdiarticle5.com/review-history/125387	https://www.sdiarticle5.com/review-history/125387	PROPN
aji-147	114	47	shukla	shukla	NOUN
aji-147	114	48	et	et	PROPN
aji-147	114	49	al	al	PROPN
aji-147	114	50	.	.	PROPN
aji-147	114	51	;	;	PUNCT
aji-147	114	52	asian	asian	PROPN
aji-147	114	53	j.	j.	PROPN
aji-147	114	54	immunol	immunol	PROPN
aji-147	114	55	.	.	PROPN
aji-147	114	56	,	,	PUNCT
aji-147	114	57	vol	vol	NOUN
aji-147	114	58	.	.	PROPN
aji-147	115	1	7	7	NUM
aji-147	115	2	,	,	PUNCT
aji-147	115	3	no	no	INTJ
aji-147	115	4	.	.	NOUN
aji-147	115	5	1	1	NUM
aji-147	115	6	,	,	PUNCT
aji-147	115	7	pp	pp	ADJ
aji-147	115	8	.	.	PUNCT
aji-147	116	1	228	228	NUM
aji-147	116	2	-	-	SYM
aji-147	116	3	246	246	NUM
aji-147	116	4	,	,	PUNCT
aji-147	116	5	2024	2024	NUM
aji-147	116	6	;	;	PUNCT
aji-147	116	7	article	article	NOUN
aji-147	116	8	no.aji.125387	no.aji.125387	NOUN
aji-147	116	9	229	229	NUM
aji-147	117	1	abstract	abstract	ADV
aji-147	117	2	the	the	DET
aji-147	117	3	ongoing	ongoing	ADJ
aji-147	117	4	covid-19	covid-19	PROPN
aji-147	117	5	pandemic	pandemic	NOUN
aji-147	117	6	underscores	underscore	VERB
aji-147	117	7	the	the	DET
aji-147	117	8	urgent	urgent	ADJ
aji-147	117	9	need	need	NOUN
aji-147	117	10	for	for	ADP
aji-147	117	11	effective	effective	ADJ
aji-147	117	12	vaccination	vaccination	NOUN
aji-147	117	13	strategies	strategy	NOUN
aji-147	117	14	to	to	PART
aji-147	117	15	mitigate	mitigate	VERB
aji-147	117	16	disease	disease	NOUN
aji-147	117	17	burden	burden	NOUN
aji-147	117	18	.	.	PUNCT
aji-147	118	1	the	the	DET
aji-147	118	2	development	development	NOUN
aji-147	118	3	of	of	ADP
aji-147	118	4	neutralizing	neutralize	VERB
aji-147	118	5	antibodies	antibody	NOUN
aji-147	118	6	is	be	AUX
aji-147	118	7	a	a	DET
aji-147	118	8	critical	critical	ADJ
aji-147	118	9	indicator	indicator	NOUN
aji-147	118	10	of	of	ADP
aji-147	118	11	host	host	NOUN
aji-147	118	12	defence	defence	NOUN
aji-147	118	13	mechanisms	mechanism	NOUN
aji-147	118	14	against	against	ADP
aji-147	118	15	life	life	NOUN
aji-147	118	16	-	-	PUNCT
aji-147	118	17	threatening	threaten	VERB
aji-147	118	18	infectious	infectious	ADJ
aji-147	118	19	diseases	disease	NOUN
aji-147	118	20	,	,	PUNCT
aji-147	118	21	such	such	ADJ
aji-147	118	22	as	as	ADP
aji-147	118	23	those	those	PRON
aji-147	118	24	caused	cause	VERB
aji-147	118	25	by	by	ADP
aji-147	118	26	sarscov-2	sarscov-2	PROPN
aji-147	118	27	.	.	PUNCT
aji-147	119	1	understanding	understand	VERB
aji-147	119	2	the	the	DET
aji-147	119	3	fundamental	fundamental	ADJ
aji-147	119	4	biological	biological	ADJ
aji-147	119	5	mechanisms	mechanism	NOUN
aji-147	119	6	and	and	CCONJ
aji-147	119	7	substantiality	substantiality	NOUN
aji-147	119	8	of	of	ADP
aji-147	119	9	these	these	DET
aji-147	119	10	antibodies	antibody	NOUN
aji-147	119	11	'	'	PART
aji-147	119	12	production	production	NOUN
aji-147	119	13	is	be	AUX
aji-147	119	14	essential	essential	ADJ
aji-147	119	15	for	for	ADP
aji-147	119	16	developing	develop	VERB
aji-147	119	17	effective	effective	ADJ
aji-147	119	18	vaccines	vaccine	NOUN
aji-147	119	19	,	,	PUNCT
aji-147	119	20	particularly	particularly	ADV
aji-147	119	21	in	in	ADP
aji-147	119	22	the	the	DET
aji-147	119	23	face	face	NOUN
aji-147	119	24	of	of	ADP
aji-147	119	25	emerging	emerge	VERB
aji-147	119	26	variants	variant	NOUN
aji-147	119	27	.	.	PUNCT
aji-147	120	1	circulating	circulate	VERB
aji-147	120	2	t	t	PROPN
aji-147	120	3	follicular	follicular	ADJ
aji-147	120	4	helper	helper	NOUN
aji-147	120	5	(	(	PUNCT
aji-147	120	6	ctfh	ctfh	NOUN
aji-147	120	7	)	)	PUNCT
aji-147	120	8	cells	cell	NOUN
aji-147	120	9	,	,	PUNCT
aji-147	120	10	which	which	PRON
aji-147	120	11	have	have	AUX
aji-147	120	12	emerged	emerge	VERB
aji-147	120	13	as	as	ADP
aji-147	120	14	significant	significant	ADJ
aji-147	120	15	predictors	predictor	NOUN
aji-147	120	16	of	of	ADP
aji-147	120	17	neutralizing	neutralize	VERB
aji-147	120	18	antibody	antibody	NOUN
aji-147	120	19	levels	level	NOUN
aji-147	120	20	,	,	PUNCT
aji-147	120	21	are	be	AUX
aji-147	120	22	of	of	ADP
aji-147	120	23	utmost	utmost	ADJ
aji-147	120	24	importance	importance	NOUN
aji-147	120	25	in	in	ADP
aji-147	120	26	shaping	shape	VERB
aji-147	120	27	long	long	ADJ
aji-147	120	28	-	-	PUNCT
aji-147	120	29	term	term	NOUN
aji-147	120	30	immunity	immunity	NOUN
aji-147	120	31	following	follow	VERB
aji-147	120	32	vaccination	vaccination	NOUN
aji-147	120	33	.	.	PUNCT
aji-147	121	1	we	we	PRON
aji-147	121	2	emphasize	emphasize	VERB
aji-147	121	3	the	the	DET
aji-147	121	4	pivotal	pivotal	ADJ
aji-147	121	5	role	role	NOUN
aji-147	121	6	of	of	ADP
aji-147	121	7	ctfh	ctfh	NOUN
aji-147	121	8	cells	cell	NOUN
aji-147	121	9	in	in	ADP
aji-147	121	10	shaping	shape	VERB
aji-147	121	11	long	long	ADJ
aji-147	121	12	-	-	PUNCT
aji-147	121	13	term	term	NOUN
aji-147	121	14	immunity	immunity	NOUN
aji-147	121	15	,	,	PUNCT
aji-147	121	16	providing	provide	VERB
aji-147	121	17	reassurance	reassurance	NOUN
aji-147	121	18	about	about	ADP
aji-147	121	19	the	the	DET
aji-147	121	20	effectiveness	effectiveness	NOUN
aji-147	121	21	of	of	ADP
aji-147	121	22	vaccines	vaccine	NOUN
aji-147	121	23	.	.	PUNCT
aji-147	122	1	in	in	ADP
aji-147	122	2	this	this	DET
aji-147	122	3	study	study	NOUN
aji-147	122	4	,	,	PUNCT
aji-147	122	5	we	we	PRON
aji-147	122	6	elucidate	elucidate	VERB
aji-147	122	7	the	the	DET
aji-147	122	8	functions	function	NOUN
aji-147	122	9	of	of	ADP
aji-147	122	10	ctfh	ctfh	NOUN
aji-147	122	11	cells	cell	NOUN
aji-147	122	12	and	and	CCONJ
aji-147	122	13	their	their	PRON
aji-147	122	14	lymphoid	lymphoid	NOUN
aji-147	122	15	counterparts	counterpart	NOUN
aji-147	122	16	during	during	ADP
aji-147	122	17	immune	immune	ADJ
aji-147	122	18	responses	response	NOUN
aji-147	122	19	to	to	ADP
aji-147	122	20	sars	sar	NOUN
aji-147	122	21	-	-	PUNCT
aji-147	122	22	cov-2	cov-2	NOUN
aji-147	122	23	,	,	PUNCT
aji-147	122	24	particularly	particularly	ADV
aji-147	122	25	in	in	ADP
aji-147	122	26	the	the	DET
aji-147	122	27	context	context	NOUN
aji-147	122	28	of	of	ADP
aji-147	122	29	spike	spike	ADJ
aji-147	122	30	protein	protein	NOUN
aji-147	122	31	vaccination	vaccination	NOUN
aji-147	122	32	.	.	PUNCT
aji-147	123	1	we	we	PRON
aji-147	123	2	explore	explore	VERB
aji-147	123	3	the	the	DET
aji-147	123	4	phenotypic	phenotypic	ADJ
aji-147	123	5	diversity	diversity	NOUN
aji-147	123	6	of	of	ADP
aji-147	123	7	ctfh	ctfh	NOUN
aji-147	123	8	cells	cell	NOUN
aji-147	123	9	and	and	CCONJ
aji-147	123	10	their	their	PRON
aji-147	123	11	potential	potential	NOUN
aji-147	123	12	as	as	ADP
aji-147	123	13	biomarkers	biomarker	NOUN
aji-147	123	14	for	for	ADP
aji-147	123	15	development	development	NOUN
aji-147	123	16	of	of	ADP
aji-147	123	17	sars	sar	NOUN
aji-147	123	18	-	-	PUNCT
aji-147	123	19	cov-2	cov-2	PART
aji-147	123	20	vaccine	vaccine	NOUN
aji-147	123	21	efficacy	efficacy	NOUN
aji-147	123	22	with	with	ADP
aji-147	123	23	long	long	ADV
aji-147	123	24	-	-	PUNCT
aji-147	123	25	lasting	last	VERB
aji-147	123	26	immunity	immunity	NOUN
aji-147	123	27	.	.	PUNCT
aji-147	124	1	the	the	DET
aji-147	124	2	identification	identification	NOUN
aji-147	124	3	of	of	ADP
aji-147	124	4	specific	specific	ADJ
aji-147	124	5	ctfh	ctfh	NOUN
aji-147	124	6	subgroups	subgroup	NOUN
aji-147	124	7	may	may	AUX
aji-147	124	8	inform	inform	VERB
aji-147	124	9	strategies	strategy	NOUN
aji-147	124	10	for	for	ADP
aji-147	124	11	enhancing	enhance	VERB
aji-147	124	12	vaccine	vaccine	NOUN
aji-147	124	13	responses	response	NOUN
aji-147	124	14	,	,	PUNCT
aji-147	124	15	especially	especially	ADV
aji-147	124	16	concerning	concern	VERB
aji-147	124	17	new	new	ADJ
aji-147	124	18	sars	sar	NOUN
aji-147	124	19	-	-	PUNCT
aji-147	124	20	cov-2	cov-2	NOUN
aji-147	124	21	variant	variant	NOUN
aji-147	124	22	-	-	PUNCT
aji-147	124	23	specific	specific	ADJ
aji-147	124	24	vaccines	vaccine	NOUN
aji-147	124	25	.	.	PUNCT
aji-147	125	1	future	future	ADJ
aji-147	125	2	research	research	NOUN
aji-147	125	3	directions	direction	NOUN
aji-147	125	4	will	will	AUX
aji-147	125	5	focus	focus	VERB
aji-147	125	6	on	on	ADP
aji-147	125	7	harnessing	harness	VERB
aji-147	125	8	the	the	DET
aji-147	125	9	predictive	predictive	ADJ
aji-147	125	10	capabilities	capability	NOUN
aji-147	125	11	of	of	ADP
aji-147	125	12	ctfh	ctfh	NOUN
aji-147	125	13	cells	cell	NOUN
aji-147	125	14	to	to	PART
aji-147	125	15	optimize	optimize	VERB
aji-147	125	16	vaccine	vaccine	NOUN
aji-147	125	17	development	development	NOUN
aji-147	125	18	and	and	CCONJ
aji-147	125	19	improve	improve	VERB
aji-147	125	20	immunological	immunological	ADJ
aji-147	125	21	outcomes	outcome	NOUN
aji-147	125	22	against	against	ADP
aji-147	125	23	evolving	evolve	VERB
aji-147	125	24	sars	sar	NOUN
aji-147	125	25	-	-	PUNCT
aji-147	125	26	cov-2	cov-2	NOUN
aji-147	125	27	strains	strain	NOUN
aji-147	125	28	.	.	PUNCT
aji-147	126	1	keywords	keyword	NOUN
aji-147	126	2	:	:	PUNCT
aji-147	126	3	t	t	PROPN
aji-147	126	4	follicular	follicular	ADJ
aji-147	126	5	helper	helper	NOUN
aji-147	126	6	cells	cell	NOUN
aji-147	126	7	;	;	PUNCT
aji-147	126	8	sars	sar	NOUN
aji-147	126	9	-	-	PUNCT
aji-147	126	10	cov-2	cov-2	NUM
aji-147	126	11	;	;	PUNCT
aji-147	126	12	covid-19	covid-19	PROPN
aji-147	126	13	;	;	PUNCT
aji-147	126	14	cd4	cd4	PROPN
aji-147	126	15	+	+	PROPN
aji-147	126	16	t	t	NOUN
aji-147	126	17	cells	cell	NOUN
aji-147	126	18	.	.	PUNCT
aji-147	127	1	abbreviations	abbreviation	NOUN
aji-147	127	2	pd-1	pd-1	ADP
aji-147	127	3	:	:	PUNCT
aji-147	127	4	programmed	program	VERB
aji-147	127	5	cell	cell	NOUN
aji-147	127	6	death	death	NOUN
aji-147	127	7	protein-1	protein-1	NUM
aji-147	127	8	ccr7	ccr7	NOUN
aji-147	127	9	:	:	PUNCT
aji-147	127	10	cc	cc	ADJ
aji-147	127	11	-	-	ADJ
aji-147	127	12	chemokine	chemokine	ADJ
aji-147	127	13	receptor	receptor	NOUN
aji-147	127	14	7	7	NUM
aji-147	127	15	cxcr3	cxcr3	NOUN
aji-147	127	16	:	:	PUNCT
aji-147	127	17	cxc	cxc	NOUN
aji-147	127	18	-	-	PUNCT
aji-147	127	19	chemokine	chemokine	ADJ
aji-147	127	20	receptor	receptor	NOUN
aji-147	127	21	3	3	NUM
aji-147	127	22	ccr6	ccr6	PROPN
aji-147	127	23	:	:	PUNCT
aji-147	127	24	cxc	cxc	NOUN
aji-147	127	25	-	-	PUNCT
aji-147	127	26	chemokine	chemokine	ADJ
aji-147	127	27	receptor	receptor	NOUN
aji-147	127	28	6	6	NUM
aji-147	127	29	cxcr5	cxcr5	NOUN
aji-147	127	30	:	:	PUNCT
aji-147	127	31	cxc	cxc	NOUN
aji-147	127	32	-	-	PUNCT
aji-147	127	33	chemokine	chemokine	ADJ
aji-147	127	34	receptor	receptor	NOUN
aji-147	127	35	5	5	NUM
aji-147	127	36	icos	icos	PROPN
aji-147	127	37	:	:	PUNCT
aji-147	127	38	inducible	inducible	ADJ
aji-147	127	39	t	t	PROPN
aji-147	127	40	cell	cell	NOUN
aji-147	127	41	co	co	NOUN
aji-147	127	42	-	-	NOUN
aji-147	127	43	stimulator	stimulator	ADJ
aji-147	127	44	tfh	tfh	NOUN
aji-147	127	45	:	:	PUNCT
aji-147	127	46	follicular	follicular	ADJ
aji-147	127	47	helper	helper	NOUN
aji-147	127	48	t	t	NOUN
aji-147	127	49	cell	cell	NOUN
aji-147	127	50	ctfh	ctfh	NOUN
aji-147	127	51	:	:	PUNCT
aji-147	127	52	circulating	circulate	VERB
aji-147	127	53	tfh	tfh	PROPN
aji-147	127	54	cell	cell	NOUN
aji-147	127	55	1	1	NUM
aji-147	127	56	.	.	PUNCT
aji-147	127	57	introduction	introduction	NOUN
aji-147	127	58	the	the	DET
aji-147	127	59	emergence	emergence	NOUN
aji-147	127	60	of	of	ADP
aji-147	127	61	sars	sar	NOUN
aji-147	127	62	-	-	PUNCT
aji-147	127	63	cov-2	cov-2	NOUN
aji-147	127	64	,	,	PUNCT
aji-147	127	65	the	the	DET
aji-147	127	66	virus	virus	NOUN
aji-147	127	67	responsible	responsible	ADJ
aji-147	127	68	for	for	ADP
aji-147	127	69	the	the	DET
aji-147	127	70	covid-19	covid-19	PROPN
aji-147	127	71	pandemic	pandemic	NOUN
aji-147	127	72	,	,	PUNCT
aji-147	127	73	has	have	AUX
aji-147	127	74	prompted	prompt	VERB
aji-147	127	75	an	an	DET
aji-147	127	76	unprecedented	unprecedented	ADJ
aji-147	127	77	global	global	ADJ
aji-147	127	78	effort	effort	NOUN
aji-147	127	79	to	to	PART
aji-147	127	80	develop	develop	VERB
aji-147	127	81	effective	effective	ADJ
aji-147	127	82	vaccines	vaccine	NOUN
aji-147	127	83	.	.	PUNCT
aji-147	128	1	among	among	ADP
aji-147	128	2	the	the	DET
aji-147	128	3	most	most	ADV
aji-147	128	4	promising	promising	ADJ
aji-147	128	5	vaccine	vaccine	NOUN
aji-147	128	6	platforms	platform	NOUN
aji-147	128	7	are	be	AUX
aji-147	128	8	those	those	PRON
aji-147	128	9	based	base	VERB
aji-147	128	10	on	on	ADP
aji-147	128	11	mrna	mrna	PROPN
aji-147	128	12	technology	technology	PROPN
aji-147	128	13	,	,	PUNCT
aji-147	128	14	which	which	PRON
aji-147	128	15	offers	offer	VERB
aji-147	128	16	several	several	ADJ
aji-147	128	17	advantages	advantage	NOUN
aji-147	128	18	,	,	PUNCT
aji-147	128	19	including	include	VERB
aji-147	128	20	rapid	rapid	ADJ
aji-147	128	21	development	development	NOUN
aji-147	128	22	,	,	PUNCT
aji-147	128	23	scalability	scalability	NOUN
aji-147	128	24	,	,	PUNCT
aji-147	128	25	and	and	CCONJ
aji-147	128	26	the	the	DET
aji-147	128	27	potential	potential	NOUN
aji-147	128	28	for	for	ADP
aji-147	128	29	modification	modification	NOUN
aji-147	128	30	[	[	X
aji-147	128	31	1	1	NUM
aji-147	128	32	]	]	PUNCT
aji-147	128	33	.	.	PUNCT
aji-147	129	1	as	as	SCONJ
aji-147	129	2	vaccination	vaccination	NOUN
aji-147	129	3	campaigns	campaign	NOUN
aji-147	129	4	have	have	AUX
aji-147	129	5	progressed	progress	VERB
aji-147	129	6	worldwide	worldwide	ADV
aji-147	129	7	,	,	PUNCT
aji-147	129	8	understanding	understand	VERB
aji-147	129	9	the	the	DET
aji-147	129	10	immune	immune	ADJ
aji-147	129	11	responses	response	NOUN
aji-147	129	12	elicited	elicit	VERB
aji-147	129	13	by	by	ADP
aji-147	129	14	these	these	DET
aji-147	129	15	vaccines	vaccine	NOUN
aji-147	129	16	has	have	AUX
aji-147	129	17	become	become	VERB
aji-147	129	18	paramount	paramount	ADJ
aji-147	129	19	.	.	PUNCT
aji-147	130	1	investigating	investigate	VERB
aji-147	130	2	the	the	DET
aji-147	130	3	dynamics	dynamic	NOUN
aji-147	130	4	of	of	ADP
aji-147	130	5	circulating	circulate	VERB
aji-147	130	6	t	t	PROPN
aji-147	130	7	-	-	PUNCT
aji-147	130	8	follicular	follicular	ADJ
aji-147	130	9	helper	helper	NOUN
aji-147	130	10	cells	cell	NOUN
aji-147	130	11	(	(	PUNCT
aji-147	130	12	ctfh	ctfh	NOUN
aji-147	130	13	)	)	PUNCT
aji-147	130	14	,	,	PUNCT
aji-147	130	15	a	a	DET
aji-147	130	16	subset	subset	NOUN
aji-147	130	17	of	of	ADP
aji-147	130	18	cd4	cd4	PROPN
aji-147	130	19	+	+	PROPN
aji-147	130	20	t	t	NOUN
aji-147	130	21	cells	cell	NOUN
aji-147	130	22	crucial	crucial	ADJ
aji-147	130	23	for	for	ADP
aji-147	130	24	b	b	PROPN
aji-147	130	25	cell	cell	NOUN
aji-147	130	26	activation	activation	NOUN
aji-147	130	27	and	and	CCONJ
aji-147	130	28	antibody	antibody	NOUN
aji-147	130	29	production	production	NOUN
aji-147	130	30	is	be	AUX
aji-147	130	31	essential	essential	ADJ
aji-147	130	32	for	for	ADP
aji-147	130	33	evaluating	evaluate	VERB
aji-147	130	34	vaccine	vaccine	NOUN
aji-147	130	35	efficacy	efficacy	NOUN
aji-147	130	36	and	and	CCONJ
aji-147	130	37	durability	durability	NOUN
aji-147	130	38	[	[	X
aji-147	130	39	2	2	NUM
aji-147	130	40	]	]	PUNCT
aji-147	130	41	.	.	PUNCT
aji-147	131	1	the	the	DET
aji-147	131	2	role	role	NOUN
aji-147	131	3	of	of	ADP
aji-147	131	4	ctfh	ctfh	NOUN
aji-147	131	5	cells	cell	NOUN
aji-147	131	6	in	in	ADP
aji-147	131	7	orchestrating	orchestrate	VERB
aji-147	131	8	humoral	humoral	ADJ
aji-147	131	9	immune	immune	ADJ
aji-147	131	10	responses	response	NOUN
aji-147	131	11	has	have	AUX
aji-147	131	12	been	be	AUX
aji-147	131	13	extensively	extensively	ADV
aji-147	131	14	studied	study	VERB
aji-147	131	15	in	in	ADP
aji-147	131	16	the	the	DET
aji-147	131	17	context	context	NOUN
aji-147	131	18	of	of	ADP
aji-147	131	19	various	various	ADJ
aji-147	131	20	infections	infection	NOUN
aji-147	131	21	and	and	CCONJ
aji-147	131	22	vaccinations	vaccination	NOUN
aji-147	131	23	.	.	PUNCT
aji-147	132	1	these	these	DET
aji-147	132	2	specialized	specialized	ADJ
aji-147	132	3	t	t	PROPN
aji-147	132	4	cells	cell	NOUN
aji-147	132	5	live	live	VERB
aji-147	132	6	within	within	ADP
aji-147	132	7	secondary	secondary	ADJ
aji-147	132	8	lymphoid	lymphoid	ADJ
aji-147	132	9	organs	organ	NOUN
aji-147	132	10	,	,	PUNCT
aji-147	132	11	interacting	interact	VERB
aji-147	132	12	with	with	ADP
aji-147	132	13	b	b	NOUN
aji-147	132	14	cells	cell	NOUN
aji-147	132	15	to	to	PART
aji-147	132	16	promote	promote	VERB
aji-147	132	17	germinal	germinal	ADJ
aji-147	132	18	center	center	NOUN
aji-147	132	19	reactions	reaction	NOUN
aji-147	132	20	,	,	PUNCT
aji-147	132	21	affinity	affinity	NOUN
aji-147	132	22	maturation	maturation	NOUN
aji-147	132	23	,	,	PUNCT
aji-147	132	24	and	and	CCONJ
aji-147	132	25	the	the	DET
aji-147	132	26	generation	generation	NOUN
aji-147	132	27	of	of	ADP
aji-147	132	28	longlived	longlived	ADJ
aji-147	132	29	plasma	plasma	NOUN
aji-147	132	30	cells	cell	NOUN
aji-147	132	31	and	and	CCONJ
aji-147	132	32	memory	memory	NOUN
aji-147	132	33	b	b	PROPN
aji-147	132	34	cells	cell	NOUN
aji-147	132	35	.	.	PUNCT
aji-147	133	1	importantly	importantly	ADV
aji-147	133	2	,	,	PUNCT
aji-147	133	3	ctfh	ctfh	NOUN
aji-147	133	4	cells	cell	NOUN
aji-147	133	5	play	play	VERB
aji-147	133	6	a	a	DET
aji-147	133	7	central	central	ADJ
aji-147	133	8	role	role	NOUN
aji-147	133	9	in	in	ADP
aji-147	133	10	shaping	shape	VERB
aji-147	133	11	the	the	DET
aji-147	133	12	size	size	NOUN
aji-147	133	13	and	and	CCONJ
aji-147	133	14	quality	quality	NOUN
aji-147	133	15	of	of	ADP
aji-147	133	16	antibody	antibody	NOUN
aji-147	133	17	responses	response	NOUN
aji-147	133	18	,	,	PUNCT
aji-147	133	19	which	which	PRON
aji-147	133	20	are	be	AUX
aji-147	133	21	critical	critical	ADJ
aji-147	133	22	for	for	ADP
aji-147	133	23	protection	protection	NOUN
aji-147	133	24	against	against	ADP
aji-147	133	25	viral	viral	ADJ
aji-147	133	26	infections	infection	NOUN
aji-147	133	27	[	[	X
aji-147	133	28	3	3	NUM
aji-147	133	29	]	]	PUNCT
aji-147	133	30	.	.	PUNCT
aji-147	134	1	in	in	ADP
aji-147	134	2	the	the	DET
aji-147	134	3	context	context	NOUN
aji-147	134	4	of	of	ADP
aji-147	134	5	sars	sar	NOUN
aji-147	134	6	-	-	PUNCT
aji-147	134	7	cov-2	cov-2	NOUN
aji-147	134	8	mrna	mrna	NOUN
aji-147	134	9	vaccination	vaccination	NOUN
aji-147	134	10	,	,	PUNCT
aji-147	134	11	understanding	understand	VERB
aji-147	134	12	the	the	DET
aji-147	134	13	kinetics	kinetic	NOUN
aji-147	134	14	and	and	CCONJ
aji-147	134	15	durability	durability	NOUN
aji-147	134	16	of	of	ADP
aji-147	134	17	ctfh	ctfh	NOUN
aji-147	134	18	cell	cell	NOUN
aji-147	134	19	responses	response	NOUN
aji-147	134	20	is	be	AUX
aji-147	134	21	particularly	particularly	ADV
aji-147	134	22	interesting	interesting	ADJ
aji-147	134	23	.	.	PUNCT
aji-147	135	1	mrna	mrna	PROPN
aji-147	135	2	vaccines	vaccine	NOUN
aji-147	135	3	,	,	PUNCT
aji-147	135	4	such	such	ADJ
aji-147	135	5	as	as	ADP
aji-147	135	6	those	those	PRON
aji-147	135	7	developed	develop	VERB
aji-147	135	8	by	by	ADP
aji-147	135	9	pfizer	pfizer	NOUN
aji-147	135	10	-	-	PUNCT
aji-147	135	11	biontech	biontech	PROPN
aji-147	135	12	and	and	CCONJ
aji-147	135	13	moderna	moderna	PROPN
aji-147	135	14	,	,	PUNCT
aji-147	135	15	encode	encode	VERB
aji-147	135	16	the	the	DET
aji-147	135	17	viral	viral	ADJ
aji-147	135	18	spike	spike	NOUN
aji-147	135	19	(	(	PUNCT
aji-147	135	20	s	s	NOUN
aji-147	135	21	)	)	PUNCT
aji-147	135	22	protein	protein	NOUN
aji-147	135	23	,	,	PUNCT
aji-147	135	24	which	which	PRON
aji-147	135	25	mediates	mediate	VERB
aji-147	135	26	viral	viral	ADJ
aji-147	135	27	entry	entry	NOUN
aji-147	135	28	into	into	ADP
aji-147	135	29	host	host	NOUN
aji-147	135	30	cells	cell	NOUN
aji-147	135	31	.	.	PUNCT
aji-147	136	1	upon	upon	SCONJ
aji-147	136	2	vaccination	vaccination	NOUN
aji-147	136	3	,	,	PUNCT
aji-147	136	4	antigen	antigen	NOUN
aji-147	136	5	-	-	PUNCT
aji-147	136	6	presenting	present	VERB
aji-147	136	7	cells	cell	NOUN
aji-147	136	8	process	process	NOUN
aji-147	136	9	and	and	CCONJ
aji-147	136	10	present	present	NOUN
aji-147	136	11	s	s	PART
aji-147	136	12	protein	protein	NOUN
aji-147	136	13	fragments	fragment	NOUN
aji-147	136	14	to	to	ADP
aji-147	136	15	t	t	NOUN
aji-147	136	16	cells	cell	NOUN
aji-147	136	17	,	,	PUNCT
aji-147	136	18	leading	lead	VERB
aji-147	136	19	to	to	ADP
aji-147	136	20	the	the	DET
aji-147	136	21	activation	activation	NOUN
aji-147	136	22	and	and	CCONJ
aji-147	136	23	differentiation	differentiation	NOUN
aji-147	136	24	of	of	ADP
aji-147	136	25	ctfh	ctfh	NOUN
aji-147	136	26	cells	cell	NOUN
aji-147	136	27	.	.	PUNCT
aji-147	137	1	these	these	DET
aji-147	137	2	ctfh	ctfh	NOUN
aji-147	137	3	cells	cell	NOUN
aji-147	137	4	then	then	ADV
aji-147	137	5	migrate	migrate	VERB
aji-147	137	6	to	to	ADP
aji-147	137	7	b	b	NOUN
aji-147	137	8	cell	cell	NOUN
aji-147	137	9	follicles	follicle	NOUN
aji-147	137	10	within	within	ADP
aji-147	137	11	lymphoid	lymphoid	ADJ
aji-147	137	12	organs	organ	NOUN
aji-147	137	13	,	,	PUNCT
aji-147	137	14	where	where	SCONJ
aji-147	137	15	they	they	PRON
aji-147	137	16	provide	provide	VERB
aji-147	137	17	help	help	NOUN
aji-147	137	18	to	to	ADP
aji-147	137	19	b	b	NOUN
aji-147	137	20	cells	cell	NOUN
aji-147	137	21	undergoing	undergo	VERB
aji-147	137	22	somatic	somatic	ADJ
aji-147	137	23	hypermutation	hypermutation	NOUN
aji-147	137	24	and	and	CCONJ
aji-147	137	25	class	class	NOUN
aji-147	137	26	-	-	PUNCT
aji-147	137	27	switch	switch	NOUN
aji-147	137	28	recombination	recombination	NOUN
aji-147	137	29	,	,	PUNCT
aji-147	137	30	ultimately	ultimately	ADV
aji-147	137	31	promoting	promote	VERB
aji-147	137	32	the	the	DET
aji-147	137	33	production	production	NOUN
aji-147	137	34	of	of	ADP
aji-147	137	35	high	high	ADJ
aji-147	137	36	-	-	PUNCT
aji-147	137	37	affinity	affinity	NOUN
aji-147	137	38	antibodies	antibody	NOUN
aji-147	137	39	against	against	ADP
aji-147	137	40	sars	sar	NOUN
aji-147	137	41	-	-	PUNCT
aji-147	137	42	cov-2	cov-2	PART
aji-147	137	43	[	[	X
aji-147	137	44	4,5	4,5	NUM
aji-147	137	45	]	]	PUNCT
aji-147	137	46	.	.	PUNCT
aji-147	138	1	initial	initial	ADJ
aji-147	138	2	studies	study	NOUN
aji-147	138	3	investigating	investigate	VERB
aji-147	138	4	ctfh	ctfh	NOUN
aji-147	138	5	responses	response	NOUN
aji-147	138	6	to	to	ADP
aji-147	138	7	sars	sar	NOUN
aji-147	138	8	-	-	PUNCT
aji-147	138	9	cov-2	cov-2	NOUN
aji-147	138	10	mrna	mrna	NOUN
aji-147	138	11	vaccination	vaccination	NOUN
aji-147	138	12	have	have	AUX
aji-147	138	13	offered	offer	VERB
aji-147	138	14	valuable	valuable	ADJ
aji-147	138	15	insights	insight	NOUN
aji-147	138	16	into	into	ADP
aji-147	138	17	the	the	DET
aji-147	138	18	kinetics	kinetic	NOUN
aji-147	138	19	and	and	CCONJ
aji-147	138	20	size	size	NOUN
aji-147	138	21	of	of	ADP
aji-147	138	22	these	these	DET
aji-147	138	23	responses	response	NOUN
aji-147	138	24	.	.	PUNCT
aji-147	139	1	for	for	ADP
aji-147	139	2	instance	instance	NOUN
aji-147	139	3	,	,	PUNCT
aji-147	139	4	several	several	ADJ
aji-147	139	5	reports	report	NOUN
aji-147	139	6	have	have	AUX
aji-147	139	7	shown	show	VERB
aji-147	139	8	robust	robust	ADJ
aji-147	139	9	expansion	expansion	NOUN
aji-147	139	10	of	of	ADP
aji-147	139	11	ctfh	ctfh	NOUN
aji-147	139	12	cells	cell	NOUN
aji-147	139	13	following	follow	VERB
aji-147	139	14	vaccination	vaccination	NOUN
aji-147	139	15	,	,	PUNCT
aji-147	139	16	peaking	peak	VERB
aji-147	139	17	within	within	ADP
aji-147	139	18	weeks	week	NOUN
aji-147	139	19	after	after	ADP
aji-147	139	20	the	the	DET
aji-147	139	21	first	first	ADJ
aji-147	139	22	dose	dose	NOUN
aji-147	139	23	and	and	CCONJ
aji-147	139	24	declining	decline	VERB
aji-147	139	25	gradually	gradually	ADV
aji-147	139	26	thereafter	thereafter	ADV
aji-147	139	27	.	.	PUNCT
aji-147	140	1	significantly	significantly	ADV
aji-147	140	2	,	,	PUNCT
aji-147	140	3	the	the	DET
aji-147	140	4	frequency	frequency	NOUN
aji-147	140	5	and	and	CCONJ
aji-147	140	6	functionality	functionality	NOUN
aji-147	140	7	of	of	ADP
aji-147	140	8	ctfh	ctfh	NOUN
aji-147	140	9	cells	cell	NOUN
aji-147	140	10	have	have	AUX
aji-147	140	11	been	be	AUX
aji-147	140	12	correlated	correlate	VERB
aji-147	140	13	with	with	ADP
aji-147	140	14	the	the	DET
aji-147	140	15	size	size	NOUN
aji-147	140	16	and	and	CCONJ
aji-147	140	17	persistence	persistence	NOUN
aji-147	140	18	of	of	ADP
aji-147	140	19	antibody	antibody	NOUN
aji-147	140	20	responses	response	NOUN
aji-147	140	21	,	,	PUNCT
aji-147	140	22	suggesting	suggest	VERB
aji-147	140	23	their	their	PRON
aji-147	140	24	crucial	crucial	ADJ
aji-147	140	25	role	role	NOUN
aji-147	140	26	in	in	ADP
aji-147	140	27	vaccine	vaccine	NOUN
aji-147	140	28	-	-	PUNCT
aji-147	140	29	induced	induce	VERB
aji-147	140	30	immunity	immunity	NOUN
aji-147	140	31	.	.	PUNCT
aji-147	141	1	furthermore	furthermore	ADV
aji-147	141	2	,	,	PUNCT
aji-147	141	3	shukla	shukla	NOUN
aji-147	141	4	et	et	PROPN
aji-147	141	5	al	al	PROPN
aji-147	141	6	.	.	PROPN
aji-147	141	7	;	;	PUNCT
aji-147	141	8	asian	asian	PROPN
aji-147	141	9	j.	j.	PROPN
aji-147	141	10	immunol	immunol	PROPN
aji-147	141	11	.	.	PROPN
aji-147	141	12	,	,	PUNCT
aji-147	141	13	vol	vol	NOUN
aji-147	141	14	.	.	PROPN
aji-147	141	15	7	7	NUM
aji-147	141	16	,	,	PUNCT
aji-147	141	17	no	no	INTJ
aji-147	141	18	.	.	NOUN
aji-147	141	19	1	1	NUM
aji-147	141	20	,	,	PUNCT
aji-147	141	21	pp	pp	ADJ
aji-147	141	22	.	.	PUNCT
aji-147	142	1	228	228	NUM
aji-147	142	2	-	-	SYM
aji-147	142	3	246	246	NUM
aji-147	142	4	,	,	PUNCT
aji-147	142	5	2024	2024	NUM
aji-147	142	6	;	;	PUNCT
aji-147	142	7	article	article	NOUN
aji-147	142	8	no.aji.125387	no.aji.125387	VERB
aji-147	142	9	230	230	NUM
aji-147	142	10	emerging	emerge	VERB
aji-147	142	11	evidence	evidence	NOUN
aji-147	142	12	suggests	suggest	VERB
aji-147	142	13	that	that	SCONJ
aji-147	142	14	ctfh	ctfh	NOUN
aji-147	142	15	cell	cell	NOUN
aji-147	142	16	responses	response	NOUN
aji-147	142	17	to	to	ADP
aji-147	142	18	sars	sar	NOUN
aji-147	142	19	-	-	PUNCT
aji-147	142	20	cov-2	cov-2	NOUN
aji-147	142	21	mrna	mrna	NOUN
aji-147	142	22	vaccination	vaccination	NOUN
aji-147	142	23	may	may	AUX
aji-147	142	24	show	show	VERB
aji-147	142	25	heterogeneity	heterogeneity	NOUN
aji-147	142	26	across	across	ADP
aji-147	142	27	individuals	individual	NOUN
aji-147	142	28	,	,	PUNCT
aji-147	142	29	influenced	influence	VERB
aji-147	142	30	by	by	ADP
aji-147	142	31	factors	factor	NOUN
aji-147	142	32	such	such	ADJ
aji-147	142	33	as	as	ADP
aji-147	142	34	age	age	NOUN
aji-147	142	35	,	,	PUNCT
aji-147	142	36	sex	sex	NOUN
aji-147	142	37	,	,	PUNCT
aji-147	142	38	and	and	CCONJ
aji-147	142	39	immunological	immunological	ADJ
aji-147	142	40	history	history	NOUN
aji-147	142	41	.	.	PUNCT
aji-147	143	1	understanding	understand	VERB
aji-147	143	2	the	the	DET
aji-147	143	3	determinants	determinant	NOUN
aji-147	143	4	of	of	ADP
aji-147	143	5	ctfh	ctfh	NOUN
aji-147	143	6	cell	cell	NOUN
aji-147	143	7	dynamics	dynamic	NOUN
aji-147	143	8	and	and	CCONJ
aji-147	143	9	their	their	PRON
aji-147	143	10	impact	impact	NOUN
aji-147	143	11	on	on	ADP
aji-147	143	12	vaccine	vaccine	NOUN
aji-147	143	13	efficacy	efficacy	NOUN
aji-147	143	14	and	and	CCONJ
aji-147	143	15	durability	durability	NOUN
aji-147	143	16	is	be	AUX
aji-147	143	17	essential	essential	ADJ
aji-147	143	18	for	for	ADP
aji-147	143	19	optimizing	optimize	VERB
aji-147	143	20	vaccination	vaccination	NOUN
aji-147	143	21	strategies	strategy	NOUN
aji-147	143	22	and	and	CCONJ
aji-147	143	23	informing	inform	VERB
aji-147	143	24	public	public	ADJ
aji-147	143	25	health	health	NOUN
aji-147	143	26	policies	policy	NOUN
aji-147	143	27	[	[	X
aji-147	143	28	6,7	6,7	NUM
aji-147	143	29	]	]	PUNCT
aji-147	143	30	.	.	PUNCT
aji-147	144	1	the	the	DET
aji-147	144	2	immunoglobulin	immunoglobulin	NOUN
aji-147	144	3	family	family	NOUN
aji-147	144	4	consists	consist	VERB
aji-147	144	5	of	of	ADP
aji-147	144	6	five	five	NUM
aji-147	144	7	classes	class	NOUN
aji-147	144	8	:	:	PUNCT
aji-147	144	9	igm	igm	PROPN
aji-147	144	10	,	,	PUNCT
aji-147	144	11	iga	iga	PROPN
aji-147	144	12	,	,	PUNCT
aji-147	144	13	ige	ige	PROPN
aji-147	144	14	,	,	PUNCT
aji-147	144	15	igg	igg	PROPN
aji-147	144	16	,	,	PUNCT
aji-147	144	17	and	and	CCONJ
aji-147	144	18	igd	igd	PROPN
aji-147	144	19	.	.	PUNCT
aji-147	145	1	each	each	DET
aji-147	145	2	class	class	NOUN
aji-147	145	3	has	have	VERB
aji-147	145	4	its	its	PRON
aji-147	145	5	characteristics	characteristic	NOUN
aji-147	145	6	and	and	CCONJ
aji-147	145	7	function	function	NOUN
aji-147	145	8	[	[	X
aji-147	145	9	8	8	NUM
aji-147	145	10	]	]	PUNCT
aji-147	145	11	.	.	PUNCT
aji-147	146	1	primary	primary	ADJ
aji-147	146	2	immunoglobulin	immunoglobulin	PROPN
aji-147	146	3	m	m	PROPN
aji-147	146	4	(	(	PUNCT
aji-147	146	5	igm	igm	PROPN
aji-147	146	6	)	)	PUNCT
aji-147	146	7	is	be	AUX
aji-147	146	8	expressed	express	VERB
aji-147	146	9	in	in	ADP
aji-147	146	10	the	the	DET
aji-147	146	11	early	early	ADJ
aji-147	146	12	stages	stage	NOUN
aji-147	146	13	of	of	ADP
aji-147	146	14	b	b	NOUN
aji-147	146	15	cell	cell	NOUN
aji-147	146	16	maturation	maturation	NOUN
aji-147	146	17	and	and	CCONJ
aji-147	146	18	is	be	AUX
aji-147	146	19	linked	link	VERB
aji-147	146	20	to	to	ADP
aji-147	146	21	primary	primary	ADJ
aji-147	146	22	immunological	immunological	ADJ
aji-147	146	23	responses	response	NOUN
aji-147	146	24	.	.	PUNCT
aji-147	147	1	iga	iga	PROPN
aji-147	147	2	protects	protect	VERB
aji-147	147	3	mucosal	mucosal	NOUN
aji-147	147	4	surfaces	surface	NOUN
aji-147	147	5	from	from	ADP
aji-147	147	6	bacteria	bacteria	NOUN
aji-147	147	7	,	,	PUNCT
aji-147	147	8	viruses	virus	NOUN
aji-147	147	9	,	,	PUNCT
aji-147	147	10	and	and	CCONJ
aji-147	147	11	toxins	toxin	NOUN
aji-147	147	12	.	.	PUNCT
aji-147	148	1	ige	ige	PROPN
aji-147	148	2	plays	play	VERB
aji-147	148	3	a	a	DET
aji-147	148	4	role	role	NOUN
aji-147	148	5	in	in	ADP
aji-147	148	6	allergic	allergic	ADJ
aji-147	148	7	reactions	reaction	NOUN
aji-147	148	8	,	,	PUNCT
aji-147	148	9	hypersensitivity	hypersensitivity	NOUN
aji-147	148	10	reactions	reaction	NOUN
aji-147	148	11	,	,	PUNCT
aji-147	148	12	and	and	CCONJ
aji-147	148	13	the	the	DET
aji-147	148	14	defense	defense	NOUN
aji-147	148	15	against	against	ADP
aji-147	148	16	parasitic	parasitic	ADJ
aji-147	148	17	infections	infection	NOUN
aji-147	148	18	.	.	PUNCT
aji-147	149	1	igg	igg	PROPN
aji-147	149	2	,	,	PUNCT
aji-147	149	3	which	which	PRON
aji-147	149	4	is	be	AUX
aji-147	149	5	functionally	functionally	ADV
aji-147	149	6	divided	divide	VERB
aji-147	149	7	into	into	ADP
aji-147	149	8	four	four	NUM
aji-147	149	9	subclasses	subclass	NOUN
aji-147	149	10	(	(	PUNCT
aji-147	149	11	igg1	igg1	NOUN
aji-147	149	12	,	,	PUNCT
aji-147	149	13	igg2	igg2	PROPN
aji-147	149	14	,	,	PUNCT
aji-147	149	15	igg3	igg3	PROPN
aji-147	149	16	,	,	PUNCT
aji-147	149	17	and	and	CCONJ
aji-147	149	18	igg4	igg4	PROPN
aji-147	149	19	)	)	PUNCT
aji-147	149	20	,	,	PUNCT
aji-147	149	21	is	be	AUX
aji-147	149	22	essential	essential	ADJ
aji-147	149	23	for	for	ADP
aji-147	149	24	both	both	CCONJ
aji-147	149	25	the	the	DET
aji-147	149	26	effectiveness	effectiveness	NOUN
aji-147	149	27	of	of	ADP
aji-147	149	28	vaccinations	vaccination	NOUN
aji-147	149	29	and	and	CCONJ
aji-147	149	30	antiviral	antiviral	ADJ
aji-147	149	31	defences	defence	NOUN
aji-147	149	32	.	.	PUNCT
aji-147	150	1	igd	igd	NOUN
aji-147	150	2	has	have	VERB
aji-147	150	3	a	a	DET
aji-147	150	4	short	short	ADJ
aji-147	150	5	serum	serum	NOUN
aji-147	150	6	half	half	ADJ
aji-147	150	7	-	-	PUNCT
aji-147	150	8	life	life	NOUN
aji-147	150	9	and	and	CCONJ
aji-147	150	10	is	be	AUX
aji-147	150	11	present	present	ADJ
aji-147	150	12	at	at	ADP
aji-147	150	13	low	low	ADJ
aji-147	150	14	concentrations	concentration	NOUN
aji-147	150	15	,	,	PUNCT
aji-147	150	16	and	and	CCONJ
aji-147	150	17	its	its	PRON
aji-147	150	18	specific	specific	ADJ
aji-147	150	19	function	function	NOUN
aji-147	150	20	is	be	AUX
aji-147	150	21	currently	currently	ADV
aji-147	150	22	unknown	unknown	ADJ
aji-147	150	23	[	[	X
aji-147	150	24	8,9	8,9	NUM
aji-147	150	25	]	]	X
aji-147	150	26	(	(	PUNCT
aji-147	150	27	fig	fig	NOUN
aji-147	150	28	.	.	PUNCT
aji-147	150	29	1	1	NUM
aji-147	150	30	)	)	PUNCT
aji-147	150	31	.	.	PUNCT
aji-147	151	1	this	this	DET
aji-147	151	2	review	review	NOUN
aji-147	151	3	aims	aim	VERB
aji-147	151	4	to	to	PART
aji-147	151	5	comprehensively	comprehensively	ADV
aji-147	151	6	evaluate	evaluate	VERB
aji-147	151	7	the	the	DET
aji-147	151	8	current	current	ADJ
aji-147	151	9	literature	literature	NOUN
aji-147	151	10	on	on	ADP
aji-147	151	11	human	human	ADJ
aji-147	151	12	ctfh	ctfh	NOUN
aji-147	151	13	cell	cell	NOUN
aji-147	151	14	responses	response	NOUN
aji-147	151	15	to	to	ADP
aji-147	151	16	sars	sar	NOUN
aji-147	151	17	-	-	PUNCT
aji-147	151	18	cov-2	cov-2	NOUN
aji-147	151	19	mrna	mrna	NOUN
aji-147	151	20	vaccination	vaccination	NOUN
aji-147	151	21	,	,	PUNCT
aji-147	151	22	focusing	focus	VERB
aji-147	151	23	on	on	ADP
aji-147	151	24	the	the	DET
aji-147	151	25	kinetics	kinetic	NOUN
aji-147	151	26	,	,	PUNCT
aji-147	151	27	size	size	NOUN
aji-147	151	28	,	,	PUNCT
aji-147	151	29	durability	durability	NOUN
aji-147	151	30	,	,	PUNCT
aji-147	151	31	and	and	CCONJ
aji-147	151	32	correlates	correlate	VERB
aji-147	151	33	of	of	ADP
aji-147	151	34	protection	protection	NOUN
aji-147	151	35	.	.	PUNCT
aji-147	152	1	we	we	PRON
aji-147	152	2	will	will	AUX
aji-147	152	3	discuss	discuss	VERB
aji-147	152	4	key	key	ADJ
aji-147	152	5	findings	finding	NOUN
aji-147	152	6	from	from	ADP
aji-147	152	7	clinical	clinical	ADJ
aji-147	152	8	studies	study	NOUN
aji-147	152	9	and	and	CCONJ
aji-147	152	10	preclinical	preclinical	ADJ
aji-147	152	11	models	model	NOUN
aji-147	152	12	,	,	PUNCT
aji-147	152	13	highlighting	highlight	VERB
aji-147	152	14	gaps	gap	NOUN
aji-147	152	15	in	in	ADP
aji-147	152	16	knowledge	knowledge	NOUN
aji-147	152	17	and	and	CCONJ
aji-147	152	18	areas	area	NOUN
aji-147	152	19	for	for	ADP
aji-147	152	20	future	future	ADJ
aji-147	152	21	research	research	NOUN
aji-147	152	22	.	.	PUNCT
aji-147	153	1	additionally	additionally	ADV
aji-147	153	2	,	,	PUNCT
aji-147	153	3	we	we	PRON
aji-147	153	4	will	will	AUX
aji-147	153	5	explore	explore	VERB
aji-147	153	6	the	the	DET
aji-147	153	7	implications	implication	NOUN
aji-147	153	8	of	of	ADP
aji-147	153	9	ctfh	ctfh	NOUN
aji-147	153	10	cell	cell	NOUN
aji-147	153	11	responses	response	NOUN
aji-147	153	12	for	for	ADP
aji-147	153	13	vaccine	vaccine	NOUN
aji-147	153	14	development	development	NOUN
aji-147	153	15	,	,	PUNCT
aji-147	153	16	including	include	VERB
aji-147	153	17	strategies	strategy	NOUN
aji-147	153	18	to	to	PART
aji-147	153	19	enhance	enhance	VERB
aji-147	153	20	immunogenicity	immunogenicity	NOUN
aji-147	153	21	and	and	CCONJ
aji-147	153	22	durability	durability	NOUN
aji-147	153	23	.	.	PUNCT
aji-147	154	1	by	by	ADP
aji-147	154	2	elucidating	elucidate	VERB
aji-147	154	3	the	the	DET
aji-147	154	4	role	role	NOUN
aji-147	154	5	of	of	ADP
aji-147	154	6	ctfh	ctfh	NOUN
aji-147	154	7	cells	cell	NOUN
aji-147	154	8	in	in	ADP
aji-147	154	9	vaccineinduced	vaccineinduce	VERB
aji-147	154	10	immunity	immunity	NOUN
aji-147	154	11	against	against	ADP
aji-147	154	12	sars	sar	NOUN
aji-147	154	13	-	-	PUNCT
aji-147	154	14	cov-2	cov-2	NOUN
aji-147	154	15	,	,	PUNCT
aji-147	154	16	this	this	DET
aji-147	154	17	review	review	NOUN
aji-147	154	18	aims	aim	VERB
aji-147	154	19	to	to	PART
aji-147	154	20	contribute	contribute	VERB
aji-147	154	21	to	to	ADP
aji-147	154	22	the	the	DET
aji-147	154	23	ongoing	ongoing	ADJ
aji-147	154	24	efforts	effort	NOUN
aji-147	154	25	to	to	PART
aji-147	154	26	control	control	VERB
aji-147	154	27	the	the	DET
aji-147	154	28	covid-19	covid-19	PROPN
aji-147	154	29	pandemic	pandemic	NOUN
aji-147	154	30	and	and	CCONJ
aji-147	154	31	prepare	prepare	VERB
aji-147	154	32	for	for	ADP
aji-147	154	33	future	future	ADJ
aji-147	154	34	outbreaks	outbreak	NOUN
aji-147	154	35	.	.	PUNCT
aji-147	155	1	fig	fig	NOUN
aji-147	155	2	.	.	PUNCT
aji-147	156	1	1	1	X
aji-147	156	2	.	.	PUNCT
aji-147	156	3	shows	show	VERB
aji-147	156	4	how	how	SCONJ
aji-147	156	5	several	several	ADJ
aji-147	156	6	tfh	tfh	NOUN
aji-147	156	7	cell	cell	NOUN
aji-147	156	8	subsets	subset	NOUN
aji-147	156	9	contribute	contribute	VERB
aji-147	156	10	to	to	ADP
aji-147	156	11	the	the	DET
aji-147	156	12	production	production	NOUN
aji-147	156	13	of	of	ADP
aji-147	156	14	immunoglobulins	immunoglobulin	NOUN
aji-147	156	15	with	with	ADP
aji-147	156	16	several	several	ADJ
aji-147	156	17	functions	function	NOUN
aji-147	156	18	.	.	PUNCT
aji-147	157	1	pre	pre	ADJ
aji-147	157	2	-	-	ADJ
aji-147	157	3	tfh	tfh	ADJ
aji-147	157	4	(	(	PUNCT
aji-147	157	5	ptfh	ptfh	PROPN
aji-147	157	6	)	)	PUNCT
aji-147	157	7	cells	cell	NOUN
aji-147	157	8	can	can	AUX
aji-147	157	9	differentiate	differentiate	VERB
aji-147	157	10	into	into	ADP
aji-147	157	11	tfh1	tfh1	NOUN
aji-147	157	12	,	,	PUNCT
aji-147	157	13	tfh2	tfh2	PROPN
aji-147	157	14	,	,	PUNCT
aji-147	157	15	or	or	CCONJ
aji-147	157	16	tfh17	tfh17	NOUN
aji-147	157	17	phenotypes	phenotype	NOUN
aji-147	157	18	in	in	ADP
aji-147	157	19	response	response	NOUN
aji-147	157	20	to	to	ADP
aji-147	157	21	different	different	ADJ
aji-147	157	22	microenvironmental	microenvironmental	ADJ
aji-147	157	23	signals	signal	NOUN
aji-147	157	24	from	from	ADP
aji-147	157	25	different	different	ADJ
aji-147	157	26	healthy	healthy	ADJ
aji-147	157	27	or	or	CCONJ
aji-147	157	28	pathological	pathological	ADJ
aji-147	157	29	conditions	condition	NOUN
aji-147	157	30	.	.	PUNCT
aji-147	158	1	because	because	SCONJ
aji-147	158	2	each	each	DET
aji-147	158	3	subgroup	subgroup	NOUN
aji-147	158	4	of	of	ADP
aji-147	158	5	tfh	tfh	PROPN
aji-147	158	6	cells	cell	NOUN
aji-147	158	7	has	have	VERB
aji-147	158	8	specific	specific	ADJ
aji-147	158	9	functional	functional	ADJ
aji-147	158	10	characteristics	characteristic	NOUN
aji-147	158	11	,	,	PUNCT
aji-147	158	12	they	they	PRON
aji-147	158	13	can	can	AUX
aji-147	158	14	coordinate	coordinate	VERB
aji-147	158	15	b	b	PRON
aji-147	158	16	cell	cell	NOUN
aji-147	158	17	development	development	NOUN
aji-147	158	18	towards	towards	ADP
aji-147	158	19	producing	produce	VERB
aji-147	158	20	various	various	ADJ
aji-147	158	21	immunoglobulin	immunoglobulin	NOUN
aji-147	158	22	types	type	NOUN
aji-147	158	23	essential	essential	ADJ
aji-147	158	24	for	for	ADP
aji-147	158	25	various	various	ADJ
aji-147	158	26	immunological	immunological	ADJ
aji-147	158	27	responses	response	NOUN
aji-147	158	28	.	.	PUNCT
aji-147	159	1	reproduced	reproduce	VERB
aji-147	159	2	/	/	SYM
aji-147	159	3	adapted	adapt	VERB
aji-147	159	4	with	with	ADP
aji-147	159	5	permission	permission	NOUN
aji-147	159	6	[	[	X
aji-147	159	7	9	9	NUM
aji-147	159	8	]	]	PUNCT
aji-147	159	9	.	.	PUNCT
aji-147	160	1	shukla	shukla	NOUN
aji-147	160	2	et	et	PROPN
aji-147	160	3	al	al	PROPN
aji-147	160	4	.	.	PROPN
aji-147	160	5	;	;	PUNCT
aji-147	160	6	asian	asian	PROPN
aji-147	160	7	j.	j.	PROPN
aji-147	160	8	immunol	immunol	PROPN
aji-147	160	9	.	.	PROPN
aji-147	160	10	,	,	PUNCT
aji-147	160	11	vol	vol	NOUN
aji-147	160	12	.	.	PROPN
aji-147	161	1	7	7	NUM
aji-147	161	2	,	,	PUNCT
aji-147	161	3	no	no	INTJ
aji-147	161	4	.	.	NOUN
aji-147	161	5	1	1	NUM
aji-147	161	6	,	,	PUNCT
aji-147	161	7	pp	pp	ADJ
aji-147	161	8	.	.	PUNCT
aji-147	162	1	228	228	NUM
aji-147	162	2	-	-	SYM
aji-147	162	3	246	246	NUM
aji-147	162	4	,	,	PUNCT
aji-147	162	5	2024	2024	NUM
aji-147	162	6	;	;	PUNCT
aji-147	163	1	article	article	NOUN
aji-147	163	2	no.aji.125387	no.aji.125387	NOUN
aji-147	163	3	231	231	NUM
aji-147	163	4	2	2	NUM
aji-147	163	5	.	.	PUNCT
aji-147	163	6	emerging	emerge	VERB
aji-147	163	7	role	role	NOUN
aji-147	163	8	of	of	ADP
aji-147	163	9	tfh	tfh	PROPN
aji-147	163	10	cells	cell	NOUN
aji-147	163	11	for	for	ADP
aji-147	163	12	novel	novel	ADJ
aji-147	163	13	sars	sar	NOUN
aji-147	163	14	-	-	PUNCT
aji-147	163	15	cov-2	cov-2	NOUN
aji-147	163	16	vaccine	vaccine	NOUN
aji-147	163	17	development	development	NOUN
aji-147	163	18	according	accord	VERB
aji-147	163	19	to	to	ADP
aji-147	163	20	the	the	DET
aji-147	163	21	findings	finding	NOUN
aji-147	163	22	,	,	PUNCT
aji-147	163	23	cd4	cd4	PROPN
aji-147	163	24	t	t	PROPN
aji-147	163	25	-	-	PUNCT
aji-147	163	26	cell	cell	NOUN
aji-147	163	27	responses	response	NOUN
aji-147	163	28	to	to	ADP
aji-147	163	29	sars	sar	NOUN
aji-147	163	30	-	-	PUNCT
aji-147	163	31	cov-2	cov-2	NUM
aji-147	163	32	were	be	AUX
aji-147	163	33	80–100	80–100	NUM
aji-147	163	34	%	%	NOUN
aji-147	163	35	on	on	ADP
aji-147	163	36	antigenspecific	antigenspecific	PROPN
aji-147	163	37	t	t	PROPN
aji-147	163	38	-	-	PUNCT
aji-147	163	39	cell	cell	NOUN
aji-147	163	40	responses	response	NOUN
aji-147	163	41	in	in	ADP
aji-147	163	42	patients	patient	NOUN
aji-147	163	43	treated	treat	VERB
aji-147	163	44	after	after	ADP
aji-147	163	45	sars	sar	NOUN
aji-147	163	46	-	-	PUNCT
aji-147	163	47	cov-2	cov-2	PART
aji-147	163	48	infection	infection	NOUN
aji-147	163	49	,	,	PUNCT
aji-147	163	50	with	with	ADP
aji-147	163	51	most	most	ADJ
aji-147	163	52	research	research	NOUN
aji-147	163	53	mainly	mainly	ADV
aji-147	163	54	concentrating	concentrate	VERB
aji-147	163	55	on	on	ADP
aji-147	163	56	spike	spike	PROPN
aji-147	163	57	(	(	PUNCT
aji-147	163	58	s	s	NOUN
aji-147	163	59	)	)	PUNCT
aji-147	163	60	protein	protein	NOUN
aji-147	164	1	[	[	X
aji-147	164	2	10	10	NUM
aji-147	164	3	-	-	SYM
aji-147	164	4	13	13	NUM
aji-147	164	5	]	]	PUNCT
aji-147	164	6	.	.	PUNCT
aji-147	165	1	according	accord	VERB
aji-147	165	2	to	to	ADP
aji-147	165	3	other	other	ADJ
aji-147	165	4	investigations	investigation	NOUN
aji-147	165	5	,	,	PUNCT
aji-147	165	6	t	t	PROPN
aji-147	165	7	-	-	PUNCT
aji-147	165	8	cells	cell	NOUN
aji-147	165	9	have	have	AUX
aji-147	165	10	also	also	ADV
aji-147	165	11	been	be	AUX
aji-147	165	12	found	find	VERB
aji-147	165	13	to	to	PART
aji-147	165	14	target	target	VERB
aji-147	165	15	the	the	DET
aji-147	165	16	nucleocapsid	nucleocapsid	ADJ
aji-147	165	17	(	(	PUNCT
aji-147	165	18	n	n	CCONJ
aji-147	165	19	)	)	PUNCT
aji-147	165	20	and	and	CCONJ
aji-147	165	21	membrane	membrane	NOUN
aji-147	165	22	(	(	PUNCT
aji-147	165	23	m	m	NOUN
aji-147	165	24	)	)	PUNCT
aji-147	165	25	proteins	protein	NOUN
aji-147	165	26	[	[	X
aji-147	165	27	14	14	NUM
aji-147	165	28	]	]	PUNCT
aji-147	165	29	.	.	PUNCT
aji-147	166	1	developing	develop	VERB
aji-147	166	2	effective	effective	ADJ
aji-147	166	3	sars	sar	NOUN
aji-147	166	4	-	-	PUNCT
aji-147	166	5	cov-2	cov-2	PART
aji-147	166	6	vaccines	vaccine	NOUN
aji-147	166	7	has	have	AUX
aji-147	166	8	been	be	AUX
aji-147	166	9	recognized	recognize	VERB
aji-147	166	10	as	as	ADP
aji-147	166	11	a	a	DET
aji-147	166	12	significant	significant	ADJ
aji-147	166	13	step	step	NOUN
aji-147	166	14	toward	toward	ADP
aji-147	166	15	preventing	prevent	VERB
aji-147	166	16	the	the	DET
aji-147	166	17	covid-19	covid-19	PROPN
aji-147	166	18	pandemic	pandemic	NOUN
aji-147	166	19	.	.	PUNCT
aji-147	167	1	neutralizing	neutralize	VERB
aji-147	167	2	antibodies	antibody	NOUN
aji-147	167	3	(	(	PUNCT
aji-147	167	4	nab	nab	NOUN
aji-147	167	5	)	)	PUNCT
aji-147	167	6	are	be	AUX
aji-147	167	7	a	a	DET
aji-147	167	8	reliable	reliable	ADJ
aji-147	167	9	indicator	indicator	NOUN
aji-147	167	10	of	of	ADP
aji-147	167	11	immunity	immunity	NOUN
aji-147	167	12	against	against	ADP
aji-147	167	13	infection	infection	NOUN
aji-147	167	14	and	and	CCONJ
aji-147	167	15	immunization	immunization	NOUN
aji-147	167	16	in	in	ADP
aji-147	167	17	rhesus	rhesus	NOUN
aji-147	167	18	macaques	macaque	NOUN
aji-147	167	19	[	[	X
aji-147	167	20	15,16	15,16	NUM
aji-147	167	21	]	]	PUNCT
aji-147	167	22	.	.	PUNCT
aji-147	168	1	neutralizing	neutralize	VERB
aji-147	168	2	antibodies	antibody	NOUN
aji-147	168	3	have	have	AUX
aji-147	168	4	been	be	AUX
aji-147	168	5	identified	identify	VERB
aji-147	168	6	as	as	ADP
aji-147	168	7	the	the	DET
aji-147	168	8	critical	critical	ADJ
aji-147	168	9	factor	factor	NOUN
aji-147	168	10	of	of	ADP
aji-147	168	11	vaccination	vaccination	NOUN
aji-147	168	12	effectiveness	effectiveness	NOUN
aji-147	168	13	in	in	ADP
aji-147	168	14	phase	phase	NOUN
aji-147	168	15	i	i	PROPN
aji-147	168	16	/	/	SYM
aji-147	168	17	ii	ii	PROPN
aji-147	168	18	trials	trial	NOUN
aji-147	168	19	of	of	ADP
aji-147	168	20	the	the	DET
aji-147	168	21	pfizer	pfizer	NOUN
aji-147	168	22	and	and	CCONJ
aji-147	168	23	moderna	moderna	PROPN
aji-147	168	24	vaccines	vaccine	NOUN
aji-147	168	25	and	and	CCONJ
aji-147	168	26	many	many	ADJ
aji-147	168	27	other	other	ADJ
aji-147	168	28	candidate	candidate	NOUN
aji-147	168	29	vaccines	vaccine	NOUN
aji-147	168	30	[	[	X
aji-147	168	31	17	17	NUM
aji-147	168	32	-	-	SYM
aji-147	168	33	20	20	NUM
aji-147	168	34	]	]	PUNCT
aji-147	168	35	.	.	PUNCT
aji-147	169	1	whereas	whereas	SCONJ
aji-147	169	2	the	the	DET
aji-147	169	3	pfizer	pfizer	NOUN
aji-147	169	4	vaccine	vaccine	NOUN
aji-147	169	5	was	be	AUX
aji-147	169	6	showcased	showcase	VERB
aji-147	169	7	to	to	PART
aji-147	169	8	induce	induce	VERB
aji-147	169	9	cd4	cd4	PROPN
aji-147	169	10	and	and	CCONJ
aji-147	169	11	cd8	cd8	PROPN
aji-147	169	12	t	t	PROPN
aji-147	169	13	-	-	PUNCT
aji-147	169	14	cell	cell	NOUN
aji-147	169	15	responses	response	NOUN
aji-147	169	16	in	in	ADP
aji-147	169	17	trial	trial	NOUN
aji-147	169	18	participants	participant	NOUN
aji-147	169	19	,	,	PUNCT
aji-147	169	20	and	and	CCONJ
aji-147	169	21	vaccine	vaccine	NOUN
aji-147	169	22	-	-	PUNCT
aji-147	169	23	induced	induce	VERB
aji-147	169	24	cd4	cd4	PROPN
aji-147	169	25	t	t	PROPN
aji-147	169	26	-	-	PUNCT
aji-147	169	27	cell	cell	NOUN
aji-147	169	28	responses	response	NOUN
aji-147	169	29	correlated	correlate	VERB
aji-147	169	30	with	with	ADP
aji-147	169	31	antibody	antibody	NOUN
aji-147	169	32	levels	level	NOUN
aji-147	169	33	[	[	X
aji-147	169	34	21	21	NUM
aji-147	169	35	]	]	PUNCT
aji-147	169	36	,	,	PUNCT
aji-147	169	37	with	with	ADP
aji-147	169	38	our	our	PRON
aji-147	169	39	knowledge	knowledge	NOUN
aji-147	169	40	of	of	ADP
aji-147	169	41	both	both	CCONJ
aji-147	169	42	the	the	DET
aji-147	169	43	precise	precise	ADJ
aji-147	169	44	immune	immune	ADJ
aji-147	169	45	factors	factor	NOUN
aji-147	169	46	that	that	PRON
aji-147	169	47	are	be	AUX
aji-147	169	48	associated	associate	VERB
aji-147	169	49	with	with	ADP
aji-147	169	50	protection	protection	NOUN
aji-147	169	51	as	as	ADV
aji-147	169	52	well	well	ADV
aji-147	169	53	as	as	ADP
aji-147	169	54	the	the	DET
aji-147	169	55	durability	durability	NOUN
aji-147	169	56	of	of	ADP
aji-147	169	57	this	this	DET
aji-147	169	58	immune	immune	ADJ
aji-147	169	59	function	function	NOUN
aji-147	169	60	is	be	AUX
aji-147	169	61	still	still	ADV
aji-147	169	62	lacking	lack	VERB
aji-147	169	63	.	.	PUNCT
aji-147	170	1	furthermore	furthermore	ADV
aji-147	170	2	,	,	PUNCT
aji-147	170	3	the	the	DET
aji-147	170	4	factors	factor	NOUN
aji-147	170	5	that	that	PRON
aji-147	170	6	trigger	trigger	VERB
aji-147	170	7	the	the	DET
aji-147	170	8	production	production	NOUN
aji-147	170	9	of	of	ADP
aji-147	170	10	nab	nab	NOUN
aji-147	170	11	in	in	ADP
aji-147	170	12	the	the	DET
aji-147	170	13	presence	presence	NOUN
aji-147	170	14	of	of	ADP
aji-147	170	15	spontaneous	spontaneous	ADJ
aji-147	170	16	sars	sar	NOUN
aji-147	170	17	-	-	PUNCT
aji-147	170	18	cov-2	cov-2	PART
aji-147	170	19	infection	infection	NOUN
aji-147	170	20	are	be	AUX
aji-147	170	21	crucial	crucial	ADJ
aji-147	170	22	to	to	PART
aji-147	170	23	investigate	investigate	VERB
aji-147	170	24	,	,	PUNCT
aji-147	170	25	especially	especially	ADV
aji-147	170	26	in	in	ADP
aji-147	170	27	the	the	DET
aji-147	170	28	situation	situation	NOUN
aji-147	170	29	of	of	ADP
aji-147	170	30	new	new	ADJ
aji-147	170	31	viral	viral	ADJ
aji-147	170	32	variations	variation	NOUN
aji-147	170	33	that	that	PRON
aji-147	170	34	may	may	AUX
aji-147	170	35	be	be	AUX
aji-147	170	36	different	different	ADJ
aji-147	170	37	mechanisms	mechanism	NOUN
aji-147	170	38	of	of	ADP
aji-147	170	39	pathogenic	pathogenic	ADJ
aji-147	170	40	infections	infection	NOUN
aji-147	170	41	developing	develop	VERB
aji-147	170	42	[	[	X
aji-147	170	43	22,23	22,23	NOUN
aji-147	170	44	]	]	PUNCT
aji-147	170	45	.	.	PUNCT
aji-147	171	1	several	several	ADJ
aji-147	171	2	studies	study	NOUN
aji-147	171	3	have	have	AUX
aji-147	171	4	found	find	VERB
aji-147	171	5	a	a	DET
aji-147	171	6	significant	significant	ADJ
aji-147	171	7	increase	increase	NOUN
aji-147	171	8	in	in	ADP
aji-147	171	9	activation	activation	NOUN
aji-147	171	10	and	and	CCONJ
aji-147	171	11	exhaustion	exhaustion	NOUN
aji-147	171	12	markers	marker	NOUN
aji-147	171	13	on	on	ADP
aji-147	171	14	t	t	PROPN
aji-147	171	15	cells	cell	NOUN
aji-147	171	16	in	in	ADP
aji-147	171	17	moderate	moderate	ADJ
aji-147	171	18	and	and	CCONJ
aji-147	171	19	severe	severe	ADJ
aji-147	171	20	sars	sar	NOUN
aji-147	171	21	-	-	PUNCT
aji-147	171	22	cov-2	cov-2	NOUN
aji-147	171	23	illnesses	illness	NOUN
aji-147	171	24	[	[	X
aji-147	171	25	2427	2427	NUM
aji-147	171	26	]	]	PUNCT
aji-147	171	27	.	.	PUNCT
aji-147	172	1	whereas	whereas	SCONJ
aji-147	172	2	studying	study	VERB
aji-147	172	3	lymphoid	lymphoid	ADJ
aji-147	172	4	tissues	tissue	NOUN
aji-147	172	5	directly	directly	ADV
aji-147	172	6	within	within	ADP
aji-147	172	7	patients	patient	NOUN
aji-147	172	8	is	be	AUX
aji-147	172	9	challenging	challenging	ADJ
aji-147	172	10	,	,	PUNCT
aji-147	172	11	circulating	circulate	VERB
aji-147	172	12	t	t	NOUN
aji-147	172	13	follicular	follicular	ADJ
aji-147	172	14	cells	cell	NOUN
aji-147	172	15	(	(	PUNCT
aji-147	172	16	ctfh	ctfh	NOUN
aji-147	172	17	)	)	PUNCT
aji-147	172	18	,	,	PUNCT
aji-147	172	19	also	also	ADV
aji-147	172	20	known	know	VERB
aji-147	172	21	as	as	ADP
aji-147	172	22	t	t	PROPN
aji-147	172	23	follicular	follicular	ADJ
aji-147	172	24	helper	helper	NOUN
aji-147	172	25	cells	cell	NOUN
aji-147	172	26	(	(	PUNCT
aji-147	172	27	tfh	tfh	PROPN
aji-147	172	28	)	)	PUNCT
aji-147	172	29	,	,	PUNCT
aji-147	172	30	act	act	VERB
aji-147	172	31	as	as	ADP
aji-147	172	32	a	a	DET
aji-147	172	33	helpful	helpful	ADJ
aji-147	172	34	alternative	alternative	NOUN
aji-147	172	35	for	for	ADP
aji-147	172	36	investigating	investigate	VERB
aji-147	172	37	tfh	tfh	PROPN
aji-147	172	38	responses	response	NOUN
aji-147	172	39	in	in	ADP
aji-147	172	40	germinal	germinal	ADJ
aji-147	172	41	centers	center	NOUN
aji-147	172	42	.	.	PUNCT
aji-147	173	1	however	however	ADV
aji-147	173	2	,	,	PUNCT
aji-147	173	3	significant	significant	ADJ
aji-147	173	4	debate	debate	NOUN
aji-147	173	5	was	be	AUX
aji-147	173	6	over	over	ADP
aji-147	173	7	the	the	DET
aji-147	173	8	optimum	optimum	ADJ
aji-147	173	9	method	method	NOUN
aji-147	173	10	to	to	PART
aji-147	173	11	recognize	recognize	VERB
aji-147	173	12	these	these	DET
aji-147	173	13	cells	cell	NOUN
aji-147	173	14	.	.	PUNCT
aji-147	174	1	it	it	PRON
aji-147	174	2	was	be	AUX
aji-147	174	3	widely	widely	ADV
aji-147	174	4	agreed	agree	VERB
aji-147	174	5	that	that	SCONJ
aji-147	174	6	they	they	PRON
aji-147	174	7	express	express	VERB
aji-147	174	8	cxcr5	cxcr5	PROPN
aji-147	174	9	,	,	PUNCT
aji-147	174	10	a	a	DET
aji-147	174	11	lymph	lymph	NOUN
aji-147	174	12	node	node	NOUN
aji-147	174	13	homing	home	VERB
aji-147	174	14	receptor	receptor	NOUN
aji-147	174	15	,	,	PUNCT
aji-147	174	16	but	but	CCONJ
aji-147	174	17	several	several	ADJ
aji-147	174	18	researchers	researcher	NOUN
aji-147	174	19	also	also	ADV
aji-147	174	20	utilized	utilize	VERB
aji-147	174	21	pd1	pd1	VERB
aji-147	174	22	expression	expression	NOUN
aji-147	174	23	in	in	ADP
aji-147	174	24	combination	combination	NOUN
aji-147	174	25	with	with	ADP
aji-147	174	26	cxcr5	cxcr5	PROPN
aji-147	174	27	to	to	PART
aji-147	174	28	identify	identify	VERB
aji-147	174	29	ctfh	ctfh	NOUN
aji-147	174	30	[	[	X
aji-147	174	31	28	28	NUM
aji-147	174	32	-	-	SYM
aji-147	174	33	30	30	NUM
aji-147	174	34	]	]	PUNCT
aji-147	174	35	.	.	PUNCT
aji-147	175	1	even	even	ADV
aji-147	175	2	though	though	SCONJ
aji-147	175	3	the	the	DET
aji-147	175	4	number	number	NOUN
aji-147	175	5	of	of	ADP
aji-147	175	6	cxcr5	cxcr5	PROPN
aji-147	175	7	+	+	CCONJ
aji-147	175	8	pd1	pd1	NOUN
aji-147	175	9	+	+	X
aji-147	175	10	cd4	cd4	PROPN
aji-147	175	11	t	t	NOUN
aji-147	175	12	cells	cell	NOUN
aji-147	175	13	in	in	ADP
aji-147	175	14	the	the	DET
aji-147	175	15	bloodstream	bloodstream	NOUN
aji-147	175	16	is	be	AUX
aji-147	175	17	generally	generally	ADV
aji-147	175	18	low	low	ADJ
aji-147	175	19	,	,	PUNCT
aji-147	175	20	these	these	DET
aji-147	175	21	cells	cell	NOUN
aji-147	175	22	are	be	AUX
aji-147	175	23	closely	closely	ADV
aji-147	175	24	related	relate	VERB
aji-147	175	25	to	to	ADP
aji-147	175	26	tfh	tfh	PROPN
aji-147	175	27	in	in	ADP
aji-147	175	28	lymphoid	lymphoid	ADJ
aji-147	175	29	tissue	tissue	NOUN
aji-147	175	30	[	[	X
aji-147	175	31	31	31	NUM
aji-147	175	32	]	]	PUNCT
aji-147	175	33	and	and	CCONJ
aji-147	175	34	enhance	enhance	VERB
aji-147	175	35	adaptive	adaptive	ADJ
aji-147	175	36	immunity	immunity	NOUN
aji-147	175	37	defences	defence	NOUN
aji-147	175	38	[	[	X
aji-147	175	39	32,33	32,33	NUM
aji-147	175	40	]	]	PUNCT
aji-147	175	41	.	.	PUNCT
aji-147	176	1	in	in	ADP
aji-147	176	2	the	the	DET
aji-147	176	3	circumstances	circumstance	NOUN
aji-147	176	4	of	of	ADP
aji-147	176	5	infection	infection	NOUN
aji-147	176	6	and	and	CCONJ
aji-147	176	7	vaccination	vaccination	NOUN
aji-147	176	8	against	against	ADP
aji-147	176	9	numerous	numerous	ADJ
aji-147	176	10	diseases	disease	NOUN
aji-147	176	11	,	,	PUNCT
aji-147	176	12	antigen	antigen	NOUN
aji-147	176	13	-	-	PUNCT
aji-147	176	14	specific	specific	ADJ
aji-147	176	15	ctfh	ctfh	NOUN
aji-147	176	16	is	be	AUX
aji-147	176	17	associated	associate	VERB
aji-147	176	18	significantly	significantly	ADV
aji-147	176	19	with	with	ADP
aji-147	176	20	neutralizing	neutralizing	ADJ
aji-147	176	21	antibodies	antibody	NOUN
aji-147	176	22	[	[	X
aji-147	176	23	29,34	29,34	NUM
aji-147	176	24	-	-	SYM
aji-147	176	25	38	38	NUM
aji-147	176	26	]	]	PUNCT
aji-147	176	27	.	.	PUNCT
aji-147	177	1	even	even	ADV
aji-147	177	2	if	if	SCONJ
aji-147	177	3	ctfh	ctfh	NOUN
aji-147	177	4	responses	response	NOUN
aji-147	177	5	were	be	AUX
aji-147	177	6	not	not	PART
aji-147	177	7	discussed	discuss	VERB
aji-147	177	8	in	in	ADP
aji-147	177	9	the	the	DET
aji-147	177	10	specific	specific	ADJ
aji-147	177	11	situation	situation	NOUN
aji-147	177	12	of	of	ADP
aji-147	177	13	sars	sars	PROPN
aji-147	177	14	-	-	PUNCT
aji-147	177	15	cov	cov	PROPN
aji-147	177	16	or	or	CCONJ
aji-147	177	17	mers	mer	NOUN
aji-147	177	18	-	-	PUNCT
aji-147	177	19	cov	cov	NOUN
aji-147	177	20	infection	infection	NOUN
aji-147	177	21	,	,	PUNCT
aji-147	177	22	cd4	cd4	PROPN
aji-147	177	23	t	t	PROPN
aji-147	177	24	-	-	PUNCT
aji-147	177	25	cell	cell	NOUN
aji-147	177	26	responses	response	NOUN
aji-147	177	27	were	be	AUX
aji-147	177	28	demonstrated	demonstrate	VERB
aji-147	177	29	to	to	PART
aji-147	177	30	be	be	AUX
aji-147	177	31	crucial	crucial	ADJ
aji-147	177	32	in	in	ADP
aji-147	177	33	regulating	regulate	VERB
aji-147	177	34	sars	sar	NOUN
aji-147	177	35	-	-	PUNCT
aji-147	177	36	cov	cov	NOUN
aji-147	177	37	throughout	throughout	ADP
aji-147	177	38	mouse	mouse	NOUN
aji-147	177	39	models	model	NOUN
aji-147	177	40	[	[	X
aji-147	177	41	39	39	NUM
aji-147	177	42	]	]	PUNCT
aji-147	177	43	,	,	PUNCT
aji-147	177	44	as	as	ADV
aji-147	177	45	well	well	ADV
aji-147	177	46	as	as	ADP
aji-147	177	47	tfh	tfh	PROPN
aji-147	177	48	frequencies	frequency	NOUN
aji-147	177	49	in	in	ADP
aji-147	177	50	draining	drain	VERB
aji-147	177	51	lymph	lymph	NOUN
aji-147	177	52	nodes	node	NOUN
aji-147	177	53	associated	associate	VERB
aji-147	177	54	with	with	ADP
aji-147	177	55	neutralizing	neutralizing	ADJ
aji-147	177	56	antibodies	antibody	NOUN
aji-147	177	57	throughout	throughout	ADP
aji-147	177	58	the	the	DET
aji-147	177	59	latest	late	ADJ
aji-147	177	60	research	research	NOUN
aji-147	177	61	on	on	ADP
aji-147	177	62	the	the	DET
aji-147	177	63	mers	mer	NOUN
aji-147	177	64	-	-	PUNCT
aji-147	177	65	cov	cov	NOUN
aji-147	177	66	vaccine	vaccine	NOUN
aji-147	177	67	in	in	ADP
aji-147	177	68	mice	mouse	NOUN
aji-147	177	69	[	[	X
aji-147	177	70	40	40	NUM
aji-147	177	71	]	]	PUNCT
aji-147	177	72	.	.	PUNCT
aji-147	178	1	much	much	ADJ
aji-147	178	2	research	research	NOUN
aji-147	178	3	about	about	ADP
aji-147	178	4	sars	sar	NOUN
aji-147	178	5	-	-	PUNCT
aji-147	178	6	cov-2	cov-2	NOUN
aji-147	178	7	-	-	PUNCT
aji-147	178	8	specific	specific	ADJ
aji-147	178	9	t	t	NOUN
aji-147	178	10	follicular	follicular	ADJ
aji-147	178	11	helper	helper	NOUN
aji-147	178	12	cellular	cellular	ADJ
aji-147	178	13	transformation	transformation	NOUN
aji-147	178	14	by	by	ADP
aji-147	178	15	different	different	ADJ
aji-147	178	16	signaling	signal	VERB
aji-147	178	17	pathways	pathway	NOUN
aji-147	178	18	exists	exist	VERB
aji-147	178	19	.	.	PUNCT
aji-147	179	1	thevarajan	thevarajan	NOUN
aji-147	179	2	et	et	PROPN
aji-147	179	3	al	al	PROPN
aji-147	179	4	.	.	PROPN
aji-147	179	5	were	be	AUX
aji-147	179	6	among	among	ADP
aji-147	179	7	the	the	DET
aji-147	179	8	first	first	ADJ
aji-147	179	9	to	to	PART
aji-147	179	10	publish	publish	VERB
aji-147	179	11	sars	sar	NOUN
aji-147	179	12	-	-	PUNCT
aji-147	179	13	cov-2	cov-2	NOUN
aji-147	179	14	ctfh	ctfh	NOUN
aji-147	179	15	frequencies	frequency	NOUN
aji-147	179	16	,	,	PUNCT
aji-147	179	17	discovering	discover	VERB
aji-147	179	18	that	that	SCONJ
aji-147	179	19	overall	overall	ADJ
aji-147	179	20	ctfh	ctfh	NOUN
aji-147	179	21	frequencies	frequency	NOUN
aji-147	179	22	are	be	AUX
aji-147	179	23	increased	increase	VERB
aji-147	179	24	during	during	ADP
aji-147	179	25	acute	acute	ADJ
aji-147	179	26	infection	infection	NOUN
aji-147	179	27	[	[	X
aji-147	179	28	41	41	NUM
aji-147	179	29	]	]	PUNCT
aji-147	179	30	.	.	PUNCT
aji-147	180	1	several	several	ADJ
aji-147	180	2	studies	study	NOUN
aji-147	180	3	have	have	AUX
aji-147	180	4	discovered	discover	VERB
aji-147	180	5	a	a	DET
aji-147	180	6	link	link	NOUN
aji-147	180	7	between	between	ADP
aji-147	180	8	total	total	NOUN
aji-147	180	9	cd4	cd4	PROPN
aji-147	180	10	t	t	PROPN
aji-147	180	11	-	-	PUNCT
aji-147	180	12	cell	cell	NOUN
aji-147	180	13	frequencies	frequency	NOUN
aji-147	180	14	and	and	CCONJ
aji-147	180	15	antibody	antibody	NOUN
aji-147	180	16	levels	level	NOUN
aji-147	180	17	[	[	X
aji-147	180	18	42,43	42,43	X
aji-147	180	19	]	]	X
aji-147	180	20	.	.	PUNCT
aji-147	181	1	another	another	DET
aji-147	181	2	research	research	NOUN
aji-147	181	3	report	report	NOUN
aji-147	181	4	enhanced	enhance	VERB
aji-147	181	5	gene	gene	NOUN
aji-147	181	6	expression	expression	NOUN
aji-147	181	7	of	of	ADP
aji-147	181	8	cxcr5	cxcr5	PROPN
aji-147	181	9	and	and	CCONJ
aji-147	181	10	icos	icos	PROPN
aji-147	181	11	,	,	PUNCT
aji-147	181	12	two	two	NUM
aji-147	181	13	tfh	tfh	PROPN
aji-147	181	14	markers	marker	NOUN
aji-147	181	15	,	,	PUNCT
aji-147	181	16	among	among	ADP
aji-147	181	17	sars	sar	NOUN
aji-147	181	18	-	-	PUNCT
aji-147	181	19	cov-2	cov-2	NOUN
aji-147	181	20	-	-	PUNCT
aji-147	181	21	specific	specific	ADJ
aji-147	181	22	cd4	cd4	PROPN
aji-147	181	23	t	t	PROPN
aji-147	181	24	-	-	PUNCT
aji-147	181	25	cells	cell	NOUN
aji-147	181	26	but	but	CCONJ
aji-147	181	27	did	do	AUX
aji-147	181	28	not	not	PART
aji-147	181	29	confirm	confirm	VERB
aji-147	181	30	ctfh	ctfh	NOUN
aji-147	181	31	effects	effect	NOUN
aji-147	181	32	[	[	X
aji-147	181	33	44	44	NUM
aji-147	181	34	]	]	PUNCT
aji-147	181	35	.	.	PUNCT
aji-147	182	1	however	however	ADV
aji-147	182	2	,	,	PUNCT
aji-147	182	3	kaneko	kaneko	PROPN
aji-147	182	4	et	et	PROPN
aji-147	182	5	al	al	PROPN
aji-147	182	6	.	.	PROPN
aji-147	182	7	discovered	discover	VERB
aji-147	182	8	that	that	SCONJ
aji-147	182	9	bcl6expression	bcl6expression	PROPN
aji-147	182	10	throughout	throughout	ADP
aji-147	182	11	germinal	germinal	ADJ
aji-147	182	12	centre	centre	NOUN
aji-147	182	13	tfh	tfh	PROPN
aji-147	182	14	has	have	AUX
aji-147	182	15	been	be	AUX
aji-147	182	16	lost	lose	VERB
aji-147	182	17	within	within	ADP
aji-147	182	18	thoracic	thoracic	NOUN
aji-147	182	19	lymph	lymph	NOUN
aji-147	182	20	nodes	node	NOUN
aji-147	182	21	of	of	ADP
aji-147	182	22	deceased	deceased	ADJ
aji-147	182	23	donors	donor	NOUN
aji-147	182	24	with	with	ADP
aji-147	182	25	covid-19	covid-19	PROPN
aji-147	182	26	,	,	PUNCT
aji-147	182	27	implying	imply	VERB
aji-147	182	28	that	that	SCONJ
aji-147	182	29	tfh	tfh	PROPN
aji-147	182	30	response	response	NOUN
aji-147	182	31	initiation	initiation	NOUN
aji-147	182	32	may	may	AUX
aji-147	182	33	be	be	AUX
aji-147	182	34	inhibited	inhibit	VERB
aji-147	182	35	in	in	ADP
aji-147	182	36	serious	serious	ADJ
aji-147	182	37	sars	sar	NOUN
aji-147	182	38	-	-	PUNCT
aji-147	182	39	cov-2	cov-2	PART
aji-147	182	40	infection	infection	NOUN
aji-147	182	41	[	[	X
aji-147	182	42	45	45	NUM
aji-147	182	43	]	]	PUNCT
aji-147	182	44	.	.	PUNCT
aji-147	183	1	the	the	DET
aji-147	183	2	initiation	initiation	NOUN
aji-147	183	3	of	of	ADP
aji-147	183	4	antigen	antigen	NOUN
aji-147	183	5	-	-	PUNCT
aji-147	183	6	specific	specific	ADJ
aji-147	183	7	tfh	tfh	NOUN
aji-147	183	8	responses	response	NOUN
aji-147	183	9	,	,	PUNCT
aji-147	183	10	especially	especially	ADV
aji-147	183	11	in	in	ADP
aji-147	183	12	asymptomatic	asymptomatic	ADJ
aji-147	183	13	patients	patient	NOUN
aji-147	183	14	with	with	ADP
aji-147	183	15	covid-19	covid-19	PROPN
aji-147	183	16	,	,	PUNCT
aji-147	183	17	is	be	AUX
aji-147	183	18	still	still	ADV
aji-147	183	19	a	a	DET
aji-147	183	20	mystery	mystery	NOUN
aji-147	183	21	.	.	PUNCT
aji-147	184	1	in	in	ADP
aji-147	184	2	their	their	PRON
aji-147	184	3	study	study	NOUN
aji-147	184	4	,	,	PUNCT
aji-147	184	5	juno	juno	PROPN
aji-147	184	6	et	et	PROPN
aji-147	184	7	al	al	PROPN
aji-147	184	8	.	.	PROPN
aji-147	184	9	investigated	investigate	VERB
aji-147	184	10	circulating	circulating	PROPN
aji-147	184	11	tfh	tfh	PROPN
aji-147	184	12	,	,	PUNCT
aji-147	184	13	recognized	recognize	VERB
aji-147	184	14	as	as	ADP
aji-147	184	15	cd45ra	cd45ra	ADJ
aji-147	184	16	cxcr5	cxcr5	PROPN
aji-147	184	17	+	+	CCONJ
aji-147	184	18	cd4	cd4	PROPN
aji-147	184	19	t	t	NOUN
aji-147	184	20	cells	cell	NOUN
aji-147	184	21	,	,	PUNCT
aji-147	184	22	in	in	ADP
aji-147	184	23	the	the	DET
aji-147	184	24	blood	blood	NOUN
aji-147	184	25	of	of	ADP
aji-147	184	26	sars	sar	NOUN
aji-147	184	27	-	-	PUNCT
aji-147	184	28	cov-2	cov-2	NOUN
aji-147	184	29	infected	infected	ADJ
aji-147	184	30	people	people	NOUN
aji-147	184	31	.	.	PUNCT
aji-147	185	1	they	they	PRON
aji-147	185	2	discovered	discover	VERB
aji-147	185	3	a	a	DET
aji-147	185	4	link	link	NOUN
aji-147	185	5	between	between	ADP
aji-147	185	6	s	s	VERB
aji-147	185	7	protein	protein	NOUN
aji-147	185	8	-	-	PUNCT
aji-147	185	9	specific	specific	ADJ
aji-147	185	10	ctfh	ctfh	NOUN
aji-147	185	11	and	and	CCONJ
aji-147	185	12	nab	nab	NOUN
aji-147	185	13	,	,	PUNCT
aji-147	185	14	indicating	indicate	VERB
aji-147	185	15	that	that	SCONJ
aji-147	185	16	effective	effective	ADJ
aji-147	185	17	tfh	tfh	PROPN
aji-147	185	18	responses	response	NOUN
aji-147	185	19	were	be	AUX
aji-147	185	20	produced	produce	VERB
aji-147	185	21	in	in	ADP
aji-147	185	22	moderate	moderate	ADJ
aji-147	185	23	sars	sar	NOUN
aji-147	185	24	-	-	PUNCT
aji-147	185	25	cov-2	cov-2	PART
aji-147	185	26	infection	infection	NOUN
aji-147	185	27	[	[	X
aji-147	185	28	46	46	NUM
aji-147	185	29	]	]	PUNCT
aji-147	185	30	.	.	PUNCT
aji-147	186	1	unfortunately	unfortunately	ADV
aji-147	186	2	,	,	PUNCT
aji-147	186	3	these	these	DET
aji-147	186	4	findings	finding	NOUN
aji-147	186	5	leave	leave	VERB
aji-147	186	6	other	other	ADJ
aji-147	186	7	aspects	aspect	NOUN
aji-147	186	8	unresolved	unresolved	ADJ
aji-147	186	9	,	,	PUNCT
aji-147	186	10	particularly	particularly	ADV
aji-147	186	11	once	once	SCONJ
aji-147	186	12	those	those	DET
aji-147	186	13	responses	response	NOUN
aji-147	186	14	change	change	VERB
aji-147	186	15	throughout	throughout	ADP
aji-147	186	16	the	the	DET
aji-147	186	17	recovery	recovery	NOUN
aji-147	186	18	period	period	NOUN
aji-147	186	19	.	.	PUNCT
aji-147	187	1	even	even	ADV
aji-147	187	2	though	though	SCONJ
aji-147	187	3	this	this	DET
aji-147	187	4	research	research	NOUN
aji-147	187	5	work	work	NOUN
aji-147	187	6	provided	provide	VERB
aji-147	187	7	a	a	DET
aji-147	187	8	preliminary	preliminary	ADJ
aji-147	187	9	look	look	NOUN
aji-147	187	10	at	at	ADP
aji-147	187	11	antigen	antigen	ADJ
aji-147	187	12	specific	specific	ADJ
aji-147	187	13	tfh	tfh	PROPN
aji-147	187	14	responses	response	NOUN
aji-147	187	15	,	,	PUNCT
aji-147	187	16	which	which	PRON
aji-147	187	17	included	include	VERB
aji-147	187	18	pd1	pd1	NOUN
aji-147	187	19	,	,	PUNCT
aji-147	187	20	a	a	DET
aji-147	187	21	conventional	conventional	ADJ
aji-147	187	22	tfh	tfh	NOUN
aji-147	187	23	marker	marker	NOUN
aji-147	187	24	,	,	PUNCT
aji-147	187	25	within	within	ADP
aji-147	187	26	the	the	DET
aji-147	187	27	research	research	NOUN
aji-147	187	28	frame	frame	NOUN
aji-147	187	29	,	,	PUNCT
aji-147	187	30	pd1	pd1	VERB
aji-147	187	31	expression	expression	NOUN
aji-147	187	32	needed	need	VERB
aji-147	187	33	more	more	ADV
aji-147	187	34	utilized	utilize	VERB
aji-147	187	35	to	to	PART
aji-147	187	36	characterize	characterize	VERB
aji-147	187	37	the	the	DET
aji-147	187	38	tfh	tfh	PROPN
aji-147	187	39	population	population	NOUN
aji-147	187	40	and	and	CCONJ
aji-147	187	41	was	be	AUX
aji-147	187	42	not	not	PART
aji-147	187	43	published	publish	VERB
aji-147	187	44	.	.	PUNCT
aji-147	188	1	furthermore	furthermore	ADV
aji-147	188	2	,	,	PUNCT
aji-147	188	3	ox40	ox40	PROPN
aji-147	188	4	and	and	CCONJ
aji-147	188	5	cd25	cd25	PROPN
aji-147	188	6	were	be	AUX
aji-147	188	7	utilized	utilize	VERB
aji-147	188	8	as	as	ADP
aji-147	188	9	initiation	initiation	NOUN
aji-147	188	10	markers	marker	NOUN
aji-147	188	11	to	to	PART
aji-147	188	12	detect	detect	VERB
aji-147	188	13	antigen	antigen	NOUN
aji-147	188	14	-	-	PUNCT
aji-147	188	15	specific	specific	ADJ
aji-147	188	16	responses	response	NOUN
aji-147	188	17	that	that	PRON
aji-147	188	18	have	have	AUX
aji-147	188	19	already	already	ADV
aji-147	188	20	been	be	AUX
aji-147	188	21	reported	report	VERB
aji-147	188	22	and	and	CCONJ
aji-147	188	23	demonstrated	demonstrate	VERB
aji-147	188	24	to	to	PART
aji-147	188	25	contain	contain	VERB
aji-147	188	26	a	a	DET
aji-147	188	27	significant	significant	ADJ
aji-147	188	28	fraction	fraction	NOUN
aji-147	188	29	of	of	ADP
aji-147	188	30	regulating	regulate	VERB
aji-147	188	31	t	t	PROPN
aji-147	188	32	-	-	PUNCT
aji-147	188	33	cells	cell	NOUN
aji-147	188	34	[	[	X
aji-147	188	35	47	47	NUM
aji-147	188	36	]	]	PUNCT
aji-147	188	37	.	.	PUNCT
aji-147	189	1	a	a	DET
aji-147	189	2	current	current	ADJ
aji-147	189	3	study	study	NOUN
aji-147	189	4	has	have	VERB
aji-147	189	5	the	the	DET
aji-147	189	6	durability	durability	NOUN
aji-147	189	7	of	of	ADP
aji-147	189	8	s	s	NOUN
aji-147	189	9	proteinspecific	proteinspecific	NOUN
aji-147	189	10	cd4	cd4	PROPN
aji-147	189	11	t	t	PROPN
aji-147	189	12	-	-	PUNCT
aji-147	189	13	cell	cell	NOUN
aji-147	189	14	responses	response	NOUN
aji-147	189	15	after	after	ADP
aji-147	189	16	recovery	recovery	NOUN
aji-147	189	17	[	[	X
aji-147	189	18	48	48	NUM
aji-147	189	19	]	]	PUNCT
aji-147	189	20	.	.	PUNCT
aji-147	190	1	the	the	DET
aji-147	190	2	authors	author	NOUN
aji-147	190	3	have	have	AUX
aji-147	190	4	considered	consider	VERB
aji-147	190	5	only	only	ADV
aji-147	190	6	the	the	DET
aji-147	190	7	incidence	incidence	NOUN
aji-147	190	8	of	of	ADP
aji-147	190	9	circulating	circulate	VERB
aji-147	190	10	tfh	tfh	PROPN
aji-147	190	11	(	(	PUNCT
aji-147	190	12	icos+	icos+	ADV
aji-147	190	13	cxcr5	cxcr5	PROPN
aji-147	190	14	+	+	CCONJ
aji-147	190	15	cd4	cd4	PROPN
aji-147	190	16	t	t	NOUN
aji-147	190	17	cells	cell	NOUN
aji-147	190	18	)	)	PUNCT
aji-147	190	19	each	each	DET
aji-147	190	20	month	month	NOUN
aji-147	190	21	and	and	CCONJ
aji-147	190	22	three	three	NUM
aji-147	190	23	months	month	NOUN
aji-147	190	24	after	after	SCONJ
aji-147	190	25	the	the	DET
aji-147	190	26	symptoms	symptom	NOUN
aji-147	190	27	started	start	VERB
aji-147	190	28	.	.	PUNCT
aji-147	191	1	while	while	SCONJ
aji-147	191	2	they	they	PRON
aji-147	191	3	found	find	VERB
aji-147	191	4	responses	response	NOUN
aji-147	191	5	higher	high	ADJ
aji-147	191	6	than	than	ADP
aji-147	191	7	backgrounds	background	NOUN
aji-147	191	8	after	after	ADP
aji-147	191	9	three	three	NUM
aji-147	191	10	months	month	NOUN
aji-147	191	11	,	,	PUNCT
aji-147	191	12	there	there	PRON
aji-147	191	13	was	be	VERB
aji-147	191	14	no	no	DET
aji-147	191	15	change	change	NOUN
aji-147	191	16	throughout	throughout	ADP
aji-147	191	17	the	the	DET
aji-147	191	18	duration	duration	NOUN
aji-147	191	19	.	.	PUNCT
aji-147	192	1	shukla	shukla	NOUN
aji-147	192	2	et	et	PROPN
aji-147	192	3	al	al	PROPN
aji-147	192	4	.	.	PROPN
aji-147	192	5	;	;	PUNCT
aji-147	192	6	asian	asian	PROPN
aji-147	192	7	j.	j.	PROPN
aji-147	192	8	immunol	immunol	PROPN
aji-147	192	9	.	.	PROPN
aji-147	192	10	,	,	PUNCT
aji-147	192	11	vol	vol	NOUN
aji-147	192	12	.	.	PROPN
aji-147	193	1	7	7	NUM
aji-147	193	2	,	,	PUNCT
aji-147	193	3	no	no	INTJ
aji-147	193	4	.	.	NOUN
aji-147	193	5	1	1	NUM
aji-147	193	6	,	,	PUNCT
aji-147	193	7	pp	pp	ADJ
aji-147	193	8	.	.	PUNCT
aji-147	194	1	228	228	NUM
aji-147	194	2	-	-	SYM
aji-147	194	3	246	246	NUM
aji-147	194	4	,	,	PUNCT
aji-147	194	5	2024	2024	NUM
aji-147	194	6	;	;	PUNCT
aji-147	195	1	article	article	NOUN
aji-147	195	2	no.aji.125387	no.aji.125387	VERB
aji-147	195	3	232	232	NUM
aji-147	195	4	additional	additional	ADJ
aji-147	195	5	analysis	analysis	NOUN
aji-147	195	6	of	of	ADP
aji-147	195	7	cd4	cd4	PROPN
aji-147	195	8	t	t	PROPN
aji-147	195	9	-	-	PUNCT
aji-147	195	10	cell	cell	NOUN
aji-147	195	11	and	and	CCONJ
aji-147	195	12	ctfh	ctfh	NOUN
aji-147	195	13	responses	response	NOUN
aji-147	195	14	during	during	ADP
aji-147	195	15	the	the	DET
aji-147	195	16	recovery	recovery	NOUN
aji-147	195	17	period	period	NOUN
aji-147	195	18	might	might	AUX
aji-147	195	19	help	help	VERB
aji-147	195	20	to	to	PART
aji-147	195	21	determine	determine	VERB
aji-147	195	22	how	how	SCONJ
aji-147	195	23	much	much	ADJ
aji-147	195	24	these	these	DET
aji-147	195	25	responses	response	NOUN
aji-147	195	26	change	change	VERB
aji-147	195	27	and	and	CCONJ
aji-147	195	28	evolve	evolve	VERB
aji-147	195	29	.	.	PUNCT
aji-147	196	1	several	several	ADJ
aji-147	196	2	recent	recent	ADJ
aji-147	196	3	studies	study	NOUN
aji-147	196	4	[	[	X
aji-147	196	5	49,50	49,50	X
aji-147	196	6	]	]	PUNCT
aji-147	196	7	have	have	AUX
aji-147	196	8	investigated	investigate	VERB
aji-147	196	9	ctfh	ctfh	NOUN
aji-147	196	10	groups	group	NOUN
aji-147	196	11	up	up	ADP
aji-147	196	12	to	to	PART
aji-147	196	13	6	6	NUM
aji-147	196	14	months	month	NOUN
aji-147	196	15	after	after	ADP
aji-147	196	16	the	the	DET
aji-147	196	17	onset	onset	NOUN
aji-147	196	18	of	of	ADP
aji-147	196	19	symptoms	symptom	NOUN
aji-147	196	20	.	.	PUNCT
aji-147	197	1	(	(	PUNCT
aji-147	197	2	investigations	investigation	NOUN
aji-147	197	3	used	use	VERB
aji-147	197	4	too	too	ADV
aji-147	197	5	much	much	ADJ
aji-147	197	6	)	)	PUNCT
aji-147	197	7	.	.	PUNCT
aji-147	198	1	unfortunately	unfortunately	ADV
aji-147	198	2	,	,	PUNCT
aji-147	198	3	this	this	DET
aji-147	198	4	ongoing	ongoing	ADJ
aji-147	198	5	research	research	NOUN
aji-147	198	6	failed	fail	VERB
aji-147	198	7	due	due	ADP
aji-147	198	8	to	to	ADP
aji-147	198	9	the	the	DET
aji-147	198	10	failure	failure	NOUN
aji-147	198	11	to	to	PART
aji-147	198	12	examine	examine	VERB
aji-147	198	13	connections	connection	NOUN
aji-147	198	14	among	among	ADP
aji-147	198	15	antigen	antigen	ADV
aji-147	198	16	-	-	PUNCT
aji-147	198	17	specific	specific	ADJ
aji-147	198	18	ctfh	ctfh	NOUN
aji-147	198	19	and	and	CCONJ
aji-147	198	20	sars	sar	NOUN
aji-147	198	21	-	-	PUNCT
aji-147	198	22	cov-2specific	cov-2specific	NOUN
aji-147	198	23	antibodies	antibodie	VERB
aji-147	198	24	.	.	PUNCT
aji-147	199	1	in	in	ADP
aji-147	199	2	addition	addition	NOUN
aji-147	199	3	,	,	PUNCT
aji-147	199	4	these	these	DET
aji-147	199	5	types	type	NOUN
aji-147	199	6	of	of	ADP
aji-147	199	7	research	research	NOUN
aji-147	199	8	were	be	AUX
aji-147	199	9	predominantly	predominantly	ADV
aji-147	199	10	concerned	concerned	ADJ
aji-147	199	11	with	with	ADP
aji-147	199	12	s	s	VERB
aji-147	199	13	protein	protein	NOUN
aji-147	199	14	-	-	PUNCT
aji-147	199	15	specific	specific	ADJ
aji-147	199	16	effects	effect	NOUN
aji-147	199	17	.	.	PUNCT
aji-147	200	1	for	for	ADP
aji-147	200	2	example	example	NOUN
aji-147	200	3	,	,	PUNCT
aji-147	200	4	infrastructural	infrastructural	ADJ
aji-147	200	5	assistance	assistance	NOUN
aji-147	200	6	emerges	emerge	VERB
aji-147	200	7	in	in	ADP
aji-147	200	8	hiv	hiv	PROPN
aji-147	200	9	infection	infection	NOUN
aji-147	200	10	during	during	ADP
aji-147	200	11	vaccination	vaccination	NOUN
aji-147	200	12	,	,	PUNCT
aji-147	200	13	when	when	SCONJ
aji-147	200	14	cd4	cd4	PROPN
aji-147	200	15	t	t	PROPN
aji-147	200	16	-	-	PUNCT
aji-147	200	17	cell	cell	NOUN
aji-147	200	18	responses	response	NOUN
aji-147	200	19	towards	towards	ADP
aji-147	200	20	internal	internal	ADJ
aji-147	200	21	structural	structural	ADJ
aji-147	200	22	proteins	protein	NOUN
aji-147	200	23	correspond	correspond	VERB
aji-147	200	24	with	with	ADP
aji-147	200	25	neutralizing	neutralizing	ADJ
aji-147	200	26	antibodies	antibody	NOUN
aji-147	200	27	against	against	ADP
aji-147	200	28	the	the	DET
aji-147	200	29	outer	outer	ADJ
aji-147	200	30	envelope	envelope	NOUN
aji-147	200	31	protein	protein	NOUN
aji-147	200	32	[	[	X
aji-147	200	33	51,52	51,52	NUM
aji-147	200	34	]	]	PUNCT
aji-147	200	35	,	,	PUNCT
aji-147	200	36	emphasizing	emphasize	VERB
aji-147	200	37	the	the	DET
aji-147	200	38	necessity	necessity	NOUN
aji-147	200	39	of	of	ADP
aji-147	200	40	studying	study	VERB
aji-147	200	41	ctfh	ctfh	NOUN
aji-147	200	42	responses	response	NOUN
aji-147	200	43	from	from	ADP
aji-147	200	44	across	across	ADP
aji-147	200	45	the	the	DET
aji-147	200	46	sars	sar	NOUN
aji-147	200	47	-	-	PUNCT
aji-147	200	48	cov-2	cov-2	NOUN
aji-147	200	49	proteome	proteome	NOUN
aji-147	200	50	.	.	PUNCT
aji-147	201	1	boppana	boppana	PROPN
aji-147	201	2	et	et	PROPN
aji-147	201	3	al	al	PROPN
aji-147	201	4	.	.	PROPN
aji-147	201	5	report	report	PROPN
aji-147	201	6	on	on	ADP
aji-147	201	7	sars	sar	NOUN
aji-147	201	8	-	-	PUNCT
aji-147	201	9	cov-2	cov-2	NOUN
aji-147	201	10	-	-	PUNCT
aji-147	201	11	specific	specific	ADJ
aji-147	201	12	cd4	cd4	PROPN
aji-147	201	13	t	t	PROPN
aji-147	201	14	-	-	PUNCT
aji-147	201	15	cell	cell	NOUN
aji-147	201	16	activation	activation	NOUN
aji-147	201	17	to	to	ADP
aji-147	201	18	membrane	membrane	NOUN
aji-147	201	19	(	(	PUNCT
aji-147	201	20	m	m	NOUN
aji-147	201	21	)	)	PUNCT
aji-147	201	22	,	,	PUNCT
aji-147	201	23	nucleocapsid	nucleocapsid	ADJ
aji-147	201	24	(	(	PUNCT
aji-147	201	25	n	n	CCONJ
aji-147	201	26	)	)	PUNCT
aji-147	201	27	,	,	PUNCT
aji-147	201	28	and	and	CCONJ
aji-147	201	29	spike	spike	ADJ
aji-147	201	30	(	(	PUNCT
aji-147	201	31	s	s	NOUN
aji-147	201	32	)	)	PUNCT
aji-147	201	33	proteins	protein	NOUN
aji-147	201	34	in	in	ADP
aji-147	201	35	26	26	NUM
aji-147	201	36	recovered	recover	VERB
aji-147	201	37	patients	patient	NOUN
aji-147	201	38	who	who	PRON
aji-147	201	39	were	be	AUX
aji-147	201	40	studied	study	VERB
aji-147	201	41	in	in	ADP
aji-147	201	42	real	real	ADJ
aji-147	201	43	-	-	PUNCT
aji-147	201	44	time	time	NOUN
aji-147	201	45	.	.	PUNCT
aji-147	202	1	they	they	PRON
aji-147	202	2	studied	study	VERB
aji-147	202	3	antigen	antigen	NOUN
aji-147	202	4	-	-	PUNCT
aji-147	202	5	specific	specific	ADJ
aji-147	202	6	ctfh	ctfh	NOUN
aji-147	202	7	(	(	PUNCT
aji-147	202	8	cxcr5	cxcr5	NOUN
aji-147	202	9	+	+	CCONJ
aji-147	202	10	pd1	pd1	NOUN
aji-147	202	11	+	+	SYM
aji-147	202	12	cd4	cd4	PROPN
aji-147	202	13	t	t	NOUN
aji-147	202	14	cells	cell	NOUN
aji-147	202	15	)	)	PUNCT
aji-147	202	16	and	and	CCONJ
aji-147	202	17	found	find	VERB
aji-147	202	18	connections	connection	NOUN
aji-147	202	19	among	among	ADP
aji-147	202	20	antigenspecific	antigenspecific	ADJ
aji-147	202	21	ctfh	ctfh	NOUN
aji-147	202	22	responses	response	NOUN
aji-147	202	23	across	across	ADP
aji-147	202	24	all	all	DET
aji-147	202	25	protein	protein	NOUN
aji-147	202	26	specificities	specificity	NOUN
aji-147	202	27	with	with	ADP
aji-147	202	28	antibody	antibody	NOUN
aji-147	202	29	neutralization	neutralization	NOUN
aji-147	202	30	during	during	ADP
aji-147	202	31	the	the	DET
aji-147	202	32	first	first	ADJ
aji-147	202	33	convalescent	convalescent	NOUN
aji-147	202	34	visit	visit	NOUN
aji-147	202	35	.	.	PUNCT
aji-147	203	1	they	they	PRON
aji-147	203	2	observed	observe	VERB
aji-147	203	3	that	that	SCONJ
aji-147	203	4	the	the	DET
aji-147	203	5	m	m	VERB
aji-147	203	6	protein	protein	NOUN
aji-147	203	7	-	-	PUNCT
aji-147	203	8	specific	specific	ADJ
aji-147	203	9	ctfh	ctfh	NOUN
aji-147	203	10	responses	response	NOUN
aji-147	203	11	increase	increase	VERB
aji-147	203	12	during	during	ADP
aji-147	203	13	check	check	NOUN
aji-147	203	14	up	up	ADP
aji-147	203	15	1	1	NUM
aji-147	203	16	towards	towards	PART
aji-147	203	17	check	check	VERB
aji-147	203	18	up	up	ADP
aji-147	203	19	2	2	NUM
aji-147	203	20	(	(	PUNCT
aji-147	203	21	>	>	SYM
aji-147	203	22	5	5	NUM
aji-147	203	23	%	%	NOUN
aji-147	203	24	activation	activation	NOUN
aji-147	203	25	of	of	ADP
aji-147	203	26	the	the	DET
aji-147	203	27	total	total	ADJ
aji-147	203	28	ctfh	ctfh	NOUN
aji-147	203	29	population	population	NOUN
aji-147	203	30	)	)	PUNCT
aji-147	203	31	.	.	PUNCT
aji-147	204	1	these	these	DET
aji-147	204	2	responses	response	NOUN
aji-147	204	3	did	do	AUX
aji-147	204	4	not	not	PART
aji-147	204	5	correspond	correspond	VERB
aji-147	204	6	to	to	PART
aji-147	204	7	antibody	antibody	NOUN
aji-147	204	8	neutralization	neutralization	NOUN
aji-147	204	9	at	at	ADP
aji-147	204	10	only	only	ADV
aji-147	204	11	the	the	DET
aji-147	204	12	second	second	ADJ
aji-147	204	13	recovered	recover	VERB
aji-147	204	14	visit	visit	NOUN
aji-147	204	15	and	and	CCONJ
aji-147	204	16	more	more	ADJ
aji-147	204	17	than	than	ADP
aji-147	204	18	thirty	thirty	NUM
aji-147	204	19	days	day	NOUN
aji-147	204	20	after	after	ADP
aji-147	204	21	illness	illness	NOUN
aji-147	204	22	onset	onset	NOUN
aji-147	204	23	.	.	PUNCT
aji-147	205	1	such	such	ADJ
aji-147	205	2	findings	finding	NOUN
aji-147	205	3	are	be	AUX
aji-147	205	4	always	always	ADV
aji-147	205	5	the	the	DET
aji-147	205	6	earliest	early	ADJ
aji-147	205	7	to	to	PART
aji-147	205	8	investigate	investigate	VERB
aji-147	205	9	the	the	DET
aji-147	205	10	speed	speed	NOUN
aji-147	205	11	of	of	ADP
aji-147	205	12	ctfh	ctfh	NOUN
aji-147	205	13	responses	response	NOUN
aji-147	205	14	following	follow	VERB
aji-147	205	15	sars	sar	NOUN
aji-147	205	16	-	-	PUNCT
aji-147	205	17	cov-2	cov-2	PART
aji-147	205	18	infection	infection	NOUN
aji-147	205	19	and	and	CCONJ
aji-147	205	20	the	the	DET
aji-147	205	21	link	link	NOUN
aji-147	205	22	between	between	ADP
aji-147	205	23	neutralizing	neutralize	VERB
aji-147	205	24	antibodies	antibody	NOUN
aji-147	205	25	and	and	CCONJ
aji-147	205	26	ctfh	ctfh	NOUN
aji-147	205	27	sensitivities	sensitivity	NOUN
aji-147	205	28	to	to	ADP
aji-147	205	29	sars	sars	PROPN
aji-147	205	30	-	-	PUNCT
aji-147	205	31	cov-2	cov-2	NOUN
aji-147	205	32	m	m	NOUN
aji-147	205	33	and	and	CCONJ
aji-147	205	34	n	n	PRON
aji-147	205	35	proteins	protein	NOUN
aji-147	205	36	.	.	PUNCT
aji-147	206	1	this	this	DET
aji-147	206	2	research	research	NOUN
aji-147	206	3	also	also	ADV
aji-147	206	4	suggests	suggest	VERB
aji-147	206	5	that	that	SCONJ
aji-147	206	6	ctfh	ctfh	PROPN
aji-147	206	7	development	development	NOUN
aji-147	206	8	may	may	AUX
aji-147	206	9	be	be	AUX
aji-147	206	10	postponed	postpone	VERB
aji-147	206	11	in	in	ADP
aji-147	206	12	sars	sar	NOUN
aji-147	206	13	-	-	PUNCT
aji-147	206	14	cov-2	cov-2	PART
aji-147	206	15	infections	infection	NOUN
aji-147	206	16	[	[	X
aji-147	206	17	53	53	NUM
aji-147	206	18	]	]	PUNCT
aji-147	206	19	.	.	PUNCT
aji-147	207	1	3	3	X
aji-147	207	2	.	.	X
aji-147	207	3	phenotypes	phenotype	NOUN
aji-147	207	4	and	and	CCONJ
aji-147	207	5	functions	function	NOUN
aji-147	207	6	of	of	ADP
aji-147	207	7	follicular	follicular	ADJ
aji-147	207	8	helper	helper	NOUN
aji-147	207	9	t	t	PROPN
aji-147	207	10	cells	cell	NOUN
aji-147	207	11	(	(	PUNCT
aji-147	207	12	tfh	tfh	NOUN
aji-147	207	13	)	)	PUNCT
aji-147	207	14	of	of	ADP
aji-147	207	15	sars	sar	NOUN
aji-147	207	16	-	-	PUNCT
aji-147	207	17	cov-2	cov-2	NOUN
aji-147	207	18	infection	infection	NOUN
aji-147	207	19	follicular	follicular	ADJ
aji-147	207	20	helper	helper	NOUN
aji-147	207	21	t	t	PROPN
aji-147	207	22	cells	cell	NOUN
aji-147	207	23	(	(	PUNCT
aji-147	207	24	tfh	tfh	NOUN
aji-147	207	25	)	)	PUNCT
aji-147	207	26	cells	cell	NOUN
aji-147	207	27	are	be	AUX
aji-147	207	28	used	use	VERB
aji-147	207	29	as	as	ADP
aji-147	207	30	a	a	DET
aji-147	207	31	functional	functional	ADJ
aji-147	207	32	indicator	indicator	NOUN
aji-147	207	33	;	;	PUNCT
aji-147	207	34	they	they	PRON
aji-147	207	35	can	can	AUX
aji-147	207	36	promote	promote	VERB
aji-147	207	37	b	b	NOUN
aji-147	207	38	cells	cell	NOUN
aji-147	207	39	by	by	ADP
aji-147	207	40	increasing	increase	VERB
aji-147	207	41	antibody	antibody	NOUN
aji-147	207	42	production	production	NOUN
aji-147	207	43	,	,	PUNCT
aji-147	207	44	long	long	ADV
aji-147	207	45	-	-	PUNCT
aji-147	207	46	lived	live	VERB
aji-147	207	47	plasma	plasma	NOUN
aji-147	207	48	cells	cell	NOUN
aji-147	207	49	,	,	PUNCT
aji-147	207	50	and	and	CCONJ
aji-147	207	51	memory	memory	NOUN
aji-147	207	52	b	b	PROPN
aji-147	207	53	cells	cell	NOUN
aji-147	207	54	[	[	X
aji-147	207	55	54,55	54,55	X
aji-147	207	56	]	]	PUNCT
aji-147	207	57	.	.	PUNCT
aji-147	208	1	tfh	tfh	PROPN
aji-147	208	2	cell	cell	NOUN
aji-147	208	3	markers	marker	NOUN
aji-147	208	4	,	,	PUNCT
aji-147	208	5	which	which	PRON
aji-147	208	6	typically	typically	ADV
aji-147	208	7	include	include	VERB
aji-147	208	8	chemokine	chemokine	ADJ
aji-147	208	9	receptor	receptor	NOUN
aji-147	208	10	cxcr5	cxcr5	PROPN
aji-147	208	11	,	,	PUNCT
aji-147	208	12	transcription	transcription	NOUN
aji-147	208	13	factor	factor	NOUN
aji-147	208	14	bcl-6	bcl-6	NOUN
aji-147	208	15	,	,	PUNCT
aji-147	208	16	pd-1	pd-1	X
aji-147	208	17	,	,	PUNCT
aji-147	208	18	cd40	cd40	PROPN
aji-147	208	19	ligand	ligand	NOUN
aji-147	208	20	(	(	PUNCT
aji-147	208	21	cd40l	cd40l	NOUN
aji-147	208	22	)	)	PUNCT
aji-147	208	23	,	,	PUNCT
aji-147	208	24	and	and	CCONJ
aji-147	208	25	icos	icos	PROPN
aji-147	208	26	in	in	ADP
aji-147	208	27	humans	human	NOUN
aji-147	208	28	and	and	CCONJ
aji-147	208	29	mice	mouse	NOUN
aji-147	208	30	,	,	PUNCT
aji-147	208	31	are	be	AUX
aji-147	208	32	essential	essential	ADJ
aji-147	208	33	for	for	ADP
aji-147	208	34	identifying	identify	VERB
aji-147	208	35	tfh	tfh	NOUN
aji-147	208	36	cells	cell	NOUN
aji-147	208	37	with	with	ADP
aji-147	208	38	their	their	PRON
aji-147	208	39	various	various	ADJ
aji-147	208	40	subgroups	subgroup	NOUN
aji-147	208	41	not	not	PART
aji-147	208	42	only	only	ADV
aji-147	208	43	in	in	ADP
aji-147	208	44	lymphoid	lymphoid	ADJ
aji-147	208	45	tissue	tissue	NOUN
aji-147	208	46	but	but	CCONJ
aji-147	208	47	also	also	ADV
aji-147	208	48	in	in	ADP
aji-147	208	49	circulation	circulation	NOUN
aji-147	208	50	[	[	X
aji-147	208	51	56	56	NUM
aji-147	208	52	-	-	SYM
aji-147	208	53	59	59	NUM
aji-147	208	54	]	]	PUNCT
aji-147	208	55	.	.	PUNCT
aji-147	209	1	additionally	additionally	ADV
aji-147	209	2	,	,	PUNCT
aji-147	209	3	the	the	DET
aji-147	209	4	phenotypes	phenotype	NOUN
aji-147	209	5	of	of	ADP
aji-147	209	6	tfh	tfh	PROPN
aji-147	209	7	cells	cell	NOUN
aji-147	209	8	were	be	AUX
aji-147	209	9	linked	link	VERB
aji-147	209	10	to	to	ADP
aji-147	209	11	distinct	distinct	ADJ
aji-147	209	12	phases	phase	NOUN
aji-147	209	13	of	of	ADP
aji-147	209	14	immunological	immunological	ADJ
aji-147	209	15	responses	response	NOUN
aji-147	209	16	[	[	X
aji-147	209	17	60,61	60,61	NOUN
aji-147	209	18	]	]	X
aji-147	209	19	.	.	PUNCT
aji-147	210	1	within	within	ADP
aji-147	210	2	secondary	secondary	ADJ
aji-147	210	3	lymphoid	lymphoid	ADJ
aji-147	210	4	organs	organ	NOUN
aji-147	210	5	,	,	PUNCT
aji-147	210	6	naïve	naïve	PROPN
aji-147	210	7	cd4	cd4	PROPN
aji-147	210	8	+	+	PROPN
aji-147	210	9	t	t	NOUN
aji-147	210	10	cells	cell	NOUN
aji-147	210	11	develop	develop	VERB
aji-147	210	12	into	into	ADP
aji-147	210	13	tfh	tfh	PROPN
aji-147	210	14	cells	cell	NOUN
aji-147	210	15	through	through	ADP
aji-147	210	16	cxcr5	cxcr5	PROPN
aji-147	210	17	overexpression	overexpression	NOUN
aji-147	210	18	and	and	CCONJ
aji-147	210	19	ccr7	ccr7	VERB
aji-147	210	20	reduced	reduce	VERB
aji-147	210	21	expression	expression	NOUN
aji-147	210	22	,	,	PUNCT
aji-147	210	23	which	which	PRON
aji-147	210	24	is	be	AUX
aji-147	210	25	controlled	control	VERB
aji-147	210	26	by	by	ADP
aji-147	210	27	antigen	antigen	NOUN
aji-147	210	28	-	-	PUNCT
aji-147	210	29	specific	specific	ADJ
aji-147	210	30	conventional	conventional	ADJ
aji-147	210	31	dendritic	dendritic	ADJ
aji-147	210	32	cells	cell	NOUN
aji-147	210	33	(	(	PUNCT
aji-147	210	34	dcs	dcs	PROPN
aji-147	210	35	)	)	PUNCT
aji-147	210	36	and	and	CCONJ
aji-147	210	37	monocytederived	monocytederive	VERB
aji-147	210	38	dcs	dcs	PROPN
aji-147	211	1	[	[	X
aji-147	211	2	58,62,63	58,62,63	NUM
aji-147	211	3	]	]	X
aji-147	211	4	.	.	PUNCT
aji-147	212	1	tfh	tfh	PROPN
aji-147	212	2	cells	cell	NOUN
aji-147	212	3	migrate	migrate	VERB
aji-147	212	4	into	into	ADP
aji-147	212	5	cxc	cxc	NOUN
aji-147	212	6	-	-	PUNCT
aji-147	212	7	chemokine	chemokine	ADJ
aji-147	212	8	ligand	ligand	NOUN
aji-147	212	9	13	13	NUM
aji-147	212	10	(	(	PUNCT
aji-147	212	11	cxcl13)-enriched	cxcl13)-enriche	VERB
aji-147	212	12	b	b	NUM
aji-147	212	13	lymphoid	lymphoid	NOUN
aji-147	212	14	follicles	follicle	NOUN
aji-147	212	15	inside	inside	ADP
aji-147	212	16	the	the	DET
aji-147	212	17	germinal	germinal	ADJ
aji-147	212	18	centre	centre	NOUN
aji-147	212	19	(	(	PUNCT
aji-147	212	20	gc	gc	PROPN
aji-147	212	21	)	)	PUNCT
aji-147	212	22	due	due	ADP
aji-147	212	23	to	to	ADP
aji-147	212	24	enhanced	enhance	VERB
aji-147	212	25	cxcr5	cxcr5	PROPN
aji-147	212	26	and	and	CCONJ
aji-147	212	27	reduced	reduce	VERB
aji-147	212	28	ccr7	ccr7	PROPN
aji-147	213	1	[	[	X
aji-147	213	2	58,64	58,64	NUM
aji-147	213	3	]	]	PUNCT
aji-147	213	4	.	.	PUNCT
aji-147	214	1	in	in	ADP
aji-147	214	2	human	human	ADJ
aji-147	214	3	and	and	CCONJ
aji-147	214	4	mouse	mouse	PROPN
aji-147	214	5	gcs	gcs	PROPN
aji-147	214	6	,	,	PUNCT
aji-147	214	7	the	the	DET
aji-147	214	8	unique	unique	ADJ
aji-147	214	9	transcription	transcription	NOUN
aji-147	214	10	factor	factor	NOUN
aji-147	214	11	bcl-6	bcl-6	PUNCT
aji-147	214	12	was	be	AUX
aji-147	214	13	exclusively	exclusively	ADV
aji-147	214	14	expressed	express	VERB
aji-147	214	15	among	among	ADP
aji-147	214	16	tfh	tfh	PROPN
aji-147	214	17	cells	cell	NOUN
aji-147	214	18	and	and	CCONJ
aji-147	214	19	was	be	AUX
aji-147	214	20	highly	highly	ADV
aji-147	214	21	expressed	express	VERB
aji-147	214	22	within	within	ADP
aji-147	214	23	cxcr5hiccr7low/-tfh	cxcr5hiccr7low/-tfh	PROPN
aji-147	214	24	cells	cell	NOUN
aji-147	214	25	[	[	X
aji-147	214	26	64	64	NUM
aji-147	214	27	-	-	SYM
aji-147	214	28	67	67	NUM
aji-147	214	29	]	]	PUNCT
aji-147	214	30	.	.	PUNCT
aji-147	215	1	a	a	DET
aji-147	215	2	cytokine	cytokine	NOUN
aji-147	215	3	,	,	PUNCT
aji-147	215	4	interleukin-21	interleukin-21	PROPN
aji-147	215	5	(	(	PUNCT
aji-147	215	6	il-21	il-21	NUM
aji-147	215	7	)	)	PUNCT
aji-147	215	8	,	,	PUNCT
aji-147	215	9	is	be	AUX
aji-147	215	10	firmly	firmly	ADV
aji-147	215	11	and	and	CCONJ
aji-147	215	12	selectively	selectively	ADV
aji-147	215	13	released	release	VERB
aji-147	215	14	only	only	ADV
aji-147	215	15	tfh	tfh	NUM
aji-147	215	16	cells	cell	NOUN
aji-147	215	17	,	,	PUNCT
aji-147	215	18	which	which	PRON
aji-147	215	19	increases	increase	VERB
aji-147	215	20	tfh	tfh	NOUN
aji-147	215	21	cell	cell	NOUN
aji-147	215	22	proliferation	proliferation	NOUN
aji-147	215	23	and	and	CCONJ
aji-147	215	24	enhances	enhance	VERB
aji-147	215	25	b	b	NOUN
aji-147	215	26	cell	cell	NOUN
aji-147	215	27	differentiation	differentiation	NOUN
aji-147	215	28	and	and	CCONJ
aji-147	215	29	antibody	antibody	NOUN
aji-147	215	30	production	production	NOUN
aji-147	215	31	,	,	PUNCT
aji-147	215	32	which	which	PRON
aji-147	215	33	is	be	AUX
aji-147	215	34	typical	typical	ADJ
aji-147	215	35	for	for	ADP
aji-147	215	36	tfh	tfh	PROPN
aji-147	215	37	cells	cell	NOUN
aji-147	215	38	[	[	X
aji-147	215	39	68	68	NUM
aji-147	215	40	-	-	SYM
aji-147	215	41	72	72	NUM
aji-147	215	42	]	]	PUNCT
aji-147	215	43	.	.	PUNCT
aji-147	216	1	in	in	ADP
aji-147	216	2	both	both	DET
aji-147	216	3	mice	mouse	NOUN
aji-147	216	4	as	as	ADV
aji-147	216	5	well	well	ADV
aji-147	216	6	as	as	ADP
aji-147	216	7	humans	human	NOUN
aji-147	216	8	,	,	PUNCT
aji-147	216	9	icos	icos	ADJ
aji-147	216	10	reduction	reduction	NOUN
aji-147	216	11	greatly	greatly	ADV
aji-147	216	12	lowers	lower	VERB
aji-147	216	13	gc	gc	PROPN
aji-147	216	14	reactions	reaction	NOUN
aji-147	216	15	but	but	CCONJ
aji-147	216	16	also	also	ADV
aji-147	216	17	tfh	tfh	PROPN
aji-147	216	18	cells	cell	NOUN
aji-147	216	19	,	,	PUNCT
aji-147	216	20	indicating	indicate	VERB
aji-147	216	21	that	that	SCONJ
aji-147	216	22	icos	icos	ADJ
aji-147	216	23	expression	expression	NOUN
aji-147	216	24	in	in	ADP
aji-147	216	25	tfh	tfh	PROPN
aji-147	216	26	cells	cell	NOUN
aji-147	216	27	is	be	AUX
aji-147	216	28	required	require	VERB
aji-147	216	29	during	during	ADP
aji-147	216	30	tfh	tfh	PROPN
aji-147	216	31	cell	cell	NOUN
aji-147	216	32	differentiation	differentiation	NOUN
aji-147	216	33	and	and	CCONJ
aji-147	216	34	maintenance	maintenance	NOUN
aji-147	216	35	,	,	PUNCT
aji-147	216	36	gc	gc	PROPN
aji-147	216	37	production	production	NOUN
aji-147	216	38	,	,	PUNCT
aji-147	216	39	and	and	CCONJ
aji-147	216	40	b	b	X
aji-147	216	41	cell	cell	NOUN
aji-147	216	42	differentiation	differentiation	NOUN
aji-147	216	43	,	,	PUNCT
aji-147	216	44	including	include	VERB
aji-147	216	45	antibody	antibody	NOUN
aji-147	216	46	responses	response	NOUN
aji-147	216	47	[	[	X
aji-147	216	48	7375]–66	7375]–66	NOUN
aji-147	216	49	]	]	X
aji-147	216	50	.	.	PUNCT
aji-147	217	1	as	as	ADP
aji-147	217	2	an	an	DET
aji-147	217	3	essential	essential	ADJ
aji-147	217	4	effector	effector	NOUN
aji-147	217	5	molecule	molecule	NOUN
aji-147	217	6	,	,	PUNCT
aji-147	217	7	icos	icos	PROPN
aji-147	217	8	could	could	AUX
aji-147	217	9	also	also	ADV
aji-147	217	10	promote	promote	VERB
aji-147	217	11	il-21	il-21	PRON
aji-147	217	12	release	release	NOUN
aji-147	217	13	within	within	ADP
aji-147	217	14	tfh	tfh	PROPN
aji-147	217	15	cells	cell	NOUN
aji-147	217	16	[	[	X
aji-147	217	17	75	75	NUM
aji-147	217	18	-	-	SYM
aji-147	217	19	77	77	NUM
aji-147	217	20	]	]	PUNCT
aji-147	217	21	.	.	PUNCT
aji-147	218	1	tfh	tfh	PROPN
aji-147	218	2	cell	cell	NOUN
aji-147	218	3	development	development	NOUN
aji-147	218	4	and	and	CCONJ
aji-147	218	5	activation	activation	NOUN
aji-147	218	6	could	could	AUX
aji-147	218	7	be	be	AUX
aji-147	218	8	considerably	considerably	ADV
aji-147	218	9	enhanced	enhance	VERB
aji-147	218	10	by	by	ADP
aji-147	218	11	increased	increase	VERB
aji-147	218	12	pd-1	pd-1	ADP
aji-147	218	13	expression	expression	NOUN
aji-147	218	14	[	[	X
aji-147	218	15	78	78	NUM
aji-147	218	16	-	-	SYM
aji-147	218	17	80	80	NUM
aji-147	218	18	]	]	PUNCT
aji-147	218	19	.	.	PUNCT
aji-147	219	1	tfh	tfh	PROPN
aji-147	219	2	cells	cell	NOUN
aji-147	219	3	were	be	AUX
aji-147	219	4	usually	usually	ADV
aji-147	219	5	classified	classify	VERB
aji-147	219	6	as	as	ADP
aji-147	219	7	having	have	VERB
aji-147	219	8	three	three	NUM
aji-147	219	9	phenotypes	phenotype	NOUN
aji-147	219	10	:	:	PUNCT
aji-147	219	11	precursortfh	precursortfh	PROPN
aji-147	219	12	(	(	PUNCT
aji-147	219	13	pre	pre	ADJ
aji-147	219	14	-	-	ADJ
aji-147	219	15	tfh	tfh	ADJ
aji-147	219	16	)	)	PUNCT
aji-147	219	17	cells	cell	NOUN
aji-147	219	18	,	,	PUNCT
aji-147	219	19	canonical	canonical	ADJ
aji-147	219	20	gc	gc	PROPN
aji-147	219	21	tfh	tfh	PROPN
aji-147	219	22	cells	cell	NOUN
aji-147	219	23	with	with	ADP
aji-147	219	24	pd-1++	pd-1++	PROPN
aji-147	219	25	and	and	CCONJ
aji-147	219	26	icos++bcl-6	icos++bcl-6	NOUN
aji-147	219	27	+	+	NOUN
aji-147	219	28	ccr7cxcr5++cd4	ccr7cxcr5++cd4	PROPN
aji-147	219	29	+	+	ADP
aji-147	219	30	t	t	NOUN
aji-147	219	31	cells	cell	NOUN
aji-147	219	32	characterized	characterize	VERB
aji-147	219	33	as	as	ADP
aji-147	219	34	pd-1	pd-1	ADV
aji-147	219	35	+	+	NOUN
aji-147	219	36	icos+	icos+	X
aji-147	219	37	bcl6lowccr7lowcxcr5	bcl6lowccr7lowcxcr5	PROPN
aji-147	219	38	+	+	CCONJ
aji-147	219	39	cd4	cd4	PROPN
aji-147	219	40	+	+	PROPN
aji-147	219	41	t	t	NOUN
aji-147	219	42	cells	cell	NOUN
aji-147	219	43	,	,	PUNCT
aji-147	219	44	and	and	CCONJ
aji-147	219	45	memory	memory	NOUN
aji-147	219	46	tfh	tfh	PROPN
aji-147	219	47	cells	cell	NOUN
aji-147	219	48	similar	similar	ADJ
aji-147	219	49	to	to	ADP
aji-147	219	50	pre	pre	ADJ
aji-147	219	51	-	-	ADJ
aji-147	219	52	tfh	tfh	ADJ
aji-147	219	53	cells	cell	NOUN
aji-147	219	54	in	in	ADP
aji-147	219	55	lymphoid	lymphoid	ADJ
aji-147	219	56	tissue	tissue	NOUN
aji-147	220	1	[	[	X
aji-147	220	2	33,81,82	33,81,82	NUM
aji-147	220	3	]	]	X
aji-147	220	4	.	.	PUNCT
aji-147	221	1	tfh	tfh	NUM
aji-147	221	2	cells	cell	NOUN
aji-147	221	3	regulate	regulate	VERB
aji-147	221	4	b	b	PRON
aji-147	221	5	cell	cell	NOUN
aji-147	221	6	differentiation	differentiation	NOUN
aji-147	221	7	,	,	PUNCT
aji-147	221	8	becoming	become	VERB
aji-147	221	9	memory	memory	NOUN
aji-147	221	10	b	b	NOUN
aji-147	221	11	cells	cell	NOUN
aji-147	221	12	as	as	ADV
aji-147	221	13	well	well	ADV
aji-147	221	14	as	as	ADP
aji-147	221	15	plasma	plasma	NOUN
aji-147	221	16	cells	cell	NOUN
aji-147	221	17	in	in	ADP
aji-147	221	18	gc	gc	PROPN
aji-147	221	19	,	,	PUNCT
aji-147	221	20	and	and	CCONJ
aji-147	221	21	even	even	ADV
aji-147	221	22	select	select	VERB
aji-147	221	23	for	for	ADP
aji-147	221	24	highaffinity	highaffinity	NOUN
aji-147	221	25	antibody	antibody	NOUN
aji-147	221	26	production	production	NOUN
aji-147	221	27	to	to	PART
aji-147	221	28	form	form	VERB
aji-147	221	29	long	long	ADJ
aji-147	221	30	-	-	PUNCT
aji-147	221	31	term	term	NOUN
aji-147	221	32	innate	innate	ADJ
aji-147	221	33	immunity	immunity	NOUN
aji-147	221	34	[	[	X
aji-147	221	35	83	83	NUM
aji-147	221	36	-	-	SYM
aji-147	221	37	86	86	NUM
aji-147	221	38	]	]	PUNCT
aji-147	221	39	.	.	PUNCT
aji-147	222	1	circulating	circulate	VERB
aji-147	222	2	tfh	tfh	PROPN
aji-147	222	3	(	(	PUNCT
aji-147	222	4	ctfh	ctfh	NOUN
aji-147	222	5	)	)	PUNCT
aji-147	222	6	cells	cell	NOUN
aji-147	222	7	in	in	ADP
aji-147	222	8	the	the	DET
aji-147	222	9	blood	blood	NOUN
aji-147	222	10	typically	typically	ADV
aji-147	222	11	have	have	VERB
aji-147	222	12	two	two	NUM
aji-147	222	13	different	different	ADJ
aji-147	222	14	phenotypes	phenotype	NOUN
aji-147	222	15	:	:	PUNCT
aji-147	222	16	central	central	ADJ
aji-147	222	17	memory	memory	NOUN
aji-147	222	18	tfh	tfh	PROPN
aji-147	222	19	cells	cell	NOUN
aji-147	222	20	(	(	PUNCT
aji-147	222	21	pd-1icos	pd-1icos	PROPN
aji-147	222	22	-	-	PUNCT
aji-147	222	23	ccr7highbcl-6cxcr5	ccr7highbcl-6cxcr5	NOUN
aji-147	222	24	+	+	CCONJ
aji-147	222	25	cd4	cd4	PROPN
aji-147	222	26	+	+	PROPN
aji-147	222	27	t	t	NOUN
aji-147	222	28	cells	cell	NOUN
aji-147	222	29	)	)	PUNCT
aji-147	222	30	and	and	CCONJ
aji-147	222	31	effector	effector	NOUN
aji-147	222	32	memory	memory	NOUN
aji-147	222	33	tfh	tfh	PROPN
aji-147	222	34	cells	cell	NOUN
aji-147	222	35	(	(	PUNCT
aji-147	222	36	pd1+icos+ccr7lowbcl-6cxcr5	pd1+icos+ccr7lowbcl-6cxcr5	PROPN
aji-147	222	37	+	+	SYM
aji-147	222	38	cd4	cd4	PROPN
aji-147	222	39	+	+	PROPN
aji-147	222	40	t	t	NOUN
aji-147	222	41	cells	cell	NOUN
aji-147	222	42	)	)	PUNCT
aji-147	223	1	[	[	X
aji-147	223	2	61,87,88	61,87,88	NUM
aji-147	223	3	]	]	PUNCT
aji-147	223	4	.	.	PUNCT
aji-147	224	1	similarly	similarly	ADV
aji-147	224	2	,	,	PUNCT
aji-147	224	3	ctfh	ctfh	NOUN
aji-147	224	4	cells	cell	NOUN
aji-147	224	5	were	be	AUX
aji-147	224	6	categorized	categorize	VERB
aji-147	224	7	under	under	ADP
aji-147	224	8	three	three	NUM
aji-147	224	9	subgroups	subgroup	NOUN
aji-147	224	10	depending	depend	VERB
aji-147	224	11	on	on	ADP
aji-147	224	12	the	the	DET
aji-147	224	13	expression	expression	NOUN
aji-147	224	14	of	of	ADP
aji-147	224	15	either	either	DET
aji-147	224	16	cxcr3	cxcr3	PROPN
aji-147	224	17	as	as	ADV
aji-147	224	18	well	well	ADV
aji-147	224	19	as	as	ADP
aji-147	224	20	ccr6	ccr6	NOUN
aji-147	224	21	:	:	PUNCT
aji-147	224	22	tfh1	tfh1	NOUN
aji-147	224	23	(	(	PUNCT
aji-147	224	24	cxcr3	cxcr3	PROPN
aji-147	224	25	+	+	SYM
aji-147	224	26	ccr6-	ccr6-	NUM
aji-147	224	27	)	)	PUNCT
aji-147	224	28	,	,	PUNCT
aji-147	224	29	tfh2	tfh2	PROPN
aji-147	224	30	(	(	PUNCT
aji-147	224	31	cxcr3ccr6	cxcr3ccr6	NOUN
aji-147	224	32	)	)	PUNCT
aji-147	224	33	,	,	PUNCT
aji-147	224	34	tfh17	tfh17	NOUN
aji-147	224	35	(	(	PUNCT
aji-147	224	36	cxcr3ccr6	cxcr3ccr6	NOUN
aji-147	224	37	+	+	NOUN
aji-147	224	38	)	)	PUNCT
aji-147	224	39	,	,	PUNCT
aji-147	224	40	and	and	CCONJ
aji-147	224	41	tfh1/17	tfh1/17	PRON
aji-147	224	42	(	(	PUNCT
aji-147	224	43	cxcr3	cxcr3	NOUN
aji-147	224	44	+	+	CCONJ
aji-147	224	45	ccr6	ccr6	ADJ
aji-147	224	46	+	+	NOUN
aji-147	224	47	)	)	PUNCT
aji-147	224	48	cells	cell	NOUN
aji-147	224	49	that	that	PRON
aji-147	224	50	contain	contain	VERB
aji-147	224	51	the	the	DET
aji-147	224	52	hallmark	hallmark	ADJ
aji-147	224	53	gene	gene	NOUN
aji-147	224	54	transcription	transcription	NOUN
aji-147	224	55	factors	factor	NOUN
aji-147	224	56	and	and	CCONJ
aji-147	224	57	cytokines	cytokine	VERB
aji-147	224	58	comprising	comprise	VERB
aji-147	224	59	th1	th1	NOUN
aji-147	224	60	(	(	PUNCT
aji-147	224	61	t	t	NOUN
aji-147	224	62	-	-	PUNCT
aji-147	224	63	bet	bet	NOUN
aji-147	224	64	as	as	ADV
aji-147	224	65	well	well	ADV
aji-147	224	66	as	as	ADP
aji-147	224	67	ifn	ifn	NOUN
aji-147	224	68	-	-	PUNCT
aji-147	224	69	g	g	NOUN
aji-147	224	70	)	)	PUNCT
aji-147	224	71	,	,	PUNCT
aji-147	224	72	th2	th2	PROPN
aji-147	224	73	(	(	PUNCT
aji-147	224	74	gata3	gata3	PROPN
aji-147	224	75	,	,	PUNCT
aji-147	224	76	il-4	il-4	X
aji-147	224	77	,	,	PUNCT
aji-147	224	78	il-5	il-5	NOUN
aji-147	224	79	,	,	PUNCT
aji-147	224	80	and	and	CCONJ
aji-147	224	81	il-13	il-13	NUM
aji-147	224	82	)	)	PUNCT
aji-147	224	83	,	,	PUNCT
aji-147	224	84	with	with	ADP
aji-147	224	85	th17	th17	PROPN
aji-147	224	86	(	(	PUNCT
aji-147	224	87	rorgt	rorgt	NOUN
aji-147	224	88	,	,	PUNCT
aji-147	224	89	il-17	il-17	X
aji-147	224	90	,	,	PUNCT
aji-147	224	91	and	and	CCONJ
aji-147	224	92	shukla	shukla	NOUN
aji-147	224	93	et	et	PROPN
aji-147	224	94	al	al	PROPN
aji-147	224	95	.	.	PROPN
aji-147	224	96	;	;	PUNCT
aji-147	225	1	asian	asian	PROPN
aji-147	225	2	j.	j.	PROPN
aji-147	225	3	immunol	immunol	PROPN
aji-147	225	4	.	.	PROPN
aji-147	225	5	,	,	PUNCT
aji-147	225	6	vol	vol	NOUN
aji-147	225	7	.	.	PROPN
aji-147	225	8	7	7	NUM
aji-147	225	9	,	,	PUNCT
aji-147	225	10	no	no	INTJ
aji-147	225	11	.	.	NOUN
aji-147	225	12	1	1	NUM
aji-147	225	13	,	,	PUNCT
aji-147	225	14	pp	pp	ADJ
aji-147	225	15	.	.	PUNCT
aji-147	226	1	228	228	NUM
aji-147	226	2	-	-	SYM
aji-147	226	3	246	246	NUM
aji-147	226	4	,	,	PUNCT
aji-147	226	5	2024	2024	NUM
aji-147	226	6	;	;	PUNCT
aji-147	226	7	article	article	NOUN
aji-147	226	8	no.aji.125387	no.aji.125387	VERB
aji-147	226	9	233	233	NUM
aji-147	226	10	il-22	il-22	NOUN
aji-147	226	11	)	)	PUNCT
aji-147	226	12	cells	cell	NOUN
aji-147	227	1	[	[	X
aji-147	227	2	61,87,89	61,87,89	NUM
aji-147	227	3	]	]	PUNCT
aji-147	227	4	.	.	PUNCT
aji-147	228	1	ctfh2	ctfh2	NOUN
aji-147	228	2	with	with	ADP
aji-147	228	3	ctfh17	ctfh17	NOUN
aji-147	228	4	cells	cell	NOUN
aji-147	228	5	potentially	potentially	ADV
aji-147	228	6	stimulates	stimulate	VERB
aji-147	228	7	b	b	PRON
aji-147	228	8	cell	cell	NOUN
aji-147	228	9	differentiation	differentiation	NOUN
aji-147	228	10	with	with	ADP
aji-147	228	11	antibody	antibody	NOUN
aji-147	228	12	production	production	NOUN
aji-147	228	13	and	and	CCONJ
aji-147	228	14	regulates	regulate	VERB
aji-147	228	15	(	(	PUNCT
aji-147	228	16	ig	ig	NOUN
aji-147	228	17	-	-	PUNCT
aji-147	228	18	antibodies	antibodies	ADV
aji-147	228	19	)	)	PUNCT
aji-147	228	20	isotype	isotype	NOUN
aji-147	228	21	changing	changing	NOUN
aji-147	228	22	.	.	PUNCT
aji-147	229	1	although	although	SCONJ
aji-147	229	2	ctfh1	ctfh1	ADJ
aji-147	229	3	cells	cell	NOUN
aji-147	229	4	are	be	AUX
aji-147	229	5	not	not	PART
aji-147	229	6	commonly	commonly	ADV
aji-147	229	7	considered	consider	VERB
aji-147	229	8	b	b	NUM
aji-147	229	9	cell	cell	NOUN
aji-147	229	10	helpers	helper	NOUN
aji-147	229	11	,	,	PUNCT
aji-147	229	12	icos+	icos+	ADV
aji-147	229	13	pd1highccr7lowctfh1	pd1highccr7lowctfh1	ADJ
aji-147	229	14	cells	cell	NOUN
aji-147	229	15	control	control	VERB
aji-147	229	16	b	b	NOUN
aji-147	229	17	cell	cell	NOUN
aji-147	229	18	differentiation	differentiation	NOUN
aji-147	229	19	and	and	CCONJ
aji-147	229	20	trigger	trigger	NOUN
aji-147	229	21	antibody	antibody	NOUN
aji-147	229	22	responses	response	NOUN
aji-147	229	23	[	[	X
aji-147	229	24	89	89	NUM
aji-147	229	25	-	-	SYM
aji-147	229	26	95	95	NUM
aji-147	229	27	]	]	PUNCT
aji-147	229	28	.	.	PUNCT
aji-147	230	1	depending	depend	VERB
aji-147	230	2	on	on	ADP
aji-147	230	3	the	the	DET
aji-147	230	4	expression	expression	NOUN
aji-147	230	5	of	of	ADP
aji-147	230	6	icos	icos	PROPN
aji-147	230	7	,	,	PUNCT
aji-147	230	8	pd-1	pd-1	ADV
aji-147	230	9	,	,	PUNCT
aji-147	230	10	and	and	CCONJ
aji-147	230	11	ccr7	ccr7	PROPN
aji-147	230	12	,	,	PUNCT
aji-147	230	13	as	as	ADV
aji-147	230	14	well	well	ADV
aji-147	230	15	as	as	ADP
aji-147	230	16	cxcr3	cxcr3	NOUN
aji-147	230	17	and	and	CCONJ
aji-147	230	18	ccr6	ccr6	PROPN
aji-147	230	19	,	,	PUNCT
aji-147	230	20	these	these	DET
aji-147	230	21	findings	finding	NOUN
aji-147	230	22	show	show	VERB
aji-147	230	23	functionally	functionally	ADV
aji-147	230	24	different	different	ADJ
aji-147	230	25	ctfh	ctfh	NOUN
aji-147	230	26	cell	cell	NOUN
aji-147	230	27	subgroups	subgroup	NOUN
aji-147	230	28	.	.	PUNCT
aji-147	231	1	furthermore	furthermore	ADV
aji-147	231	2	,	,	PUNCT
aji-147	231	3	emerging	emerge	VERB
aji-147	231	4	unique	unique	ADJ
aji-147	231	5	subgroups	subgroup	NOUN
aji-147	231	6	distinguish	distinguish	VERB
aji-147	231	7	among	among	ADP
aji-147	231	8	th1	th1	PROPN
aji-147	231	9	,	,	PUNCT
aji-147	231	10	th2	th2	PROPN
aji-147	231	11	,	,	PUNCT
aji-147	231	12	and	and	CCONJ
aji-147	231	13	th17	th17	PROPN
aji-147	231	14	cells	cell	NOUN
aji-147	231	15	while	while	SCONJ
aji-147	231	16	sharing	share	VERB
aji-147	231	17	some	some	DET
aji-147	231	18	fundamental	fundamental	ADJ
aji-147	231	19	properties	property	NOUN
aji-147	231	20	.	.	PUNCT
aji-147	232	1	tfh	tfh	NUM
aji-147	232	2	-	-	PUNCT
aji-147	232	3	like	like	ADJ
aji-147	232	4	cells	cell	NOUN
aji-147	232	5	were	be	AUX
aji-147	232	6	also	also	ADV
aji-147	232	7	recognized	recognize	VERB
aji-147	232	8	in	in	ADP
aji-147	232	9	non	non	ADJ
aji-147	232	10	-	-	ADJ
aji-147	232	11	lymphoid	lymphoid	ADJ
aji-147	232	12	tissues	tissue	NOUN
aji-147	232	13	,	,	PUNCT
aji-147	232	14	such	such	ADJ
aji-147	232	15	as	as	ADP
aji-147	232	16	arthritis	arthritis	NOUN
aji-147	232	17	synovium	synovium	NOUN
aji-147	232	18	and	and	CCONJ
aji-147	232	19	skin	skin	NOUN
aji-147	232	20	,	,	PUNCT
aji-147	232	21	but	but	CCONJ
aji-147	232	22	also	also	ADV
aji-147	232	23	salivary	salivary	VERB
aji-147	232	24	glands	gland	NOUN
aji-147	232	25	of	of	ADP
aji-147	232	26	patients	patient	NOUN
aji-147	232	27	,	,	PUNCT
aji-147	232	28	that	that	SCONJ
aji-147	232	29	also	also	ADV
aji-147	232	30	widely	widely	ADV
aji-147	232	31	express	express	VERB
aji-147	232	32	low	low	ADJ
aji-147	232	33	expression	expression	NOUN
aji-147	232	34	of	of	ADP
aji-147	232	35	cxcr5	cxcr5	PROPN
aji-147	232	36	and	and	CCONJ
aji-147	232	37	bcl-6	bcl-6	PUNCT
aji-147	232	38	and	and	CCONJ
aji-147	232	39	high	high	ADJ
aji-147	232	40	pd-1	pd-1	ADJ
aji-147	232	41	,	,	PUNCT
aji-147	232	42	icos	icos	PROPN
aji-147	232	43	,	,	PUNCT
aji-147	232	44	ox40	ox40	PROPN
aji-147	232	45	,	,	PUNCT
aji-147	232	46	and	and	CCONJ
aji-147	232	47	il21	il21	PROPN
aji-147	232	48	,	,	PUNCT
aji-147	232	49	especially	especially	ADV
aji-147	232	50	in	in	ADP
aji-147	232	51	comparison	comparison	NOUN
aji-147	232	52	to	to	ADP
aji-147	232	53	tfh	tfh	NOUN
aji-147	232	54	cells	cell	NOUN
aji-147	232	55	in	in	ADP
aji-147	232	56	secondary	secondary	ADJ
aji-147	232	57	lymphoid	lymphoid	ADJ
aji-147	232	58	organs	organ	NOUN
aji-147	232	59	,	,	PUNCT
aji-147	232	60	that	that	PRON
aji-147	232	61	also	also	ADV
aji-147	232	62	express	express	VERB
aji-147	232	63	tissue	tissue	NOUN
aji-147	232	64	-	-	PUNCT
aji-147	232	65	specific	specific	ADJ
aji-147	232	66	chemokine	chemokine	ADJ
aji-147	232	67	receptors	receptor	NOUN
aji-147	232	68	,	,	PUNCT
aji-147	232	69	such	such	ADJ
aji-147	232	70	as	as	ADP
aji-147	232	71	ccr2	ccr2	PROPN
aji-147	232	72	,	,	PUNCT
aji-147	232	73	ccr5	ccr5	PROPN
aji-147	232	74	,	,	PUNCT
aji-147	232	75	cx3c	cx3c	ADJ
aji-147	232	76	-	-	ADJ
aji-147	232	77	chemokine	chemokine	ADJ
aji-147	232	78	receptor	receptor	NOUN
aji-147	232	79	1	1	NUM
aji-147	232	80	(	(	PUNCT
aji-147	232	81	cx3cr1	cx3cr1	NOUN
aji-147	232	82	)	)	PUNCT
aji-147	232	83	and	and	CCONJ
aji-147	232	84	cxcr4	cxcr4	NOUN
aji-147	233	1	[	[	X
aji-147	233	2	82,96	82,96	NUM
aji-147	233	3	-	-	SYM
aji-147	233	4	100	100	NUM
aji-147	233	5	]	]	PUNCT
aji-147	233	6	.	.	PUNCT
aji-147	234	1	tfh13	tfh13	NOUN
aji-147	234	2	cells	cell	NOUN
aji-147	234	3	,	,	PUNCT
aji-147	234	4	a	a	DET
aji-147	234	5	unique	unique	ADJ
aji-147	234	6	tfh	tfh	NOUN
aji-147	234	7	cell	cell	NOUN
aji-147	234	8	subgroup	subgroup	NOUN
aji-147	234	9	that	that	PRON
aji-147	234	10	produces	produce	VERB
aji-147	234	11	and	and	CCONJ
aji-147	234	12	secretes	secrete	NOUN
aji-147	234	13	il-4	il-4	X
aji-147	234	14	with	with	ADP
aji-147	234	15	il-13	il-13	NUM
aji-147	234	16	,	,	PUNCT
aji-147	234	17	have	have	AUX
aji-147	234	18	been	be	AUX
aji-147	234	19	newly	newly	ADV
aji-147	234	20	found	find	VERB
aji-147	234	21	to	to	PART
aji-147	234	22	be	be	AUX
aji-147	234	23	essential	essential	ADJ
aji-147	234	24	for	for	ADP
aji-147	234	25	ige	ige	PROPN
aji-147	234	26	production	production	NOUN
aji-147	234	27	in	in	ADP
aji-147	234	28	both	both	CCONJ
aji-147	234	29	human	human	ADJ
aji-147	234	30	and	and	CCONJ
aji-147	234	31	mouse	mouse	NOUN
aji-147	234	32	allergies	allergy	NOUN
aji-147	234	33	,	,	PUNCT
aji-147	234	34	and	and	CCONJ
aji-147	234	35	they	they	PRON
aji-147	234	36	exhibit	exhibit	VERB
aji-147	234	37	the	the	DET
aji-147	234	38	signaling	signal	VERB
aji-147	234	39	molecules	molecule	NOUN
aji-147	234	40	bcl-6	bcl-6	PUNCT
aji-147	234	41	and	and	CCONJ
aji-147	234	42	gata3	gata3	NOUN
aji-147	235	1	[	[	X
aji-147	235	2	101	101	NUM
aji-147	235	3	-	-	SYM
aji-147	235	4	103	103	NUM
aji-147	235	5	]	]	PUNCT
aji-147	235	6	.	.	PUNCT
aji-147	236	1	according	accord	VERB
aji-147	236	2	to	to	ADP
aji-147	236	3	current	current	ADJ
aji-147	236	4	research	research	NOUN
aji-147	236	5	,	,	PUNCT
aji-147	236	6	specific	specific	ADJ
aji-147	236	7	phenotypes	phenotype	NOUN
aji-147	236	8	for	for	ADP
aji-147	236	9	tfh	tfh	PROPN
aji-147	236	10	cells	cell	NOUN
aji-147	236	11	are	be	AUX
aji-147	236	12	required	require	VERB
aji-147	236	13	during	during	ADP
aji-147	236	14	b	b	PROPN
aji-147	236	15	cell	cell	NOUN
aji-147	236	16	differentiation	differentiation	NOUN
aji-147	236	17	and	and	CCONJ
aji-147	236	18	high	high	ADJ
aji-147	236	19	-	-	PUNCT
aji-147	236	20	affinity	affinity	NOUN
aji-147	236	21	antibody	antibody	NOUN
aji-147	236	22	production	production	NOUN
aji-147	236	23	(	(	PUNCT
aji-147	236	24	table	table	NOUN
aji-147	236	25	1	1	NUM
aji-147	236	26	)	)	PUNCT
aji-147	236	27	.	.	PUNCT
aji-147	237	1	more	more	ADV
aji-147	237	2	importantly	importantly	ADV
aji-147	237	3	,	,	PUNCT
aji-147	237	4	follicular	follicular	ADJ
aji-147	237	5	regulatory	regulatory	ADJ
aji-147	237	6	t	t	PROPN
aji-147	237	7	(	(	PUNCT
aji-147	237	8	tfr	tfr	PROPN
aji-147	237	9	)	)	PUNCT
aji-147	237	10	cells	cell	NOUN
aji-147	237	11	are	be	AUX
aji-147	237	12	a	a	DET
aji-147	237	13	subpopulation	subpopulation	NOUN
aji-147	237	14	of	of	ADP
aji-147	237	15	foxp3	foxp3	NOUN
aji-147	237	16	+	+	CCONJ
aji-147	237	17	treg	treg	PROPN
aji-147	237	18	cells	cell	NOUN
aji-147	237	19	inside	inside	ADP
aji-147	237	20	the	the	DET
aji-147	237	21	gc	gc	PROPN
aji-147	237	22	,	,	PUNCT
aji-147	237	23	launched	launch	VERB
aji-147	237	24	through	through	ADP
aji-147	237	25	foxp3+/-precursors	foxp3+/-precursor	NOUN
aji-147	237	26	and	and	CCONJ
aji-147	237	27	not	not	PART
aji-147	237	28	just	just	ADV
aji-147	237	29	from	from	ADP
aji-147	237	30	tfh	tfh	PROPN
aji-147	237	31	cells	cell	NOUN
aji-147	237	32	[	[	X
aji-147	237	33	104	104	NUM
aji-147	237	34	-	-	SYM
aji-147	237	35	107	107	NUM
aji-147	237	36	]	]	PUNCT
aji-147	237	37	.	.	PUNCT
aji-147	238	1	tfr	tfr	PROPN
aji-147	238	2	cells	cell	NOUN
aji-147	238	3	express	express	VERB
aji-147	238	4	tfh	tfh	PROPN
aji-147	238	5	cell	cell	NOUN
aji-147	238	6	markers	marker	NOUN
aji-147	238	7	such	such	ADJ
aji-147	238	8	as	as	ADP
aji-147	238	9	cxcr5	cxcr5	PROPN
aji-147	238	10	,	,	PUNCT
aji-147	238	11	bcl-6	bcl-6	ADV
aji-147	238	12	,	,	PUNCT
aji-147	238	13	pd-1	pd-1	ADV
aji-147	238	14	,	,	PUNCT
aji-147	238	15	and	and	CCONJ
aji-147	238	16	icos	icos	PROPN
aji-147	238	17	and	and	CCONJ
aji-147	238	18	treg	treg	PROPN
aji-147	238	19	cell	cell	NOUN
aji-147	238	20	molecules	molecule	NOUN
aji-147	238	21	such	such	ADJ
aji-147	238	22	as	as	ADP
aji-147	238	23	cd25	cd25	PROPN
aji-147	238	24	,	,	PUNCT
aji-147	238	25	foxp3	foxp3	NOUN
aji-147	238	26	,	,	PUNCT
aji-147	238	27	blimp-1	blimp-1	PROPN
aji-147	238	28	,	,	PUNCT
aji-147	238	29	and	and	CCONJ
aji-147	238	30	ctla-4	ctla-4	NUM
aji-147	239	1	[	[	PUNCT
aji-147	239	2	108	108	NUM
aji-147	239	3	-	-	SYM
aji-147	239	4	111	111	NUM
aji-147	239	5	]	]	PUNCT
aji-147	239	6	.	.	PUNCT
aji-147	240	1	tfr	tfr	PROPN
aji-147	240	2	cells	cell	NOUN
aji-147	240	3	,	,	PUNCT
aji-147	240	4	like	like	ADP
aji-147	240	5	treg	treg	PROPN
aji-147	240	6	cells	cell	NOUN
aji-147	240	7	,	,	PUNCT
aji-147	240	8	play	play	VERB
aji-147	240	9	a	a	DET
aji-147	240	10	significant	significant	ADJ
aji-147	240	11	role	role	NOUN
aji-147	240	12	in	in	ADP
aji-147	240	13	immunosuppression	immunosuppression	NOUN
aji-147	240	14	that	that	PRON
aji-147	240	15	is	be	AUX
aji-147	240	16	greater	great	ADJ
aji-147	240	17	than	than	ADP
aji-147	240	18	that	that	PRON
aji-147	240	19	of	of	ADP
aji-147	240	20	tfh	tfh	PROPN
aji-147	240	21	cells	cell	NOUN
aji-147	240	22	.	.	PUNCT
aji-147	241	1	tfh	tfh	NUM
aji-147	241	2	cells	cell	NOUN
aji-147	241	3	can	can	AUX
aji-147	241	4	restrict	restrict	VERB
aji-147	241	5	gc	gc	PROPN
aji-147	241	6	responses	response	NOUN
aji-147	241	7	and	and	CCONJ
aji-147	241	8	reduce	reduce	VERB
aji-147	241	9	tfh	tfh	PROPN
aji-147	241	10	and	and	CCONJ
aji-147	241	11	b	b	NOUN
aji-147	241	12	cell	cell	NOUN
aji-147	241	13	activation	activation	NOUN
aji-147	241	14	inside	inside	ADP
aji-147	241	15	gcs	gcs	PROPN
aji-147	241	16	via	via	ADP
aji-147	241	17	inhibitory	inhibitory	ADJ
aji-147	241	18	molecules	molecule	NOUN
aji-147	241	19	such	such	ADJ
aji-147	241	20	as	as	ADP
aji-147	241	21	ctla-4	ctla-4	PROPN
aji-147	241	22	,	,	PUNCT
aji-147	241	23	pd-1	pd-1	ADV
aji-147	241	24	,	,	PUNCT
aji-147	241	25	and	and	CCONJ
aji-147	241	26	il-10	il-10	PRON
aji-147	241	27	,	,	PUNCT
aji-147	241	28	as	as	ADV
aji-147	241	29	well	well	ADV
aji-147	241	30	as	as	ADP
aji-147	241	31	tgf	tgf	PROPN
aji-147	241	32	-	-	PUNCT
aji-147	241	33	b	b	NOUN
aji-147	241	34	production	production	NOUN
aji-147	241	35	.	.	PUNCT
aji-147	242	1	tfh	tfh	PROPN
aji-147	242	2	/	/	SYM
aji-147	242	3	tfr	tfr	PROPN
aji-147	242	4	cell	cell	NOUN
aji-147	242	5	equilibrium	equilibrium	NOUN
aji-147	242	6	was	be	AUX
aji-147	242	7	required	require	VERB
aji-147	242	8	to	to	PART
aji-147	242	9	regulate	regulate	VERB
aji-147	242	10	immunological	immunological	ADJ
aji-147	242	11	homeostasis	homeostasis	NOUN
aji-147	242	12	and	and	CCONJ
aji-147	242	13	modulate	modulate	VERB
aji-147	242	14	innate	innate	ADJ
aji-147	242	15	immunity	immunity	NOUN
aji-147	242	16	[	[	X
aji-147	242	17	92,96,111	92,96,111	NUM
aji-147	242	18	-	-	SYM
aji-147	242	19	114	114	NUM
aji-147	242	20	]	]	PUNCT
aji-147	242	21	.	.	PUNCT
aji-147	243	1	4	4	X
aji-147	243	2	.	.	X
aji-147	243	3	mechanism	mechanism	NOUN
aji-147	243	4	of	of	ADP
aji-147	243	5	sars	sar	NOUN
aji-147	243	6	-	-	PUNCT
aji-147	243	7	cov-2	cov-2	NOUN
aji-147	243	8	mrna	mrna	NOUN
aji-147	243	9	“	"	PUNCT
aji-147	243	10	presently	presently	ADV
aji-147	243	11	,	,	PUNCT
aji-147	243	12	the	the	DET
aji-147	243	13	emerging	emerge	VERB
aji-147	243	14	sars	sar	NOUN
aji-147	243	15	-	-	PUNCT
aji-147	243	16	cov-2	cov-2	PART
aji-147	243	17	infectious	infectious	ADJ
aji-147	243	18	outbreak	outbreak	NOUN
aji-147	243	19	is	be	AUX
aji-147	243	20	causing	cause	VERB
aji-147	243	21	a	a	DET
aji-147	243	22	significant	significant	ADJ
aji-147	243	23	challenge	challenge	NOUN
aji-147	243	24	for	for	ADP
aji-147	243	25	global	global	ADJ
aji-147	243	26	healthcare	healthcare	NOUN
aji-147	243	27	across	across	ADP
aji-147	243	28	the	the	DET
aji-147	243	29	globe	globe	NOUN
aji-147	243	30	.	.	PUNCT
aji-147	244	1	innate	innate	ADJ
aji-147	244	2	immunity	immunity	NOUN
aji-147	244	3	is	be	AUX
aji-147	244	4	required	require	VERB
aji-147	244	5	for	for	ADP
aji-147	244	6	neutralizing	neutralize	VERB
aji-147	244	7	antibodies	antibody	NOUN
aji-147	244	8	and	and	CCONJ
aji-147	244	9	is	be	AUX
aji-147	244	10	essential	essential	ADJ
aji-147	244	11	in	in	ADP
aji-147	244	12	vaccination	vaccination	NOUN
aji-147	244	13	reactions	reaction	NOUN
aji-147	244	14	against	against	ADP
aji-147	244	15	pathogenic	pathogenic	ADJ
aji-147	244	16	virus	virus	NOUN
aji-147	244	17	infections	infection	NOUN
aji-147	244	18	,	,	PUNCT
aji-147	244	19	such	such	ADJ
aji-147	244	20	as	as	ADP
aji-147	244	21	sars	sar	NOUN
aji-147	244	22	-	-	PUNCT
aji-147	244	23	cov2	cov2	PROPN
aji-147	244	24	,	,	PUNCT
aji-147	244	25	which	which	PRON
aji-147	244	26	have	have	AUX
aji-147	244	27	been	be	AUX
aji-147	244	28	linked	link	VERB
aji-147	244	29	to	to	ADP
aji-147	244	30	tfh	tfh	PROPN
aji-147	244	31	cell	cell	NOUN
aji-147	244	32	differentiation	differentiation	NOUN
aji-147	244	33	and	and	CCONJ
aji-147	244	34	function	function	NOUN
aji-147	244	35	”	"	PUNCT
aji-147	245	1	[	[	X
aji-147	245	2	55,115	55,115	NUM
aji-147	245	3	-	-	SYM
aji-147	245	4	120	120	NUM
aji-147	245	5	]	]	PUNCT
aji-147	245	6	(	(	PUNCT
aji-147	245	7	fig	fig	NOUN
aji-147	245	8	.	.	PUNCT
aji-147	245	9	2	2	NUM
aji-147	245	10	)	)	PUNCT
aji-147	245	11	.	.	PUNCT
aji-147	246	1	tfh	tfh	PROPN
aji-147	246	2	cells	cell	NOUN
aji-147	246	3	have	have	AUX
aji-147	246	4	been	be	AUX
aji-147	246	5	studied	study	VERB
aji-147	246	6	for	for	ADP
aji-147	246	7	their	their	PRON
aji-147	246	8	role	role	NOUN
aji-147	246	9	in	in	ADP
aji-147	246	10	regulating	regulate	VERB
aji-147	246	11	the	the	DET
aji-147	246	12	eradication	eradication	NOUN
aji-147	246	13	of	of	ADP
aji-147	246	14	sars	sar	NOUN
aji-147	246	15	-	-	PUNCT
aji-147	246	16	cov-2	cov-2	PART
aji-147	246	17	infections	infection	NOUN
aji-147	246	18	and	and	CCONJ
aji-147	246	19	developing	develop	VERB
aji-147	246	20	novel	novel	ADJ
aji-147	246	21	vaccines	vaccine	NOUN
aji-147	246	22	.	.	PUNCT
aji-147	247	1	much	much	ADJ
aji-147	247	2	research	research	NOUN
aji-147	247	3	showed	show	VERB
aji-147	247	4	a	a	DET
aji-147	247	5	high	high	ADJ
aji-147	247	6	frequency	frequency	NOUN
aji-147	247	7	of	of	ADP
aji-147	247	8	ctfh	ctfh	NOUN
aji-147	247	9	cells	cell	NOUN
aji-147	247	10	with	with	ADP
aji-147	247	11	the	the	DET
aji-147	247	12	cxcr5+icos+pd-1	cxcr5+icos+pd-1	NOUN
aji-147	247	13	+	+	NOUN
aji-147	247	14	phenotype	phenotype	NOUN
aji-147	247	15	.	.	PUNCT
aji-147	248	1	in	in	ADP
aji-147	248	2	a	a	DET
aji-147	248	3	patient	patient	NOUN
aji-147	248	4	with	with	ADP
aji-147	248	5	especially	especially	ADV
aji-147	248	6	non	non	ADJ
aji-147	248	7	-	-	ADJ
aji-147	248	8	recovering	recovering	ADJ
aji-147	248	9	covid19	covid19	NOUN
aji-147	248	10	patient	patient	NOUN
aji-147	248	11	,	,	PUNCT
aji-147	248	12	specific	specific	ADJ
aji-147	248	13	plasma	plasma	NOUN
aji-147	248	14	sars	sar	NOUN
aji-147	248	15	-	-	PUNCT
aji-147	248	16	cov-2	cov-2	NOUN
aji-147	248	17	-	-	PUNCT
aji-147	248	18	binding	bind	VERB
aji-147	248	19	igm	igm	NOUN
aji-147	248	20	and	and	CCONJ
aji-147	248	21	igg	igg	PROPN
aji-147	248	22	antibodies	antibody	NOUN
aji-147	248	23	increased	increase	VERB
aji-147	248	24	exponentially	exponentially	ADV
aji-147	248	25	approximately	approximately	ADV
aji-147	248	26	20	20	NUM
aji-147	248	27	days	day	NOUN
aji-147	248	28	after	after	ADP
aji-147	248	29	infection	infection	NOUN
aji-147	248	30	,	,	PUNCT
aji-147	248	31	with	with	ADP
aji-147	248	32	a	a	DET
aji-147	248	33	combination	combination	NOUN
aji-147	248	34	of	of	ADP
aji-147	248	35	enhanced	enhanced	ADJ
aji-147	248	36	specific	specific	ADJ
aji-147	248	37	plasma	plasma	NOUN
aji-147	248	38	sarscov-2	sarscov-2	ADV
aji-147	248	39	-	-	PUNCT
aji-147	248	40	binding	bind	VERB
aji-147	248	41	igm	igm	NOUN
aji-147	248	42	as	as	ADV
aji-147	248	43	well	well	ADV
aji-147	248	44	as	as	SCONJ
aji-147	248	45	igg	igg	PROPN
aji-147	248	46	antibodies	antibodie	VERB
aji-147	249	1	[	[	X
aji-147	249	2	41	41	NUM
aji-147	249	3	]	]	PUNCT
aji-147	249	4	.	.	PUNCT
aji-147	250	1	single	single	ADJ
aji-147	250	2	-	-	PUNCT
aji-147	250	3	cell	cell	NOUN
aji-147	250	4	investigation	investigation	NOUN
aji-147	250	5	showed	show	VERB
aji-147	250	6	that	that	SCONJ
aji-147	250	7	individuals	individual	NOUN
aji-147	250	8	with	with	ADP
aji-147	250	9	active	active	ADJ
aji-147	250	10	covid-19	covid-19	PROPN
aji-147	250	11	infection	infection	NOUN
aji-147	250	12	had	have	VERB
aji-147	250	13	higher	high	ADJ
aji-147	250	14	frequencies	frequency	NOUN
aji-147	250	15	of	of	ADP
aji-147	250	16	ctfh	ctfh	NOUN
aji-147	250	17	cells	cell	NOUN
aji-147	250	18	and	and	CCONJ
aji-147	250	19	a	a	DET
aji-147	250	20	large	large	ADJ
aji-147	250	21	percentage	percentage	NOUN
aji-147	250	22	with	with	ADP
aji-147	250	23	specific	specific	ADJ
aji-147	250	24	anti	anti	ADJ
aji-147	250	25	-	-	ADJ
aji-147	250	26	sars	sar	NOUN
aji-147	250	27	-	-	PUNCT
aji-147	250	28	cov-2	cov-2	NOUN
aji-147	250	29	antibodies	antibodie	VERB
aji-147	250	30	,	,	PUNCT
aji-147	250	31	such	such	ADJ
aji-147	250	32	as	as	ADP
aji-147	250	33	iga	iga	PROPN
aji-147	250	34	and	and	CCONJ
aji-147	250	35	igg	igg	PROPN
aji-147	251	1	[	[	X
aji-147	251	2	121	121	NUM
aji-147	251	3	]	]	PUNCT
aji-147	251	4	.	.	PUNCT
aji-147	252	1	“	"	PUNCT
aji-147	252	2	in	in	ADP
aji-147	252	3	recovered	recover	VERB
aji-147	252	4	covid-19	covid-19	PROPN
aji-147	252	5	patients	patient	NOUN
aji-147	252	6	,	,	PUNCT
aji-147	252	7	the	the	DET
aji-147	252	8	percentages	percentage	NOUN
aji-147	252	9	of	of	ADP
aji-147	252	10	spike	spike	NOUN
aji-147	252	11	(	(	PUNCT
aji-147	252	12	s)-specific	s)-specific	PUNCT
aji-147	252	13	ctfh	ctfh	NOUN
aji-147	252	14	cells	cell	NOUN
aji-147	252	15	(	(	PUNCT
aji-147	252	16	cd3+cd4+cd45ra	cd3+cd4+cd45ra	ADJ
aji-147	252	17	–	–	PUNCT
aji-147	252	18	cxcr5	cxcr5	NOUN
aji-147	252	19	+	+	NOUN
aji-147	252	20	)	)	PUNCT
aji-147	252	21	are	be	AUX
aji-147	252	22	continuously	continuously	ADV
aji-147	252	23	produced	produce	VERB
aji-147	252	24	after	after	ADP
aji-147	252	25	s	s	NOUN
aji-147	252	26	-	-	PUNCT
aji-147	252	27	peptide	peptide	ADJ
aji-147	252	28	activation	activation	NOUN
aji-147	252	29	and	and	CCONJ
aji-147	252	30	show	show	VERB
aji-147	252	31	a	a	DET
aji-147	252	32	significant	significant	ADJ
aji-147	252	33	phenotypic	phenotypic	ADJ
aji-147	252	34	inclination	inclination	NOUN
aji-147	252	35	toward	toward	ADP
aji-147	252	36	the	the	DET
aji-147	252	37	accr6+cxcr3	accr6+cxcr3	PROPN
aji-147	252	38	-	-	PUNCT
aji-147	252	39	ctfh17	ctfh17	NOUN
aji-147	252	40	cell	cell	NOUN
aji-147	252	41	phenotype	phenotype	NOUN
aji-147	252	42	.	.	PUNCT
aji-147	253	1	another	another	DET
aji-147	253	2	study	study	NOUN
aji-147	253	3	discovered	discover	VERB
aji-147	253	4	that	that	SCONJ
aji-147	253	5	significantly	significantly	ADV
aji-147	253	6	enlarged	enlarge	VERB
aji-147	253	7	cxcr3+ctfh1	cxcr3+ctfh1	NOUN
aji-147	253	8	cells	cell	NOUN
aji-147	253	9	were	be	AUX
aji-147	253	10	associated	associate	VERB
aji-147	253	11	with	with	ADP
aji-147	253	12	such	such	DET
aji-147	253	13	a	a	DET
aji-147	253	14	solid	solid	ADJ
aji-147	253	15	neutralizing	neutralizing	ADJ
aji-147	253	16	immunological	immunological	ADJ
aji-147	253	17	response	response	NOUN
aji-147	253	18	to	to	ADP
aji-147	253	19	influenza	influenza	NOUN
aji-147	253	20	vaccination	vaccination	NOUN
aji-147	253	21	and	and	CCONJ
aji-147	253	22	live	live	VERB
aji-147	253	23	attenuated	attenuate	VERB
aji-147	253	24	yellow	yellow	ADJ
aji-147	253	25	fever	fever	NOUN
aji-147	253	26	immunization	immunization	NOUN
aji-147	253	27	”	"	PUNCT
aji-147	254	1	[	[	X
aji-147	254	2	37,122	37,122	NUM
aji-147	254	3	]	]	PUNCT
aji-147	254	4	.	.	PUNCT
aji-147	255	1	the	the	DET
aji-147	255	2	latest	late	ADJ
aji-147	255	3	research	research	NOUN
aji-147	255	4	found	find	VERB
aji-147	255	5	that	that	SCONJ
aji-147	255	6	increasing	increase	VERB
aji-147	255	7	numbers	number	NOUN
aji-147	255	8	of	of	ADP
aji-147	255	9	ccr7lowpd-1	ccr7lowpd-1	ADJ
aji-147	255	10	+	+	PROPN
aji-147	255	11	ctfh	ctfh	NOUN
aji-147	255	12	-	-	PUNCT
aji-147	255	13	effector	effector	NOUN
aji-147	255	14	memory	memory	NOUN
aji-147	255	15	(	(	PUNCT
aji-147	255	16	em	em	PRON
aji-147	255	17	)	)	PUNCT
aji-147	255	18	,	,	PUNCT
aji-147	255	19	ctfh1	ctfh1	NOUN
aji-147	255	20	but	but	CCONJ
aji-147	255	21	instead	instead	ADV
aji-147	255	22	ctfh2	ctfh2	NOUN
aji-147	255	23	cells	cell	NOUN
aji-147	255	24	,	,	PUNCT
aji-147	255	25	and	and	CCONJ
aji-147	255	26	also	also	ADV
aji-147	255	27	high	high	ADJ
aji-147	255	28	il-1b	il-1b	PROPN
aji-147	255	29	and	and	CCONJ
aji-147	255	30	tnf	tnf	PROPN
aji-147	255	31	-	-	PUNCT
aji-147	255	32	a	a	PROPN
aji-147	255	33	,	,	PUNCT
aji-147	255	34	are	be	AUX
aji-147	255	35	found	find	VERB
aji-147	255	36	in	in	ADP
aji-147	255	37	cxcr5+cd45racd25	cxcr5+cd45racd25	ADJ
aji-147	255	38	-	-	PUNCT
aji-147	255	39	cd4+t	cd4+t	ADJ
aji-147	255	40	cells	cell	NOUN
aji-147	255	41	,	,	PUNCT
aji-147	255	42	and	and	CCONJ
aji-147	255	43	therefore	therefore	ADV
aji-147	255	44	,	,	PUNCT
aji-147	255	45	ctfh1	ctfh1	ADJ
aji-147	255	46	cells	cell	NOUN
aji-147	255	47	were	be	AUX
aji-147	255	48	related	relate	VERB
aji-147	255	49	to	to	ADP
aji-147	255	50	increased	increase	VERB
aji-147	255	51	sars	sar	NOUN
aji-147	255	52	-	-	PUNCT
aji-147	255	53	cov-2	cov-2	NOUN
aji-147	255	54	-	-	PUNCT
aji-147	255	55	specific	specific	ADJ
aji-147	255	56	igg	igg	PROPN
aji-147	255	57	/	/	SYM
aji-147	255	58	igm	igm	PROPN
aji-147	255	59	antibodies	antibodie	VERB
aji-147	255	60	.	.	PUNCT
aji-147	256	1	while	while	SCONJ
aji-147	256	2	ccr7highpd-1	ccr7highpd-1	NOUN
aji-147	256	3	-	-	ADJ
aji-147	256	4	ctfh	ctfh	ADJ
aji-147	256	5	-	-	PUNCT
aji-147	256	6	central	central	ADJ
aji-147	256	7	memory	memory	NOUN
aji-147	256	8	(	(	PUNCT
aji-147	256	9	cm	cm	NOUN
aji-147	256	10	)	)	PUNCT
aji-147	256	11	and	and	CCONJ
aji-147	256	12	ctfh17	ctfh17	NOUN
aji-147	256	13	cells	cell	NOUN
aji-147	256	14	within	within	ADP
aji-147	256	15	cxcr5+cd45racd25cd4+t	cxcr5+cd45racd25cd4+t	NOUN
aji-147	256	16	cells	cell	NOUN
aji-147	256	17	were	be	AUX
aji-147	256	18	reduced	reduce	VERB
aji-147	256	19	in	in	ADP
aji-147	256	20	recovered	recovered	ADJ
aji-147	256	21	patients	patient	NOUN
aji-147	256	22	compared	compare	VERB
aji-147	256	23	to	to	ADP
aji-147	256	24	healthy	healthy	ADJ
aji-147	256	25	patients	patient	NOUN
aji-147	256	26	,	,	PUNCT
aji-147	256	27	ctfr	ctfr	VERB
aji-147	256	28	cells	cell	NOUN
aji-147	256	29	within	within	ADP
aji-147	256	30	treg	treg	PROPN
aji-147	256	31	cells	cell	NOUN
aji-147	256	32	were	be	AUX
aji-147	256	33	increased	increase	VERB
aji-147	256	34	.	.	PUNCT
aji-147	257	1	the	the	DET
aji-147	257	2	frequency	frequency	NOUN
aji-147	257	3	of	of	ADP
aji-147	257	4	high	high	ADJ
aji-147	257	5	ctfh	ctfh	NOUN
aji-147	257	6	-	-	PUNCT
aji-147	257	7	em	em	PROPN
aji-147	257	8	,	,	PUNCT
aji-147	257	9	low	low	ADJ
aji-147	257	10	ctfh	ctfh	NOUN
aji-147	257	11	-	-	PUNCT
aji-147	257	12	cm	cm	NOUN
aji-147	257	13	,	,	PUNCT
aji-147	257	14	and	and	CCONJ
aji-147	257	15	ctfr	ctfr	NOUN
aji-147	257	16	cells	cell	NOUN
aji-147	257	17	was	be	AUX
aji-147	257	18	also	also	ADV
aji-147	257	19	associated	associate	VERB
aji-147	257	20	with	with	ADP
aji-147	257	21	disease	disease	NOUN
aji-147	257	22	severity	severity	NOUN
aji-147	257	23	[	[	X
aji-147	257	24	43	43	NUM
aji-147	257	25	]	]	PUNCT
aji-147	257	26	.	.	PUNCT
aji-147	258	1	these	these	DET
aji-147	258	2	findings	finding	NOUN
aji-147	258	3	suggest	suggest	VERB
aji-147	258	4	that	that	SCONJ
aji-147	258	5	ctfh	ctfh	NOUN
aji-147	258	6	cell	cell	NOUN
aji-147	258	7	morphological	morphological	ADJ
aji-147	258	8	characteristics	characteristic	NOUN
aji-147	258	9	can	can	AUX
aji-147	258	10	produce	produce	VERB
aji-147	258	11	significant	significant	ADJ
aji-147	258	12	neutralized	neutralize	VERB
aji-147	258	13	antibodies	antibody	NOUN
aji-147	258	14	toward	toward	ADP
aji-147	258	15	sars	sar	NOUN
aji-147	258	16	-	-	PUNCT
aji-147	258	17	cov-2	cov-2	NOUN
aji-147	258	18	in	in	ADP
aji-147	258	19	covid-19	covid-19	PROPN
aji-147	258	20	-	-	PUNCT
aji-147	258	21	recovered	recover	VERB
aji-147	258	22	patients	patient	NOUN
aji-147	258	23	,	,	PUNCT
aji-147	258	24	which	which	PRON
aji-147	258	25	will	will	AUX
aji-147	258	26	help	help	VERB
aji-147	258	27	develop	develop	VERB
aji-147	258	28	antibody	antibody	NOUN
aji-147	258	29	-	-	PUNCT
aji-147	258	30	based	base	VERB
aji-147	258	31	treatments	treatment	NOUN
aji-147	258	32	and	and	CCONJ
aji-147	258	33	vaccines	vaccine	NOUN
aji-147	258	34	for	for	ADP
aji-147	258	35	covid-19	covid-19	PROPN
aji-147	258	36	.	.	PUNCT
aji-147	258	37	shukla	shukla	PROPN
aji-147	258	38	et	et	PROPN
aji-147	258	39	al	al	PROPN
aji-147	258	40	.	.	PROPN
aji-147	258	41	;	;	PUNCT
aji-147	259	1	asian	asian	PROPN
aji-147	259	2	j.	j.	PROPN
aji-147	259	3	immunol	immunol	PROPN
aji-147	259	4	.	.	PROPN
aji-147	259	5	,	,	PUNCT
aji-147	259	6	vol	vol	NOUN
aji-147	259	7	.	.	PROPN
aji-147	259	8	7	7	NUM
aji-147	259	9	,	,	PUNCT
aji-147	259	10	no	no	INTJ
aji-147	259	11	.	.	NOUN
aji-147	259	12	1	1	NUM
aji-147	259	13	,	,	PUNCT
aji-147	259	14	pp	pp	ADJ
aji-147	259	15	.	.	PUNCT
aji-147	260	1	228	228	NUM
aji-147	260	2	-	-	SYM
aji-147	260	3	246	246	NUM
aji-147	260	4	,	,	PUNCT
aji-147	260	5	2024	2024	NUM
aji-147	260	6	;	;	PUNCT
aji-147	260	7	article	article	NOUN
aji-147	260	8	no.aji.125387	no.aji.125387	NOUN
aji-147	260	9	234	234	NUM
aji-147	260	10	table	table	NOUN
aji-147	260	11	1	1	NUM
aji-147	260	12	.	.	PUNCT
aji-147	261	1	phenotypes	phenotype	NOUN
aji-147	261	2	of	of	ADP
aji-147	261	3	tfh	tfh	PROPN
aji-147	261	4	cell	cell	NOUN
aji-147	261	5	subsets	subset	NOUN
aji-147	261	6	in	in	ADP
aji-147	261	7	blood	blood	NOUN
aji-147	261	8	and	and	CCONJ
aji-147	261	9	lymphoid	lymphoid	ADJ
aji-147	261	10	tissue	tissue	NOUN
aji-147	261	11	location	location	NOUN
aji-147	261	12	cell	cell	NOUN
aji-147	261	13	subsets	subset	NOUN
aji-147	261	14	phenotypic	phenotypic	NOUN
aji-147	261	15	markers	marker	NOUN
aji-147	261	16	ref	ref	NOUN
aji-147	261	17	.	.	PUNCT
aji-147	262	1	lymphoid	lymphoid	ADJ
aji-147	262	2	tissues	tissue	NOUN
aji-147	262	3	pre	pre	ADJ
aji-147	262	4	-	-	ADJ
aji-147	262	5	tfh	tfh	ADJ
aji-147	262	6	cells	cell	NOUN
aji-147	262	7	pd-1	pd-1	ADP
aji-147	262	8	+	+	PROPN
aji-147	262	9	icos+	icos+	X
aji-147	262	10	ccr7lowbcl-6lowblimp-1cxcr5	ccr7lowbcl-6lowblimp-1cxcr5	NOUN
aji-147	262	11	+	+	CCONJ
aji-147	263	1	[	[	X
aji-147	263	2	62,87,88	62,87,88	NUM
aji-147	263	3	]	]	X
aji-147	263	4	gc	gc	PROPN
aji-147	263	5	tfh	tfh	PROPN
aji-147	263	6	cells	cells	PROPN
aji-147	263	7	pd-1++icos++ccr7bcl-6	pd-1++icos++ccr7bcl-6	NOUN
aji-147	263	8	+	+	CCONJ
aji-147	263	9	blimp-1cxcr5++	blimp-1cxcr5++	NOUN
aji-147	263	10	memory	memory	NOUN
aji-147	263	11	tfh	tfh	PROPN
aji-147	263	12	cells	cell	NOUN
aji-147	263	13	pd-1	pd-1	ADP
aji-147	263	14	+	+	PROPN
aji-147	263	15	icos+	icos+	X
aji-147	263	16	ccr7lowbcl-6lowblimp-1cxcr5	ccr7lowbcl-6lowblimp-1cxcr5	NOUN
aji-147	263	17	+	+	CCONJ
aji-147	263	18	blood	blood	NOUN
aji-147	263	19	ctfh1/17	ctfh1/17	NOUN
aji-147	263	20	cells	cell	NOUN
aji-147	263	21	ifn	ifn	PROPN
aji-147	263	22	-	-	PUNCT
aji-147	263	23	g	g	NOUN
aji-147	263	24	+	+	PROPN
aji-147	263	25	il-17a+	il-17a+	PROPN
aji-147	263	26	bcl-6blimp-1cxcr5	bcl-6blimp-1cxcr5	PROPN
aji-147	263	27	+	+	CCONJ
aji-147	263	28	(	(	PUNCT
aji-147	263	29	or	or	CCONJ
aji-147	263	30	)	)	PUNCT
aji-147	263	31	cxcr3	cxcr3	PROPN
aji-147	263	32	+	+	CCONJ
aji-147	263	33	ccr6	ccr6	PROPN
aji-147	263	34	+	+	CCONJ
aji-147	263	35	bcl-6blimp-1cxcr5	bcl-6blimp-1cxcr5	NOUN
aji-147	263	36	+	+	NUM
aji-147	263	37	ctfh17	ctfh17	NOUN
aji-147	263	38	cells	cells	PROPN
aji-147	263	39	il-17a+	il-17a+	PROPN
aji-147	263	40	bcl-6blimp-1cxcr5	bcl-6blimp-1cxcr5	PROPN
aji-147	263	41	+	+	CCONJ
aji-147	263	42	(	(	PUNCT
aji-147	263	43	or	or	CCONJ
aji-147	263	44	)	)	PUNCT
aji-147	263	45	cxcr3ccr6	cxcr3ccr6	NOUN
aji-147	263	46	+	+	CCONJ
aji-147	263	47	bcl-6blimp-1cxcr5	bcl-6blimp-1cxcr5	NOUN
aji-147	263	48	+	+	ADJ
aji-147	263	49	ctfh2	ctfh2	NOUN
aji-147	263	50	cells	cell	NOUN
aji-147	263	51	il-4	il-4	X
aji-147	263	52	+	+	NUM
aji-147	263	53	bcl-6blimp-1cxcr5	bcl-6blimp-1cxcr5	X
aji-147	263	54	+	+	NUM
aji-147	263	55	(	(	PUNCT
aji-147	263	56	or	or	CCONJ
aji-147	263	57	)	)	PUNCT
aji-147	263	58	cxcr3ccr6bcl-6blimp-1cxcr5	cxcr3ccr6bcl-6blimp-1cxcr5	X
aji-147	263	59	+	+	X
aji-147	263	60	ctfh1	ctfh1	NOUN
aji-147	263	61	cells	cell	NOUN
aji-147	263	62	ifn	ifn	NOUN
aji-147	263	63	-	-	PUNCT
aji-147	263	64	g	g	NOUN
aji-147	263	65	+	+	NUM
aji-147	263	66	bcl-6blimp-1cxcr5	bcl-6blimp-1cxcr5	X
aji-147	263	67	+	+	NUM
aji-147	263	68	(	(	PUNCT
aji-147	263	69	or	or	CCONJ
aji-147	263	70	)	)	PUNCT
aji-147	263	71	pd-1	pd-1	ADV
aji-147	263	72	+	+	ADJ
aji-147	263	73	icos+	icos+	ADP
aji-147	263	74	ccr7lowcxcr3	ccr7lowcxcr3	PROPN
aji-147	263	75	+	+	PROPN
aji-147	263	76	ccr6bcl-6blimp-1cxcr5	ccr6bcl-6blimp-1cxcr5	PROPN
aji-147	263	77	+	+	CCONJ
aji-147	263	78	effector	effector	NOUN
aji-147	263	79	memory	memory	NOUN
aji-147	263	80	tfh	tfh	PROPN
aji-147	263	81	cells	cell	NOUN
aji-147	263	82	cd40l+	cd40l+	NOUN
aji-147	263	83	/pd-1	/pd-1	PUNCT
aji-147	264	1	+	+	NUM
aji-147	264	2	/icos+	/icos+	ADJ
aji-147	264	3	ccr7lowbcl-6blimp-1cxcr5	ccr7lowbcl-6blimp-1cxcr5	PROPN
aji-147	264	4	+	+	CCONJ
aji-147	264	5	central	central	ADJ
aji-147	264	6	memory	memory	NOUN
aji-147	264	7	tfh	tfh	PROPN
aji-147	264	8	cells	cell	NOUN
aji-147	264	9	pd-1icos	pd-1icos	PROPN
aji-147	264	10	-	-	PUNCT
aji-147	264	11	ccr7highbcl-6blimp-1cxcr5	ccr7highbcl-6blimp-1cxcr5	NOUN
aji-147	264	12	+	+	NOUN
aji-147	264	13	ctfh13	ctfh13	NOUN
aji-147	264	14	cells	cell	NOUN
aji-147	264	15	il-13hiil-4hiil-5hiil-21lowbcl-6	il-13hiil-4hiil-5hiil-21lowbcl-6	NOUN
aji-147	264	16	+	+	ADJ
aji-147	264	17	gata3	gata3	PROPN
aji-147	264	18	+	+	X
aji-147	264	19	cxcr5	cxcr5	PROPN
aji-147	265	1	+	+	X
aji-147	265	2	[	[	X
aji-147	265	3	101	101	NUM
aji-147	265	4	-	-	SYM
aji-147	265	5	103	103	NUM
aji-147	265	6	]	]	X
aji-147	265	7	†	†	PROPN
aji-147	265	8	pd-1	pd-1	PROPN
aji-147	265	9	,	,	PUNCT
aji-147	265	10	programmed	program	VERB
aji-147	265	11	cell	cell	NOUN
aji-147	265	12	death	death	NOUN
aji-147	265	13	protein-1	protein-1	PROPN
aji-147	265	14	;	;	PUNCT
aji-147	265	15	ccr7	ccr7	PROPN
aji-147	265	16	,	,	PUNCT
aji-147	265	17	cc	cc	NOUN
aji-147	265	18	-	-	ADJ
aji-147	265	19	chemokine	chemokine	ADJ
aji-147	265	20	receptor	receptor	NOUN
aji-147	265	21	7	7	NUM
aji-147	265	22	;	;	PUNCT
aji-147	265	23	cxcr3	cxcr3	PROPN
aji-147	265	24	,	,	PUNCT
aji-147	265	25	cxc	cxc	NOUN
aji-147	265	26	-	-	PUNCT
aji-147	265	27	chemokine	chemokine	ADJ
aji-147	265	28	receptor	receptor	NOUN
aji-147	265	29	3	3	NUM
aji-147	265	30	;	;	PUNCT
aji-147	265	31	ccr6	ccr6	NOUN
aji-147	265	32	,	,	PUNCT
aji-147	265	33	cxc	cxc	NOUN
aji-147	265	34	-	-	PUNCT
aji-147	265	35	chemokine	chemokine	ADJ
aji-147	265	36	receptor	receptor	NOUN
aji-147	265	37	6	6	NUM
aji-147	265	38	;	;	PUNCT
aji-147	265	39	cxcr5	cxcr5	PROPN
aji-147	265	40	,	,	PUNCT
aji-147	265	41	cxc	cxc	NOUN
aji-147	265	42	-	-	PUNCT
aji-147	265	43	chemokine	chemokine	ADJ
aji-147	265	44	receptor	receptor	NOUN
aji-147	265	45	5	5	NUM
aji-147	265	46	;	;	PUNCT
aji-147	265	47	icos	icos	PROPN
aji-147	265	48	,	,	PUNCT
aji-147	265	49	inducible	inducible	ADJ
aji-147	265	50	t	t	PROPN
aji-147	265	51	cell	cell	NOUN
aji-147	265	52	co	co	NOUN
aji-147	265	53	-	-	NOUN
aji-147	265	54	stimulator	stimulator	NOUN
aji-147	265	55	shukla	shukla	NOUN
aji-147	265	56	et	et	PROPN
aji-147	265	57	al	al	PROPN
aji-147	265	58	.	.	PROPN
aji-147	265	59	;	;	PUNCT
aji-147	265	60	asian	asian	PROPN
aji-147	265	61	j.	j.	PROPN
aji-147	265	62	immunol	immunol	PROPN
aji-147	265	63	.	.	PROPN
aji-147	265	64	,	,	PUNCT
aji-147	265	65	vol	vol	NOUN
aji-147	265	66	.	.	PROPN
aji-147	265	67	7	7	NUM
aji-147	265	68	,	,	PUNCT
aji-147	265	69	no	no	INTJ
aji-147	265	70	.	.	NOUN
aji-147	265	71	1	1	NUM
aji-147	265	72	,	,	PUNCT
aji-147	265	73	pp	pp	ADJ
aji-147	265	74	.	.	PUNCT
aji-147	266	1	228	228	NUM
aji-147	266	2	-	-	SYM
aji-147	266	3	246	246	NUM
aji-147	266	4	,	,	PUNCT
aji-147	266	5	2024	2024	NUM
aji-147	266	6	;	;	PUNCT
aji-147	266	7	article	article	NOUN
aji-147	266	8	no.aji.125387	no.aji.125387	NOUN
aji-147	266	9	235	235	NUM
aji-147	266	10	table	table	NOUN
aji-147	266	11	2	2	NUM
aji-147	266	12	.	.	PUNCT
aji-147	267	1	tfh	tfh	NOUN
aji-147	267	2	cell	cell	NOUN
aji-147	267	3	responses	response	NOUN
aji-147	267	4	in	in	ADP
aji-147	267	5	various	various	ADJ
aji-147	267	6	vaccine	vaccine	NOUN
aji-147	267	7	candidates	candidate	NOUN
aji-147	267	8	of	of	ADP
aji-147	267	9	sars	sar	NOUN
aji-147	267	10	-	-	PUNCT
aji-147	267	11	cov-2	cov-2	PART
aji-147	267	12	vaccine	vaccine	NOUN
aji-147	267	13	candidates	candidate	NOUN
aji-147	267	14	phenotypes	phenotype	NOUN
aji-147	267	15	function	function	VERB
aji-147	267	16	antibody	antibody	NOUN
aji-147	267	17	isotypes	isotype	NOUN
aji-147	267	18	ref	ref	VERB
aji-147	267	19	.	.	PUNCT
aji-147	268	1	mrna	mrna	PROPN
aji-147	268	2	vaccines	vaccine	NOUN
aji-147	268	3	bnt162b2	bnt162b2	PROPN
aji-147	268	4	mrna	mrna	PROPN
aji-147	268	5	vaccine	vaccine	NOUN
aji-147	268	6	aim+	aim+	PROPN
aji-147	268	7	cxcr5	cxcr5	PROPN
aji-147	268	8	+	+	CCONJ
aji-147	268	9	cd45ra	cd45ra	PROPN
aji-147	268	10	-	-	PUNCT
aji-147	268	11	cd3	cd3	VERB
aji-147	268	12	+	+	CCONJ
aji-147	268	13	ctfh	ctfh	NOUN
aji-147	268	14	cells	cell	NOUN
aji-147	268	15	expansion	expansion	NOUN
aji-147	268	16	,	,	PUNCT
aji-147	268	17	aim	aim	VERB
aji-147	268	18	cells	cell	NOUN
aji-147	268	19	include	include	VERB
aji-147	268	20	cd69	cd69	PROPN
aji-147	268	21	+	+	NOUN
aji-147	268	22	ox40	ox40	PROPN
aji-147	268	23	+	+	CCONJ
aji-147	268	24	or	or	CCONJ
aji-147	268	25	cd69	cd69	PROPN
aji-147	268	26	+	+	PROPN
aji-147	268	27	cd40l+	cd40l+	NOUN
aji-147	268	28	(	(	PUNCT
aji-147	268	29	or	or	CCONJ
aji-147	268	30	)	)	PUNCT
aji-147	268	31	cd69	cd69	PROPN
aji-147	268	32	+	+	CCONJ
aji-147	268	33	4	4	NUM
aji-147	268	34	-	-	PUNCT
aji-147	268	35	1bb+	1bb+	NUM
aji-147	268	36	(	(	PUNCT
aji-147	268	37	or	or	CCONJ
aji-147	268	38	)	)	PUNCT
aji-147	269	1	ox40	ox40	PROPN
aji-147	269	2	+	+	NUM
aji-147	269	3	4	4	NUM
aji-147	269	4	-	-	PUNCT
aji-147	269	5	1bb+	1bb+	NUM
aji-147	269	6	(	(	PUNCT
aji-147	269	7	or	or	CCONJ
aji-147	269	8	)	)	PUNCT
aji-147	269	9	cd40l+	cd40l+	NOUN
aji-147	269	10	4	4	NUM
aji-147	269	11	-	-	SYM
aji-147	269	12	1bb+	1bb+	NUM
aji-147	269	13	(	(	PUNCT
aji-147	269	14	or	or	CCONJ
aji-147	269	15	)	)	PUNCT
aji-147	269	16	cd40l+	cd40l+	NOUN
aji-147	270	1	ox40	ox40	PROPN
aji-147	270	2	+	+	CCONJ
aji-147	270	3	positively	positively	ADV
aji-147	270	4	correlate	correlate	VERB
aji-147	270	5	with	with	ADP
aji-147	270	6	anti	anti	ADJ
aji-147	270	7	-	-	ADJ
aji-147	270	8	spikespecific	spikespecific	ADJ
aji-147	270	9	iga	iga	PROPN
aji-147	270	10	and	and	CCONJ
aji-147	270	11	igg	igg	PROPN
aji-147	270	12	titers	titer	NOUN
aji-147	270	13	.	.	PUNCT
aji-147	271	1	iga	iga	PROPN
aji-147	271	2	,	,	PUNCT
aji-147	271	3	igg	igg	PROPN
aji-147	272	1	[	[	X
aji-147	272	2	124	124	NUM
aji-147	272	3	]	]	X
aji-147	272	4	rbd	rbd	PROPN
aji-147	272	5	mrna	mrna	PROPN
aji-147	272	6	(	(	PUNCT
aji-147	272	7	receptor	receptor	NOUN
aji-147	272	8	binding	bind	VERB
aji-147	272	9	domain	domain	NOUN
aji-147	272	10	,	,	PUNCT
aji-147	272	11	rbd	rbd	NOUN
aji-147	272	12	)	)	PUNCT
aji-147	272	13	b220	b220	PROPN
aji-147	272	14	-	-	PUNCT
aji-147	272	15	cd4	cd4	PROPN
aji-147	272	16	+	+	ADJ
aji-147	272	17	cd44hicd62l	cd44hicd62l	PROPN
aji-147	272	18	-	-	PUNCT
aji-147	272	19	cxcr5	cxcr5	NOUN
aji-147	272	20	+	+	CCONJ
aji-147	272	21	bcl-6	bcl-6	PUNCT
aji-147	272	22	+	+	ADJ
aji-147	272	23	tfh	tfh	NOUN
aji-147	272	24	cells	cell	NOUN
aji-147	272	25	,	,	PUNCT
aji-147	272	26	b220	b220	PROPN
aji-147	272	27	cd4	cd4	PROPN
aji-147	272	28	+	+	PROPN
aji-147	272	29	cd44hicxcr5	cd44hicxcr5	NOUN
aji-147	272	30	+	+	CCONJ
aji-147	272	31	pd-1hi	pd-1hi	ADJ
aji-147	272	32	il-21	il-21	PRON
aji-147	272	33	+	+	ADJ
aji-147	272	34	tfh	tfh	NOUN
aji-147	272	35	cells	cell	NOUN
aji-147	272	36	,	,	PUNCT
aji-147	272	37	b220cd4	b220cd4	PROPN
aji-147	272	38	+	+	SYM
aji-147	272	39	cd44hicxcr5	cd44hicxcr5	NOUN
aji-147	272	40	+	+	CCONJ
aji-147	272	41	bcl-6	bcl-6	PUNCT
aji-147	272	42	+	+	ADJ
aji-147	272	43	icos+	icos+	PROPN
aji-147	272	44	tfh	tfh	PROPN
aji-147	272	45	cells	cell	NOUN
aji-147	272	46	,	,	PUNCT
aji-147	272	47	b220cd4	b220cd4	NUM
aji-147	272	48	+	+	SYM
aji-147	272	49	cd44hicxcr5	cd44hicxcr5	NOUN
aji-147	272	50	+	+	CCONJ
aji-147	272	51	pd-1hi	pd-1hi	VERB
aji-147	272	52	ifn	ifn	NOUN
aji-147	272	53	-	-	PUNCT
aji-147	272	54	g	g	NOUN
aji-147	272	55	+	+	CCONJ
aji-147	272	56	tfh	tfh	PROPN
aji-147	272	57	cells	cell	NOUN
aji-147	272	58	notable	notable	ADJ
aji-147	272	59	expansion	expansion	NOUN
aji-147	272	60	elicit	elicit	VERB
aji-147	272	61	potent	potent	ADJ
aji-147	272	62	sars	sar	NOUN
aji-147	272	63	-	-	PUNCT
aji-147	272	64	cov-2	cov-2	NOUN
aji-147	272	65	-	-	PUNCT
aji-147	272	66	specific	specific	ADJ
aji-147	272	67	gc	gc	PROPN
aji-147	272	68	b	b	PROPN
aji-147	272	69	responses	response	NOUN
aji-147	272	70	and	and	CCONJ
aji-147	272	71	induce	induce	VERB
aji-147	272	72	robust	robust	ADJ
aji-147	272	73	and	and	CCONJ
aji-147	272	74	specific	specific	ADJ
aji-147	272	75	antibody	antibody	NOUN
aji-147	272	76	responses	response	NOUN
aji-147	272	77	,	,	PUNCT
aji-147	272	78	including	include	VERB
aji-147	272	79	neutralizing	neutralize	VERB
aji-147	272	80	antibodies	antibody	NOUN
aji-147	272	81	.	.	PUNCT
aji-147	273	1	gg1	gg1	NOUN
aji-147	273	2	,	,	PUNCT
aji-147	273	3	igg2a	igg2a	PROPN
aji-147	273	4	,	,	PUNCT
aji-147	273	5	igg2b	igg2b	PRON
aji-147	273	6	,	,	PUNCT
aji-147	273	7	full	full	ADJ
aji-147	273	8	sδ	sδ	ADJ
aji-147	273	9	furin	furin	NOUN
aji-147	273	10	mrna	mrna	PROPN
aji-147	273	11	b220cd4	b220cd4	PROPN
aji-147	273	12	+	+	CCONJ
aji-147	273	13	cd44hicd62l	cd44hicd62l	PROPN
aji-147	273	14	-	-	PUNCT
aji-147	273	15	cxcr5	cxcr5	NOUN
aji-147	273	16	+	+	CCONJ
aji-147	273	17	bcl-6	bcl-6	PUNCT
aji-147	273	18	+	+	ADJ
aji-147	273	19	tfh	tfh	NOUN
aji-147	273	20	cells	cell	NOUN
aji-147	273	21	,	,	PUNCT
aji-147	273	22	b220cd4	b220cd4	NUM
aji-147	273	23	+	+	SYM
aji-147	273	24	cd44hicxcr5	cd44hicxcr5	NOUN
aji-147	273	25	+	+	CCONJ
aji-147	273	26	pd-1hi	pd-1hi	ADJ
aji-147	273	27	il-21	il-21	PRON
aji-147	273	28	+	+	ADJ
aji-147	273	29	tfh	tfh	NOUN
aji-147	273	30	cells	cell	NOUN
aji-147	273	31	,	,	PUNCT
aji-147	273	32	b220	b220	PROPN
aji-147	273	33	-	-	PUNCT
aji-147	273	34	cd4	cd4	PROPN
aji-147	273	35	+	+	PROPN
aji-147	273	36	cd44hicxcr5	cd44hicxcr5	NOUN
aji-147	273	37	+	+	CCONJ
aji-147	273	38	bcl-6	bcl-6	PUNCT
aji-147	273	39	+	+	ADJ
aji-147	273	40	icos+	icos+	PROPN
aji-147	273	41	tfh	tfh	PROPN
aji-147	273	42	cells	cell	NOUN
aji-147	273	43	b220	b220	PROPN
aji-147	273	44	-	-	PUNCT
aji-147	273	45	cd4	cd4	PROPN
aji-147	273	46	+	+	PROPN
aji-147	273	47	cd44hicxcr5	cd44hicxcr5	ADJ
aji-147	273	48	+	+	CCONJ
aji-147	273	49	pd-1hi	pd-1hi	ADJ
aji-147	273	50	elicit	elicit	ADJ
aji-147	273	51	potent	potent	ADJ
aji-147	273	52	sars	sar	NOUN
aji-147	273	53	-	-	PUNCT
aji-147	273	54	cov-2	cov-2	NOUN
aji-147	273	55	-	-	PUNCT
aji-147	273	56	specific	specific	ADJ
aji-147	273	57	gc	gc	PROPN
aji-147	273	58	b	b	PROPN
aji-147	273	59	responses	response	NOUN
aji-147	273	60	and	and	CCONJ
aji-147	273	61	induce	induce	VERB
aji-147	273	62	robust	robust	ADJ
aji-147	273	63	and	and	CCONJ
aji-147	273	64	specific	specific	ADJ
aji-147	273	65	antibody	antibody	NOUN
aji-147	273	66	responses	response	NOUN
aji-147	273	67	,	,	PUNCT
aji-147	273	68	including	include	VERB
aji-147	273	69	neutralizing	neutralize	VERB
aji-147	273	70	antibodies	antibody	NOUN
aji-147	273	71	.	.	PUNCT
aji-147	274	1	igg1	igg1	NOUN
aji-147	274	2	,	,	PUNCT
aji-147	274	3	igg2a	igg2a	PROPN
aji-147	274	4	,	,	PUNCT
aji-147	274	5	igg2b	igg2b	PRON
aji-147	274	6	,	,	PUNCT
aji-147	274	7	[	[	X
aji-147	274	8	130	130	NUM
aji-147	274	9	]	]	PUNCT
aji-147	274	10	mrna-1273	mrna-1273	NOUN
aji-147	274	11	il-21	il-21	PRON
aji-147	274	12	+	+	ADJ
aji-147	274	13	cxcr5	cxcr5	PROPN
aji-147	274	14	+	+	CCONJ
aji-147	274	15	pd−1	pd−1	PROPN
aji-147	274	16	+	+	PROPN
aji-147	274	17	icos+	icos+	PROPN
aji-147	274	18	tfh	tfh	PROPN
aji-147	274	19	cells	cell	NOUN
aji-147	274	20	expansion	expansion	NOUN
aji-147	274	21	.	.	PUNCT
aji-147	275	1	induce	induce	VERB
aji-147	275	2	robust	robust	ADJ
aji-147	275	3	and	and	CCONJ
aji-147	275	4	specific	specific	ADJ
aji-147	275	5	antibody	antibody	NOUN
aji-147	275	6	responses	response	NOUN
aji-147	275	7	,	,	PUNCT
aji-147	275	8	including	include	VERB
aji-147	275	9	neutralizing	neutralize	VERB
aji-147	275	10	antibodies	antibody	NOUN
aji-147	275	11	.	.	PUNCT
aji-147	276	1	iga	iga	PROPN
aji-147	276	2	,	,	PUNCT
aji-147	276	3	igg	igg	PROPN
aji-147	277	1	[	[	X
aji-147	277	2	123	123	NUM
aji-147	277	3	]	]	PUNCT
aji-147	277	4	protein	protein	NOUN
aji-147	277	5	vaccines	vaccine	NOUN
aji-147	277	6	strifk	strifk	NOUN
aji-147	277	7	-	-	PUNCT
aji-147	277	8	fh002c	fh002c	PROPN
aji-147	277	9	pd-1	pd-1	X
aji-147	277	10	+	+	PROPN
aji-147	277	11	cxcr5	cxcr5	PROPN
aji-147	277	12	+	+	CCONJ
aji-147	277	13	cd4	cd4	PROPN
aji-147	277	14	+	+	CCONJ
aji-147	277	15	tfh	tfh	ADJ
aji-147	277	16	cells	cell	NOUN
aji-147	277	17	expansion	expansion	NOUN
aji-147	277	18	induce	induce	VERB
aji-147	277	19	specific	specific	ADJ
aji-147	277	20	antibody	antibody	NOUN
aji-147	277	21	responses	response	NOUN
aji-147	277	22	,	,	PUNCT
aji-147	277	23	including	include	VERB
aji-147	277	24	neutralizing	neutralize	VERB
aji-147	277	25	antibodies	antibody	NOUN
aji-147	277	26	.	.	PUNCT
aji-147	278	1	igg	igg	PROPN
aji-147	278	2	,	,	PUNCT
aji-147	278	3	igg1	igg1	PROPN
aji-147	278	4	,	,	PUNCT
aji-147	278	5	igg2a	igg2a	PROPN
aji-147	278	6	,	,	PUNCT
aji-147	278	7	igg2b	igg2b	PUNCT
aji-147	279	1	[	[	X
aji-147	279	2	129	129	NUM
aji-147	279	3	]	]	X
aji-147	279	4	spike	spike	X
aji-147	279	5	(	(	PUNCT
aji-147	279	6	s	s	NOUN
aji-147	279	7	)	)	PUNCT
aji-147	279	8	and	and	CCONJ
aji-147	279	9	receptor	receptor	NOUN
aji-147	279	10	binding	bind	VERB
aji-147	279	11	domain	domain	NOUN
aji-147	279	12	(	(	PUNCT
aji-147	279	13	rbd	rbd	NOUN
aji-147	279	14	)	)	PUNCT
aji-147	279	15	protein	protein	NOUN
aji-147	279	16	subunit	subunit	NOUN
aji-147	279	17	vaccine	vaccine	NOUN
aji-147	279	18	cxcr5++bcl-6	cxcr5++bcl-6	PROPN
aji-147	279	19	+	+	CCONJ
aji-147	279	20	cd4	cd4	PROPN
aji-147	279	21	+	+	PROPN
aji-147	279	22	cd3	cd3	ADJ
aji-147	279	23	+	+	PROPN
aji-147	279	24	b220	b220	PROPN
aji-147	279	25	-	-	PUNCT
aji-147	279	26	tfh	tfh	PROPN
aji-147	279	27	cells	cell	NOUN
aji-147	279	28	expansion	expansion	NOUN
aji-147	279	29	induce	induce	VERB
aji-147	279	30	specific	specific	ADJ
aji-147	279	31	antibody	antibody	NOUN
aji-147	279	32	responses	response	NOUN
aji-147	279	33	,	,	PUNCT
aji-147	279	34	including	include	VERB
aji-147	279	35	neutralizing	neutralize	VERB
aji-147	279	36	antibodies	antibody	NOUN
aji-147	279	37	.	.	PUNCT
aji-147	280	1	igg	igg	PROPN
aji-147	281	1	[	[	X
aji-147	281	2	125	125	NUM
aji-147	281	3	]	]	X
aji-147	281	4	nvx	nvx	PROPN
aji-147	281	5	-	-	PUNCT
aji-147	281	6	cov2373	cov2373	NOUN
aji-147	281	7	cxcr5	cxcr5	PROPN
aji-147	282	1	+	+	X
aji-147	282	2	pd-1	pd-1	X
aji-147	282	3	+	+	CCONJ
aji-147	282	4	cd4	cd4	PROPN
aji-147	282	5	+	+	ADJ
aji-147	282	6	tfh	tfh	ADJ
aji-147	282	7	cells	cell	NOUN
aji-147	282	8	expansion	expansion	NOUN
aji-147	282	9	induce	induce	VERB
aji-147	282	10	specific	specific	ADJ
aji-147	282	11	antibody	antibody	NOUN
aji-147	282	12	responses	response	NOUN
aji-147	282	13	,	,	PUNCT
aji-147	282	14	including	include	VERB
aji-147	282	15	neutralizing	neutralize	VERB
aji-147	282	16	antibodies	antibody	NOUN
aji-147	282	17	.	.	PUNCT
aji-147	283	1	igg	igg	PROPN
aji-147	284	1	[	[	X
aji-147	284	2	4	4	NUM
aji-147	284	3	]	]	X
aji-147	284	4	rrbd	rrbd	NOUN
aji-147	284	5	-	-	PUNCT
aji-147	284	6	addavax	addavax	NOUN
aji-147	284	7	b220	b220	PROPN
aji-147	284	8	-	-	PUNCT
aji-147	284	9	cd4	cd4	PROPN
aji-147	284	10	+	+	ADJ
aji-147	284	11	cd44hicd62l	cd44hicd62l	PROPN
aji-147	284	12	-	-	PUNCT
aji-147	284	13	cxcr5	cxcr5	NOUN
aji-147	284	14	+	+	CCONJ
aji-147	284	15	bcl-6	bcl-6	PUNCT
aji-147	284	16	+	+	ADJ
aji-147	284	17	tfh	tfh	NOUN
aji-147	284	18	cells	cell	NOUN
aji-147	284	19	,	,	PUNCT
aji-147	284	20	b220cd4	b220cd4	NUM
aji-147	284	21	+	+	SYM
aji-147	284	22	cd44hicxcr5	cd44hicxcr5	NOUN
aji-147	284	23	+	+	CCONJ
aji-147	284	24	pd-1hi	pd-1hi	ADJ
aji-147	284	25	il-21	il-21	NOUN
aji-147	284	26	+	+	ADJ
aji-147	284	27	tfh	tfh	NUM
aji-147	284	28	cells	cell	NOUN
aji-147	284	29	b220	b220	PROPN
aji-147	284	30	-	-	PUNCT
aji-147	284	31	cd4	cd4	PROPN
aji-147	284	32	+	+	PROPN
aji-147	284	33	cd44hicxcr5	cd44hicxcr5	NOUN
aji-147	284	34	+	+	CCONJ
aji-147	284	35	pd-1hi	pd-1hi	ADJ
aji-147	284	36	il-4	il-4	NOUN
aji-147	284	37	+	+	CCONJ
aji-147	284	38	tfh	tfh	NOUN
aji-147	284	39	cells	cell	NOUN
aji-147	284	40	slight	slight	ADJ
aji-147	284	41	expansion	expansion	NOUN
aji-147	284	42	delay	delay	NOUN
aji-147	284	43	in	in	ADP
aji-147	284	44	eliciting	elicit	VERB
aji-147	284	45	potent	potent	ADJ
aji-147	284	46	sarscov-2	sarscov-2	NOUN
aji-147	284	47	-	-	PUNCT
aji-147	284	48	specific	specific	ADJ
aji-147	284	49	gc	gc	PROPN
aji-147	284	50	b	b	PROPN
aji-147	284	51	responses	response	NOUN
aji-147	284	52	induces	induce	VERB
aji-147	284	53	robust	robust	ADJ
aji-147	284	54	and	and	CCONJ
aji-147	284	55	specific	specific	ADJ
aji-147	284	56	antibody	antibody	NOUN
aji-147	284	57	responses	response	NOUN
aji-147	284	58	,	,	PUNCT
aji-147	284	59	including	include	VERB
aji-147	284	60	neutralizing	neutralize	VERB
aji-147	284	61	antibodies	antibody	NOUN
aji-147	284	62	.	.	PUNCT
aji-147	285	1	igg1	igg1	NOUN
aji-147	285	2	[	[	X
aji-147	285	3	130	130	NUM
aji-147	285	4	]	]	X
aji-147	285	5	†	†	PROPN
aji-147	285	6	tfh	tfh	PROPN
aji-147	285	7	,	,	PUNCT
aji-147	285	8	follicular	follicular	ADJ
aji-147	285	9	helper	helper	NOUN
aji-147	285	10	t	t	NOUN
aji-147	285	11	cell	cell	NOUN
aji-147	285	12	;	;	PUNCT
aji-147	285	13	ctfh	ctfh	NOUN
aji-147	285	14	,	,	PUNCT
aji-147	285	15	circulating	circulate	VERB
aji-147	285	16	tfh	tfh	PROPN
aji-147	285	17	cell	cell	NOUN
aji-147	285	18	shukla	shukla	NOUN
aji-147	285	19	et	et	PROPN
aji-147	285	20	al	al	PROPN
aji-147	285	21	.	.	PROPN
aji-147	285	22	;	;	PUNCT
aji-147	285	23	asian	asian	PROPN
aji-147	285	24	j.	j.	PROPN
aji-147	285	25	immunol	immunol	PROPN
aji-147	285	26	.	.	PROPN
aji-147	285	27	,	,	PUNCT
aji-147	285	28	vol	vol	NOUN
aji-147	285	29	.	.	PROPN
aji-147	285	30	7	7	NUM
aji-147	285	31	,	,	PUNCT
aji-147	285	32	no	no	INTJ
aji-147	285	33	.	.	NOUN
aji-147	285	34	1	1	NUM
aji-147	285	35	,	,	PUNCT
aji-147	285	36	pp	pp	ADJ
aji-147	285	37	.	.	PUNCT
aji-147	286	1	228	228	NUM
aji-147	286	2	-	-	SYM
aji-147	286	3	246	246	NUM
aji-147	286	4	,	,	PUNCT
aji-147	286	5	2024	2024	NUM
aji-147	286	6	;	;	PUNCT
aji-147	287	1	article	article	NOUN
aji-147	287	2	no.aji.125387	no.aji.125387	NOUN
aji-147	287	3	236	236	NUM
aji-147	287	4	fig	fig	NOUN
aji-147	287	5	.	.	PUNCT
aji-147	288	1	2	2	X
aji-147	288	2	.	.	X
aji-147	288	3	the	the	DET
aji-147	288	4	involvement	involvement	NOUN
aji-147	288	5	of	of	ADP
aji-147	288	6	signaling	signal	VERB
aji-147	288	7	pathways	pathway	NOUN
aji-147	288	8	in	in	ADP
aji-147	288	9	controlling	control	VERB
aji-147	288	10	tfh	tfh	NOUN
aji-147	288	11	cell	cell	NOUN
aji-147	288	12	differentiation	differentiation	NOUN
aji-147	288	13	and	and	CCONJ
aji-147	288	14	function	function	NOUN
aji-147	288	15	in	in	ADP
aji-147	288	16	sars	sar	NOUN
aji-147	288	17	-	-	PUNCT
aji-147	288	18	cov-2	cov-2	PART
aji-147	288	19	infection	infection	NOUN
aji-147	288	20	with	with	ADP
aji-147	288	21	vaccines	vaccine	NOUN
aji-147	288	22	.	.	PUNCT
aji-147	289	1	when	when	SCONJ
aji-147	289	2	exposed	expose	VERB
aji-147	289	3	to	to	ADP
aji-147	289	4	sars	sar	NOUN
aji-147	289	5	-	-	PUNCT
aji-147	289	6	cov-2	cov-2	PART
aji-147	289	7	or	or	CCONJ
aji-147	289	8	viral	viral	ADJ
aji-147	289	9	antigens	antigen	NOUN
aji-147	289	10	,	,	PUNCT
aji-147	289	11	naive	naive	ADJ
aji-147	289	12	cd4	cd4	PROPN
aji-147	289	13	+	+	PROPN
aji-147	289	14	t	t	NOUN
aji-147	289	15	cells	cell	NOUN
aji-147	289	16	were	be	AUX
aji-147	289	17	activated	activate	VERB
aji-147	289	18	through	through	ADP
aji-147	289	19	apcs	apc	NOUN
aji-147	289	20	(	(	PUNCT
aji-147	289	21	dcs	dcs	PROPN
aji-147	289	22	)	)	PUNCT
aji-147	289	23	,	,	PUNCT
aji-147	289	24	which	which	PRON
aji-147	289	25	are	be	AUX
aji-147	289	26	triggered	trigger	VERB
aji-147	289	27	against	against	ADP
aji-147	289	28	antigen	antigen	NOUN
aji-147	289	29	-	-	PUNCT
aji-147	289	30	specific	specific	ADJ
aji-147	289	31	pretfh	pretfh	NOUN
aji-147	289	32	cells	cell	NOUN
aji-147	289	33	by	by	ADP
aji-147	289	34	the	the	DET
aji-147	289	35	association	association	NOUN
aji-147	289	36	of	of	ADP
aji-147	289	37	mhc	mhc	PROPN
aji-147	289	38	-	-	PUNCT
aji-147	289	39	ii	ii	PROPN
aji-147	289	40	molecules	molecule	NOUN
aji-147	289	41	between	between	ADP
aji-147	289	42	dcs	dcs	PROPN
aji-147	289	43	with	with	ADP
aji-147	289	44	cognate	cognate	NOUN
aji-147	289	45	tcr	tcr	PROPN
aji-147	289	46	on	on	ADP
aji-147	289	47	cd4	cd4	PROPN
aji-147	289	48	+	+	PROPN
aji-147	289	49	t	t	NOUN
aji-147	289	50	cells	cell	NOUN
aji-147	289	51	,	,	PUNCT
aji-147	289	52	and	and	CCONJ
aji-147	289	53	the	the	DET
aji-147	289	54	expression	expression	NOUN
aji-147	289	55	of	of	ADP
aji-147	289	56	costimulatory	costimulatory	ADJ
aji-147	289	57	molecules	molecule	NOUN
aji-147	289	58	with	with	ADP
aji-147	289	59	cytokine	cytokine	ADJ
aji-147	289	60	production	production	NOUN
aji-147	289	61	,	,	PUNCT
aji-147	289	62	pre	pre	ADJ
aji-147	289	63	-	-	ADJ
aji-147	289	64	tfh	tfh	ADJ
aji-147	289	65	cells	cell	NOUN
aji-147	289	66	associate	associate	VERB
aji-147	289	67	with	with	ADP
aji-147	289	68	active	active	ADJ
aji-147	289	69	b	b	NOUN
aji-147	289	70	cells	cell	NOUN
aji-147	289	71	at	at	ADP
aji-147	289	72	the	the	DET
aji-147	289	73	t	t	PROPN
aji-147	289	74	-	-	PUNCT
aji-147	289	75	b	b	NOUN
aji-147	289	76	boundary	boundary	NOUN
aji-147	289	77	in	in	ADP
aji-147	289	78	the	the	DET
aji-147	289	79	follicular	follicular	ADJ
aji-147	289	80	zone	zone	NOUN
aji-147	289	81	,	,	PUNCT
aji-147	289	82	wherein	wherein	SCONJ
aji-147	289	83	they	they	PRON
aji-147	289	84	develop	develop	VERB
aji-147	289	85	into	into	ADP
aji-147	289	86	diverse	diverse	ADJ
aji-147	289	87	tfh	tfh	PROPN
aji-147	289	88	cell	cell	NOUN
aji-147	289	89	subtypes	subtype	NOUN
aji-147	289	90	that	that	PRON
aji-147	289	91	move	move	VERB
aji-147	289	92	to	to	ADP
aji-147	289	93	the	the	DET
aji-147	289	94	gc	gc	PROPN
aji-147	289	95	,	,	PUNCT
aji-147	289	96	wherein	wherein	SCONJ
aji-147	289	97	tfh	tfh	PROPN
aji-147	289	98	cells	cell	NOUN
aji-147	289	99	stimulate	stimulate	VERB
aji-147	289	100	b	b	PRON
aji-147	289	101	cell	cell	NOUN
aji-147	289	102	differentiation	differentiation	NOUN
aji-147	289	103	and	and	CCONJ
aji-147	289	104	specific	specific	ADJ
aji-147	289	105	antibody	antibody	NOUN
aji-147	289	106	production	production	NOUN
aji-147	289	107	.	.	PUNCT
aji-147	290	1	reproduced	reproduce	VERB
aji-147	290	2	/	/	SYM
aji-147	290	3	adapted	adapt	VERB
aji-147	290	4	with	with	ADP
aji-147	290	5	permission	permission	NOUN
aji-147	290	6	[	[	X
aji-147	290	7	131	131	NUM
aji-147	290	8	]	]	X
aji-147	290	9	shukla	shukla	NOUN
aji-147	290	10	et	et	PROPN
aji-147	290	11	al	al	PROPN
aji-147	290	12	.	.	PROPN
aji-147	290	13	;	;	PUNCT
aji-147	290	14	asian	asian	PROPN
aji-147	290	15	j.	j.	PROPN
aji-147	290	16	immunol	immunol	PROPN
aji-147	290	17	.	.	PROPN
aji-147	290	18	,	,	PUNCT
aji-147	290	19	vol	vol	NOUN
aji-147	290	20	.	.	PROPN
aji-147	291	1	7	7	NUM
aji-147	291	2	,	,	PUNCT
aji-147	291	3	no	no	INTJ
aji-147	291	4	.	.	NOUN
aji-147	291	5	1	1	NUM
aji-147	291	6	,	,	PUNCT
aji-147	291	7	pp	pp	ADJ
aji-147	291	8	.	.	PUNCT
aji-147	292	1	228	228	NUM
aji-147	292	2	-	-	SYM
aji-147	292	3	246	246	NUM
aji-147	292	4	,	,	PUNCT
aji-147	292	5	2024	2024	NUM
aji-147	292	6	;	;	PUNCT
aji-147	293	1	article	article	NOUN
aji-147	293	2	no.aji.125387	no.aji.125387	VERB
aji-147	293	3	237	237	NUM
aji-147	293	4	fig	fig	NOUN
aji-147	293	5	.	.	PUNCT
aji-147	294	1	3	3	X
aji-147	294	2	.	.	X
aji-147	294	3	lymphoid	lymphoid	VERB
aji-147	294	4	and	and	CCONJ
aji-147	294	5	circulating	circulate	VERB
aji-147	294	6	tfh	tfh	PROPN
aji-147	294	7	responses	response	NOUN
aji-147	294	8	in	in	ADP
aji-147	294	9	covid-19	covid-19	PROPN
aji-147	294	10	.	.	PUNCT
aji-147	295	1	sars	sars	PROPN
aji-147	295	2	-	-	PUNCT
aji-147	295	3	cov-2	cov-2	NOUN
aji-147	295	4	antigen	antigen	NOUN
aji-147	295	5	in	in	ADP
aji-147	295	6	the	the	DET
aji-147	295	7	lymph	lymph	NOUN
aji-147	295	8	nodes	node	NOUN
aji-147	295	9	activates	activate	VERB
aji-147	295	10	antigen	antigen	NOUN
aji-147	295	11	-	-	PUNCT
aji-147	295	12	specific	specific	ADJ
aji-147	295	13	b	b	NOUN
aji-147	295	14	cells	cell	NOUN
aji-147	295	15	and	and	CCONJ
aji-147	295	16	tfh	tfh	NUM
aji-147	295	17	cells	cell	NOUN
aji-147	295	18	.	.	PUNCT
aji-147	296	1	their	their	PRON
aji-147	296	2	interaction	interaction	NOUN
aji-147	296	3	leads	lead	VERB
aji-147	296	4	to	to	ADP
aji-147	296	5	the	the	DET
aji-147	296	6	initiation	initiation	NOUN
aji-147	296	7	of	of	ADP
aji-147	296	8	the	the	DET
aji-147	296	9	germinal	germinal	ADJ
aji-147	296	10	centre	centre	NOUN
aji-147	296	11	reaction	reaction	NOUN
aji-147	296	12	.	.	PUNCT
aji-147	297	1	this	this	DET
aji-147	297	2	results	result	VERB
aji-147	297	3	in	in	ADP
aji-147	297	4	the	the	DET
aji-147	297	5	development	development	NOUN
aji-147	297	6	of	of	ADP
aji-147	297	7	memory	memory	NOUN
aji-147	297	8	b	b	PROPN
aji-147	297	9	cells	cell	NOUN
aji-147	297	10	with	with	ADP
aji-147	297	11	increased	increase	VERB
aji-147	297	12	somatic	somatic	ADJ
aji-147	297	13	hypermutation	hypermutation	NOUN
aji-147	297	14	(	(	PUNCT
aji-147	297	15	shm	shm	NOUN
aji-147	297	16	)	)	PUNCT
aji-147	297	17	and	and	CCONJ
aji-147	297	18	increased	increase	VERB
aji-147	297	19	affinity	affinity	NOUN
aji-147	297	20	,	,	PUNCT
aji-147	297	21	as	as	ADV
aji-147	297	22	well	well	ADV
aji-147	297	23	as	as	ADP
aji-147	297	24	long	long	ADV
aji-147	297	25	-	-	PUNCT
aji-147	297	26	lived	live	VERB
aji-147	297	27	plasma	plasma	NOUN
aji-147	297	28	cells	cell	NOUN
aji-147	297	29	that	that	PRON
aji-147	297	30	traffic	traffic	NOUN
aji-147	297	31	to	to	ADP
aji-147	297	32	the	the	DET
aji-147	297	33	bone	bone	NOUN
aji-147	297	34	marrow	marrow	NOUN
aji-147	297	35	and	and	CCONJ
aji-147	297	36	provide	provide	VERB
aji-147	297	37	a	a	DET
aji-147	297	38	long	long	ADJ
aji-147	297	39	-	-	PUNCT
aji-147	297	40	term	term	NOUN
aji-147	297	41	source	source	NOUN
aji-147	297	42	of	of	ADP
aji-147	297	43	neutralizing	neutralize	VERB
aji-147	297	44	antibodies	antibody	NOUN
aji-147	297	45	.	.	PUNCT
aji-147	298	1	a	a	DET
aji-147	298	2	population	population	NOUN
aji-147	298	3	of	of	ADP
aji-147	298	4	short	short	ADV
aji-147	298	5	-	-	PUNCT
aji-147	298	6	lived	live	VERB
aji-147	298	7	antibody	antibody	NOUN
aji-147	298	8	-	-	PUNCT
aji-147	298	9	secreting	secrete	VERB
aji-147	298	10	cells	cell	NOUN
aji-147	298	11	(	(	PUNCT
aji-147	298	12	ascs	asc	NOUN
aji-147	298	13	)	)	PUNCT
aji-147	298	14	appears	appear	VERB
aji-147	298	15	in	in	ADP
aji-147	298	16	the	the	DET
aji-147	298	17	circulation	circulation	NOUN
aji-147	298	18	and	and	CCONJ
aji-147	298	19	provides	provide	VERB
aji-147	298	20	a	a	DET
aji-147	298	21	rare	rare	ADJ
aji-147	298	22	source	source	NOUN
aji-147	298	23	of	of	ADP
aji-147	298	24	neutralizing	neutralize	VERB
aji-147	298	25	antibodies	antibody	NOUN
aji-147	298	26	.	.	PUNCT
aji-147	299	1	concurrently	concurrently	ADV
aji-147	299	2	,	,	PUNCT
aji-147	299	3	a	a	DET
aji-147	299	4	population	population	NOUN
aji-147	299	5	of	of	ADP
aji-147	299	6	activated	activated	ADJ
aji-147	299	7	(	(	PUNCT
aji-147	299	8	cd38	cd38	PROPN
aji-147	299	9	+	+	PROPN
aji-147	299	10	,	,	PUNCT
aji-147	299	11	pd-1	pd-1	ADJ
aji-147	299	12	+	+	ADJ
aji-147	299	13	,	,	PUNCT
aji-147	299	14	icos+	icos+	NOUN
aji-147	299	15	)	)	PUNCT
aji-147	299	16	ctfh	ctfh	NOUN
aji-147	299	17	cells	cell	NOUN
aji-147	299	18	appears	appear	VERB
aji-147	299	19	in	in	ADP
aji-147	299	20	the	the	DET
aji-147	299	21	circulation	circulation	NOUN
aji-147	299	22	.	.	PUNCT
aji-147	300	1	this	this	DET
aji-147	300	2	population	population	NOUN
aji-147	300	3	contains	contain	VERB
aji-147	300	4	antigen	antigen	NOUN
aji-147	300	5	-	-	PUNCT
aji-147	300	6	specific	specific	ADJ
aji-147	300	7	ctfh	ctfh	NOUN
aji-147	300	8	cells	cell	NOUN
aji-147	300	9	(	(	PUNCT
aji-147	300	10	not	not	PART
aji-147	300	11	depicted	depict	VERB
aji-147	300	12	)	)	PUNCT
aji-147	300	13	.	.	PUNCT
aji-147	301	1	although	although	SCONJ
aji-147	301	2	memory	memory	NOUN
aji-147	301	3	b	b	PROPN
aji-147	301	4	cells	cell	NOUN
aji-147	301	5	and	and	CCONJ
aji-147	301	6	ascs	asc	NOUN
aji-147	301	7	are	be	AUX
aji-147	301	8	primarily	primarily	ADV
aji-147	301	9	located	locate	VERB
aji-147	301	10	in	in	ADP
aji-147	301	11	lymphoid	lymphoid	ADJ
aji-147	301	12	tissues	tissue	NOUN
aji-147	301	13	,	,	PUNCT
aji-147	301	14	they	they	PRON
aji-147	301	15	are	be	AUX
aji-147	301	16	typically	typically	ADV
aji-147	301	17	measured	measure	VERB
aji-147	301	18	in	in	ADP
aji-147	301	19	blood	blood	NOUN
aji-147	301	20	samples	sample	NOUN
aji-147	301	21	,	,	PUNCT
aji-147	301	22	which	which	PRON
aji-147	301	23	correlate	correlate	VERB
aji-147	301	24	with	with	ADP
aji-147	301	25	activated	activated	ADJ
aji-147	301	26	ctfh	ctfh	NOUN
aji-147	301	27	cells	cell	NOUN
aji-147	301	28	.	.	PUNCT
aji-147	302	1	activated	activate	VERB
aji-147	302	2	ctfh	ctfh	NOUN
aji-147	302	3	cells	cell	NOUN
aji-147	302	4	also	also	ADV
aji-147	302	5	correlate	correlate	VERB
aji-147	302	6	with	with	ADP
aji-147	302	7	the	the	DET
aji-147	302	8	development	development	NOUN
aji-147	302	9	of	of	ADP
aji-147	302	10	neutralizing	neutralize	VERB
aji-147	302	11	antibodies	antibody	NOUN
aji-147	302	12	.	.	PUNCT
aji-147	303	1	these	these	DET
aji-147	303	2	ctfh	ctfh	NOUN
aji-147	303	3	cells	cell	NOUN
aji-147	303	4	are	be	AUX
aji-147	303	5	a	a	DET
aji-147	303	6	potential	potential	ADJ
aji-147	303	7	biomarker	biomarker	NOUN
aji-147	303	8	of	of	ADP
aji-147	303	9	tfh	tfh	NOUN
aji-147	303	10	activity	activity	NOUN
aji-147	303	11	in	in	ADP
aji-147	303	12	lymphoid	lymphoid	ADJ
aji-147	303	13	tissues	tissue	NOUN
aji-147	303	14	.	.	PUNCT
aji-147	304	1	however	however	ADV
aji-147	304	2	,	,	PUNCT
aji-147	304	3	it	it	PRON
aji-147	304	4	remains	remain	VERB
aji-147	304	5	to	to	PART
aji-147	304	6	be	be	AUX
aji-147	304	7	determined	determine	VERB
aji-147	304	8	if	if	SCONJ
aji-147	304	9	this	this	DET
aji-147	304	10	population	population	NOUN
aji-147	304	11	of	of	ADP
aji-147	304	12	ctfh	ctfh	NOUN
aji-147	304	13	cells	cell	NOUN
aji-147	304	14	are	be	AUX
aji-147	304	15	predictive	predictive	ADJ
aji-147	304	16	of	of	ADP
aji-147	304	17	long	long	ADJ
aji-147	304	18	-	-	PUNCT
aji-147	304	19	term	term	NOUN
aji-147	304	20	neutralizing	neutralize	VERB
aji-147	304	21	antibodies	antibody	NOUN
aji-147	304	22	or	or	CCONJ
aji-147	304	23	the	the	DET
aji-147	304	24	development	development	NOUN
aji-147	304	25	of	of	ADP
aji-147	304	26	long	long	ADV
aji-147	304	27	-	-	PUNCT
aji-147	304	28	lived	live	VERB
aji-147	304	29	plasma	plasma	NOUN
aji-147	304	30	cells	cell	NOUN
aji-147	304	31	and	and	CCONJ
aji-147	304	32	the	the	DET
aji-147	304	33	prolonged	prolonged	ADJ
aji-147	304	34	evolution	evolution	NOUN
aji-147	304	35	of	of	ADP
aji-147	304	36	the	the	DET
aji-147	304	37	mbc	mbc	PROPN
aji-147	304	38	pool	pool	NOUN
aji-147	304	39	.	.	PUNCT
aji-147	305	1	reproduced	reproduce	VERB
aji-147	305	2	/	/	SYM
aji-147	305	3	adapted	adapt	VERB
aji-147	305	4	with	with	ADP
aji-147	305	5	permission	permission	NOUN
aji-147	305	6	[	[	X
aji-147	305	7	135	135	NUM
aji-147	305	8	]	]	PUNCT
aji-147	305	9	.	.	PUNCT
aji-147	306	1	rapid	rapid	ADJ
aji-147	306	2	advances	advance	NOUN
aji-147	306	3	have	have	AUX
aji-147	306	4	been	be	AUX
aji-147	306	5	made	make	VERB
aji-147	306	6	in	in	ADP
aji-147	306	7	designing	design	VERB
aji-147	306	8	and	and	CCONJ
aji-147	306	9	developing	develop	VERB
aji-147	306	10	sars	sar	NOUN
aji-147	306	11	-	-	PUNCT
aji-147	306	12	cov-2	cov-2	NOUN
aji-147	306	13	vaccines	vaccine	NOUN
aji-147	306	14	,	,	PUNCT
aji-147	306	15	such	such	ADJ
aji-147	306	16	as	as	ADP
aji-147	306	17	inactivated	inactivated	ADJ
aji-147	306	18	dna	dna	PROPN
aji-147	306	19	,	,	PUNCT
aji-147	306	20	mrna	mrna	PROPN
aji-147	306	21	,	,	PUNCT
aji-147	306	22	and	and	CCONJ
aji-147	306	23	specific	specific	ADJ
aji-147	306	24	sarscov-2	sarscov-2	NUM
aji-147	306	25	proteins	protein	NOUN
aji-147	306	26	[	[	X
aji-147	306	27	123	123	NUM
aji-147	306	28	]	]	PUNCT
aji-147	306	29	.	.	PUNCT
aji-147	307	1	the	the	DET
aji-147	307	2	mrna-1273	mrna-1273	ADJ
aji-147	307	3	vaccine	vaccine	NOUN
aji-147	307	4	can	can	AUX
aji-147	307	5	effectively	effectively	ADV
aji-147	307	6	activate	activate	VERB
aji-147	307	7	th1	th1	NOUN
aji-147	307	8	and	and	CCONJ
aji-147	307	9	interleukin-21	interleukin-21	PROPN
aji-147	307	10	expressing	express	VERB
aji-147	307	11	cxcr5+pd1+icos+tfh	cxcr5+pd1+icos+tfh	NOUN
aji-147	307	12	cellular	cellular	ADJ
aji-147	307	13	responses	response	NOUN
aji-147	307	14	as	as	ADV
aji-147	307	15	well	well	ADV
aji-147	307	16	as	as	ADP
aji-147	307	17	trigger	trigger	NOUN
aji-147	307	18	powerful	powerful	ADJ
aji-147	307	19	sarscov-2	sarscov-2	NUM
aji-147	307	20	neutralizing	neutralizing	ADJ
aji-147	307	21	potential	potential	NOUN
aji-147	307	22	,	,	PUNCT
aji-147	307	23	providing	provide	VERB
aji-147	307	24	quick	quick	ADJ
aji-147	307	25	protection	protection	NOUN
aji-147	307	26	against	against	ADP
aji-147	307	27	sars	sar	NOUN
aji-147	307	28	-	-	PUNCT
aji-147	307	29	cov-2	cov-2	PART
aji-147	307	30	infection	infection	NOUN
aji-147	307	31	in	in	ADP
aji-147	307	32	the	the	DET
aji-147	307	33	vertical	vertical	ADJ
aji-147	307	34	and	and	CCONJ
aji-147	307	35	horizontal	horizontal	ADJ
aji-147	307	36	airways	airway	NOUN
aji-147	307	37	of	of	ADP
aji-147	307	38	rhesus	rhesus	NOUN
aji-147	307	39	macaques	macaque	NOUN
aji-147	307	40	[	[	X
aji-147	307	41	4	4	NUM
aji-147	307	42	]	]	PUNCT
aji-147	307	43	.	.	PUNCT
aji-147	308	1	in	in	ADP
aji-147	308	2	contrast	contrast	NOUN
aji-147	308	3	to	to	ADP
aji-147	308	4	the	the	DET
aji-147	308	5	sars	sar	NOUN
aji-147	308	6	-	-	PUNCT
aji-147	308	7	cov-2	cov-2	PART
aji-147	308	8	recombinant	recombinant	ADJ
aji-147	308	9	sars	sar	NOUN
aji-147	308	10	-	-	PUNCT
aji-147	308	11	cov-2	cov-2	NOUN
aji-147	308	12	receptor	receptor	NOUN
aji-147	308	13	-	-	PUNCT
aji-147	308	14	binding	bind	VERB
aji-147	308	15	domain	domain	NOUN
aji-147	308	16	(	(	PUNCT
aji-147	308	17	rrbd	rrbd	NOUN
aji-147	308	18	)	)	PUNCT
aji-147	308	19	developed	develop	VERB
aji-147	308	20	for	for	ADP
aji-147	308	21	the	the	DET
aji-147	308	22	addavax	addavax	NOUN
aji-147	308	23	(	(	PUNCT
aji-147	308	24	rrbd	rrbd	NOUN
aji-147	308	25	-	-	PUNCT
aji-147	308	26	addavax	addavax	NOUN
aji-147	308	27	)	)	PUNCT
aji-147	308	28	protein	protein	NOUN
aji-147	308	29	vaccine	vaccine	NOUN
aji-147	308	30	gene	gene	NOUN
aji-147	308	31	,	,	PUNCT
aji-147	308	32	the	the	DET
aji-147	308	33	shukla	shukla	NOUN
aji-147	308	34	et	et	PROPN
aji-147	308	35	al	al	PROPN
aji-147	308	36	.	.	PROPN
aji-147	308	37	;	;	PUNCT
aji-147	308	38	asian	asian	PROPN
aji-147	308	39	j.	j.	PROPN
aji-147	308	40	immunol	immunol	PROPN
aji-147	308	41	.	.	PROPN
aji-147	308	42	,	,	PUNCT
aji-147	308	43	vol	vol	NOUN
aji-147	308	44	.	.	PROPN
aji-147	308	45	7	7	NUM
aji-147	308	46	,	,	PUNCT
aji-147	308	47	no	no	INTJ
aji-147	308	48	.	.	NOUN
aji-147	308	49	1	1	NUM
aji-147	308	50	,	,	PUNCT
aji-147	308	51	pp	pp	ADJ
aji-147	308	52	.	.	PUNCT
aji-147	308	53	228	228	NUM
aji-147	308	54	-	-	SYM
aji-147	308	55	246	246	NUM
aji-147	308	56	,	,	PUNCT
aji-147	308	57	2024	2024	NUM
aji-147	308	58	;	;	PUNCT
aji-147	308	59	article	article	NOUN
aji-147	308	60	no.aji.125387	no.aji.125387	VERB
aji-147	308	61	238	238	NUM
aji-147	308	62	sars	sar	NOUN
aji-147	308	63	-	-	PUNCT
aji-147	308	64	cov-2	cov-2	NOUN
aji-147	308	65	mrna	mrna	NOUN
aji-147	308	66	vaccine	vaccine	NOUN
aji-147	308	67	gene	gene	NOUN
aji-147	308	68	encodes	encode	NOUN
aji-147	308	69	rbd	rbd	NOUN
aji-147	308	70	as	as	ADV
aji-147	308	71	well	well	ADV
aji-147	308	72	as	as	ADP
aji-147	308	73	full	full	ADJ
aji-147	308	74	-	-	PUNCT
aji-147	308	75	length	length	NOUN
aji-147	308	76	spike	spike	ADJ
aji-147	308	77	protein	protein	NOUN
aji-147	308	78	efficiently	efficiently	ADV
aji-147	308	79	to	to	PART
aji-147	308	80	prompt	prompt	VERB
aji-147	308	81	sars	sar	NOUN
aji-147	308	82	-	-	PUNCT
aji-147	308	83	cov-2	cov-2	NOUN
aji-147	308	84	-	-	PUNCT
aji-147	308	85	specific	specific	ADJ
aji-147	308	86	gc	gc	PROPN
aji-147	308	87	b	b	PROPN
aji-147	308	88	and	and	CCONJ
aji-147	308	89	tfh	tfh	PROPN
aji-147	308	90	cellular	cellular	ADJ
aji-147	308	91	responses	response	NOUN
aji-147	308	92	,	,	PUNCT
aji-147	308	93	which	which	PRON
aji-147	308	94	also	also	ADV
aji-147	308	95	enhance	enhance	VERB
aji-147	308	96	specific	specific	ADJ
aji-147	308	97	neutralizing	neutralize	VERB
aji-147	308	98	antibody	antibody	NOUN
aji-147	308	99	responses	response	NOUN
aji-147	308	100	in	in	ADP
aji-147	308	101	inoculated	inoculated	ADJ
aji-147	308	102	mice	mouse	NOUN
aji-147	308	103	.	.	PUNCT
aji-147	309	1	surprisingly	surprisingly	ADV
aji-147	309	2	,	,	PUNCT
aji-147	309	3	the	the	DET
aji-147	309	4	rrbd	rrbd	ADJ
aji-147	309	5	-	-	PUNCT
aji-147	309	6	addavax	addavax	NOUN
aji-147	309	7	vaccination	vaccination	NOUN
aji-147	309	8	produced	produce	VERB
aji-147	309	9	a	a	DET
aji-147	309	10	significant	significant	ADJ
aji-147	309	11	proportion	proportion	NOUN
aji-147	309	12	of	of	ADP
aji-147	309	13	il-4	il-4	NOUN
aji-147	309	14	+	+	CCONJ
aji-147	310	1	tfh	tfh	NOUN
aji-147	310	2	cells	cell	NOUN
aji-147	310	3	[	[	X
aji-147	310	4	124	124	NUM
aji-147	310	5	]	]	PUNCT
aji-147	310	6	.	.	PUNCT
aji-147	311	1	the	the	DET
aji-147	311	2	bnt162b2	bnt162b2	PROPN
aji-147	311	3	mrna	mrna	PROPN
aji-147	311	4	vaccine	vaccine	NOUN
aji-147	311	5	against	against	ADP
aji-147	311	6	sars	sar	NOUN
aji-147	311	7	-	-	PUNCT
aji-147	311	8	cov-2	cov-2	NOUN
aji-147	311	9	produced	produce	VERB
aji-147	311	10	significant	significant	ADJ
aji-147	311	11	aim+cxcr5+cd45ra	aim+cxcr5+cd45ra	ADJ
aji-147	311	12	-	-	PUNCT
aji-147	311	13	cd3+ctfh	cd3+ctfh	NOUN
aji-147	311	14	cell	cell	NOUN
aji-147	311	15	responses	response	NOUN
aji-147	311	16	in	in	ADP
aji-147	311	17	humans	human	NOUN
aji-147	311	18	.	.	PUNCT
aji-147	312	1	aim	aim	NOUN
aji-147	312	2	(	(	PUNCT
aji-147	312	3	activation	activation	NOUN
aji-147	312	4	-	-	PUNCT
aji-147	312	5	induced	induce	VERB
aji-147	312	6	marker	marker	NOUN
aji-147	312	7	)	)	PUNCT
aji-147	312	8	cells	cell	NOUN
aji-147	312	9	are	be	AUX
aji-147	312	10	including	include	VERB
aji-147	312	11	cd69+ox40	cd69+ox40	PROPN
aji-147	312	12	+	+	SYM
aji-147	312	13	or	or	CCONJ
aji-147	312	14	cd69+cd40l+	cd69+cd40l+	PROPN
aji-147	312	15	or	or	CCONJ
aji-147	312	16	cd69	cd69	PROPN
aji-147	312	17	+	+	PROPN
aji-147	312	18	4	4	NUM
aji-147	312	19	-	-	PUNCT
aji-147	312	20	1bb+	1bb+	NUM
aji-147	312	21	or	or	CCONJ
aji-147	312	22	ox40	ox40	PROPN
aji-147	312	23	+	+	PROPN
aji-147	312	24	4	4	NUM
aji-147	312	25	-	-	PUNCT
aji-147	312	26	1bb+	1bb+	NUM
aji-147	312	27	or	or	CCONJ
aji-147	312	28	cd40l+4	cd40l+4	NOUN
aji-147	312	29	-	-	PUNCT
aji-147	312	30	1bb+	1bb+	NUM
aji-147	312	31	or	or	CCONJ
aji-147	312	32	cd40l+4	cd40l+4	NOUN
aji-147	312	33	-	-	PUNCT
aji-147	312	34	1bb+	1bb+	NOUN
aji-147	312	35	or	or	CCONJ
aji-147	312	36	cd40l	cd40l	NOUN
aji-147	313	1	[	[	X
aji-147	313	2	4	4	NUM
aji-147	313	3	]	]	PUNCT
aji-147	313	4	.	.	PUNCT
aji-147	314	1	the	the	DET
aji-147	314	2	above	above	ADJ
aji-147	314	3	results	result	NOUN
aji-147	314	4	show	show	VERB
aji-147	314	5	that	that	SCONJ
aji-147	314	6	sars	sar	NOUN
aji-147	314	7	-	-	PUNCT
aji-147	314	8	cov-2	cov-2	NOUN
aji-147	314	9	mrna	mrna	NOUN
aji-147	314	10	vaccines	vaccine	NOUN
aji-147	314	11	can	can	AUX
aji-147	314	12	help	help	VERB
aji-147	314	13	enhance	enhance	VERB
aji-147	314	14	antigenspecific	antigenspecific	PROPN
aji-147	314	15	tfh	tfh	PROPN
aji-147	314	16	cell	cell	NOUN
aji-147	314	17	differentiation	differentiation	NOUN
aji-147	314	18	and	and	CCONJ
aji-147	314	19	b	b	NOUN
aji-147	314	20	cell	cell	NOUN
aji-147	314	21	responses	response	NOUN
aji-147	314	22	,	,	PUNCT
aji-147	314	23	as	as	ADV
aji-147	314	24	well	well	ADV
aji-147	314	25	as	as	ADP
aji-147	314	26	the	the	DET
aji-147	314	27	production	production	NOUN
aji-147	314	28	of	of	ADP
aji-147	314	29	protective	protective	ADJ
aji-147	314	30	immune	immune	ADJ
aji-147	314	31	responses	response	NOUN
aji-147	314	32	by	by	ADP
aji-147	314	33	producing	produce	VERB
aji-147	314	34	antibodies	antibody	NOUN
aji-147	314	35	,	,	PUNCT
aji-147	314	36	making	make	VERB
aji-147	314	37	them	they	PRON
aji-147	314	38	especially	especially	ADV
aji-147	314	39	potential	potential	ADJ
aji-147	314	40	for	for	ADP
aji-147	314	41	eliciting	elicit	VERB
aji-147	314	42	high	high	ADJ
aji-147	314	43	-	-	PUNCT
aji-147	314	44	quality	quality	NOUN
aji-147	314	45	adaptive	adaptive	ADJ
aji-147	314	46	immune	immune	ADJ
aji-147	314	47	responses	response	NOUN
aji-147	314	48	to	to	PART
aji-147	314	49	regulate	regulate	VERB
aji-147	314	50	as	as	ADV
aji-147	314	51	well	well	ADV
aji-147	314	52	as	as	ADP
aji-147	314	53	eradicate	eradicate	VERB
aji-147	314	54	sars	sar	NOUN
aji-147	314	55	-	-	PUNCT
aji-147	314	56	cov-2	cov-2	NOUN
aji-147	314	57	infection	infection	NOUN
aji-147	314	58	.	.	PUNCT
aji-147	315	1	moreover	moreover	ADV
aji-147	315	2	,	,	PUNCT
aji-147	315	3	“	"	PUNCT
aji-147	315	4	target	target	VERB
aji-147	315	5	protein	protein	NOUN
aji-147	315	6	vaccines	vaccine	NOUN
aji-147	315	7	such	such	ADJ
aji-147	315	8	as	as	ADP
aji-147	315	9	the	the	DET
aji-147	315	10	sars	sar	NOUN
aji-147	315	11	-	-	PUNCT
aji-147	315	12	cov-2	cov-2	NOUN
aji-147	315	13	subunit	subunit	NOUN
aji-147	315	14	vaccine	vaccine	NOUN
aji-147	315	15	(	(	PUNCT
aji-147	315	16	nvx	nvx	NOUN
aji-147	315	17	-	-	PUNCT
aji-147	315	18	cov2373	cov2373	NOUN
aji-147	315	19	)	)	PUNCT
aji-147	315	20	with	with	ADP
aji-147	315	21	both	both	CCONJ
aji-147	315	22	the	the	DET
aji-147	315	23	full	full	ADJ
aji-147	315	24	-	-	PUNCT
aji-147	315	25	length	length	NOUN
aji-147	315	26	spike	spike	NOUN
aji-147	315	27	(	(	PUNCT
aji-147	315	28	s)-protein	s)-protein	NOUN
aji-147	315	29	,	,	PUNCT
aji-147	315	30	strifkfh002c	strifkfh002c	ADV
aji-147	315	31	,	,	PUNCT
aji-147	315	32	as	as	ADV
aji-147	315	33	well	well	ADV
aji-147	315	34	as	as	ADP
aji-147	315	35	the	the	DET
aji-147	315	36	spike	spike	ADJ
aji-147	315	37	(	(	PUNCT
aji-147	315	38	s)/receptor	s)/receptor	NOUN
aji-147	315	39	binding	bind	VERB
aji-147	315	40	domain	domain	NOUN
aji-147	315	41	(	(	PUNCT
aji-147	315	42	rbd	rbd	NOUN
aji-147	315	43	)	)	PUNCT
aji-147	315	44	protein	protein	NOUN
aji-147	315	45	subunit	subunit	NOUN
aji-147	315	46	vaccine	vaccine	NOUN
aji-147	315	47	remarkably	remarkably	ADV
aji-147	315	48	stimulate	stimulate	VERB
aji-147	315	49	specific	specific	ADJ
aji-147	315	50	ctfh	ctfh	NOUN
aji-147	315	51	cell	cell	NOUN
aji-147	315	52	but	but	CCONJ
aji-147	315	53	also	also	ADV
aji-147	315	54	gc	gc	PROPN
aji-147	315	55	b	b	PROPN
aji-147	315	56	cell	cell	NOUN
aji-147	315	57	responses	response	NOUN
aji-147	315	58	,	,	PUNCT
aji-147	315	59	leading	lead	VERB
aji-147	315	60	to	to	ADP
aji-147	315	61	high	high	ADJ
aji-147	315	62	sarscov-2	sarscov-2	NOUN
aji-147	315	63	”	"	PUNCT
aji-147	316	1	[	[	X
aji-147	316	2	125	125	NUM
aji-147	316	3	-	-	SYM
aji-147	316	4	127	127	NUM
aji-147	316	5	]	]	PUNCT
aji-147	316	6	neutralizing	neutralizing	ADJ
aji-147	316	7	levels	level	NOUN
aji-147	316	8	of	of	ADP
aji-147	316	9	antibodies	antibody	NOUN
aji-147	316	10	(	(	PUNCT
aji-147	316	11	table	table	NOUN
aji-147	316	12	2	2	NUM
aji-147	316	13	)	)	PUNCT
aji-147	316	14	.	.	PUNCT
aji-147	317	1	several	several	ADJ
aji-147	317	2	human	human	ADJ
aji-147	317	3	clinical	clinical	ADJ
aji-147	317	4	studies	study	NOUN
aji-147	317	5	show	show	VERB
aji-147	317	6	that	that	SCONJ
aji-147	317	7	immobilized	immobilize	VERB
aji-147	317	8	sars	sar	NOUN
aji-147	317	9	-	-	PUNCT
aji-147	317	10	cov-2	cov-2	PART
aji-147	317	11	vaccinations	vaccination	NOUN
aji-147	317	12	can	can	AUX
aji-147	317	13	produce	produce	VERB
aji-147	317	14	sufficient	sufficient	ADJ
aji-147	317	15	high	high	ADJ
aji-147	317	16	neutralizing	neutralizing	ADJ
aji-147	317	17	levels	level	NOUN
aji-147	317	18	of	of	ADP
aji-147	317	19	antibodies	antibody	NOUN
aji-147	317	20	to	to	PART
aji-147	317	21	decrease	decrease	VERB
aji-147	317	22	the	the	DET
aji-147	317	23	rate	rate	NOUN
aji-147	317	24	of	of	ADP
aji-147	317	25	patients	patient	NOUN
aji-147	317	26	developing	develop	VERB
aji-147	317	27	severe	severe	ADJ
aji-147	317	28	covid-19	covid-19	PROPN
aji-147	318	1	[	[	X
aji-147	318	2	127129	127129	NUM
aji-147	318	3	]	]	PUNCT
aji-147	318	4	.	.	PUNCT
aji-147	319	1	such	such	ADJ
aji-147	319	2	findings	finding	NOUN
aji-147	319	3	imply	imply	VERB
aji-147	319	4	that	that	SCONJ
aji-147	319	5	sars	sar	NOUN
aji-147	319	6	-	-	PUNCT
aji-147	319	7	cov-2	cov-2	PART
aji-147	319	8	vaccinations	vaccination	NOUN
aji-147	319	9	can	can	AUX
aji-147	319	10	boost	boost	VERB
aji-147	319	11	host	host	NOUN
aji-147	319	12	immune	immune	ADJ
aji-147	319	13	response	response	NOUN
aji-147	319	14	,	,	PUNCT
aji-147	319	15	increase	increase	VERB
aji-147	319	16	neutralizing	neutralize	VERB
aji-147	319	17	antibody	antibody	NOUN
aji-147	319	18	levels	level	NOUN
aji-147	319	19	,	,	PUNCT
aji-147	319	20	and	and	CCONJ
aji-147	319	21	reduce	reduce	VERB
aji-147	319	22	the	the	DET
aji-147	319	23	death	death	NOUN
aji-147	319	24	rate	rate	NOUN
aji-147	319	25	of	of	ADP
aji-147	319	26	critically	critically	ADV
aji-147	319	27	ill	ill	ADJ
aji-147	319	28	patients	patient	NOUN
aji-147	319	29	.	.	PUNCT
aji-147	320	1	meanwhile	meanwhile	ADV
aji-147	320	2	,	,	PUNCT
aji-147	320	3	in	in	ADP
aji-147	320	4	serious	serious	ADJ
aji-147	320	5	covid-19	covid-19	PROPN
aji-147	320	6	patients	patient	NOUN
aji-147	320	7	,	,	PUNCT
aji-147	320	8	the	the	DET
aji-147	320	9	absence	absence	NOUN
aji-147	320	10	of	of	ADP
aji-147	320	11	gc	gc	PROPN
aji-147	320	12	structures	structure	NOUN
aji-147	320	13	lowers	lower	VERB
aji-147	320	14	bcl-6	bcl-6	PUNCT
aji-147	320	15	+	+	CCONJ
aji-147	320	16	tfh	tfh	NOUN
aji-147	320	17	cells	cell	NOUN
aji-147	320	18	.	.	PUNCT
aji-147	321	1	interestingly	interestingly	ADV
aji-147	321	2	,	,	PUNCT
aji-147	321	3	sars	sar	NOUN
aji-147	321	4	-	-	PUNCT
aji-147	321	5	cov-2	cov-2	NOUN
aji-147	321	6	-	-	PUNCT
aji-147	321	7	specific	specific	ADJ
aji-147	321	8	tfh	tfh	NOUN
aji-147	321	9	cells	cell	NOUN
aji-147	321	10	significantly	significantly	ADV
aji-147	321	11	increased	increase	VERB
aji-147	321	12	in	in	ADP
aji-147	321	13	moderate	moderate	ADJ
aji-147	321	14	and	and	CCONJ
aji-147	321	15	asymptomatic	asymptomatic	ADJ
aji-147	321	16	covid-19	covid-19	PROPN
aji-147	321	17	patients	patient	NOUN
aji-147	321	18	.	.	PUNCT
aji-147	322	1	vaccines	vaccine	NOUN
aji-147	322	2	also	also	ADV
aji-147	322	3	can	can	AUX
aji-147	322	4	stimulate	stimulate	VERB
aji-147	322	5	tfh	tfh	NUM
aji-147	322	6	cell	cell	NOUN
aji-147	322	7	differentiation	differentiation	NOUN
aji-147	322	8	and	and	CCONJ
aji-147	322	9	gc	gc	PROPN
aji-147	322	10	production	production	NOUN
aji-147	322	11	,	,	PUNCT
aji-147	322	12	including	include	VERB
aji-147	322	13	defensive	defensive	ADJ
aji-147	322	14	antibody	antibody	NOUN
aji-147	322	15	responses	response	NOUN
aji-147	322	16	.	.	PUNCT
aji-147	323	1	5	5	X
aji-147	323	2	.	.	X
aji-147	323	3	human	human	ADJ
aji-147	323	4	circulating	circulating	PROPN
aji-147	323	5	t	t	PROPN
aji-147	323	6	follicular	follicular	ADJ
aji-147	323	7	helper	helper	NOUN
aji-147	323	8	cells	cell	NOUN
aji-147	323	9	(	(	PUNCT
aji-147	323	10	ctfh	ctfh	NOUN
aji-147	323	11	)	)	PUNCT
aji-147	323	12	response	response	NOUN
aji-147	323	13	against	against	ADP
aji-147	323	14	covid-19	covid-19	PROPN
aji-147	323	15	activated	activated	ADJ
aji-147	323	16	ctfh	ctfh	NOUN
aji-147	323	17	(	(	PUNCT
aji-147	323	18	pd-1+icos+	pd-1+icos+	NOUN
aji-147	323	19	)	)	PUNCT
aji-147	324	1	[	[	X
aji-147	324	2	41,43,132	41,43,132	NUM
aji-147	324	3	-	-	SYM
aji-147	324	4	134	134	NUM
aji-147	324	5	]	]	PUNCT
aji-147	324	6	with	with	ADP
aji-147	324	7	enhanced	enhanced	ADJ
aji-147	324	8	expression	expression	NOUN
aji-147	324	9	of	of	ADP
aji-147	324	10	cd38	cd38	PROPN
aji-147	324	11	[	[	X
aji-147	324	12	135	135	NUM
aji-147	324	13	]	]	PUNCT
aji-147	324	14	but	but	CCONJ
aji-147	324	15	also	also	ADV
aji-147	324	16	decreased	decrease	VERB
aji-147	324	17	expression	expression	NOUN
aji-147	324	18	of	of	ADP
aji-147	324	19	ccr7	ccr7	PROPN
aji-147	324	20	[	[	X
aji-147	324	21	43	43	NUM
aji-147	324	22	]	]	PUNCT
aji-147	324	23	is	be	AUX
aji-147	324	24	seen	see	VERB
aji-147	324	25	in	in	ADP
aji-147	324	26	the	the	DET
aji-147	324	27	blood	blood	NOUN
aji-147	324	28	during	during	ADP
aji-147	324	29	acute	acute	ADJ
aji-147	324	30	infection	infection	NOUN
aji-147	324	31	.	.	PUNCT
aji-147	325	1	such	such	ADJ
aji-147	325	2	activated	activate	VERB
aji-147	325	3	pd-1+icos+	pd-1+icos+	NOUN
aji-147	325	4	ctfh	ctfh	NOUN
aji-147	325	5	cells	cell	NOUN
aji-147	325	6	appear	appear	VERB
aji-147	325	7	spontaneously	spontaneously	ADV
aji-147	325	8	throughout	throughout	ADP
aji-147	325	9	the	the	DET
aji-147	325	10	infection	infection	NOUN
aji-147	325	11	but	but	CCONJ
aji-147	325	12	typically	typically	ADV
aji-147	325	13	decrease	decrease	VERB
aji-147	325	14	14	14	NUM
aji-147	325	15	days	day	NOUN
aji-147	325	16	after	after	ADP
aji-147	325	17	symptom	symptom	NOUN
aji-147	325	18	onset	onset	NOUN
aji-147	325	19	.	.	PUNCT
aji-147	326	1	as	as	ADP
aji-147	326	2	a	a	DET
aji-147	326	3	result	result	NOUN
aji-147	326	4	,	,	PUNCT
aji-147	326	5	antigenspecific	antigenspecific	PROPN
aji-147	326	6	t	t	NOUN
aji-147	326	7	cell	cell	NOUN
aji-147	326	8	tests	test	NOUN
aji-147	326	9	(	(	PUNCT
aji-147	326	10	activation	activation	NOUN
aji-147	326	11	-	-	PUNCT
aji-147	326	12	induced	induce	VERB
aji-147	326	13	marker	marker	NOUN
aji-147	326	14	(	(	PUNCT
aji-147	326	15	aim	aim	NOUN
aji-147	326	16	)	)	PUNCT
aji-147	326	17	and	and	CCONJ
aji-147	326	18	intracellular	intracellular	ADJ
aji-147	326	19	cytokine	cytokine	NOUN
aji-147	326	20	staining	stain	VERB
aji-147	326	21	)	)	PUNCT
aji-147	326	22	were	be	AUX
aji-147	326	23	crucial	crucial	ADJ
aji-147	326	24	to	to	ADP
aji-147	326	25	evaluating	evaluate	VERB
aji-147	326	26	sars	sar	NOUN
aji-147	326	27	-	-	PUNCT
aji-147	326	28	cov-2	cov-2	NOUN
aji-147	326	29	-	-	PUNCT
aji-147	326	30	specific	specific	ADJ
aji-147	326	31	ctfh	ctfh	NOUN
aji-147	326	32	responses	response	NOUN
aji-147	326	33	throughout	throughout	ADP
aji-147	326	34	recovery	recovery	NOUN
aji-147	326	35	.	.	PUNCT
aji-147	327	1	these	these	DET
aji-147	327	2	studies	study	NOUN
aji-147	327	3	have	have	AUX
aji-147	327	4	also	also	ADV
aji-147	327	5	shown	show	VERB
aji-147	327	6	that	that	SCONJ
aji-147	327	7	s	s	NOUN
aji-147	327	8	-	-	PUNCT
aji-147	327	9	specific	specific	ADJ
aji-147	327	10	ctfh	ctfh	NOUN
aji-147	327	11	cells	cell	NOUN
aji-147	327	12	that	that	PRON
aji-147	327	13	arise	arise	VERB
aji-147	327	14	following	follow	VERB
aji-147	327	15	acute	acute	ADJ
aji-147	327	16	infection	infection	NOUN
aji-147	327	17	[	[	X
aji-147	327	18	136	136	NUM
aji-147	327	19	]	]	PUNCT
aji-147	327	20	remain	remain	VERB
aji-147	327	21	in	in	ADP
aji-147	327	22	convalescent	convalescent	NOUN
aji-147	327	23	patients	patient	NOUN
aji-147	327	24	for	for	ADP
aji-147	327	25	at	at	ADV
aji-147	327	26	least	least	ADV
aji-147	327	27	6	6	NUM
aji-147	327	28	months	month	NOUN
aji-147	327	29	[	[	X
aji-147	327	30	32	32	NUM
aji-147	327	31	]	]	PUNCT
aji-147	327	32	,	,	PUNCT
aji-147	327	33	with	with	ADP
aji-147	327	34	a	a	DET
aji-147	327	35	half	half	ADJ
aji-147	327	36	-	-	PUNCT
aji-147	327	37	life	life	NOUN
aji-147	327	38	of	of	ADP
aji-147	327	39	approximately	approximately	ADV
aji-147	327	40	129	129	NUM
aji-147	327	41	days	day	NOUN
aji-147	327	42	[	[	X
aji-147	327	43	50	50	NUM
aji-147	327	44	]	]	PUNCT
aji-147	327	45	.	.	PUNCT
aji-147	328	1	the	the	DET
aji-147	328	2	link	link	NOUN
aji-147	328	3	between	between	ADP
aji-147	328	4	ctfh	ctfh	NOUN
aji-147	328	5	frequencies	frequency	NOUN
aji-147	328	6	,	,	PUNCT
aji-147	328	7	morphological	morphological	ADJ
aji-147	328	8	and	and	CCONJ
aji-147	328	9	functional	functional	ADJ
aji-147	328	10	polarization	polarization	NOUN
aji-147	328	11	,	,	PUNCT
aji-147	328	12	and	and	CCONJ
aji-147	328	13	sars	sar	NOUN
aji-147	328	14	-	-	PUNCT
aji-147	328	15	cov-2	cov-2	NOUN
aji-147	328	16	serologic	serologic	NOUN
aji-147	328	17	responses	response	NOUN
aji-147	328	18	have	have	AUX
aji-147	328	19	been	be	AUX
aji-147	328	20	investigated	investigate	VERB
aji-147	328	21	.	.	PUNCT
aji-147	329	1	most	most	ADJ
aji-147	329	2	of	of	ADP
aji-147	329	3	the	the	DET
aji-147	329	4	pd1+icos+	pd1+icos+	NOUN
aji-147	329	5	ctfh	ctfh	NOUN
aji-147	329	6	populations	population	NOUN
aji-147	329	7	formed	form	VERB
aji-147	329	8	during	during	ADP
aji-147	329	9	the	the	DET
aji-147	329	10	acute	acute	ADJ
aji-147	329	11	stage	stage	NOUN
aji-147	329	12	of	of	ADP
aji-147	329	13	covid-19	covid-19	PROPN
aji-147	329	14	are	be	AUX
aji-147	329	15	cxcr3+ctfh1	cxcr3+ctfh1	NOUN
aji-147	329	16	cells	cell	NOUN
aji-147	329	17	[	[	X
aji-147	329	18	132,134	132,134	NUM
aji-147	329	19	]	]	PUNCT
aji-147	329	20	,	,	PUNCT
aji-147	329	21	similar	similar	ADJ
aji-147	329	22	to	to	ADP
aji-147	329	23	influenza	influenza	ADJ
aji-147	329	24	infection	infection	NOUN
aji-147	329	25	[	[	X
aji-147	329	26	137	137	NUM
aji-147	329	27	]	]	PUNCT
aji-147	329	28	.	.	PUNCT
aji-147	330	1	moreover	moreover	ADV
aji-147	330	2	,	,	PUNCT
aji-147	330	3	the	the	DET
aji-147	330	4	investigation	investigation	NOUN
aji-147	330	5	of	of	ADP
aji-147	330	6	s	s	NOUN
aji-147	330	7	-	-	PUNCT
aji-147	330	8	specific	specific	ADJ
aji-147	330	9	ctfh	ctfh	NOUN
aji-147	330	10	showed	show	VERB
aji-147	330	11	a	a	DET
aji-147	330	12	completely	completely	ADV
aji-147	330	13	dominant	dominant	ADJ
aji-147	330	14	population	population	NOUN
aji-147	330	15	of	of	ADP
aji-147	330	16	cxcr3	cxcr3	PROPN
aji-147	330	17	–	–	PUNCT
aji-147	330	18	ccr6	ccr6	NOUN
aji-147	330	19	+	+	NUM
aji-147	330	20	cells	cell	NOUN
aji-147	330	21	[	[	X
aji-147	330	22	46,49,136	46,49,136	NOUN
aji-147	330	23	]	]	X
aji-147	330	24	.	.	PUNCT
aji-147	331	1	remarkably	remarkably	ADV
aji-147	331	2	,	,	PUNCT
aji-147	331	3	the	the	DET
aji-147	331	4	fraction	fraction	NOUN
aji-147	331	5	of	of	ADP
aji-147	331	6	cxcr3	cxcr3	PROPN
aji-147	331	7	–	–	PUNCT
aji-147	331	8	ccr6	ccr6	ADJ
aji-147	331	9	+	+	CCONJ
aji-147	331	10	s	s	ADJ
aji-147	331	11	-	-	PUNCT
aji-147	331	12	specific	specific	ADJ
aji-147	331	13	ctfh	ctfh	NOUN
aji-147	331	14	cells	cell	NOUN
aji-147	331	15	during	during	ADP
aji-147	331	16	late	late	ADJ
aji-147	331	17	convalescence	convalescence	NOUN
aji-147	331	18	(	(	PUNCT
aji-147	331	19	6	6	NUM
aji-147	331	20	months	month	NOUN
aji-147	331	21	)	)	PUNCT
aji-147	331	22	is	be	AUX
aji-147	331	23	more	more	ADV
aji-147	331	24	significant	significant	ADJ
aji-147	331	25	than	than	ADP
aji-147	331	26	that	that	PRON
aji-147	331	27	in	in	ADP
aji-147	331	28	initial	initial	ADJ
aji-147	331	29	convalescence	convalescence	NOUN
aji-147	331	30	(	(	PUNCT
aji-147	331	31	1–2	1–2	NUM
aji-147	331	32	months	month	NOUN
aji-147	331	33	)	)	PUNCT
aji-147	331	34	or	or	CCONJ
aji-147	331	35	even	even	ADV
aji-147	331	36	during	during	ADP
aji-147	331	37	the	the	DET
aji-147	331	38	acute	acute	ADJ
aji-147	331	39	stage	stage	NOUN
aji-147	331	40	[	[	X
aji-147	331	41	49,136	49,136	NUM
aji-147	331	42	]	]	PUNCT
aji-147	331	43	.	.	PUNCT
aji-147	332	1	despite	despite	SCONJ
aji-147	332	2	the	the	DET
aji-147	332	3	presence	presence	NOUN
aji-147	332	4	of	of	ADP
aji-147	332	5	cxcr3ccr6	cxcr3ccr6	NOUN
aji-147	332	6	+	+	NUM
aji-147	332	7	ctfh17	ctfh17	NOUN
aji-147	332	8	cells	cell	NOUN
aji-147	332	9	,	,	PUNCT
aji-147	332	10	antigen	antigen	NOUN
aji-147	332	11	-	-	PUNCT
aji-147	332	12	specific	specific	ADJ
aji-147	332	13	ctfh	ctfh	NOUN
aji-147	332	14	cells	cell	NOUN
aji-147	332	15	from	from	ADP
aji-147	332	16	covid-19	covid-19	PROPN
aji-147	332	17	patients	patient	NOUN
aji-147	332	18	routinely	routinely	ADV
aji-147	332	19	release	release	VERB
aji-147	332	20	ifn	ifn	NOUN
aji-147	332	21	and	and	CCONJ
aji-147	332	22	il-21	il-21	NOUN
aji-147	332	23	,	,	PUNCT
aji-147	332	24	even	even	ADV
aji-147	332	25	when	when	SCONJ
aji-147	332	26	il-17	il-17	ADV
aji-147	332	27	is	be	AUX
aji-147	332	28	not	not	PART
aji-147	332	29	present	present	ADJ
aji-147	332	30	,	,	PUNCT
aji-147	332	31	according	accord	VERB
aji-147	332	32	to	to	ADP
aji-147	332	33	multiple	multiple	ADJ
aji-147	332	34	independent	independent	ADJ
aji-147	332	35	studies	study	NOUN
aji-147	332	36	[	[	X
aji-147	332	37	46,48	46,48	NUM
aji-147	332	38	-	-	SYM
aji-147	332	39	50,133,136,137	50,133,136,137	NUM
aji-147	332	40	]	]	PUNCT
aji-147	332	41	.	.	PUNCT
aji-147	333	1	the	the	DET
aji-147	333	2	development	development	NOUN
aji-147	333	3	of	of	ADP
aji-147	333	4	effective	effective	ADJ
aji-147	333	5	neutralizing	neutralize	VERB
aji-147	333	6	antibody	antibody	NOUN
aji-147	333	7	responses	response	NOUN
aji-147	333	8	has	have	AUX
aji-147	333	9	been	be	AUX
aji-147	333	10	associated	associate	VERB
aji-147	333	11	with	with	ADP
aji-147	333	12	a	a	DET
aji-147	333	13	phenotypic	phenotypic	ADJ
aji-147	333	14	polarization	polarization	NOUN
aji-147	333	15	of	of	ADP
aji-147	333	16	ctfh	ctfh	NOUN
aji-147	333	17	.	.	PUNCT
aji-147	334	1	furthermore	furthermore	ADV
aji-147	334	2	,	,	PUNCT
aji-147	334	3	high	high	ADJ
aji-147	334	4	levels	level	NOUN
aji-147	334	5	of	of	ADP
aji-147	334	6	serum	serum	NOUN
aji-147	334	7	spike	spike	NOUN
aji-147	334	8	binding	bind	VERB
aji-147	334	9	and	and	CCONJ
aji-147	334	10	neutralizing	neutralize	VERB
aji-147	334	11	antibodies	antibody	NOUN
aji-147	334	12	were	be	AUX
aji-147	334	13	strongly	strongly	ADV
aji-147	334	14	associated	associate	VERB
aji-147	334	15	with	with	ADP
aji-147	334	16	cxcr3	cxcr3	NOUN
aji-147	334	17	+	+	CCONJ
aji-147	334	18	ctfh1	ctfh1	ADJ
aji-147	334	19	cells	cell	NOUN
aji-147	334	20	.	.	PUNCT
aji-147	335	1	this	this	PRON
aji-147	335	2	was	be	AUX
aji-147	335	3	true	true	ADJ
aji-147	335	4	not	not	PART
aji-147	335	5	only	only	ADV
aji-147	335	6	for	for	ADP
aji-147	335	7	the	the	DET
aji-147	335	8	overall	overall	ADJ
aji-147	335	9	icos+pd-1	icos+pd-1	ADJ
aji-147	335	10	+	+	ADJ
aji-147	335	11	ctfh1	ctfh1	ADJ
aji-147	335	12	populations	population	NOUN
aji-147	335	13	(	(	PUNCT
aji-147	335	14	which	which	PRON
aji-147	335	15	corresponds	correspond	VERB
aji-147	335	16	to	to	ADP
aji-147	335	17	asc	asc	PROPN
aji-147	335	18	responses	response	NOUN
aji-147	335	19	and	and	CCONJ
aji-147	335	20	plasma	plasma	NOUN
aji-147	335	21	cxcl13	cxcl13	NOUN
aji-147	335	22	)	)	PUNCT
aji-147	336	1	[	[	X
aji-147	336	2	43,132	43,132	NUM
aji-147	336	3	-	-	SYM
aji-147	336	4	134	134	NUM
aji-147	336	5	]	]	PUNCT
aji-147	336	6	,	,	PUNCT
aji-147	336	7	but	but	CCONJ
aji-147	336	8	also	also	ADV
aji-147	336	9	for	for	ADP
aji-147	336	10	sspecific	sspecific	ADJ
aji-147	336	11	ctfh1	ctfh1	NOUN
aji-147	337	1	[	[	X
aji-147	337	2	46	46	NUM
aji-147	337	3	]	]	PUNCT
aji-147	337	4	.	.	PUNCT
aji-147	338	1	the	the	DET
aji-147	338	2	activation	activation	NOUN
aji-147	338	3	of	of	ADP
aji-147	338	4	ctfh1	ctfh1	NOUN
aji-147	338	5	cells	cell	NOUN
aji-147	338	6	in	in	ADP
aji-147	338	7	acute	acute	PROPN
aji-147	338	8	covid-19	covid-19	PROPN
aji-147	338	9	significantly	significantly	ADV
aji-147	338	10	corresponds	correspond	VERB
aji-147	338	11	with	with	ADP
aji-147	338	12	both	both	CCONJ
aji-147	338	13	the	the	DET
aji-147	338	14	confirmatory	confirmatory	NOUN
aji-147	338	15	testing	testing	NOUN
aji-147	338	16	and	and	CCONJ
aji-147	338	17	antibody	antibody	NOUN
aji-147	338	18	production	production	NOUN
aji-147	338	19	of	of	ADP
aji-147	338	20	rbd	rbd	NOUN
aji-147	338	21	-	-	PUNCT
aji-147	338	22	specific	specific	ADJ
aji-147	338	23	igm	igm	NOUN
aji-147	338	24	antibodies	antibodie	VERB
aji-147	339	1	[	[	X
aji-147	339	2	46	46	NUM
aji-147	339	3	]	]	PUNCT
aji-147	339	4	.	.	PUNCT
aji-147	340	1	“	"	PUNCT
aji-147	340	2	the	the	DET
aji-147	340	3	association	association	NOUN
aji-147	340	4	between	between	ADP
aji-147	340	5	ctfh2	ctfh2	PROPN
aji-147	340	6	,	,	PUNCT
aji-147	340	7	ctfh17	ctfh17	NOUN
aji-147	340	8	,	,	PUNCT
aji-147	340	9	and	and	CCONJ
aji-147	340	10	antibody	antibody	NOUN
aji-147	340	11	response	response	NOUN
aji-147	340	12	,	,	PUNCT
aji-147	340	13	on	on	ADP
aji-147	340	14	the	the	DET
aji-147	340	15	other	other	ADJ
aji-147	340	16	hand	hand	NOUN
aji-147	340	17	,	,	PUNCT
aji-147	340	18	varies	vary	VERB
aji-147	340	19	among	among	ADP
aji-147	340	20	cohorts	cohort	NOUN
aji-147	340	21	and	and	CCONJ
aji-147	340	22	tests	test	NOUN
aji-147	340	23	.	.	PUNCT
aji-147	341	1	the	the	DET
aji-147	341	2	discovery	discovery	NOUN
aji-147	341	3	of	of	ADP
aji-147	341	4	sspecific	sspecific	ADJ
aji-147	341	5	ctfh	ctfh	NOUN
aji-147	341	6	led	lead	VERB
aji-147	341	7	to	to	ADP
aji-147	341	8	the	the	DET
aji-147	341	9	conclusion	conclusion	NOUN
aji-147	341	10	that	that	SCONJ
aji-147	341	11	the	the	DET
aji-147	341	12	occurrence	occurrence	NOUN
aji-147	341	13	of	of	ADP
aji-147	341	14	ctfh2	ctfh2	NOUN
aji-147	341	15	responses	response	NOUN
aji-147	341	16	was	be	AUX
aji-147	341	17	positively	positively	ADV
aji-147	341	18	correlated	correlate	VERB
aji-147	341	19	with	with	ADP
aji-147	341	20	increasing	increase	VERB
aji-147	341	21	neutralizing	neutralizing	ADJ
aji-147	341	22	levels	level	NOUN
aji-147	341	23	of	of	ADP
aji-147	341	24	antibodies	antibody	NOUN
aji-147	341	25	,	,	PUNCT
aji-147	341	26	whereas	whereas	SCONJ
aji-147	341	27	s	s	X
aji-147	341	28	-	-	PUNCT
aji-147	341	29	specific	specific	ADJ
aji-147	341	30	ctfh17	ctfh17	NOUN
aji-147	341	31	showed	show	VERB
aji-147	341	32	a	a	DET
aji-147	341	33	significant	significant	ADJ
aji-147	341	34	negative	negative	ADJ
aji-147	341	35	correlation	correlation	NOUN
aji-147	341	36	with	with	ADP
aji-147	341	37	neutralizing	neutralize	VERB
aji-147	341	38	activity	activity	NOUN
aji-147	341	39	”	"	PUNCT
aji-147	342	1	[	[	X
aji-147	342	2	46	46	NUM
aji-147	342	3	]	]	PUNCT
aji-147	342	4	.	.	PUNCT
aji-147	343	1	overall	overall	ADJ
aji-147	343	2	,	,	PUNCT
aji-147	343	3	icos+pd1	icos+pd1	PRON
aji-147	343	4	+	+	SYM
aji-147	343	5	ctfh2/17	ctfh2/17	NOUN
aji-147	343	6	cells	cell	NOUN
aji-147	343	7	were	be	AUX
aji-147	343	8	significantly	significantly	ADV
aji-147	343	9	negatively	negatively	ADV
aji-147	343	10	correlated	correlate	VERB
aji-147	343	11	with	with	ADP
aji-147	343	12	antibody	antibody	NOUN
aji-147	343	13	response	response	NOUN
aji-147	343	14	in	in	ADP
aji-147	343	15	different	different	ADJ
aji-147	343	16	populations	population	NOUN
aji-147	343	17	[	[	X
aji-147	343	18	43,46,133,134	43,46,133,134	X
aji-147	343	19	]	]	X
aji-147	343	20	.	.	PUNCT
aji-147	344	1	therefore	therefore	ADV
aji-147	344	2	,	,	PUNCT
aji-147	344	3	the	the	DET
aji-147	344	4	present	present	ADJ
aji-147	344	5	shukla	shukla	NOUN
aji-147	344	6	et	et	PROPN
aji-147	344	7	al	al	PROPN
aji-147	344	8	.	.	PROPN
aji-147	344	9	;	;	PUNCT
aji-147	344	10	asian	asian	PROPN
aji-147	344	11	j.	j.	PROPN
aji-147	344	12	immunol	immunol	PROPN
aji-147	344	13	.	.	PROPN
aji-147	344	14	,	,	PUNCT
aji-147	344	15	vol	vol	NOUN
aji-147	344	16	.	.	PROPN
aji-147	344	17	7	7	NUM
aji-147	344	18	,	,	PUNCT
aji-147	344	19	no	no	INTJ
aji-147	344	20	.	.	NOUN
aji-147	344	21	1	1	NUM
aji-147	344	22	,	,	PUNCT
aji-147	344	23	pp	pp	ADJ
aji-147	344	24	.	.	PUNCT
aji-147	345	1	228	228	NUM
aji-147	345	2	-	-	SYM
aji-147	345	3	246	246	NUM
aji-147	345	4	,	,	PUNCT
aji-147	345	5	2024	2024	NUM
aji-147	345	6	;	;	PUNCT
aji-147	345	7	article	article	NOUN
aji-147	345	8	no.aji.125387	no.aji.125387	NOUN
aji-147	345	9	239	239	NUM
aji-147	345	10	findings	finding	NOUN
aji-147	345	11	show	show	VERB
aji-147	345	12	that	that	SCONJ
aji-147	345	13	cxcr3	cxcr3	NOUN
aji-147	345	14	+	+	CCONJ
aji-147	345	15	ctfh1	ctfh1	ADJ
aji-147	345	16	cells	cell	NOUN
aji-147	345	17	are	be	AUX
aji-147	345	18	a	a	DET
aji-147	345	19	significant	significant	ADJ
aji-147	345	20	correlate	correlate	NOUN
aji-147	345	21	of	of	ADP
aji-147	345	22	neutralizing	neutralize	VERB
aji-147	345	23	as	as	ADV
aji-147	345	24	well	well	ADV
aji-147	345	25	as	as	ADP
aji-147	345	26	overall	overall	ADJ
aji-147	345	27	antibodies	antibody	NOUN
aji-147	345	28	towards	towards	ADP
aji-147	345	29	sars	sar	NOUN
aji-147	345	30	-	-	PUNCT
aji-147	345	31	cov-2	cov-2	NOUN
aji-147	345	32	,	,	PUNCT
aji-147	345	33	but	but	CCONJ
aji-147	345	34	the	the	DET
aji-147	345	35	roles	role	NOUN
aji-147	345	36	of	of	ADP
aji-147	345	37	cxcr3	cxcr3	NOUN
aji-147	345	38	–	–	PUNCT
aji-147	345	39	ctfh2	ctfh2	NOUN
aji-147	345	40	and	and	CCONJ
aji-147	345	41	ctfh17	ctfh17	NOUN
aji-147	345	42	cells	cell	NOUN
aji-147	345	43	,	,	PUNCT
aji-147	345	44	as	as	ADV
aji-147	345	45	well	well	ADV
aji-147	345	46	as	as	ADP
aji-147	345	47	the	the	DET
aji-147	345	48	differences	difference	NOUN
aji-147	345	49	between	between	ADP
aji-147	345	50	total	total	NOUN
aji-147	345	51	icos+pd1	icos+pd1	NUM
aji-147	345	52	+	+	CCONJ
aji-147	345	53	and	and	CCONJ
aji-147	345	54	aim+	aim+	PROPN
aji-147	345	55	ctfh	ctfh	NOUN
aji-147	345	56	cells	cell	NOUN
aji-147	345	57	,	,	PUNCT
aji-147	345	58	deserve	deserve	VERB
aji-147	345	59	additional	additional	ADJ
aji-147	345	60	exploration	exploration	NOUN
aji-147	345	61	.	.	PUNCT
aji-147	346	1	whereas	whereas	SCONJ
aji-147	346	2	most	most	ADJ
aji-147	346	3	research	research	NOUN
aji-147	346	4	has	have	AUX
aji-147	346	5	concentrated	concentrate	VERB
aji-147	346	6	on	on	ADP
aji-147	346	7	sspecific	sspecific	ADJ
aji-147	346	8	ctfh	ctfh	NOUN
aji-147	346	9	cells	cell	NOUN
aji-147	346	10	,	,	PUNCT
aji-147	346	11	n	n	NOUN
aji-147	346	12	and	and	CCONJ
aji-147	346	13	m	m	ADJ
aji-147	346	14	-	-	ADJ
aji-147	346	15	specific	specific	ADJ
aji-147	346	16	ctfh	ctfh	NOUN
aji-147	346	17	cells	cell	NOUN
aji-147	346	18	were	be	AUX
aji-147	346	19	also	also	ADV
aji-147	346	20	investigated	investigate	VERB
aji-147	346	21	[	[	PRON
aji-147	346	22	53,136,138	53,136,138	NUM
aji-147	346	23	]	]	PUNCT
aji-147	346	24	.	.	PUNCT
aji-147	347	1	the	the	DET
aji-147	347	2	proportion	proportion	NOUN
aji-147	347	3	of	of	ADP
aji-147	347	4	ctfh	ctfh	NOUN
aji-147	347	5	cells	cell	NOUN
aji-147	347	6	specific	specific	ADJ
aji-147	347	7	for	for	ADP
aji-147	347	8	s	s	PROPN
aji-147	347	9	,	,	PUNCT
aji-147	347	10	n	n	CCONJ
aji-147	347	11	,	,	PUNCT
aji-147	347	12	and	and	CCONJ
aji-147	347	13	m	m	PROPN
aji-147	347	14	was	be	AUX
aji-147	347	15	shown	show	VERB
aji-147	347	16	to	to	PART
aji-147	347	17	be	be	AUX
aji-147	347	18	favourably	favourably	ADV
aji-147	347	19	linked	link	VERB
aji-147	347	20	to	to	ADP
aji-147	347	21	increased	increase	VERB
aji-147	347	22	plasma	plasma	NOUN
aji-147	347	23	neutralization	neutralization	NOUN
aji-147	347	24	activity	activity	NOUN
aji-147	347	25	with	with	ADP
aji-147	347	26	n	n	CCONJ
aji-147	347	27	-	-	PUNCT
aji-147	347	28	specific	specific	ADJ
aji-147	347	29	igg	igg	NOUN
aji-147	347	30	antibodies	antibodie	VERB
aji-147	348	1	[	[	X
aji-147	348	2	53	53	NUM
aji-147	348	3	]	]	PUNCT
aji-147	348	4	.	.	PUNCT
aji-147	349	1	remarkably	remarkably	ADV
aji-147	349	2	,	,	PUNCT
aji-147	349	3	for	for	SCONJ
aji-147	349	4	ctfh	ctfh	NOUN
aji-147	349	5	cells	cell	NOUN
aji-147	349	6	specific	specific	ADJ
aji-147	349	7	towards	towards	ADP
aji-147	349	8	various	various	ADJ
aji-147	349	9	sars	sar	NOUN
aji-147	349	10	-	-	PUNCT
aji-147	349	11	cov-2	cov-2	PART
aji-147	349	12	antigens	antigen	NOUN
aji-147	349	13	,	,	PUNCT
aji-147	349	14	polarisation	polarisation	NOUN
aji-147	349	15	throughout	throughout	ADP
aji-147	349	16	ctfh1	ctfh1	NOUN
aji-147	349	17	,	,	PUNCT
aji-147	349	18	ctfh2	ctfh2	NOUN
aji-147	349	19	,	,	PUNCT
aji-147	349	20	and	and	CCONJ
aji-147	349	21	ctfh17	ctfh17	NOUN
aji-147	349	22	subgroups	subgroup	NOUN
aji-147	349	23	has	have	AUX
aji-147	349	24	been	be	AUX
aji-147	349	25	shown	show	VERB
aji-147	349	26	to	to	PART
aji-147	349	27	change	change	VERB
aji-147	349	28	[	[	X
aji-147	349	29	138	138	NUM
aji-147	349	30	]	]	PUNCT
aji-147	349	31	,	,	PUNCT
aji-147	349	32	but	but	CCONJ
aji-147	349	33	the	the	DET
aji-147	349	34	relevance	relevance	NOUN
aji-147	349	35	of	of	ADP
aji-147	349	36	this	this	DET
aji-147	349	37	result	result	NOUN
aji-147	349	38	is	be	AUX
aji-147	349	39	still	still	ADV
aji-147	349	40	unknown	unknown	ADJ
aji-147	349	41	.	.	PUNCT
aji-147	350	1	a	a	DET
aji-147	350	2	possible	possible	ADJ
aji-147	350	3	decrease	decrease	NOUN
aji-147	350	4	of	of	ADP
aji-147	350	5	tfh	tfh	NOUN
aji-147	350	6	cells	cell	NOUN
aji-147	350	7	has	have	AUX
aji-147	350	8	also	also	ADV
aji-147	350	9	been	be	AUX
aji-147	350	10	identified	identify	VERB
aji-147	350	11	in	in	ADP
aji-147	350	12	some	some	DET
aji-147	350	13	patients	patient	NOUN
aji-147	350	14	with	with	ADP
aji-147	350	15	acute	acute	PROPN
aji-147	350	16	covid-19	covid-19	PROPN
aji-147	350	17	.	.	PUNCT
aji-147	351	1	in	in	ADP
aji-147	351	2	particular	particular	ADJ
aji-147	351	3	,	,	PUNCT
aji-147	351	4	gc	gc	PROPN
aji-147	351	5	-	-	PUNCT
aji-147	351	6	b	b	NOUN
aji-147	351	7	cells	cell	NOUN
aji-147	351	8	and	and	CCONJ
aji-147	351	9	tfh	tfh	NUM
aji-147	351	10	cells	cell	NOUN
aji-147	351	11	were	be	AUX
aji-147	351	12	shown	show	VERB
aji-147	351	13	to	to	PART
aji-147	351	14	be	be	AUX
aji-147	351	15	reduced	reduce	VERB
aji-147	351	16	in	in	ADP
aji-147	351	17	lymphoid	lymphoid	ADJ
aji-147	351	18	tissues	tissue	NOUN
aji-147	351	19	of	of	ADP
aji-147	351	20	a	a	DET
aji-147	351	21	subgroup	subgroup	NOUN
aji-147	351	22	of	of	ADP
aji-147	351	23	deceased	deceased	ADJ
aji-147	351	24	covid-19	covid-19	PROPN
aji-147	351	25	patients	patient	NOUN
aji-147	351	26	[	[	X
aji-147	351	27	45,53	45,53	NOUN
aji-147	351	28	]	]	PUNCT
aji-147	351	29	.	.	PUNCT
aji-147	352	1	“	"	PUNCT
aji-147	352	2	furthermore	furthermore	ADV
aji-147	352	3	,	,	PUNCT
aji-147	352	4	a	a	DET
aji-147	352	5	population	population	NOUN
aji-147	352	6	with	with	ADP
aji-147	352	7	ctfh	ctfh	NOUN
aji-147	352	8	cells	cell	NOUN
aji-147	352	9	expressing	express	VERB
aji-147	352	10	cytotoxicity	cytotoxicity	NOUN
aji-147	352	11	-	-	PUNCT
aji-147	352	12	associated	associate	VERB
aji-147	352	13	genes	gene	NOUN
aji-147	352	14	,	,	PUNCT
aji-147	352	15	including	include	VERB
aji-147	352	16	prf1	prf1	NOUN
aji-147	352	17	and	and	CCONJ
aji-147	352	18	gzmb	gzmb	PROPN
aji-147	352	19	(	(	PUNCT
aji-147	352	20	encoding	encode	VERB
aji-147	352	21	perforin	perforin	NOUN
aji-147	352	22	and	and	CCONJ
aji-147	352	23	granzyme	granzyme	NOUN
aji-147	352	24	b	b	PROPN
aji-147	352	25	)	)	PUNCT
aji-147	352	26	,	,	PUNCT
aji-147	352	27	was	be	AUX
aji-147	352	28	enhanced	enhance	VERB
aji-147	352	29	in	in	ADP
aji-147	352	30	hospitalized	hospitalize	VERB
aji-147	352	31	vs.	vs.	ADP
aji-147	352	32	nonhospitalized	nonhospitalize	VERB
aji-147	352	33	patients	patient	NOUN
aji-147	352	34	.	.	PUNCT
aji-147	353	1	it	it	PRON
aji-147	353	2	was	be	AUX
aji-147	353	3	also	also	ADV
aji-147	353	4	linked	link	VERB
aji-147	353	5	with	with	ADP
aji-147	353	6	decreased	decrease	VERB
aji-147	353	7	antibody	antibody	NOUN
aji-147	353	8	levels	level	NOUN
aji-147	353	9	to	to	ADP
aji-147	353	10	s	s	NOUN
aji-147	353	11	”	"	PUNCT
aji-147	353	12	[	[	X
aji-147	353	13	139	139	NUM
aji-147	353	14	]	]	PUNCT
aji-147	353	15	.	.	PUNCT
aji-147	354	1	such	such	ADJ
aji-147	354	2	findings	finding	NOUN
aji-147	354	3	contradict	contradict	VERB
aji-147	354	4	the	the	DET
aji-147	354	5	more	more	ADV
aji-147	354	6	significant	significant	ADJ
aji-147	354	7	antibodies	antibody	NOUN
aji-147	354	8	found	find	VERB
aji-147	354	9	in	in	ADP
aji-147	354	10	acute	acute	NOUN
aji-147	354	11	covid-19	covid-19	PROPN
aji-147	355	1	[	[	X
aji-147	355	2	132	132	NUM
aji-147	355	3	]	]	PUNCT
aji-147	355	4	because	because	SCONJ
aji-147	355	5	decreased	decrease	VERB
aji-147	355	6	tfh	tfh	PROPN
aji-147	355	7	function	function	NOUN
aji-147	355	8	would	would	AUX
aji-147	355	9	be	be	AUX
aji-147	355	10	predicted	predict	VERB
aji-147	355	11	to	to	PART
aji-147	355	12	decrease	decrease	VERB
aji-147	355	13	antibody	antibody	NOUN
aji-147	355	14	levels	level	NOUN
aji-147	355	15	.	.	PUNCT
aji-147	356	1	such	such	ADJ
aji-147	356	2	findings	finding	NOUN
aji-147	356	3	highlight	highlight	VERB
aji-147	356	4	the	the	DET
aji-147	356	5	need	need	NOUN
aji-147	356	6	for	for	ADP
aji-147	356	7	more	more	ADJ
aji-147	356	8	research	research	NOUN
aji-147	356	9	into	into	ADP
aji-147	356	10	the	the	DET
aji-147	356	11	nature	nature	NOUN
aji-147	356	12	and	and	CCONJ
aji-147	356	13	function	function	NOUN
aji-147	356	14	of	of	ADP
aji-147	356	15	tfh	tfh	PROPN
aji-147	356	16	cells	cell	NOUN
aji-147	356	17	in	in	ADP
aji-147	356	18	acute	acute	NOUN
aji-147	356	19	covid-19	covid-19	PROPN
aji-147	356	20	and	and	CCONJ
aji-147	356	21	whether	whether	SCONJ
aji-147	356	22	they	they	PRON
aji-147	356	23	correspond	correspond	VERB
aji-147	356	24	to	to	ADP
aji-147	356	25	a	a	DET
aji-147	356	26	specific	specific	ADJ
aji-147	356	27	population	population	NOUN
aji-147	356	28	of	of	ADP
aji-147	356	29	patients	patient	NOUN
aji-147	356	30	.	.	PUNCT
aji-147	357	1	finally	finally	ADV
aji-147	357	2	,	,	PUNCT
aji-147	357	3	total	total	ADJ
aji-147	357	4	stimulation	stimulation	NOUN
aji-147	357	5	of	of	ADP
aji-147	357	6	ctfh	ctfh	NOUN
aji-147	357	7	cells	cell	NOUN
aji-147	357	8	and	and	CCONJ
aji-147	357	9	associated	associate	VERB
aji-147	357	10	phenotypic	phenotypic	ADJ
aji-147	357	11	polarisation	polarisation	NOUN
aji-147	357	12	throughout	throughout	ADP
aji-147	357	13	covid-19	covid-19	PROPN
aji-147	357	14	are	be	AUX
aji-147	357	15	indicators	indicator	NOUN
aji-147	357	16	of	of	ADP
aji-147	357	17	b	b	NOUN
aji-147	357	18	-	-	PUNCT
aji-147	357	19	cell	cell	NOUN
aji-147	357	20	reaction	reaction	NOUN
aji-147	357	21	neutralization	neutralization	NOUN
aji-147	357	22	(	(	PUNCT
aji-147	357	23	fig	fig	NOUN
aji-147	357	24	.	.	PUNCT
aji-147	358	1	3	3	NUM
aji-147	358	2	)	)	PUNCT
aji-147	358	3	.	.	PUNCT
aji-147	359	1	furthermore	furthermore	ADV
aji-147	359	2	,	,	PUNCT
aji-147	359	3	the	the	DET
aji-147	359	4	phenotypic	phenotypic	ADJ
aji-147	359	5	traits	trait	NOUN
aji-147	359	6	of	of	ADP
aji-147	359	7	the	the	DET
aji-147	359	8	different	different	ADJ
aji-147	359	9	ctfh	ctfh	NOUN
aji-147	359	10	subgroups	subgroup	NOUN
aji-147	359	11	,	,	PUNCT
aji-147	359	12	including	include	VERB
aji-147	359	13	their	their	PRON
aji-147	359	14	link	link	NOUN
aji-147	359	15	with	with	ADP
aji-147	359	16	gc	gc	PROPN
aji-147	359	17	tfh	tfh	PROPN
aji-147	359	18	activities	activity	NOUN
aji-147	359	19	,	,	PUNCT
aji-147	359	20	must	must	AUX
aji-147	359	21	be	be	AUX
aji-147	359	22	clarified	clarify	VERB
aji-147	359	23	.	.	PUNCT
aji-147	360	1	it	it	PRON
aji-147	360	2	is	be	AUX
aji-147	360	3	crucial	crucial	ADJ
aji-147	360	4	to	to	PART
aji-147	360	5	investigate	investigate	VERB
aji-147	360	6	the	the	DET
aji-147	360	7	potential	potential	NOUN
aji-147	360	8	for	for	ADP
aji-147	360	9	ctfh	ctfh	NOUN
aji-147	360	10	cells	cell	NOUN
aji-147	360	11	as	as	ADP
aji-147	360	12	indicators	indicator	NOUN
aji-147	360	13	of	of	ADP
aji-147	360	14	the	the	DET
aji-147	360	15	formation	formation	NOUN
aji-147	360	16	and	and	CCONJ
aji-147	360	17	recall	recall	NOUN
aji-147	360	18	of	of	ADP
aji-147	360	19	humoral	humoral	ADJ
aji-147	360	20	immunity	immunity	NOUN
aji-147	360	21	to	to	ADP
aji-147	360	22	sars	sar	NOUN
aji-147	360	23	-	-	PUNCT
aji-147	360	24	cov-2	cov-2	NOUN
aji-147	360	25	,	,	PUNCT
aji-147	360	26	particularly	particularly	ADV
aji-147	360	27	in	in	ADP
aji-147	360	28	developing	develop	VERB
aji-147	360	29	variants	variant	NOUN
aji-147	360	30	of	of	ADP
aji-147	360	31	concern	concern	NOUN
aji-147	360	32	(	(	PUNCT
aji-147	360	33	vocs	vocs	PROPN
aji-147	360	34	)	)	PUNCT
aji-147	360	35	with	with	ADP
aji-147	360	36	a	a	DET
aji-147	360	37	higher	high	ADJ
aji-147	360	38	potential	potential	NOUN
aji-147	360	39	for	for	ADP
aji-147	360	40	evasion	evasion	NOUN
aji-147	360	41	of	of	ADP
aji-147	360	42	humoral	humoral	ADJ
aji-147	360	43	immunity	immunity	NOUN
aji-147	360	44	.	.	PUNCT
aji-147	361	1	it	it	PRON
aji-147	361	2	is	be	AUX
aji-147	361	3	essential	essential	ADJ
aji-147	361	4	to	to	PART
aji-147	361	5	investigate	investigate	VERB
aji-147	361	6	the	the	DET
aji-147	361	7	potential	potential	NOUN
aji-147	361	8	for	for	ADP
aji-147	361	9	ctfh	ctfh	NOUN
aji-147	361	10	cells	cell	NOUN
aji-147	361	11	as	as	ADP
aji-147	361	12	indicators	indicator	NOUN
aji-147	361	13	of	of	ADP
aji-147	361	14	the	the	DET
aji-147	361	15	formation	formation	NOUN
aji-147	361	16	and	and	CCONJ
aji-147	361	17	recall	recall	NOUN
aji-147	361	18	of	of	ADP
aji-147	361	19	humoral	humoral	ADJ
aji-147	361	20	immunity	immunity	NOUN
aji-147	361	21	to	to	ADP
aji-147	361	22	sars	sar	NOUN
aji-147	361	23	-	-	PUNCT
aji-147	361	24	cov-2	cov-2	NOUN
aji-147	361	25	,	,	PUNCT
aji-147	361	26	particularly	particularly	ADV
aji-147	361	27	in	in	ADP
aji-147	361	28	developing	develop	VERB
aji-147	361	29	variants	variant	NOUN
aji-147	361	30	of	of	ADP
aji-147	361	31	concern	concern	NOUN
aji-147	361	32	(	(	PUNCT
aji-147	361	33	vocs	vocs	PROPN
aji-147	361	34	)	)	PUNCT
aji-147	361	35	with	with	ADP
aji-147	361	36	a	a	DET
aji-147	361	37	higher	high	ADJ
aji-147	361	38	potential	potential	NOUN
aji-147	361	39	for	for	ADP
aji-147	361	40	evasion	evasion	NOUN
aji-147	361	41	of	of	ADP
aji-147	361	42	humoral	humoral	ADJ
aji-147	361	43	immunity	immunity	NOUN
aji-147	361	44	.	.	PUNCT
aji-147	362	1	6	6	X
aji-147	362	2	.	.	X
aji-147	362	3	human	human	ADJ
aji-147	362	4	circulating	circulating	PROPN
aji-147	362	5	t	t	PROPN
aji-147	362	6	-	-	PUNCT
aji-147	362	7	follicular	follicular	ADJ
aji-147	362	8	helper	helper	NOUN
aji-147	362	9	cells	cell	NOUN
aji-147	362	10	(	(	PUNCT
aji-147	362	11	ctfh	ctfh	NOUN
aji-147	362	12	)	)	PUNCT
aji-147	362	13	responses	response	NOUN
aji-147	362	14	after	after	SCONJ
aji-147	362	15	sars	sar	NOUN
aji-147	362	16	-	-	PUNCT
aji-147	362	17	cov-2	cov-2	PART
aji-147	362	18	vaccination	vaccination	NOUN
aji-147	362	19	vaccination	vaccination	NOUN
aji-147	362	20	with	with	ADP
aji-147	362	21	certified	certify	VERB
aji-147	362	22	covid-19	covid-19	PROPN
aji-147	362	23	vaccines	vaccine	NOUN
aji-147	362	24	produces	produce	VERB
aji-147	362	25	antibody	antibody	NOUN
aji-147	362	26	responses	response	NOUN
aji-147	362	27	linked	link	VERB
aji-147	362	28	to	to	ADP
aji-147	362	29	infection	infection	NOUN
aji-147	362	30	prevention	prevention	NOUN
aji-147	362	31	.	.	PUNCT
aji-147	363	1	following	follow	VERB
aji-147	363	2	mrna	mrna	PROPN
aji-147	363	3	vaccination	vaccination	NOUN
aji-147	363	4	,	,	PUNCT
aji-147	363	5	examination	examination	NOUN
aji-147	363	6	of	of	ADP
aji-147	363	7	axillary	axillary	ADJ
aji-147	363	8	draining	drain	VERB
aji-147	363	9	lymph	lymph	NOUN
aji-147	363	10	nodes	node	NOUN
aji-147	363	11	showed	show	VERB
aji-147	363	12	substantial	substantial	ADJ
aji-147	363	13	gc	gc	PROPN
aji-147	363	14	responses	response	NOUN
aji-147	363	15	that	that	PRON
aji-147	363	16	were	be	AUX
aji-147	363	17	maintained	maintain	VERB
aji-147	363	18	for	for	ADP
aji-147	363	19	a	a	DET
aji-147	363	20	minimum	minimum	NOUN
aji-147	363	21	of	of	ADP
aji-147	363	22	12	12	NUM
aji-147	363	23	weeks	week	NOUN
aji-147	363	24	following	follow	VERB
aji-147	363	25	booster	booster	NOUN
aji-147	363	26	vaccination	vaccination	NOUN
aji-147	363	27	[	[	X
aji-147	363	28	140	140	NUM
aji-147	363	29	]	]	PUNCT
aji-147	363	30	.	.	PUNCT
aji-147	364	1	s	s	X
aji-147	364	2	-	-	PUNCT
aji-147	364	3	specific	specific	ADJ
aji-147	364	4	tfh	tfh	NOUN
aji-147	364	5	cells	cell	NOUN
aji-147	364	6	were	be	AUX
aji-147	364	7	significantly	significantly	ADV
aji-147	364	8	produced	produce	VERB
aji-147	364	9	at	at	ADP
aji-147	364	10	those	those	DET
aji-147	364	11	sites	site	NOUN
aji-147	364	12	because	because	SCONJ
aji-147	364	13	they	they	PRON
aji-147	364	14	were	be	AUX
aji-147	364	15	associated	associate	VERB
aji-147	364	16	with	with	ADP
aji-147	364	17	s	s	NOUN
aji-147	364	18	-	-	PUNCT
aji-147	364	19	specific	specific	ADJ
aji-147	364	20	gc	gc	PROPN
aji-147	364	21	b	b	PROPN
aji-147	364	22	cells	cell	NOUN
aji-147	364	23	[	[	X
aji-147	364	24	124,141	124,141	NUM
aji-147	364	25	]	]	PUNCT
aji-147	364	26	.	.	PUNCT
aji-147	365	1	according	accord	VERB
aji-147	365	2	to	to	ADP
aji-147	365	3	an	an	DET
aji-147	365	4	evaluation	evaluation	NOUN
aji-147	365	5	of	of	ADP
aji-147	365	6	associated	associated	ADJ
aji-147	365	7	lymph	lymph	NOUN
aji-147	365	8	nodes	node	NOUN
aji-147	365	9	and	and	CCONJ
aji-147	365	10	blood	blood	NOUN
aji-147	365	11	samples	sample	NOUN
aji-147	365	12	,	,	PUNCT
aji-147	365	13	s	s	NOUN
aji-147	365	14	-	-	PUNCT
aji-147	365	15	specific	specific	ADJ
aji-147	365	16	ctfh	ctfh	NOUN
aji-147	365	17	cells	cell	NOUN
aji-147	365	18	show	show	VERB
aji-147	365	19	an	an	DET
aji-147	365	20	activated	activated	ADJ
aji-147	365	21	phenotype	phenotype	NOUN
aji-147	365	22	(	(	PUNCT
aji-147	365	23	cd38+hla	cd38+hla	NOUN
aji-147	365	24	-	-	PUNCT
aji-147	365	25	dr+icos+	dr+icos+	NOUN
aji-147	365	26	)	)	PUNCT
aji-147	365	27	increase	increase	NOUN
aji-147	365	28	during	during	ADP
aji-147	365	29	the	the	DET
aji-147	365	30	first	first	ADJ
aji-147	365	31	month	month	NOUN
aji-147	365	32	before	before	ADP
aji-147	365	33	reverting	revert	VERB
aji-147	365	34	to	to	ADP
aji-147	365	35	a	a	DET
aji-147	365	36	resting	rest	VERB
aji-147	365	37	phenotype	phenotype	NOUN
aji-147	365	38	and	and	CCONJ
aji-147	365	39	then	then	ADV
aji-147	365	40	decreasing	decrease	VERB
aji-147	365	41	in	in	ADP
aji-147	365	42	frequency	frequency	NOUN
aji-147	365	43	.	.	PUNCT
aji-147	366	1	within	within	ADP
aji-147	366	2	a	a	DET
aji-147	366	3	minimum	minimum	NOUN
aji-147	366	4	of	of	ADP
aji-147	366	5	60	60	NUM
aji-147	366	6	days	day	NOUN
aji-147	366	7	,	,	PUNCT
aji-147	366	8	the	the	DET
aji-147	366	9	frequency	frequency	NOUN
aji-147	366	10	of	of	ADP
aji-147	366	11	s	s	NOUN
aji-147	366	12	-	-	PUNCT
aji-147	366	13	specific	specific	ADJ
aji-147	366	14	tfh	tfh	NOUN
aji-147	366	15	cells	cell	NOUN
aji-147	366	16	within	within	ADP
aji-147	366	17	lymph	lymph	NOUN
aji-147	366	18	nodes	node	NOUN
aji-147	366	19	is	be	AUX
aji-147	366	20	majorly	majorly	ADV
aji-147	366	21	consistent	consistent	ADJ
aji-147	366	22	[	[	X
aji-147	366	23	141	141	NUM
aji-147	366	24	]	]	PUNCT
aji-147	366	25	.	.	PUNCT
aji-147	367	1	despite	despite	SCONJ
aji-147	367	2	being	be	AUX
aji-147	367	3	confined	confine	VERB
aji-147	367	4	to	to	ADP
aji-147	367	5	a	a	DET
aji-147	367	6	limited	limited	ADJ
aji-147	367	7	number	number	NOUN
aji-147	367	8	of	of	ADP
aji-147	367	9	donors	donor	NOUN
aji-147	367	10	,	,	PUNCT
aji-147	367	11	our	our	PRON
aji-147	367	12	results	result	NOUN
aji-147	367	13	indicate	indicate	VERB
aji-147	367	14	that	that	SCONJ
aji-147	367	15	mrna	mrna	PROPN
aji-147	367	16	vaccines	vaccine	NOUN
aji-147	367	17	trigger	trigger	VERB
aji-147	367	18	significant	significant	ADJ
aji-147	367	19	gc	gc	PROPN
aji-147	367	20	responses	response	NOUN
aji-147	367	21	,	,	PUNCT
aji-147	367	22	which	which	PRON
aji-147	367	23	may	may	AUX
aji-147	367	24	highlight	highlight	VERB
aji-147	367	25	the	the	DET
aji-147	367	26	vaccine	vaccine	NOUN
aji-147	367	27	's	's	PART
aji-147	367	28	outstanding	outstanding	ADJ
aji-147	367	29	immunological	immunological	ADJ
aji-147	367	30	characteristics	characteristic	NOUN
aji-147	367	31	.	.	PUNCT
aji-147	368	1	vaccination	vaccination	NOUN
aji-147	368	2	of	of	ADP
aji-147	368	3	naive	naive	ADJ
aji-147	368	4	(	(	PUNCT
aji-147	368	5	previously	previously	ADV
aji-147	368	6	uninfected	uninfected	ADJ
aji-147	368	7	)	)	PUNCT
aji-147	368	8	humans	human	NOUN
aji-147	368	9	produces	produce	VERB
aji-147	368	10	s	s	NOUN
aji-147	368	11	-	-	PUNCT
aji-147	368	12	specific	specific	ADJ
aji-147	368	13	ctfh	ctfh	NOUN
aji-147	368	14	cells	cell	NOUN
aji-147	368	15	[	[	X
aji-147	368	16	142	142	NUM
aji-147	368	17	-	-	SYM
aji-147	368	18	148	148	NUM
aji-147	368	19	]	]	PUNCT
aji-147	368	20	with	with	ADP
aji-147	368	21	such	such	DET
aji-147	368	22	a	a	DET
aji-147	368	23	cxcr3	cxcr3	NOUN
aji-147	368	24	+	+	X
aji-147	368	25	phenotype	phenotype	NOUN
aji-147	368	26	[	[	X
aji-147	368	27	142	142	NUM
aji-147	368	28	]	]	PUNCT
aji-147	368	29	as	as	ADV
aji-147	368	30	well	well	ADV
aji-147	368	31	as	as	ADP
aji-147	368	32	the	the	DET
aji-147	368	33	potential	potential	NOUN
aji-147	368	34	to	to	PART
aji-147	368	35	produce	produce	VERB
aji-147	368	36	ifn	ifn	NOUN
aji-147	368	37	,	,	PUNCT
aji-147	368	38	although	although	SCONJ
aji-147	368	39	without	without	ADP
aji-147	368	40	il-17a	il-17a	PROPN
aji-147	368	41	[	[	X
aji-147	368	42	4	4	NUM
aji-147	368	43	]	]	PUNCT
aji-147	368	44	.	.	PUNCT
aji-147	369	1	at	at	ADP
aji-147	369	2	a	a	DET
aji-147	369	3	minimum	minimum	ADJ
aji-147	369	4	,	,	PUNCT
aji-147	369	5	sspecific	sspecific	ADJ
aji-147	369	6	ctfh	ctfh	NOUN
aji-147	369	7	cell	cell	NOUN
aji-147	369	8	frequency	frequency	NOUN
aji-147	369	9	increases	increase	VERB
aji-147	369	10	approximately	approximately	ADV
aji-147	369	11	one	one	NUM
aji-147	369	12	month	month	NOUN
aji-147	369	13	after	after	ADP
aji-147	369	14	immunization	immunization	NOUN
aji-147	369	15	and	and	CCONJ
aji-147	369	16	subsequently	subsequently	ADV
aji-147	369	17	decreases	decrease	VERB
aji-147	369	18	,	,	PUNCT
aji-147	369	19	compared	compare	VERB
aji-147	369	20	with	with	ADP
aji-147	369	21	sspecific	sspecific	ADJ
aji-147	369	22	th1	th1	NOUN
aji-147	369	23	cell	cell	NOUN
aji-147	369	24	frequency	frequency	NOUN
aji-147	369	25	,	,	PUNCT
aji-147	369	26	which	which	PRON
aji-147	369	27	remains	remain	VERB
aji-147	369	28	constant	constant	ADJ
aji-147	369	29	for	for	ADP
aji-147	369	30	a	a	DET
aji-147	369	31	minimum	minimum	NOUN
aji-147	369	32	of	of	ADP
aji-147	369	33	6	6	NUM
aji-147	369	34	months	month	NOUN
aji-147	369	35	[	[	X
aji-147	369	36	144	144	NUM
aji-147	369	37	]	]	PUNCT
aji-147	369	38	.	.	PUNCT
aji-147	370	1	at	at	ADP
aji-147	370	2	two	two	NUM
aji-147	370	3	weeks	week	NOUN
aji-147	370	4	following	follow	VERB
aji-147	370	5	vaccination	vaccination	NOUN
aji-147	370	6	,	,	PUNCT
aji-147	370	7	the	the	DET
aji-147	370	8	number	number	NOUN
aji-147	370	9	of	of	ADP
aji-147	370	10	sspecific	sspecific	ADJ
aji-147	370	11	ctfh	ctfh	NOUN
aji-147	370	12	cells	cell	NOUN
aji-147	370	13	and	and	CCONJ
aji-147	370	14	s	s	NOUN
aji-147	370	15	-	-	PUNCT
aji-147	370	16	specific	specific	ADJ
aji-147	370	17	conventional	conventional	ADJ
aji-147	370	18	cd4	cd4	PROPN
aji-147	370	19	+	+	PROPN
aji-147	370	20	th1	th1	NOUN
aji-147	370	21	cells	cell	NOUN
aji-147	370	22	corresponds	correspond	VERB
aji-147	370	23	to	to	ADP
aji-147	370	24	neutralizing	neutralize	VERB
aji-147	370	25	antibodies	antibody	NOUN
aji-147	370	26	against	against	ADP
aji-147	370	27	spike	spike	NOUN
aji-147	370	28	and	and	CCONJ
aji-147	370	29	vocs	vocs	PROPN
aji-147	370	30	and	and	CCONJ
aji-147	370	31	s	s	PROPN
aji-147	370	32	with	with	ADP
aji-147	370	33	rbd	rbd	NOUN
aji-147	370	34	-	-	PUNCT
aji-147	370	35	specific	specific	ADJ
aji-147	370	36	mbc	mbc	NOUN
aji-147	370	37	responses	response	NOUN
aji-147	370	38	[	[	X
aji-147	370	39	86	86	NUM
aji-147	370	40	]	]	PUNCT
aji-147	370	41	.	.	PUNCT
aji-147	371	1	this	this	PRON
aji-147	371	2	suggests	suggest	VERB
aji-147	371	3	that	that	SCONJ
aji-147	371	4	ctfh	ctfh	NOUN
aji-147	371	5	cells	cell	NOUN
aji-147	371	6	serve	serve	VERB
aji-147	371	7	as	as	ADP
aji-147	371	8	indicators	indicator	NOUN
aji-147	371	9	again	again	ADV
aji-147	371	10	for	for	ADP
aji-147	371	11	the	the	DET
aji-147	371	12	production	production	NOUN
aji-147	371	13	of	of	ADP
aji-147	371	14	neutralizing	neutralize	VERB
aji-147	371	15	antibodies	antibody	NOUN
aji-147	371	16	with	with	ADP
aji-147	371	17	mbcs	mbc	NOUN
aji-147	371	18	and	and	CCONJ
aji-147	371	19	subsequent	subsequent	ADJ
aji-147	371	20	spike	spike	ADJ
aji-147	371	21	vaccination	vaccination	NOUN
aji-147	371	22	.	.	PUNCT
aji-147	372	1	vaccinating	vaccinate	VERB
aji-147	372	2	people	people	NOUN
aji-147	372	3	who	who	PRON
aji-147	372	4	have	have	AUX
aji-147	372	5	recovered	recover	VERB
aji-147	372	6	from	from	ADP
aji-147	372	7	covid-19	covid-19	PROPN
aji-147	372	8	usually	usually	ADV
aji-147	372	9	results	result	VERB
aji-147	372	10	in	in	ADP
aji-147	372	11	higher	high	ADJ
aji-147	372	12	s	s	NOUN
aji-147	372	13	-	-	ADJ
aji-147	372	14	specific	specific	ADJ
aji-147	372	15	ctfh	ctfh	NOUN
aji-147	372	16	responses	response	NOUN
aji-147	372	17	versus	versus	ADP
aji-147	372	18	naïve	naïve	ADJ
aji-147	372	19	people	people	NOUN
aji-147	373	1	[	[	X
aji-147	373	2	4	4	NUM
aji-147	373	3	]	]	PUNCT
aji-147	373	4	.	.	PUNCT
aji-147	374	1	significantly	significantly	ADV
aji-147	374	2	,	,	PUNCT
aji-147	374	3	the	the	DET
aji-147	374	4	number	number	NOUN
aji-147	374	5	of	of	ADP
aji-147	374	6	s	s	NOUN
aji-147	374	7	-	-	PUNCT
aji-147	374	8	specific	specific	ADJ
aji-147	374	9	ctfh	ctfh	NOUN
aji-147	374	10	cells	cell	NOUN
aji-147	374	11	among	among	ADP
aji-147	374	12	recovering	recover	VERB
aji-147	374	13	patients	patient	NOUN
aji-147	374	14	before	before	SCONJ
aji-147	374	15	vaccination	vaccination	NOUN
aji-147	374	16	increases	increase	VERB
aji-147	374	17	significantly	significantly	ADV
aji-147	374	18	post	post	ADJ
aji-147	374	19	-	-	NOUN
aji-147	374	20	vaccination	vaccination	NOUN
aji-147	374	21	,	,	PUNCT
aji-147	374	22	neutralizing	neutralize	VERB
aji-147	374	23	antibody	antibody	NOUN
aji-147	374	24	levels	level	NOUN
aji-147	374	25	observed	observe	VERB
aji-147	374	26	in	in	ADP
aji-147	374	27	both	both	CCONJ
aji-147	374	28	the	the	DET
aji-147	374	29	ancestor	ancestor	NOUN
aji-147	374	30	's	's	PART
aji-147	374	31	viruses	virus	NOUN
aji-147	374	32	and	and	CCONJ
aji-147	374	33	voc	voc	NOUN
aji-147	375	1	[	[	X
aji-147	375	2	4,143	4,143	NUM
aji-147	375	3	]	]	PUNCT
aji-147	375	4	.	.	PUNCT
aji-147	376	1	therefore	therefore	ADV
aji-147	376	2	,	,	PUNCT
aji-147	376	3	it	it	PRON
aji-147	376	4	indicates	indicate	VERB
aji-147	376	5	that	that	SCONJ
aji-147	376	6	ctfh	ctfh	NOUN
aji-147	376	7	cells	cell	NOUN
aji-147	376	8	play	play	VERB
aji-147	376	9	a	a	DET
aji-147	376	10	significant	significant	ADJ
aji-147	376	11	function	function	NOUN
aji-147	376	12	as	as	ADP
aji-147	376	13	biomarkers	biomarker	NOUN
aji-147	376	14	of	of	ADP
aji-147	376	15	innate	innate	ADJ
aji-147	376	16	immunity	immunity	NOUN
aji-147	376	17	after	after	ADP
aji-147	376	18	sars	sar	NOUN
aji-147	376	19	-	-	PUNCT
aji-147	376	20	cov-2	cov-2	PART
aji-147	376	21	vaccination	vaccination	NOUN
aji-147	376	22	.	.	PUNCT
aji-147	377	1	this	this	PRON
aji-147	377	2	will	will	AUX
aji-147	377	3	be	be	AUX
aji-147	377	4	critical	critical	ADJ
aji-147	377	5	to	to	ADP
aji-147	377	6	better	well	ADV
aji-147	377	7	classifying	classify	VERB
aji-147	377	8	and	and	CCONJ
aji-147	377	9	correctly	correctly	ADV
aji-147	377	10	understanding	understand	VERB
aji-147	377	11	lymphoid	lymphoid	NOUN
aji-147	377	12	and	and	CCONJ
aji-147	377	13	circulating	circulate	VERB
aji-147	377	14	tfh	tfh	PROPN
aji-147	377	15	cell	cell	NOUN
aji-147	377	16	responses	response	NOUN
aji-147	377	17	after	after	ADP
aji-147	377	18	shukla	shukla	NOUN
aji-147	377	19	et	et	PROPN
aji-147	377	20	al	al	PROPN
aji-147	377	21	.	.	PROPN
aji-147	377	22	;	;	PUNCT
aji-147	378	1	asian	asian	PROPN
aji-147	378	2	j.	j.	PROPN
aji-147	378	3	immunol	immunol	PROPN
aji-147	378	4	.	.	PROPN
aji-147	378	5	,	,	PUNCT
aji-147	378	6	vol	vol	NOUN
aji-147	378	7	.	.	PROPN
aji-147	378	8	7	7	NUM
aji-147	378	9	,	,	PUNCT
aji-147	378	10	no	no	INTJ
aji-147	378	11	.	.	NOUN
aji-147	378	12	1	1	NUM
aji-147	378	13	,	,	PUNCT
aji-147	378	14	pp	pp	ADJ
aji-147	378	15	.	.	PUNCT
aji-147	379	1	228	228	NUM
aji-147	379	2	-	-	SYM
aji-147	379	3	246	246	NUM
aji-147	379	4	,	,	PUNCT
aji-147	379	5	2024	2024	NUM
aji-147	379	6	;	;	PUNCT
aji-147	379	7	article	article	NOUN
aji-147	379	8	no.aji.125387	no.aji.125387	VERB
aji-147	379	9	240	240	NUM
aji-147	379	10	fig	fig	NOUN
aji-147	379	11	.	.	PUNCT
aji-147	380	1	4	4	X
aji-147	380	2	.	.	X
aji-147	380	3	circulating	circulate	VERB
aji-147	380	4	tfh	tfh	PROPN
aji-147	380	5	subsets	subset	NOUN
aji-147	380	6	as	as	ADP
aji-147	380	7	correlates	correlate	NOUN
aji-147	380	8	of	of	ADP
aji-147	380	9	antibody	antibody	NOUN
aji-147	380	10	responses	response	NOUN
aji-147	380	11	.	.	PUNCT
aji-147	381	1	flow	flow	NOUN
aji-147	381	2	cytometry	cytometry	NOUN
aji-147	381	3	visualization	visualization	NOUN
aji-147	381	4	of	of	ADP
aji-147	381	5	ctfh	ctfh	NOUN
aji-147	381	6	subgroups	subgroup	NOUN
aji-147	381	7	depending	depend	VERB
aji-147	381	8	on	on	ADP
aji-147	381	9	cxcr3	cxcr3	NOUN
aji-147	381	10	as	as	ADV
aji-147	381	11	well	well	ADV
aji-147	381	12	as	as	ADP
aji-147	381	13	ccr6	ccr6	ADJ
aji-147	381	14	expression	expression	NOUN
aji-147	381	15	and	and	CCONJ
aji-147	381	16	its	its	PRON
aji-147	381	17	relationship	relationship	NOUN
aji-147	381	18	with	with	ADP
aji-147	381	19	antibody	antibody	NOUN
aji-147	381	20	responses	response	NOUN
aji-147	381	21	in	in	ADP
aji-147	381	22	different	different	ADJ
aji-147	381	23	configurations	configuration	NOUN
aji-147	381	24	.	.	PUNCT
aji-147	382	1	reproduced	reproduce	VERB
aji-147	382	2	/	/	SYM
aji-147	382	3	adapted	adapt	VERB
aji-147	382	4	with	with	ADP
aji-147	382	5	permission	permission	NOUN
aji-147	382	6	[	[	X
aji-147	382	7	135	135	NUM
aji-147	382	8	]	]	PUNCT
aji-147	382	9	.	.	PUNCT
aji-147	383	1	administration	administration	NOUN
aji-147	383	2	of	of	ADP
aji-147	383	3	various	various	ADJ
aji-147	383	4	newly	newly	ADV
aji-147	383	5	invented	invent	VERB
aji-147	383	6	vaccine	vaccine	NOUN
aji-147	383	7	systems	system	NOUN
aji-147	383	8	,	,	PUNCT
aji-147	383	9	as	as	ADV
aji-147	383	10	well	well	ADV
aji-147	383	11	as	as	ADP
aji-147	383	12	whether	whether	SCONJ
aji-147	383	13	/	/	PUNCT
aji-147	383	14	how	how	SCONJ
aji-147	383	15	they	they	PRON
aji-147	383	16	differently	differently	ADV
aji-147	383	17	activate	activate	VERB
aji-147	383	18	such	such	ADJ
aji-147	383	19	responses	response	NOUN
aji-147	383	20	,	,	PUNCT
aji-147	383	21	particularly	particularly	ADV
aji-147	383	22	in	in	ADP
aji-147	383	23	the	the	DET
aji-147	383	24	context	context	NOUN
aji-147	383	25	of	of	ADP
aji-147	383	26	heterologous	heterologous	ADJ
aji-147	383	27	prime	prime	ADJ
aji-147	383	28	-	-	PUNCT
aji-147	383	29	boost	boost	NOUN
aji-147	383	30	vaccination	vaccination	NOUN
aji-147	383	31	.	.	PUNCT
aji-147	384	1	7	7	X
aji-147	384	2	.	.	X
aji-147	384	3	future	future	ADJ
aji-147	384	4	prospective	prospective	ADJ
aji-147	384	5	of	of	ADP
aji-147	384	6	ctfhmediated	ctfhmediate	VERB
aji-147	384	7	with	with	ADP
aji-147	384	8	other	other	ADJ
aji-147	384	9	therapies	therapy	NOUN
aji-147	384	10	for	for	ADP
aji-147	384	11	sars	sar	NOUN
aji-147	384	12	-	-	PUNCT
aji-147	384	13	cov-2	cov-2	PART
aji-147	384	14	infection	infection	NOUN
aji-147	384	15	the	the	DET
aji-147	384	16	future	future	ADJ
aji-147	384	17	prospects	prospect	NOUN
aji-147	384	18	of	of	ADP
aji-147	384	19	ctfh	ctfh	NOUN
aji-147	384	20	-	-	PUNCT
aji-147	384	21	mediated	mediate	VERB
aji-147	384	22	therapies	therapy	NOUN
aji-147	384	23	in	in	ADP
aji-147	384	24	the	the	DET
aji-147	384	25	context	context	NOUN
aji-147	384	26	of	of	ADP
aji-147	384	27	sars	sar	NOUN
aji-147	384	28	-	-	PUNCT
aji-147	384	29	cov-2	cov-2	PART
aji-147	384	30	infection	infection	NOUN
aji-147	384	31	are	be	AUX
aji-147	384	32	promising	promise	VERB
aji-147	384	33	,	,	PUNCT
aji-147	384	34	particularly	particularly	ADV
aji-147	384	35	in	in	ADP
aji-147	384	36	light	light	NOUN
aji-147	384	37	of	of	ADP
aji-147	384	38	the	the	DET
aji-147	384	39	remarkable	remarkable	ADJ
aji-147	384	40	adaptability	adaptability	NOUN
aji-147	384	41	of	of	ADP
aji-147	384	42	these	these	DET
aji-147	384	43	cells	cell	NOUN
aji-147	384	44	to	to	ADP
aji-147	384	45	emerging	emerge	VERB
aji-147	384	46	variants	variant	NOUN
aji-147	384	47	.	.	PUNCT
aji-147	385	1	as	as	SCONJ
aji-147	385	2	our	our	PRON
aji-147	385	3	understanding	understanding	NOUN
aji-147	385	4	of	of	ADP
aji-147	385	5	ctfh	ctfh	NOUN
aji-147	385	6	cell	cell	NOUN
aji-147	385	7	dynamics	dynamic	NOUN
aji-147	385	8	evolves	evolve	VERB
aji-147	385	9	,	,	PUNCT
aji-147	385	10	it	it	PRON
aji-147	385	11	becomes	become	VERB
aji-147	385	12	increasingly	increasingly	ADV
aji-147	385	13	clear	clear	ADJ
aji-147	385	14	that	that	SCONJ
aji-147	385	15	their	their	PRON
aji-147	385	16	ability	ability	NOUN
aji-147	385	17	to	to	PART
aji-147	385	18	modulate	modulate	VERB
aji-147	385	19	immune	immune	ADJ
aji-147	385	20	responses	response	NOUN
aji-147	385	21	could	could	AUX
aji-147	385	22	be	be	AUX
aji-147	385	23	harnessed	harness	VERB
aji-147	385	24	in	in	ADP
aji-147	385	25	conjunction	conjunction	NOUN
aji-147	385	26	with	with	ADP
aji-147	385	27	other	other	ADJ
aji-147	385	28	therapeutic	therapeutic	ADJ
aji-147	385	29	approaches	approach	NOUN
aji-147	385	30	.	.	PUNCT
aji-147	386	1	integrating	integrate	VERB
aji-147	386	2	ctfh	ctfh	NOUN
aji-147	386	3	-	-	PUNCT
aji-147	386	4	mediated	mediate	VERB
aji-147	386	5	strategies	strategy	NOUN
aji-147	386	6	with	with	ADP
aji-147	386	7	innovative	innovative	ADJ
aji-147	386	8	hormonal	hormonal	ADJ
aji-147	386	9	therapies	therapy	NOUN
aji-147	386	10	may	may	AUX
aji-147	386	11	enhance	enhance	VERB
aji-147	386	12	vaccine	vaccine	NOUN
aji-147	386	13	efficacy	efficacy	NOUN
aji-147	386	14	and	and	CCONJ
aji-147	386	15	promote	promote	VERB
aji-147	386	16	robust	robust	ADJ
aji-147	386	17	long	long	ADJ
aji-147	386	18	-	-	PUNCT
aji-147	386	19	term	term	NOUN
aji-147	386	20	immunity	immunity	NOUN
aji-147	386	21	.	.	PUNCT
aji-147	387	1	by	by	ADP
aji-147	387	2	targeting	target	VERB
aji-147	387	3	the	the	DET
aji-147	387	4	plasticity	plasticity	NOUN
aji-147	387	5	of	of	ADP
aji-147	387	6	ctfh	ctfh	NOUN
aji-147	387	7	cells	cell	NOUN
aji-147	387	8	,	,	PUNCT
aji-147	387	9	future	future	ADJ
aji-147	387	10	interventions	intervention	NOUN
aji-147	387	11	could	could	AUX
aji-147	387	12	be	be	AUX
aji-147	387	13	designed	design	VERB
aji-147	387	14	to	to	PART
aji-147	387	15	optimize	optimize	VERB
aji-147	387	16	immune	immune	ADJ
aji-147	387	17	responses	response	NOUN
aji-147	387	18	to	to	ADP
aji-147	387	19	current	current	ADJ
aji-147	387	20	variants	variant	NOUN
aji-147	387	21	and	and	CCONJ
aji-147	387	22	potential	potential	ADJ
aji-147	387	23	future	future	ADJ
aji-147	387	24	mutations	mutation	NOUN
aji-147	387	25	of	of	ADP
aji-147	387	26	sars	sar	NOUN
aji-147	387	27	-	-	PUNCT
aji-147	387	28	cov-2	cov-2	NOUN
aji-147	387	29	,	,	PUNCT
aji-147	387	30	thereby	thereby	ADV
aji-147	387	31	improving	improve	VERB
aji-147	387	32	clinical	clinical	ADJ
aji-147	387	33	outcomes	outcome	NOUN
aji-147	387	34	and	and	CCONJ
aji-147	387	35	overall	overall	ADJ
aji-147	387	36	public	public	ADJ
aji-147	387	37	health	health	NOUN
aji-147	387	38	strategies	strategy	NOUN
aji-147	387	39	.	.	PUNCT
aji-147	388	1	8	8	X
aji-147	388	2	.	.	X
aji-147	388	3	conclusion	conclusion	NOUN
aji-147	388	4	there	there	PRON
aji-147	388	5	are	be	VERB
aji-147	388	6	strong	strong	ADJ
aji-147	388	7	indications	indication	NOUN
aji-147	388	8	that	that	SCONJ
aji-147	388	9	the	the	DET
aji-147	388	10	ctfh	ctfh	NOUN
aji-147	388	11	study	study	NOUN
aji-147	388	12	can	can	AUX
aji-147	388	13	provide	provide	VERB
aji-147	388	14	valuable	valuable	ADJ
aji-147	388	15	information	information	NOUN
aji-147	388	16	on	on	ADP
aji-147	388	17	the	the	DET
aji-147	388	18	quantitative	quantitative	ADJ
aji-147	388	19	and	and	CCONJ
aji-147	388	20	qualitative	qualitative	ADJ
aji-147	388	21	characteristics	characteristic	NOUN
aji-147	388	22	of	of	ADP
aji-147	388	23	neutralizing	neutralize	VERB
aji-147	388	24	antibodies	antibody	NOUN
aji-147	388	25	against	against	ADP
aji-147	388	26	sars	sar	NOUN
aji-147	388	27	-	-	PUNCT
aji-147	388	28	cov-2	cov-2	PART
aji-147	388	29	infection	infection	NOUN
aji-147	388	30	during	during	ADP
aji-147	388	31	vaccination	vaccination	NOUN
aji-147	388	32	(	(	PUNCT
aji-147	388	33	fig	fig	NOUN
aji-147	388	34	.	.	PUNCT
aji-147	389	1	4	4	NUM
aji-147	389	2	)	)	PUNCT
aji-147	389	3	.	.	PUNCT
aji-147	390	1	this	this	DET
aji-147	390	2	evidence	evidence	NOUN
aji-147	390	3	suggests	suggest	VERB
aji-147	390	4	that	that	SCONJ
aji-147	390	5	ctfh	ctfh	NOUN
aji-147	390	6	cells	cell	NOUN
aji-147	390	7	,	,	PUNCT
aji-147	390	8	specifically	specifically	ADV
aji-147	390	9	the	the	DET
aji-147	390	10	ctfh1	ctfh1	PROPN
aji-147	390	11	subgroup	subgroup	NOUN
aji-147	390	12	,	,	PUNCT
aji-147	390	13	were	be	AUX
aji-147	390	14	valuable	valuable	ADJ
aji-147	390	15	indicators	indicator	NOUN
aji-147	390	16	for	for	ADP
aji-147	390	17	producing	produce	VERB
aji-147	390	18	neutralizing	neutralize	VERB
aji-147	390	19	antibodies	antibody	NOUN
aji-147	390	20	and	and	CCONJ
aji-147	390	21	mbcs	mbc	NOUN
aji-147	390	22	targeting	target	VERB
aji-147	390	23	both	both	PRON
aji-147	390	24	wild	wild	ADJ
aji-147	390	25	-	-	PUNCT
aji-147	390	26	type	type	NOUN
aji-147	390	27	spike	spike	NOUN
aji-147	390	28	and	and	CCONJ
aji-147	390	29	vocs	vocs	PROPN
aji-147	390	30	.	.	PUNCT
aji-147	391	1	however	however	ADV
aji-147	391	2	,	,	PUNCT
aji-147	391	3	critical	critical	ADJ
aji-147	391	4	issues	issue	NOUN
aji-147	391	5	exist	exist	VERB
aji-147	391	6	regarding	regard	VERB
aji-147	391	7	the	the	DET
aji-147	391	8	involvement	involvement	NOUN
aji-147	391	9	of	of	ADP
aji-147	391	10	cxcr3	cxcr3	PROPN
aji-147	391	11	/	/	SYM
aji-147	391	12	ccr6	ccr6	PROPN
aji-147	391	13	ctfh	ctfh	NOUN
aji-147	391	14	subgroups	subgroup	NOUN
aji-147	391	15	in	in	ADP
aji-147	391	16	generating	generate	VERB
aji-147	391	17	neutralizing	neutralize	VERB
aji-147	391	18	antibodies	antibody	NOUN
aji-147	391	19	or	or	CCONJ
aji-147	391	20	maintaining	maintain	VERB
aji-147	391	21	spike	spike	ADJ
aji-147	391	22	-	-	PUNCT
aji-147	391	23	specific	specific	ADJ
aji-147	391	24	ctfh	ctfh	NOUN
aji-147	391	25	memory	memory	NOUN
aji-147	391	26	.	.	PUNCT
aji-147	392	1	to	to	PART
aji-147	392	2	obtain	obtain	VERB
aji-147	392	3	specific	specific	ADJ
aji-147	392	4	results	result	NOUN
aji-147	392	5	on	on	ADP
aji-147	392	6	tfh	tfh	PROPN
aji-147	392	7	's	's	PART
aji-147	392	8	ability	ability	NOUN
aji-147	392	9	to	to	PART
aji-147	392	10	produce	produce	VERB
aji-147	392	11	significant	significant	ADJ
aji-147	392	12	neutralizing	neutralizing	ADJ
aji-147	392	13	antibody	antibody	NOUN
aji-147	392	14	responses	response	NOUN
aji-147	392	15	via	via	ADP
aji-147	392	16	vaccination	vaccination	NOUN
aji-147	392	17	,	,	PUNCT
aji-147	392	18	it	it	PRON
aji-147	392	19	will	will	AUX
aji-147	392	20	be	be	AUX
aji-147	392	21	crucial	crucial	ADJ
aji-147	392	22	to	to	PART
aji-147	392	23	understand	understand	VERB
aji-147	392	24	why	why	SCONJ
aji-147	392	25	only	only	ADV
aji-147	392	26	specific	specific	ADJ
aji-147	392	27	ctfh	ctfh	NOUN
aji-147	392	28	subgroups	subgroup	NOUN
aji-147	392	29	correlate	correlate	VERB
aji-147	392	30	positively	positively	ADV
aji-147	392	31	to	to	ADP
aji-147	392	32	antibody	antibody	NOUN
aji-147	392	33	levels	level	NOUN
aji-147	392	34	and	and	CCONJ
aji-147	392	35	how	how	SCONJ
aji-147	392	36	tfh	tfh	PROPN
aji-147	392	37	quality	quality	NOUN
aji-147	392	38	may	may	AUX
aji-147	392	39	be	be	AUX
aji-147	392	40	modified	modify	VERB
aji-147	392	41	using	use	VERB
aji-147	392	42	innovative	innovative	ADJ
aji-147	392	43	vaccine	vaccine	NOUN
aji-147	392	44	platforms	platform	NOUN
aji-147	392	45	.	.	PUNCT
aji-147	393	1	furthermore	furthermore	ADV
aji-147	393	2	,	,	PUNCT
aji-147	393	3	whereas	whereas	SCONJ
aji-147	393	4	the	the	DET
aji-147	393	5	ctfh	ctfh	NOUN
aji-147	393	6	initiation	initiation	NOUN
aji-147	393	7	,	,	PUNCT
aji-147	393	8	as	as	ADV
aji-147	393	9	well	well	ADV
aji-147	393	10	as	as	ADP
aji-147	393	11	the	the	DET
aji-147	393	12	frequency	frequency	NOUN
aji-147	393	13	of	of	ADP
aji-147	393	14	antigen	antigen	NOUN
aji-147	393	15	-	-	PUNCT
aji-147	393	16	specific	specific	ADJ
aji-147	393	17	ctfh	ctfh	NOUN
aji-147	393	18	cells	cell	NOUN
aji-147	393	19	,	,	PUNCT
aji-147	393	20	are	be	AUX
aji-147	393	21	biomarkers	biomarker	NOUN
aji-147	393	22	of	of	ADP
aji-147	393	23	neutralizing	neutralize	VERB
aji-147	393	24	antibodies	antibody	NOUN
aji-147	393	25	in	in	ADP
aji-147	393	26	the	the	DET
aji-147	393	27	acute	acute	NOUN
aji-147	393	28	as	as	ADV
aji-147	393	29	well	well	ADV
aji-147	393	30	as	as	ADP
aji-147	393	31	early	early	ADJ
aji-147	393	32	phases	phase	NOUN
aji-147	393	33	of	of	ADP
aji-147	393	34	covid-19	covid-19	PROPN
aji-147	393	35	infection	infection	NOUN
aji-147	393	36	but	but	CCONJ
aji-147	393	37	also	also	ADV
aji-147	393	38	vaccination	vaccination	NOUN
aji-147	393	39	,	,	PUNCT
aji-147	393	40	it	it	PRON
aji-147	393	41	is	be	AUX
aji-147	393	42	unknown	unknown	ADJ
aji-147	393	43	whether	whether	SCONJ
aji-147	393	44	ct	ct	NUM
aji-147	393	45	cells	cell	NOUN
aji-147	393	46	indicate	indicate	VERB
aji-147	393	47	the	the	DET
aji-147	393	48	development	development	NOUN
aji-147	393	49	of	of	ADP
aji-147	393	50	long	long	ADV
aji-147	393	51	-	-	PUNCT
aji-147	393	52	lived	live	VERB
aji-147	393	53	plasma	plasma	NOUN
aji-147	393	54	cells	cell	NOUN
aji-147	393	55	or	or	CCONJ
aji-147	393	56	long	long	ADJ
aji-147	393	57	-	-	PUNCT
aji-147	393	58	term	term	NOUN
aji-147	393	59	neutralizing	neutralize	VERB
aji-147	393	60	antibodies	antibody	NOUN
aji-147	393	61	.	.	PUNCT
aji-147	394	1	researchers	researcher	NOUN
aji-147	394	2	should	should	AUX
aji-147	394	3	start	start	VERB
aji-147	394	4	understanding	understand	VERB
aji-147	394	5	more	more	ADJ
aji-147	394	6	about	about	ADP
aji-147	394	7	the	the	DET
aji-147	394	8	duration	duration	NOUN
aji-147	394	9	of	of	ADP
aji-147	394	10	gc	gc	PROPN
aji-147	394	11	tfh	tfh	PROPN
aji-147	394	12	responses	response	NOUN
aji-147	394	13	and	and	CCONJ
aji-147	394	14	their	their	PRON
aji-147	394	15	relationship	relationship	NOUN
aji-147	394	16	to	to	PART
aji-147	394	17	ctfh	ctfh	VERB
aji-147	394	18	frequencies	frequency	NOUN
aji-147	394	19	and	and	CCONJ
aji-147	394	20	phenotype	phenotype	NOUN
aji-147	394	21	as	as	SCONJ
aji-147	394	22	research	research	NOUN
aji-147	394	23	aims	aim	VERB
aji-147	394	24	to	to	PART
aji-147	394	25	comprehend	comprehend	VERB
aji-147	394	26	the	the	DET
aji-147	394	27	immunologic	immunologic	ADJ
aji-147	394	28	processes	process	NOUN
aji-147	394	29	underpinning	underpin	VERB
aji-147	394	30	the	the	DET
aji-147	394	31	persistent	persistent	ADJ
aji-147	394	32	development	development	NOUN
aji-147	394	33	of	of	ADP
aji-147	394	34	the	the	DET
aji-147	394	35	mbc	mbc	PROPN
aji-147	394	36	pool	pool	NOUN
aji-147	394	37	[	[	X
aji-147	394	38	145147	145147	NUM
aji-147	394	39	]	]	PUNCT
aji-147	394	40	.	.	PUNCT
aji-147	395	1	resolving	resolve	VERB
aji-147	395	2	these	these	DET
aji-147	395	3	concerns	concern	NOUN
aji-147	395	4	is	be	AUX
aji-147	395	5	critical	critical	ADJ
aji-147	395	6	to	to	ADP
aji-147	395	7	realizing	realize	VERB
aji-147	395	8	their	their	PRON
aji-147	395	9	promise	promise	NOUN
aji-147	395	10	of	of	ADP
aji-147	395	11	developing	develop	VERB
aji-147	395	12	efficient	efficient	ADJ
aji-147	395	13	vaccination	vaccination	NOUN
aji-147	395	14	approaches	approach	NOUN
aji-147	395	15	.	.	PUNCT
aji-147	396	1	consent	consent	NOUN
aji-147	396	2	it	it	PRON
aji-147	396	3	is	be	AUX
aji-147	396	4	not	not	PART
aji-147	396	5	applicable	applicable	ADJ
aji-147	396	6	.	.	PUNCT
aji-147	397	1	shukla	shukla	NOUN
aji-147	397	2	et	et	PROPN
aji-147	397	3	al	al	PROPN
aji-147	397	4	.	.	PROPN
aji-147	397	5	;	;	PUNCT
aji-147	397	6	asian	asian	PROPN
aji-147	397	7	j.	j.	PROPN
aji-147	397	8	immunol	immunol	PROPN
aji-147	397	9	.	.	PROPN
aji-147	397	10	,	,	PUNCT
aji-147	397	11	vol	vol	NOUN
aji-147	397	12	.	.	PROPN
aji-147	398	1	7	7	NUM
aji-147	398	2	,	,	PUNCT
aji-147	398	3	no	no	INTJ
aji-147	398	4	.	.	NOUN
aji-147	398	5	1	1	NUM
aji-147	398	6	,	,	PUNCT
aji-147	398	7	pp	pp	ADJ
aji-147	398	8	.	.	PUNCT
aji-147	399	1	228	228	NUM
aji-147	399	2	-	-	SYM
aji-147	399	3	246	246	NUM
aji-147	399	4	,	,	PUNCT
aji-147	399	5	2024	2024	NUM
aji-147	399	6	;	;	PUNCT
aji-147	399	7	article	article	NOUN
aji-147	399	8	no.aji.125387	no.aji.125387	VERB
aji-147	399	9	241	241	NUM
aji-147	399	10	ethical	ethical	ADJ
aji-147	399	11	approval	approval	NOUN
aji-147	400	1	it	it	PRON
aji-147	400	2	is	be	AUX
aji-147	400	3	not	not	PART
aji-147	400	4	applicable	applicable	ADJ
aji-147	400	5	.	.	PUNCT
aji-147	401	1	disclaimer	disclaimer	NOUN
aji-147	401	2	(	(	PUNCT
aji-147	401	3	artificial	artificial	ADJ
aji-147	401	4	intelligence	intelligence	NOUN
aji-147	401	5	)	)	PUNCT
aji-147	401	6	author(s	author(s	NOUN
aji-147	401	7	)	)	PUNCT
aji-147	401	8	hereby	hereby	ADV
aji-147	401	9	declares	declare	VERB
aji-147	401	10	that	that	SCONJ
aji-147	401	11	no	no	PRON
aji-147	401	12	generative	generative	NOUN
aji-147	401	13	ai	ai	VERB
aji-147	401	14	technologies	technology	NOUN
aji-147	401	15	such	such	ADJ
aji-147	401	16	as	as	ADP
aji-147	401	17	large	large	ADJ
aji-147	401	18	language	language	NOUN
aji-147	401	19	models	model	NOUN
aji-147	401	20	(	(	PUNCT
aji-147	401	21	chatgpt	chatgpt	NOUN
aji-147	401	22	,	,	PUNCT
aji-147	401	23	copilot	copilot	NOUN
aji-147	401	24	,	,	PUNCT
aji-147	401	25	etc	etc	X
aji-147	401	26	.	.	X
aji-147	401	27	)	)	PUNCT
aji-147	401	28	and	and	CCONJ
aji-147	401	29	text	text	NOUN
aji-147	401	30	-	-	PUNCT
aji-147	401	31	to	to	ADP
aji-147	401	32	-	-	PUNCT
aji-147	401	33	image	image	NOUN
aji-147	401	34	generators	generator	NOUN
aji-147	401	35	have	have	AUX
aji-147	401	36	been	be	AUX
aji-147	401	37	used	use	VERB
aji-147	401	38	during	during	ADP
aji-147	401	39	the	the	DET
aji-147	401	40	writing	writing	NOUN
aji-147	401	41	or	or	CCONJ
aji-147	401	42	editing	editing	NOUN
aji-147	401	43	of	of	ADP
aji-147	401	44	this	this	DET
aji-147	401	45	manuscript	manuscript	NOUN
aji-147	401	46	.	.	PUNCT
aji-147	402	1	competing	compete	VERB
aji-147	402	2	interests	interest	NOUN
aji-147	402	3	authors	author	NOUN
aji-147	402	4	have	have	AUX
aji-147	402	5	declared	declare	VERB
aji-147	402	6	that	that	SCONJ
aji-147	402	7	no	no	DET
aji-147	402	8	competing	compete	VERB
aji-147	402	9	interests	interest	NOUN
aji-147	402	10	exist	exist	VERB
aji-147	402	11	.	.	PUNCT
aji-147	403	1	references	reference	NOUN
aji-147	403	2	1	1	NUM
aji-147	403	3	.	.	PUNCT
aji-147	404	1	chi	chi	PROPN
aji-147	404	2	w	w	PROPN
aji-147	404	3	-	-	PROPN
aji-147	404	4	y	y	PROPN
aji-147	404	5	,	,	PUNCT
aji-147	404	6	et	et	PROPN
aji-147	404	7	al	al	PROPN
aji-147	404	8	.	.	PUNCT
aji-147	405	1	covid-19	covid-19	PROPN
aji-147	405	2	vaccine	vaccine	NOUN
aji-147	405	3	update	update	NOUN
aji-147	405	4	:	:	PUNCT
aji-147	405	5	vaccine	vaccine	NOUN
aji-147	405	6	effectiveness	effectiveness	NOUN
aji-147	405	7	,	,	PUNCT
aji-147	405	8	sars	sar	NOUN
aji-147	405	9	-	-	PUNCT
aji-147	405	10	cov-2	cov-2	NOUN
aji-147	405	11	variants	variant	NOUN
aji-147	405	12	,	,	PUNCT
aji-147	405	13	boosters	booster	NOUN
aji-147	405	14	,	,	PUNCT
aji-147	405	15	adverse	adverse	ADJ
aji-147	405	16	effects	effect	NOUN
aji-147	405	17	,	,	PUNCT
aji-147	405	18	and	and	CCONJ
aji-147	405	19	immune	immune	ADJ
aji-147	405	20	correlates	correlate	VERB
aji-147	405	21	of	of	ADP
aji-147	405	22	protection	protection	NOUN
aji-147	405	23	.	.	PUNCT
aji-147	406	1	j	j	PROPN
aji-147	406	2	biomed	biome	VERB
aji-147	406	3	sci	sci	PROPN
aji-147	406	4	.	.	PUNCT
aji-147	407	1	2022;29(1):82	2022;29(1):82	X
aji-147	407	2	.	.	NOUN
aji-147	407	3	2	2	NUM
aji-147	407	4	.	.	X
aji-147	407	5	herati	herati	NOUN
aji-147	407	6	rs	rs	PROPN
aji-147	407	7	,	,	PUNCT
aji-147	407	8	et	et	PROPN
aji-147	407	9	al	al	PROPN
aji-147	407	10	.	.	PROPN
aji-147	408	1	successive	successive	ADJ
aji-147	408	2	annual	annual	ADJ
aji-147	408	3	influenza	influenza	NOUN
aji-147	408	4	vaccination	vaccination	NOUN
aji-147	408	5	induces	induce	VERB
aji-147	408	6	a	a	DET
aji-147	408	7	recurrent	recurrent	ADJ
aji-147	408	8	oligoclonotypic	oligoclonotypic	ADJ
aji-147	408	9	memory	memory	NOUN
aji-147	408	10	response	response	NOUN
aji-147	408	11	in	in	ADP
aji-147	408	12	circulating	circulate	VERB
aji-147	408	13	t	t	PROPN
aji-147	408	14	follicular	follicular	ADJ
aji-147	408	15	helper	helper	NOUN
aji-147	408	16	cells	cell	NOUN
aji-147	408	17	.	.	PUNCT
aji-147	409	1	sci	sci	PROPN
aji-147	409	2	immunol	immunol	NOUN
aji-147	409	3	.	.	PUNCT
aji-147	410	1	2017;2(8	2017;2(8	NUM
aji-147	410	2	)	)	PUNCT
aji-147	410	3	.	.	PUNCT
aji-147	411	1	3	3	X
aji-147	411	2	.	.	X
aji-147	411	3	walker	walker	PROPN
aji-147	411	4	ls	ls	PROPN
aji-147	411	5	.	.	PUNCT
aji-147	412	1	the	the	DET
aji-147	412	2	link	link	NOUN
aji-147	412	3	between	between	ADP
aji-147	412	4	circulating	circulate	VERB
aji-147	412	5	follicular	follicular	ADJ
aji-147	412	6	helper	helper	NOUN
aji-147	412	7	t	t	NOUN
aji-147	412	8	cells	cell	NOUN
aji-147	412	9	and	and	CCONJ
aji-147	412	10	autoimmunity	autoimmunity	NOUN
aji-147	412	11	.	.	PUNCT
aji-147	413	1	nat	nat	PROPN
aji-147	413	2	rev	rev	PROPN
aji-147	413	3	immunol	immunol	NOUN
aji-147	413	4	.	.	PUNCT
aji-147	414	1	2022;22(9):567	2022;22(9):567	NUM
aji-147	414	2	-	-	SYM
aji-147	414	3	75	75	NUM
aji-147	414	4	.	.	PUNCT
aji-147	415	1	4	4	X
aji-147	415	2	.	.	X
aji-147	415	3	tauzin	tauzin	PROPN
aji-147	415	4	a	a	PROPN
aji-147	415	5	,	,	PUNCT
aji-147	415	6	et	et	PROPN
aji-147	415	7	al	al	PROPN
aji-147	415	8	.	.	PUNCT
aji-147	416	1	a	a	DET
aji-147	416	2	single	single	ADJ
aji-147	416	3	dose	dose	NOUN
aji-147	416	4	of	of	ADP
aji-147	416	5	the	the	DET
aji-147	416	6	sarscov-2	sarscov-2	NUM
aji-147	416	7	vaccine	vaccine	NOUN
aji-147	416	8	bnt162b2	bnt162b2	NOUN
aji-147	416	9	elicits	elicit	VERB
aji-147	416	10	fcmediated	fcmediated	ADJ
aji-147	416	11	antibody	antibody	NOUN
aji-147	416	12	effector	effector	NOUN
aji-147	416	13	functions	function	NOUN
aji-147	416	14	and	and	CCONJ
aji-147	416	15	t	t	NOUN
aji-147	416	16	cell	cell	NOUN
aji-147	416	17	responses	response	NOUN
aji-147	416	18	.	.	PUNCT
aji-147	417	1	cell	cell	NOUN
aji-147	417	2	host	host	NOUN
aji-147	417	3	microbe	microbe	NOUN
aji-147	417	4	.	.	PUNCT
aji-147	418	1	2021	2021	NUM
aji-147	418	2	;	;	PUNCT
aji-147	419	1	29(7):1137	29(7):1137	NUM
aji-147	419	2	-	-	SYM
aji-147	419	3	50.e6	50.e6	NUM
aji-147	419	4	.	.	NOUN
aji-147	419	5	5	5	NUM
aji-147	419	6	.	.	X
aji-147	419	7	sun	sun	PROPN
aji-147	419	8	z	z	PROPN
aji-147	419	9	,	,	PUNCT
aji-147	419	10	et	et	PROPN
aji-147	419	11	al	al	PROPN
aji-147	419	12	.	.	PUNCT
aji-147	420	1	the	the	DET
aji-147	420	2	role	role	NOUN
aji-147	420	3	of	of	ADP
aji-147	420	4	cellular	cellular	ADJ
aji-147	420	5	immunity	immunity	NOUN
aji-147	420	6	in	in	ADP
aji-147	420	7	the	the	DET
aji-147	420	8	protective	protective	ADJ
aji-147	420	9	efficacy	efficacy	NOUN
aji-147	420	10	of	of	ADP
aji-147	420	11	the	the	DET
aji-147	420	12	sars	sar	NOUN
aji-147	420	13	-	-	PUNCT
aji-147	420	14	cov2	cov2	PROPN
aji-147	420	15	vaccines	vaccine	NOUN
aji-147	420	16	.	.	PUNCT
aji-147	421	1	vaccines	vaccine	NOUN
aji-147	421	2	.	.	PUNCT
aji-147	422	1	2022;10(7):1103	2022;10(7):1103	NUM
aji-147	422	2	.	.	X
aji-147	422	3	6	6	NUM
aji-147	422	4	.	.	X
aji-147	422	5	boyd	boyd	PROPN
aji-147	422	6	maa	maa	PROPN
aji-147	422	7	,	,	PUNCT
aji-147	422	8	et	et	PROPN
aji-147	422	9	al	al	PROPN
aji-147	422	10	.	.	PROPN
aji-147	423	1	t	t	PROPN
aji-147	423	2	follicular	follicular	ADJ
aji-147	423	3	helper	helper	NOUN
aji-147	423	4	cell	cell	NOUN
aji-147	423	5	responses	response	NOUN
aji-147	423	6	to	to	ADP
aji-147	423	7	sars	sar	NOUN
aji-147	423	8	-	-	PUNCT
aji-147	423	9	cov-2	cov-2	PART
aji-147	423	10	vaccination	vaccination	NOUN
aji-147	423	11	among	among	ADP
aji-147	423	12	healthy	healthy	ADJ
aji-147	423	13	and	and	CCONJ
aji-147	423	14	immunocompromised	immunocompromised	ADJ
aji-147	423	15	adults	adult	NOUN
aji-147	423	16	.	.	PUNCT
aji-147	424	1	immunol	immunol	NOUN
aji-147	424	2	cell	cell	NOUN
aji-147	424	3	biol	biol	NOUN
aji-147	424	4	.	.	PUNCT
aji-147	425	1	2023;101(6	2023;101(6	NUM
aji-147	425	2	):	):	PUNCT
aji-147	425	3	504	504	NUM
aji-147	425	4	-	-	SYM
aji-147	425	5	13	13	NUM
aji-147	425	6	.	.	PUNCT
aji-147	426	1	7	7	X
aji-147	426	2	.	.	X
aji-147	427	1	zhou	zhou	PROPN
aji-147	427	2	p	p	PROPN
aji-147	427	3	,	,	PUNCT
aji-147	427	4	et	et	PROPN
aji-147	427	5	al	al	PROPN
aji-147	427	6	.	.	PUNCT
aji-147	427	7	longitudinal	longitudinal	ADJ
aji-147	427	8	analysis	analysis	NOUN
aji-147	427	9	of	of	ADP
aji-147	427	10	memory	memory	NOUN
aji-147	427	11	tfh	tfh	PROPN
aji-147	427	12	cells	cell	NOUN
aji-147	427	13	and	and	CCONJ
aji-147	427	14	antibody	antibody	NOUN
aji-147	427	15	response	response	NOUN
aji-147	427	16	following	follow	VERB
aji-147	427	17	coronavac	coronavac	NOUN
aji-147	427	18	vaccination	vaccination	NOUN
aji-147	427	19	.	.	PUNCT
aji-147	428	1	jci	jci	PROPN
aji-147	428	2	insight	insight	PROPN
aji-147	428	3	.	.	PUNCT
aji-147	428	4	2023;8(15	2023;8(15	NUM
aji-147	428	5	)	)	PUNCT
aji-147	428	6	.	.	PUNCT
aji-147	429	1	8	8	X
aji-147	429	2	.	.	X
aji-147	430	1	schroeder	schroeder	PROPN
aji-147	430	2	hw	hw	PROPN
aji-147	430	3	jr	jr	PROPN
aji-147	430	4	,	,	PUNCT
aji-147	430	5	cavacini	cavacini	PROPN
aji-147	430	6	l.	l.	PROPN
aji-147	430	7	structure	structure	NOUN
aji-147	430	8	and	and	CCONJ
aji-147	430	9	function	function	NOUN
aji-147	430	10	of	of	ADP
aji-147	430	11	immunoglobulins	immunoglobulin	NOUN
aji-147	430	12	.	.	PUNCT
aji-147	431	1	j	j	PROPN
aji-147	431	2	allergy	allergy	PROPN
aji-147	431	3	clin	clin	PROPN
aji-147	431	4	immunol	immunol	PROPN
aji-147	431	5	.	.	PUNCT
aji-147	432	1	2010;125(2):s41	2010;125(2):s41	NOUN
aji-147	432	2	-	-	PUNCT
aji-147	432	3	s52	s52	NOUN
aji-147	432	4	.	.	PUNCT
aji-147	433	1	9	9	X
aji-147	433	2	.	.	X
aji-147	433	3	chi	chi	PROPN
aji-147	433	4	x	x	PROPN
aji-147	433	5	,	,	PUNCT
aji-147	433	6	gu	gu	PROPN
aji-147	433	7	j	j	PROPN
aji-147	433	8	,	,	PUNCT
aji-147	433	9	ma	ma	PROPN
aji-147	433	10	x.	x.	PROPN
aji-147	433	11	characteristics	characteristic	NOUN
aji-147	433	12	and	and	CCONJ
aji-147	433	13	roles	role	NOUN
aji-147	433	14	of	of	ADP
aji-147	433	15	t	t	PROPN
aji-147	433	16	follicular	follicular	ADJ
aji-147	433	17	helper	helper	NOUN
aji-147	433	18	cells	cell	NOUN
aji-147	433	19	in	in	ADP
aji-147	433	20	sarscov-2	sarscov-2	NUM
aji-147	433	21	vaccine	vaccine	NOUN
aji-147	433	22	response	response	NOUN
aji-147	433	23	.	.	PUNCT
aji-147	434	1	vaccines	vaccine	NOUN
aji-147	434	2	.	.	PUNCT
aji-147	435	1	2022;10(10):1623	2022;10(10):1623	NUM
aji-147	435	2	.	.	NOUN
aji-147	436	1	10	10	NUM
aji-147	436	2	.	.	PUNCT
aji-147	437	1	weiskopf	weiskopf	PROPN
aji-147	438	1	d	d	X
aji-147	438	2	,	,	PUNCT
aji-147	438	3	et	et	PROPN
aji-147	438	4	al	al	PROPN
aji-147	438	5	.	.	PROPN
aji-147	438	6	phenotype	phenotype	NOUN
aji-147	438	7	and	and	CCONJ
aji-147	438	8	kinetics	kinetic	NOUN
aji-147	438	9	of	of	ADP
aji-147	438	10	sars	sar	NOUN
aji-147	438	11	-	-	PUNCT
aji-147	438	12	cov-2	cov-2	NOUN
aji-147	438	13	–	–	PUNCT
aji-147	438	14	specific	specific	ADJ
aji-147	438	15	t	t	NOUN
aji-147	438	16	cells	cell	NOUN
aji-147	438	17	in	in	ADP
aji-147	438	18	covid19	covid19	NOUN
aji-147	438	19	patients	patient	NOUN
aji-147	438	20	with	with	ADP
aji-147	438	21	acute	acute	ADJ
aji-147	438	22	respiratory	respiratory	ADJ
aji-147	438	23	distress	distress	NOUN
aji-147	438	24	syndrome	syndrome	NOUN
aji-147	438	25	.	.	PUNCT
aji-147	439	1	sci	sci	PROPN
aji-147	439	2	immunol	immunol	NOUN
aji-147	439	3	.	.	PUNCT
aji-147	440	1	2020;5(48	2020;5(48	NOUN
aji-147	440	2	):	):	PUNCT
aji-147	441	1	eabd2071	eabd2071	PROPN
aji-147	441	2	.	.	PUNCT
aji-147	442	1	11	11	NUM
aji-147	442	2	.	.	PUNCT
aji-147	442	3	braun	braun	PROPN
aji-147	442	4	j	j	PROPN
aji-147	442	5	,	,	PUNCT
aji-147	442	6	et	et	PROPN
aji-147	442	7	al	al	PROPN
aji-147	442	8	.	.	PUNCT
aji-147	443	1	sars	sars	PROPN
aji-147	443	2	-	-	PUNCT
aji-147	443	3	cov-2	cov-2	NOUN
aji-147	443	4	-	-	ADJ
aji-147	443	5	reactive	reactive	ADJ
aji-147	443	6	t	t	NOUN
aji-147	443	7	cells	cell	NOUN
aji-147	443	8	in	in	ADP
aji-147	443	9	healthy	healthy	ADJ
aji-147	443	10	donors	donor	NOUN
aji-147	443	11	and	and	CCONJ
aji-147	443	12	patients	patient	NOUN
aji-147	443	13	with	with	ADP
aji-147	443	14	covid-19	covid-19	PROPN
aji-147	443	15	.	.	PUNCT
aji-147	443	16	nature	nature	PROPN
aji-147	443	17	.	.	PUNCT
aji-147	444	1	2020;587(7833):270	2020;587(7833):270	NUM
aji-147	444	2	-	-	SYM
aji-147	444	3	4	4	NUM
aji-147	444	4	.	.	NOUN
aji-147	444	5	12	12	NUM
aji-147	444	6	.	.	PUNCT
aji-147	444	7	le	le	PROPN
aji-147	444	8	bert	bert	PROPN
aji-147	444	9	n	n	PROPN
aji-147	444	10	,	,	PUNCT
aji-147	444	11	et	et	PROPN
aji-147	444	12	al	al	PROPN
aji-147	444	13	.	.	PUNCT
aji-147	444	14	sars	sars	PROPN
aji-147	444	15	-	-	PUNCT
aji-147	444	16	cov-2	cov-2	NOUN
aji-147	444	17	-	-	PUNCT
aji-147	444	18	specific	specific	ADJ
aji-147	444	19	t	t	NOUN
aji-147	444	20	cell	cell	NOUN
aji-147	444	21	immunity	immunity	NOUN
aji-147	444	22	in	in	ADP
aji-147	444	23	cases	case	NOUN
aji-147	444	24	of	of	ADP
aji-147	444	25	covid-19	covid-19	PROPN
aji-147	444	26	and	and	CCONJ
aji-147	444	27	sars	sar	NOUN
aji-147	444	28	,	,	PUNCT
aji-147	444	29	and	and	CCONJ
aji-147	444	30	uninfected	uninfected	ADJ
aji-147	444	31	controls	control	NOUN
aji-147	444	32	.	.	PUNCT
aji-147	445	1	nature	nature	NOUN
aji-147	445	2	.	.	PUNCT
aji-147	446	1	2020;584(7821):457	2020;584(7821):457	NUM
aji-147	446	2	-	-	SYM
aji-147	446	3	62	62	NUM
aji-147	446	4	.	.	PUNCT
aji-147	447	1	13	13	NUM
aji-147	447	2	.	.	X
aji-147	448	1	grifoni	grifoni	VERB
aji-147	448	2	a	a	PRON
aji-147	448	3	,	,	PUNCT
aji-147	448	4	et	et	PROPN
aji-147	448	5	al	al	PROPN
aji-147	448	6	.	.	PROPN
aji-147	448	7	targets	target	NOUN
aji-147	448	8	of	of	ADP
aji-147	448	9	t	t	NOUN
aji-147	448	10	cell	cell	NOUN
aji-147	448	11	responses	response	NOUN
aji-147	448	12	to	to	ADP
aji-147	448	13	sars	sar	NOUN
aji-147	448	14	-	-	PUNCT
aji-147	448	15	cov-2	cov-2	NOUN
aji-147	448	16	coronavirus	coronavirus	NOUN
aji-147	448	17	in	in	ADP
aji-147	448	18	humans	human	NOUN
aji-147	448	19	with	with	ADP
aji-147	448	20	covid-19	covid-19	PROPN
aji-147	448	21	disease	disease	NOUN
aji-147	448	22	and	and	CCONJ
aji-147	448	23	unexposed	unexposed	ADJ
aji-147	448	24	individuals	individual	NOUN
aji-147	448	25	.	.	PUNCT
aji-147	449	1	cell	cell	NOUN
aji-147	449	2	.	.	PUNCT
aji-147	450	1	2020;181(7):1489501.e15	2020;181(7):1489501.e15	NUM
aji-147	450	2	.	.	X
aji-147	450	3	14	14	NUM
aji-147	450	4	.	.	PUNCT
aji-147	451	1	habel	habel	PROPN
aji-147	451	2	jr	jr	PROPN
aji-147	451	3	,	,	PUNCT
aji-147	451	4	et	et	PROPN
aji-147	451	5	al	al	PROPN
aji-147	451	6	.	.	PUNCT
aji-147	452	1	suboptimal	suboptimal	ADJ
aji-147	452	2	sars	sar	NOUN
aji-147	452	3	-	-	PUNCT
aji-147	452	4	cov-2−	cov-2−	NOUN
aji-147	452	5	specific	specific	PROPN
aji-147	452	6	cd8	cd8	PROPN
aji-147	452	7	+	+	PROPN
aji-147	452	8	t	t	PROPN
aji-147	452	9	cell	cell	NOUN
aji-147	452	10	response	response	NOUN
aji-147	452	11	associated	associate	VERB
aji-147	452	12	with	with	ADP
aji-147	452	13	the	the	DET
aji-147	452	14	prominent	prominent	ADJ
aji-147	452	15	hla	hla	PROPN
aji-147	452	16	-	-	PUNCT
aji-147	452	17	a*02:01	a*02:01	NOUN
aji-147	452	18	phenotype	phenotype	NOUN
aji-147	452	19	.	.	PUNCT
aji-147	453	1	proc	proc	PROPN
aji-147	453	2	natl	natl	PROPN
aji-147	453	3	acad	acad	PROPN
aji-147	453	4	sci	sci	PROPN
aji-147	453	5	u	u	PROPN
aji-147	453	6	s	s	PROPN
aji-147	453	7	a.	a.	NOUN
aji-147	453	8	2020;117(39):24384	2020;117(39):24384	NUM
aji-147	453	9	-	-	SYM
aji-147	453	10	91	91	NUM
aji-147	453	11	.	.	PUNCT
aji-147	453	12	15	15	NUM
aji-147	453	13	.	.	PUNCT
aji-147	454	1	chandrashekar	chandrashekar	VERB
aji-147	454	2	a	a	X
aji-147	454	3	,	,	PUNCT
aji-147	454	4	et	et	PROPN
aji-147	454	5	al	al	PROPN
aji-147	454	6	.	.	PUNCT
aji-147	455	1	sars	sars	PROPN
aji-147	455	2	-	-	PUNCT
aji-147	455	3	cov-2	cov-2	PART
aji-147	455	4	infection	infection	NOUN
aji-147	455	5	protects	protect	VERB
aji-147	455	6	against	against	ADP
aji-147	455	7	rechallenge	rechallenge	NOUN
aji-147	455	8	in	in	ADP
aji-147	455	9	rhesus	rhesus	NOUN
aji-147	455	10	macaques	macaque	NOUN
aji-147	455	11	.	.	PUNCT
aji-147	456	1	science	science	NOUN
aji-147	456	2	.	.	PUNCT
aji-147	457	1	2020	2020	NUM
aji-147	457	2	;	;	PUNCT
aji-147	458	1	369(6505):812	369(6505):812	NUM
aji-147	458	2	-	-	SYM
aji-147	458	3	7	7	NUM
aji-147	458	4	.	.	NOUN
aji-147	458	5	16	16	NUM
aji-147	458	6	.	.	PUNCT
aji-147	458	7	yu	yu	PROPN
aji-147	459	1	j	j	PROPN
aji-147	459	2	,	,	PUNCT
aji-147	459	3	et	et	PROPN
aji-147	459	4	al	al	PROPN
aji-147	459	5	.	.	PROPN
aji-147	459	6	dna	dna	PROPN
aji-147	459	7	vaccine	vaccine	NOUN
aji-147	459	8	protection	protection	NOUN
aji-147	459	9	against	against	ADP
aji-147	459	10	sars	sar	NOUN
aji-147	459	11	-	-	PUNCT
aji-147	459	12	cov-2	cov-2	NOUN
aji-147	459	13	in	in	ADP
aji-147	459	14	rhesus	rhesus	NOUN
aji-147	459	15	macaques	macaque	NOUN
aji-147	459	16	.	.	PUNCT
aji-147	460	1	science	science	NOUN
aji-147	460	2	.	.	PUNCT
aji-147	461	1	2020;369(6505):806	2020;369(6505):806	NUM
aji-147	461	2	-	-	SYM
aji-147	461	3	11	11	NUM
aji-147	461	4	.	.	PUNCT
aji-147	462	1	17	17	NUM
aji-147	462	2	.	.	PUNCT
aji-147	463	1	mulligan	mulligan	PROPN
aji-147	463	2	mj	mj	PROPN
aji-147	463	3	,	,	PUNCT
aji-147	463	4	et	et	PROPN
aji-147	463	5	al	al	PROPN
aji-147	463	6	.	.	PROPN
aji-147	463	7	phase	phase	PROPN
aji-147	463	8	i	i	PRON
aji-147	463	9	/	/	SYM
aji-147	463	10	ii	ii	PROPN
aji-147	463	11	study	study	NOUN
aji-147	463	12	of	of	ADP
aji-147	463	13	covid-19	covid-19	PROPN
aji-147	463	14	rna	rna	NOUN
aji-147	463	15	vaccine	vaccine	NOUN
aji-147	463	16	bnt162b1	bnt162b1	NOUN
aji-147	463	17	in	in	ADP
aji-147	463	18	adults	adult	NOUN
aji-147	463	19	.	.	PUNCT
aji-147	464	1	nature	nature	NOUN
aji-147	464	2	.	.	PUNCT
aji-147	465	1	2020;586(7830):589	2020;586(7830):589	NUM
aji-147	465	2	-	-	SYM
aji-147	465	3	93	93	NUM
aji-147	465	4	.	.	PUNCT
aji-147	466	1	18	18	NUM
aji-147	466	2	.	.	PUNCT
aji-147	466	3	jackson	jackson	PROPN
aji-147	466	4	la	la	PROPN
aji-147	466	5	,	,	PUNCT
aji-147	466	6	et	et	PROPN
aji-147	466	7	al	al	PROPN
aji-147	466	8	.	.	PUNCT
aji-147	467	1	an	an	DET
aji-147	467	2	mrna	mrna	NOUN
aji-147	467	3	vaccine	vaccine	NOUN
aji-147	467	4	against	against	ADP
aji-147	467	5	sars	sar	NOUN
aji-147	467	6	-	-	PUNCT
aji-147	467	7	cov-2	cov-2	NOUN
aji-147	467	8	—	—	PUNCT
aji-147	467	9	preliminary	preliminary	ADJ
aji-147	467	10	report	report	NOUN
aji-147	467	11	.	.	PUNCT
aji-147	468	1	n	n	PRON
aji-147	468	2	engl	engl	PROPN
aji-147	468	3	j	j	PROPN
aji-147	468	4	med	med	PROPN
aji-147	468	5	.	.	PUNCT
aji-147	468	6	2020	2020	NUM
aji-147	468	7	.	.	PUNCT
aji-147	469	1	19	19	NUM
aji-147	469	2	.	.	PUNCT
aji-147	469	3	keech	keech	PROPN
aji-147	469	4	c	c	PROPN
aji-147	469	5	,	,	PUNCT
aji-147	469	6	et	et	PROPN
aji-147	469	7	al	al	PROPN
aji-147	469	8	.	.	PROPN
aji-147	469	9	phase	phase	NOUN
aji-147	469	10	1–2	1–2	DET
aji-147	469	11	trial	trial	NOUN
aji-147	469	12	of	of	ADP
aji-147	469	13	a	a	DET
aji-147	469	14	sarscov-2	sarscov-2	NUM
aji-147	469	15	recombinant	recombinant	ADJ
aji-147	469	16	spike	spike	ADJ
aji-147	469	17	protein	protein	NOUN
aji-147	469	18	nanoparticle	nanoparticle	NOUN
aji-147	469	19	vaccine	vaccine	NOUN
aji-147	469	20	.	.	PUNCT
aji-147	470	1	n	n	PROPN
aji-147	470	2	engl	engl	PROPN
aji-147	470	3	j	j	PROPN
aji-147	470	4	med	med	PROPN
aji-147	470	5	.	.	PUNCT
aji-147	471	1	2020;383(24):2320	2020;383(24):2320	X
aji-147	471	2	-	-	SYM
aji-147	471	3	32	32	NUM
aji-147	471	4	.	.	PUNCT
aji-147	472	1	20	20	NUM
aji-147	472	2	.	.	PUNCT
aji-147	473	1	folegatti	folegatti	PROPN
aji-147	473	2	pm	pm	PROPN
aji-147	473	3	,	,	PUNCT
aji-147	473	4	et	et	PROPN
aji-147	473	5	al	al	PROPN
aji-147	473	6	.	.	PROPN
aji-147	473	7	safety	safety	NOUN
aji-147	473	8	and	and	CCONJ
aji-147	473	9	immunogenicity	immunogenicity	NOUN
aji-147	473	10	of	of	ADP
aji-147	473	11	the	the	DET
aji-147	473	12	chadox1	chadox1	ADJ
aji-147	473	13	ncov-19	ncov-19	ADJ
aji-147	473	14	vaccine	vaccine	NOUN
aji-147	473	15	against	against	ADP
aji-147	473	16	sars	sar	NOUN
aji-147	473	17	-	-	PUNCT
aji-147	473	18	cov-2	cov-2	NOUN
aji-147	473	19	:	:	PUNCT
aji-147	473	20	a	a	DET
aji-147	473	21	preliminary	preliminary	ADJ
aji-147	473	22	report	report	NOUN
aji-147	473	23	of	of	ADP
aji-147	473	24	a	a	DET
aji-147	473	25	phase	phase	NOUN
aji-147	473	26	1/2	1/2	NUM
aji-147	473	27	,	,	PUNCT
aji-147	473	28	singleblind	singleblind	NOUN
aji-147	473	29	,	,	PUNCT
aji-147	473	30	randomised	randomise	VERB
aji-147	473	31	controlled	control	VERB
aji-147	473	32	trial	trial	NOUN
aji-147	473	33	.	.	PUNCT
aji-147	474	1	the	the	DET
aji-147	474	2	lancet	lancet	NOUN
aji-147	474	3	.	.	PUNCT
aji-147	475	1	2020;396(10249):467	2020;396(10249):467	NUM
aji-147	475	2	-	-	SYM
aji-147	475	3	78	78	NUM
aji-147	475	4	.	.	PUNCT
aji-147	476	1	21	21	NUM
aji-147	476	2	.	.	PUNCT
aji-147	477	1	sahin	sahin	PROPN
aji-147	477	2	u	u	PROPN
aji-147	477	3	,	,	PUNCT
aji-147	477	4	et	et	PROPN
aji-147	477	5	al	al	PROPN
aji-147	477	6	.	.	PUNCT
aji-147	478	1	covid-19	covid-19	PROPN
aji-147	478	2	vaccine	vaccine	NOUN
aji-147	478	3	bnt162b1	bnt162b1	NOUN
aji-147	478	4	elicits	elicit	VERB
aji-147	478	5	human	human	ADJ
aji-147	478	6	antibody	antibody	NOUN
aji-147	478	7	and	and	CCONJ
aji-147	478	8	th1	th1	NOUN
aji-147	478	9	t	t	NOUN
aji-147	478	10	cell	cell	NOUN
aji-147	478	11	responses	response	NOUN
aji-147	478	12	.	.	PUNCT
aji-147	479	1	nature	nature	NOUN
aji-147	479	2	.	.	PUNCT
aji-147	480	1	2020;586(7830	2020;586(7830	NUM
aji-147	480	2	):	):	PUNCT
aji-147	480	3	594	594	NUM
aji-147	480	4	-	-	SYM
aji-147	480	5	9	9	NUM
aji-147	480	6	.	.	NOUN
aji-147	480	7	22	22	NUM
aji-147	480	8	.	.	PUNCT
aji-147	481	1	callaway	callaway	PROPN
aji-147	481	2	e.	e.	PROPN
aji-147	481	3	the	the	DET
aji-147	481	4	coronavirus	coronavirus	NOUN
aji-147	481	5	is	be	AUX
aji-147	481	6	mutating	mutate	VERB
aji-147	481	7	-	-	PUNCT
aji-147	481	8	does	do	AUX
aji-147	481	9	it	it	PRON
aji-147	481	10	matter	matter	VERB
aji-147	481	11	?	?	PUNCT
aji-147	482	1	nature	nature	NOUN
aji-147	482	2	.	.	PUNCT
aji-147	483	1	2020;585(7824	2020;585(7824	NUM
aji-147	483	2	):	):	PUNCT
aji-147	483	3	174	174	NUM
aji-147	483	4	-	-	SYM
aji-147	483	5	8	8	NUM
aji-147	483	6	.	.	NUM
aji-147	484	1	23	23	NUM
aji-147	484	2	.	.	PUNCT
aji-147	485	1	chen	chen	PROPN
aji-147	485	2	j	j	PROPN
aji-147	485	3	,	,	PUNCT
aji-147	485	4	et	et	PROPN
aji-147	485	5	al	al	PROPN
aji-147	485	6	.	.	PUNCT
aji-147	485	7	mutations	mutation	NOUN
aji-147	485	8	strengthened	strengthen	VERB
aji-147	485	9	sars	sar	NOUN
aji-147	485	10	-	-	PUNCT
aji-147	485	11	cov-2	cov-2	NOUN
aji-147	485	12	infectivity	infectivity	NOUN
aji-147	485	13	.	.	PUNCT
aji-147	486	1	j	j	PROPN
aji-147	486	2	mol	mol	PROPN
aji-147	486	3	biol	biol	PROPN
aji-147	486	4	.	.	PUNCT
aji-147	487	1	2020;432(19):5212	2020;432(19):5212	NUM
aji-147	487	2	-	-	SYM
aji-147	487	3	26	26	NUM
aji-147	487	4	.	.	PUNCT
aji-147	488	1	24	24	NUM
aji-147	488	2	.	.	PUNCT
aji-147	488	3	de	de	X
aji-147	488	4	biasi	biasi	PROPN
aji-147	488	5	s	s	PART
aji-147	488	6	,	,	PUNCT
aji-147	488	7	et	et	PROPN
aji-147	488	8	al	al	PROPN
aji-147	488	9	.	.	PROPN
aji-147	488	10	marked	mark	VERB
aji-147	488	11	t	t	PROPN
aji-147	488	12	cell	cell	NOUN
aji-147	488	13	activation	activation	NOUN
aji-147	488	14	,	,	PUNCT
aji-147	488	15	senescence	senescence	NOUN
aji-147	488	16	,	,	PUNCT
aji-147	488	17	exhaustion	exhaustion	NOUN
aji-147	488	18	and	and	CCONJ
aji-147	488	19	skewing	skew	VERB
aji-147	488	20	shukla	shukla	NOUN
aji-147	488	21	et	et	PROPN
aji-147	488	22	al	al	PROPN
aji-147	488	23	.	.	PROPN
aji-147	488	24	;	;	PUNCT
aji-147	489	1	asian	asian	PROPN
aji-147	489	2	j.	j.	PROPN
aji-147	489	3	immunol	immunol	PROPN
aji-147	489	4	.	.	PROPN
aji-147	489	5	,	,	PUNCT
aji-147	489	6	vol	vol	NOUN
aji-147	489	7	.	.	PROPN
aji-147	489	8	7	7	NUM
aji-147	489	9	,	,	PUNCT
aji-147	489	10	no	no	INTJ
aji-147	489	11	.	.	NOUN
aji-147	489	12	1	1	NUM
aji-147	489	13	,	,	PUNCT
aji-147	489	14	pp	pp	ADJ
aji-147	489	15	.	.	PUNCT
aji-147	490	1	228	228	NUM
aji-147	490	2	-	-	SYM
aji-147	490	3	246	246	NUM
aji-147	490	4	,	,	PUNCT
aji-147	490	5	2024	2024	NUM
aji-147	490	6	;	;	PUNCT
aji-147	491	1	article	article	NOUN
aji-147	491	2	no.aji.125387	no.aji.125387	VERB
aji-147	491	3	242	242	NUM
aji-147	491	4	towards	towards	ADP
aji-147	491	5	th17	th17	PROPN
aji-147	491	6	in	in	ADP
aji-147	491	7	patients	patient	NOUN
aji-147	491	8	with	with	ADP
aji-147	491	9	covid-19	covid-19	PROPN
aji-147	491	10	pneumonia	pneumonia	NOUN
aji-147	491	11	.	.	PUNCT
aji-147	492	1	nat	nat	PROPN
aji-147	492	2	commun	commun	PROPN
aji-147	492	3	.	.	PUNCT
aji-147	493	1	2020;11(1):117	2020;11(1):117	NUM
aji-147	493	2	.	.	PUNCT
aji-147	494	1	25	25	NUM
aji-147	494	2	.	.	PUNCT
aji-147	494	3	song	song	PROPN
aji-147	494	4	j	j	PROPN
aji-147	494	5	-	-	PUNCT
aji-147	494	6	w	w	PROPN
aji-147	494	7	,	,	PUNCT
aji-147	494	8	et	et	PROPN
aji-147	494	9	al	al	PROPN
aji-147	494	10	.	.	PROPN
aji-147	495	1	immunological	immunological	ADJ
aji-147	495	2	and	and	CCONJ
aji-147	495	3	inflammatory	inflammatory	ADJ
aji-147	495	4	profiles	profile	NOUN
aji-147	495	5	in	in	ADP
aji-147	495	6	mild	mild	ADJ
aji-147	495	7	and	and	CCONJ
aji-147	495	8	severe	severe	ADJ
aji-147	495	9	cases	case	NOUN
aji-147	495	10	of	of	ADP
aji-147	495	11	covid-19	covid-19	PROPN
aji-147	495	12	.	.	PUNCT
aji-147	496	1	nat	nat	PROPN
aji-147	496	2	commun	commun	PROPN
aji-147	496	3	.	.	PUNCT
aji-147	497	1	2020	2020	NUM
aji-147	497	2	;	;	PUNCT
aji-147	497	3	11(1):1	11(1):1	NUM
aji-147	497	4	-	-	SYM
aji-147	497	5	10	10	NUM
aji-147	497	6	.	.	PUNCT
aji-147	498	1	26	26	NUM
aji-147	498	2	.	.	PUNCT
aji-147	499	1	files	files	PROPN
aji-147	499	2	jk	jk	PROPN
aji-147	499	3	,	,	PUNCT
aji-147	499	4	et	et	PROPN
aji-147	499	5	al	al	PROPN
aji-147	499	6	.	.	PROPN
aji-147	499	7	sustained	sustain	VERB
aji-147	499	8	cellular	cellular	ADJ
aji-147	499	9	immune	immune	ADJ
aji-147	499	10	dysregulation	dysregulation	NOUN
aji-147	499	11	in	in	ADP
aji-147	499	12	individuals	individual	NOUN
aji-147	499	13	recovering	recover	VERB
aji-147	499	14	from	from	ADP
aji-147	499	15	sars	sar	NOUN
aji-147	499	16	-	-	PUNCT
aji-147	499	17	cov-2	cov-2	PART
aji-147	499	18	infection	infection	NOUN
aji-147	499	19	.	.	PUNCT
aji-147	500	1	j	j	PROPN
aji-147	500	2	clin	clin	PROPN
aji-147	500	3	invest	invest	PROPN
aji-147	500	4	.	.	PUNCT
aji-147	501	1	2021;131(1	2021;131(1	NUM
aji-147	501	2	)	)	PUNCT
aji-147	501	3	.	.	PUNCT
aji-147	502	1	27	27	NUM
aji-147	502	2	.	.	PUNCT
aji-147	503	1	zheng	zheng	PROPN
aji-147	503	2	hy	hy	PROPN
aji-147	503	3	,	,	PUNCT
aji-147	503	4	et	et	PROPN
aji-147	503	5	al	al	PROPN
aji-147	503	6	.	.	PROPN
aji-147	503	7	elevated	elevate	VERB
aji-147	503	8	exhaustion	exhaustion	NOUN
aji-147	503	9	levels	level	NOUN
aji-147	503	10	and	and	CCONJ
aji-147	503	11	reduced	reduce	VERB
aji-147	503	12	functional	functional	ADJ
aji-147	503	13	diversity	diversity	NOUN
aji-147	503	14	of	of	ADP
aji-147	503	15	t	t	NOUN
aji-147	503	16	cells	cell	NOUN
aji-147	503	17	in	in	ADP
aji-147	503	18	peripheral	peripheral	ADJ
aji-147	503	19	blood	blood	NOUN
aji-147	503	20	may	may	AUX
aji-147	503	21	predict	predict	VERB
aji-147	503	22	severe	severe	ADJ
aji-147	503	23	progression	progression	NOUN
aji-147	503	24	in	in	ADP
aji-147	503	25	covid-19	covid-19	PROPN
aji-147	503	26	patients	patient	NOUN
aji-147	503	27	.	.	PUNCT
aji-147	504	1	cell	cell	NOUN
aji-147	504	2	mol	mol	ADP
aji-147	504	3	immunol	immunol	NOUN
aji-147	504	4	.	.	PUNCT
aji-147	505	1	2020;17(5):541	2020;17(5):541	NUM
aji-147	505	2	-	-	PUNCT
aji-147	505	3	3	3	NUM
aji-147	505	4	.	.	NOUN
aji-147	505	5	28	28	NUM
aji-147	505	6	.	.	PUNCT
aji-147	506	1	pissani	pissani	PROPN
aji-147	506	2	f	f	PROPN
aji-147	506	3	,	,	PUNCT
aji-147	506	4	streeck	streeck	PROPN
aji-147	506	5	h.	h.	PROPN
aji-147	506	6	emerging	emerge	VERB
aji-147	506	7	concepts	concept	NOUN
aji-147	506	8	on	on	ADP
aji-147	506	9	t	t	PROPN
aji-147	506	10	follicular	follicular	ADJ
aji-147	506	11	helper	helper	NOUN
aji-147	506	12	cell	cell	NOUN
aji-147	506	13	dynamics	dynamic	NOUN
aji-147	506	14	in	in	ADP
aji-147	506	15	hiv	hiv	PROPN
aji-147	506	16	infection	infection	NOUN
aji-147	506	17	.	.	PUNCT
aji-147	507	1	trends	trend	NOUN
aji-147	507	2	immunol	immunol	NOUN
aji-147	507	3	.	.	PUNCT
aji-147	508	1	2014;35(6):27886	2014;35(6):27886	NUM
aji-147	508	2	.	.	PUNCT
aji-147	509	1	29	29	NUM
aji-147	509	2	.	.	PUNCT
aji-147	510	1	heit	heit	PROPN
aji-147	510	2	a	a	PROPN
aji-147	510	3	,	,	PUNCT
aji-147	510	4	et	et	PROPN
aji-147	510	5	al	al	PROPN
aji-147	510	6	.	.	PROPN
aji-147	510	7	vaccination	vaccination	NOUN
aji-147	510	8	establishes	establish	VERB
aji-147	510	9	clonal	clonal	ADJ
aji-147	510	10	relatives	relative	NOUN
aji-147	510	11	of	of	ADP
aji-147	510	12	germinal	germinal	ADJ
aji-147	510	13	center	center	NOUN
aji-147	510	14	t	t	NOUN
aji-147	510	15	cells	cell	NOUN
aji-147	510	16	in	in	ADP
aji-147	510	17	the	the	DET
aji-147	510	18	blood	blood	NOUN
aji-147	510	19	of	of	ADP
aji-147	510	20	humans	human	NOUN
aji-147	510	21	.	.	PUNCT
aji-147	511	1	j	j	PROPN
aji-147	511	2	exp	exp	NOUN
aji-147	511	3	med	me	VERB
aji-147	511	4	.	.	PUNCT
aji-147	512	1	2017;214(7	2017;214(7	ADV
aji-147	512	2	):	):	PUNCT
aji-147	512	3	2139	2139	NUM
aji-147	512	4	-	-	SYM
aji-147	512	5	52	52	NUM
aji-147	512	6	.	.	PUNCT
aji-147	513	1	30	30	NUM
aji-147	513	2	.	.	PUNCT
aji-147	514	1	moysi	moysi	PROPN
aji-147	514	2	e	e	PROPN
aji-147	514	3	,	,	PUNCT
aji-147	514	4	et	et	PROPN
aji-147	514	5	al	al	PROPN
aji-147	514	6	.	.	PROPN
aji-147	514	7	altered	alter	VERB
aji-147	514	8	immune	immune	ADJ
aji-147	514	9	cell	cell	NOUN
aji-147	514	10	follicular	follicular	ADJ
aji-147	514	11	dynamics	dynamic	NOUN
aji-147	514	12	in	in	ADP
aji-147	514	13	hiv	hiv	PROPN
aji-147	514	14	infection	infection	NOUN
aji-147	514	15	following	follow	VERB
aji-147	514	16	influenza	influenza	ADJ
aji-147	514	17	vaccination	vaccination	NOUN
aji-147	514	18	.	.	PUNCT
aji-147	515	1	j	j	PROPN
aji-147	515	2	clin	clin	PROPN
aji-147	515	3	invest	invest	PROPN
aji-147	515	4	.	.	PUNCT
aji-147	516	1	2018;128(7):3171	2018;128(7):3171	NUM
aji-147	516	2	-	-	SYM
aji-147	516	3	85	85	NUM
aji-147	516	4	.	.	PUNCT
aji-147	517	1	31	31	NUM
aji-147	517	2	.	.	PUNCT
aji-147	518	1	vella	vella	PROPN
aji-147	518	2	la	la	PROPN
aji-147	518	3	,	,	PUNCT
aji-147	518	4	et	et	PROPN
aji-147	518	5	al	al	PROPN
aji-147	518	6	.	.	PROPN
aji-147	518	7	t	t	PROPN
aji-147	518	8	follicular	follicular	ADJ
aji-147	518	9	helper	helper	NOUN
aji-147	518	10	cells	cell	NOUN
aji-147	518	11	in	in	ADP
aji-147	518	12	human	human	ADJ
aji-147	518	13	efferent	efferent	NOUN
aji-147	518	14	lymph	lymph	NOUN
aji-147	518	15	retain	retain	VERB
aji-147	518	16	lymphoid	lymphoid	ADJ
aji-147	518	17	characteristics	characteristic	NOUN
aji-147	518	18	.	.	PUNCT
aji-147	519	1	j	j	PROPN
aji-147	519	2	clin	clin	PROPN
aji-147	519	3	invest	invest	PROPN
aji-147	519	4	.	.	PUNCT
aji-147	520	1	2019;129(8	2019;129(8	PRON
aji-147	520	2	):	):	PUNCT
aji-147	520	3	3185	3185	NUM
aji-147	520	4	-	-	SYM
aji-147	520	5	200	200	NUM
aji-147	520	6	.	.	PUNCT
aji-147	521	1	32	32	NUM
aji-147	521	2	.	.	PUNCT
aji-147	522	1	chevalier	chevalier	NOUN
aji-147	522	2	n	n	PROPN
aji-147	522	3	,	,	PUNCT
aji-147	522	4	et	et	PROPN
aji-147	522	5	al	al	PROPN
aji-147	522	6	.	.	PUNCT
aji-147	522	7	cxcr5	cxcr5	PROPN
aji-147	522	8	expressing	express	VERB
aji-147	522	9	human	human	ADJ
aji-147	522	10	central	central	ADJ
aji-147	522	11	memory	memory	NOUN
aji-147	522	12	cd4	cd4	PROPN
aji-147	522	13	t	t	PROPN
aji-147	522	14	cells	cell	NOUN
aji-147	522	15	and	and	CCONJ
aji-147	522	16	their	their	PRON
aji-147	522	17	relevance	relevance	NOUN
aji-147	522	18	for	for	ADP
aji-147	522	19	humoral	humoral	ADJ
aji-147	522	20	immune	immune	ADJ
aji-147	522	21	responses	response	NOUN
aji-147	522	22	.	.	PUNCT
aji-147	523	1	j	j	PROPN
aji-147	523	2	immunol	immunol	NOUN
aji-147	523	3	.	.	PUNCT
aji-147	524	1	2011;186(10):555668	2011;186(10):555668	X
aji-147	524	2	.	.	NOUN
aji-147	525	1	33	33	NUM
aji-147	525	2	.	.	PUNCT
aji-147	526	1	he	he	PRON
aji-147	526	2	j	j	PROPN
aji-147	526	3	,	,	PUNCT
aji-147	526	4	et	et	PROPN
aji-147	526	5	al	al	PROPN
aji-147	526	6	.	.	PROPN
aji-147	527	1	circulating	circulate	VERB
aji-147	527	2	precursor	precursor	NOUN
aji-147	527	3	ccr7^lo^pd-1^hi^	ccr7^lo^pd-1^hi^	NOUN
aji-147	527	4	cxcr5	cxcr5	PROPN
aji-147	528	1	+	+	CCONJ
aji-147	528	2	cd4	cd4	PROPN
aji-147	528	3	+	+	PROPN
aji-147	528	4	t	t	NOUN
aji-147	528	5	cells	cell	NOUN
aji-147	528	6	indicate	indicate	VERB
aji-147	528	7	tfh	tfh	NUM
aji-147	528	8	cell	cell	NOUN
aji-147	528	9	activity	activity	NOUN
aji-147	528	10	and	and	CCONJ
aji-147	528	11	promote	promote	VERB
aji-147	528	12	antibody	antibody	NOUN
aji-147	528	13	responses	response	NOUN
aji-147	528	14	upon	upon	SCONJ
aji-147	528	15	antigen	antigen	ADJ
aji-147	528	16	reexposure	reexposure	NOUN
aji-147	528	17	.	.	PUNCT
aji-147	529	1	immunity	immunity	NOUN
aji-147	529	2	.	.	PUNCT
aji-147	530	1	2013;39(4):770	2013;39(4):770	PROPN
aji-147	530	2	-	-	PUNCT
aji-147	530	3	81	81	NUM
aji-147	530	4	.	.	PUNCT
aji-147	531	1	34	34	NUM
aji-147	531	2	.	.	PUNCT
aji-147	532	1	haltaufderhyde	haltaufderhyde	PROPN
aji-147	533	1	k	k	PROPN
aji-147	533	2	,	,	PUNCT
aji-147	533	3	et	et	PROPN
aji-147	533	4	al	al	PROPN
aji-147	533	5	.	.	PROPN
aji-147	533	6	activation	activation	NOUN
aji-147	533	7	of	of	ADP
aji-147	533	8	peripheral	peripheral	ADJ
aji-147	533	9	t	t	PROPN
aji-147	533	10	follicular	follicular	ADJ
aji-147	533	11	helper	helper	NOUN
aji-147	533	12	cells	cell	NOUN
aji-147	533	13	during	during	ADP
aji-147	533	14	acute	acute	ADJ
aji-147	533	15	dengue	dengue	NOUN
aji-147	533	16	virus	virus	NOUN
aji-147	533	17	infection	infection	NOUN
aji-147	533	18	.	.	PUNCT
aji-147	534	1	j	j	PROPN
aji-147	534	2	infect	infect	VERB
aji-147	534	3	dis	dis	PROPN
aji-147	534	4	.	.	PUNCT
aji-147	535	1	2018;218(10):1675	2018;218(10):1675	NUM
aji-147	535	2	-	-	SYM
aji-147	535	3	85	85	NUM
aji-147	535	4	.	.	NUM
aji-147	536	1	35	35	NUM
aji-147	536	2	.	.	PUNCT
aji-147	537	1	locci	locci	PROPN
aji-147	537	2	m	m	PROPN
aji-147	537	3	,	,	PUNCT
aji-147	537	4	et	et	PROPN
aji-147	537	5	al	al	PROPN
aji-147	537	6	.	.	PUNCT
aji-147	538	1	human	human	ADJ
aji-147	538	2	circulating	circulate	VERB
aji-147	538	3	pd-1	pd-1	ADJ
aji-147	538	4	+	+	CCONJ
aji-147	538	5	cxcr3−	cxcr3−	PROPN
aji-147	538	6	cxcr5	cxcr5	NOUN
aji-147	538	7	+	+	SYM
aji-147	538	8	memory	memory	NOUN
aji-147	538	9	tfh	tfh	PROPN
aji-147	538	10	cells	cell	NOUN
aji-147	538	11	are	be	AUX
aji-147	538	12	highly	highly	ADV
aji-147	538	13	functional	functional	ADJ
aji-147	538	14	and	and	CCONJ
aji-147	538	15	correlate	correlate	VERB
aji-147	538	16	with	with	ADP
aji-147	538	17	broadly	broadly	ADV
aji-147	538	18	neutralizing	neutralize	VERB
aji-147	538	19	hiv	hiv	PROPN
aji-147	538	20	antibody	antibody	NOUN
aji-147	538	21	responses	response	NOUN
aji-147	538	22	.	.	PUNCT
aji-147	539	1	immunity	immunity	NOUN
aji-147	539	2	.	.	PUNCT
aji-147	540	1	2013;39(4):758	2013;39(4):758	NUM
aji-147	540	2	-	-	SYM
aji-147	540	3	69	69	NUM
aji-147	540	4	.	.	PUNCT
aji-147	541	1	36	36	NUM
aji-147	541	2	.	.	PUNCT
aji-147	542	1	mikell	mikell	PROPN
aji-147	543	1	i	i	PRON
aji-147	543	2	,	,	PUNCT
aji-147	543	3	et	et	PROPN
aji-147	543	4	al	al	PROPN
aji-147	543	5	.	.	PROPN
aji-147	543	6	characteristics	characteristic	NOUN
aji-147	543	7	of	of	ADP
aji-147	543	8	the	the	DET
aji-147	543	9	earliest	early	ADJ
aji-147	543	10	cross	cross	ADJ
aji-147	543	11	-	-	ADJ
aji-147	543	12	neutralizing	neutralizing	ADJ
aji-147	543	13	antibody	antibody	NOUN
aji-147	543	14	response	response	NOUN
aji-147	543	15	to	to	ADP
aji-147	543	16	hiv-1	hiv-1	X
aji-147	543	17	.	.	PUNCT
aji-147	544	1	plos	plos	PROPN
aji-147	544	2	pathog	pathog	PROPN
aji-147	544	3	.	.	PUNCT
aji-147	545	1	2011;7(1):e1001251	2011;7(1):e1001251	X
aji-147	545	2	.	.	PUNCT
aji-147	546	1	37	37	NUM
aji-147	546	2	.	.	PUNCT
aji-147	547	1	bentebibel	bentebibel	PROPN
aji-147	547	2	se	se	PROPN
aji-147	547	3	,	,	PUNCT
aji-147	547	4	et	et	PROPN
aji-147	547	5	al	al	PROPN
aji-147	547	6	.	.	PROPN
aji-147	547	7	induction	induction	NOUN
aji-147	547	8	of	of	ADP
aji-147	547	9	icos+	icos+	PROPN
aji-147	547	10	cxcr3	cxcr3	PROPN
aji-147	547	11	+	+	CCONJ
aji-147	547	12	cxcr5	cxcr5	PROPN
aji-147	547	13	+	+	CCONJ
aji-147	547	14	th	th	NUM
aji-147	547	15	cells	cell	NOUN
aji-147	547	16	correlates	correlate	VERB
aji-147	547	17	with	with	ADP
aji-147	547	18	antibody	antibody	NOUN
aji-147	547	19	responses	response	NOUN
aji-147	547	20	to	to	ADP
aji-147	547	21	influenza	influenza	ADJ
aji-147	547	22	vaccination	vaccination	NOUN
aji-147	547	23	.	.	PUNCT
aji-147	548	1	sci	sci	PROPN
aji-147	548	2	transl	transl	PROPN
aji-147	548	3	med	med	PROPN
aji-147	548	4	.	.	PUNCT
aji-147	549	1	2013;5	2013;5	NUM
aji-147	549	2	:	:	PUNCT
aji-147	550	1	176ra32	176ra32	NUM
aji-147	550	2	.	.	PUNCT
aji-147	551	1	38	38	NUM
aji-147	551	2	.	.	PUNCT
aji-147	552	1	sterrett	sterrett	PROPN
aji-147	552	2	s	s	PROPN
aji-147	552	3	,	,	PUNCT
aji-147	552	4	et	et	PROPN
aji-147	552	5	al	al	PROPN
aji-147	552	6	.	.	PROPN
aji-147	552	7	peripheral	peripheral	PROPN
aji-147	552	8	cd4	cd4	PROPN
aji-147	552	9	t	t	PROPN
aji-147	552	10	follicular	follicular	ADJ
aji-147	552	11	cells	cell	NOUN
aji-147	552	12	induced	induce	VERB
aji-147	552	13	by	by	ADP
aji-147	552	14	a	a	DET
aji-147	552	15	conjugated	conjugate	VERB
aji-147	552	16	pneumococcal	pneumococcal	ADJ
aji-147	552	17	vaccine	vaccine	NOUN
aji-147	552	18	correlate	correlate	VERB
aji-147	552	19	with	with	ADP
aji-147	552	20	enhanced	enhanced	ADJ
aji-147	552	21	opsonophagocytic	opsonophagocytic	ADJ
aji-147	552	22	antibody	antibody	NOUN
aji-147	552	23	responses	response	NOUN
aji-147	552	24	in	in	ADP
aji-147	552	25	younger	young	ADJ
aji-147	552	26	individuals	individual	NOUN
aji-147	552	27	.	.	PUNCT
aji-147	553	1	vaccine	vaccine	NOUN
aji-147	553	2	.	.	PUNCT
aji-147	554	1	2020;38(7):1778	2020;38(7):1778	NUM
aji-147	554	2	-	-	SYM
aji-147	554	3	86	86	NUM
aji-147	554	4	.	.	PUNCT
aji-147	555	1	39	39	NUM
aji-147	555	2	.	.	PUNCT
aji-147	556	1	chen	chen	PROPN
aji-147	556	2	j	j	PROPN
aji-147	556	3	,	,	PUNCT
aji-147	556	4	et	et	PROPN
aji-147	556	5	al	al	PROPN
aji-147	556	6	.	.	PUNCT
aji-147	556	7	cellular	cellular	ADJ
aji-147	556	8	immune	immune	ADJ
aji-147	556	9	responses	response	NOUN
aji-147	556	10	to	to	ADP
aji-147	556	11	severe	severe	ADJ
aji-147	556	12	acute	acute	ADJ
aji-147	556	13	respiratory	respiratory	ADJ
aji-147	556	14	syndrome	syndrome	NOUN
aji-147	556	15	coronavirus	coronavirus	NOUN
aji-147	556	16	(	(	PUNCT
aji-147	556	17	sars	sars	PROPN
aji-147	556	18	-	-	PUNCT
aji-147	556	19	cov	cov	NOUN
aji-147	556	20	)	)	PUNCT
aji-147	556	21	infection	infection	NOUN
aji-147	556	22	in	in	ADP
aji-147	556	23	senescent	senescent	ADJ
aji-147	556	24	balb	balb	NOUN
aji-147	556	25	/	/	SYM
aji-147	556	26	c	c	NOUN
aji-147	556	27	mice	mouse	NOUN
aji-147	556	28	:	:	PUNCT
aji-147	556	29	cd4	cd4	PROPN
aji-147	556	30	+	+	PROPN
aji-147	556	31	t	t	NOUN
aji-147	556	32	cells	cell	NOUN
aji-147	556	33	are	be	AUX
aji-147	556	34	important	important	ADJ
aji-147	556	35	in	in	ADP
aji-147	556	36	control	control	NOUN
aji-147	556	37	of	of	ADP
aji-147	556	38	sars	sars	PROPN
aji-147	556	39	-	-	PUNCT
aji-147	556	40	cov	cov	NOUN
aji-147	556	41	infection	infection	NOUN
aji-147	556	42	.	.	PUNCT
aji-147	557	1	j	j	PROPN
aji-147	557	2	virol	virol	PROPN
aji-147	557	3	.	.	PUNCT
aji-147	558	1	2010;84(3):1289	2010;84(3):1289	NUM
aji-147	558	2	-	-	SYM
aji-147	558	3	301	301	NUM
aji-147	558	4	.	.	PUNCT
aji-147	558	5	40	40	NUM
aji-147	558	6	.	.	PUNCT
aji-147	559	1	george	george	PROPN
aji-147	559	2	pj	pj	PROPN
aji-147	559	3	,	,	PUNCT
aji-147	559	4	et	et	PROPN
aji-147	559	5	al	al	PROPN
aji-147	559	6	.	.	PUNCT
aji-147	560	1	the	the	DET
aji-147	560	2	potency	potency	NOUN
aji-147	560	3	of	of	ADP
aji-147	560	4	an	an	DET
aji-147	560	5	antimers	antimer	NOUN
aji-147	560	6	coronavirus	coronavirus	NOUN
aji-147	560	7	subunit	subunit	NOUN
aji-147	560	8	vaccine	vaccine	NOUN
aji-147	560	9	depends	depend	VERB
aji-147	560	10	on	on	ADP
aji-147	560	11	a	a	DET
aji-147	560	12	unique	unique	ADJ
aji-147	560	13	combinatorial	combinatorial	ADJ
aji-147	560	14	adjuvant	adjuvant	ADJ
aji-147	560	15	formulation	formulation	NOUN
aji-147	560	16	.	.	PUNCT
aji-147	561	1	vaccines	vaccine	NOUN
aji-147	561	2	.	.	PUNCT
aji-147	562	1	2020;8(2	2020;8(2	NUM
aji-147	562	2	):	):	PUNCT
aji-147	562	3	251	251	NUM
aji-147	562	4	.	.	PUNCT
aji-147	563	1	41	41	NUM
aji-147	563	2	.	.	PUNCT
aji-147	563	3	thevarajan	thevarajan	PROPN
aji-147	563	4	i	i	PROPN
aji-147	563	5	,	,	PUNCT
aji-147	563	6	et	et	PROPN
aji-147	563	7	al	al	PROPN
aji-147	563	8	.	.	PUNCT
aji-147	563	9	breadth	breadth	NOUN
aji-147	563	10	of	of	ADP
aji-147	563	11	concomitant	concomitant	ADJ
aji-147	563	12	immune	immune	ADJ
aji-147	563	13	responses	response	NOUN
aji-147	563	14	prior	prior	ADV
aji-147	563	15	to	to	ADP
aji-147	563	16	patient	patient	ADJ
aji-147	563	17	recovery	recovery	NOUN
aji-147	563	18	:	:	PUNCT
aji-147	563	19	a	a	DET
aji-147	563	20	case	case	NOUN
aji-147	563	21	report	report	NOUN
aji-147	563	22	of	of	ADP
aji-147	563	23	non	non	ADJ
aji-147	563	24	-	-	ADJ
aji-147	563	25	severe	severe	ADJ
aji-147	563	26	covid-19	covid-19	PROPN
aji-147	563	27	.	.	PUNCT
aji-147	564	1	nat	nat	PROPN
aji-147	564	2	med	me	VERB
aji-147	564	3	.	.	PUNCT
aji-147	565	1	2020;26(4):453	2020;26(4):453	NUM
aji-147	565	2	-	-	SYM
aji-147	565	3	5	5	NUM
aji-147	565	4	.	.	NUM
aji-147	565	5	42	42	NUM
aji-147	565	6	.	.	PUNCT
aji-147	566	1	ni	ni	PROPN
aji-147	566	2	l	l	PROPN
aji-147	566	3	,	,	PUNCT
aji-147	566	4	et	et	PROPN
aji-147	566	5	al	al	PROPN
aji-147	566	6	.	.	PUNCT
aji-147	566	7	detection	detection	NOUN
aji-147	566	8	of	of	ADP
aji-147	566	9	sars	sar	NOUN
aji-147	566	10	-	-	PUNCT
aji-147	566	11	cov-2specific	cov-2specific	ADJ
aji-147	566	12	humoral	humoral	ADJ
aji-147	566	13	and	and	CCONJ
aji-147	566	14	cellular	cellular	ADJ
aji-147	566	15	immunity	immunity	NOUN
aji-147	566	16	in	in	ADP
aji-147	566	17	covid-19	covid-19	PROPN
aji-147	566	18	convalescent	convalescent	NOUN
aji-147	566	19	individuals	individual	NOUN
aji-147	566	20	.	.	PUNCT
aji-147	567	1	immunity	immunity	NOUN
aji-147	567	2	.	.	PUNCT
aji-147	568	1	2020;52(6):971	2020;52(6):971	NUM
aji-147	568	2	-	-	PUNCT
aji-147	568	3	7.e3	7.e3	NUM
aji-147	568	4	.	.	PUNCT
aji-147	569	1	43	43	NUM
aji-147	569	2	.	.	PUNCT
aji-147	570	1	gong	gong	PROPN
aji-147	571	1	f	f	PROPN
aji-147	571	2	,	,	PUNCT
aji-147	571	3	et	et	PROPN
aji-147	571	4	al	al	PROPN
aji-147	571	5	.	.	PROPN
aji-147	571	6	peripheral	peripheral	PROPN
aji-147	571	7	cd4	cd4	PROPN
aji-147	571	8	+	+	PROPN
aji-147	571	9	t	t	NOUN
aji-147	571	10	cell	cell	NOUN
aji-147	571	11	subsets	subset	NOUN
aji-147	571	12	and	and	CCONJ
aji-147	571	13	antibody	antibody	NOUN
aji-147	571	14	response	response	NOUN
aji-147	571	15	in	in	ADP
aji-147	571	16	covid19	covid19	NOUN
aji-147	571	17	convalescent	convalescent	NOUN
aji-147	571	18	individuals	individual	NOUN
aji-147	571	19	.	.	PUNCT
aji-147	572	1	j	j	PROPN
aji-147	572	2	clin	clin	PROPN
aji-147	572	3	invest	invest	PROPN
aji-147	572	4	.	.	PUNCT
aji-147	573	1	2020;130(12):6588	2020;130(12):6588	X
aji-147	573	2	-	-	SYM
aji-147	573	3	99	99	NUM
aji-147	573	4	.	.	PUNCT
aji-147	573	5	44	44	NUM
aji-147	573	6	.	.	PUNCT
aji-147	574	1	neidleman	neidleman	PROPN
aji-147	574	2	j	j	PROPN
aji-147	574	3	,	,	PUNCT
aji-147	574	4	et	et	PROPN
aji-147	574	5	al	al	PROPN
aji-147	574	6	.	.	PUNCT
aji-147	575	1	sars	sars	PROPN
aji-147	575	2	-	-	PUNCT
aji-147	575	3	cov-2	cov-2	NOUN
aji-147	575	4	-	-	PUNCT
aji-147	575	5	specific	specific	ADJ
aji-147	575	6	t	t	NOUN
aji-147	575	7	cells	cell	NOUN
aji-147	575	8	exhibit	exhibit	VERB
aji-147	575	9	phenotypic	phenotypic	ADJ
aji-147	575	10	features	feature	NOUN
aji-147	575	11	of	of	ADP
aji-147	575	12	helper	helper	NOUN
aji-147	575	13	function	function	NOUN
aji-147	575	14	,	,	PUNCT
aji-147	575	15	lack	lack	NOUN
aji-147	575	16	of	of	ADP
aji-147	575	17	terminal	terminal	ADJ
aji-147	575	18	differentiation	differentiation	NOUN
aji-147	575	19	,	,	PUNCT
aji-147	575	20	and	and	CCONJ
aji-147	575	21	high	high	ADJ
aji-147	575	22	proliferation	proliferation	NOUN
aji-147	575	23	potential	potential	NOUN
aji-147	575	24	.	.	PUNCT
aji-147	576	1	cell	cell	NOUN
aji-147	576	2	rep	rep	PROPN
aji-147	576	3	med	med	PROPN
aji-147	576	4	.	.	PUNCT
aji-147	577	1	2020;1(6):100081	2020;1(6):100081	NUM
aji-147	577	2	.	.	PUNCT
aji-147	578	1	45	45	NUM
aji-147	578	2	.	.	PUNCT
aji-147	579	1	kaneko	kaneko	PROPN
aji-147	579	2	n	n	PROPN
aji-147	579	3	,	,	PUNCT
aji-147	579	4	et	et	PROPN
aji-147	579	5	al	al	PROPN
aji-147	579	6	.	.	PUNCT
aji-147	579	7	loss	loss	NOUN
aji-147	579	8	of	of	ADP
aji-147	579	9	bcl-6	bcl-6	NOUN
aji-147	579	10	-	-	PUNCT
aji-147	579	11	expressing	express	VERB
aji-147	579	12	t	t	NOUN
aji-147	579	13	follicular	follicular	ADJ
aji-147	579	14	helper	helper	NOUN
aji-147	579	15	cells	cell	NOUN
aji-147	579	16	and	and	CCONJ
aji-147	579	17	germinal	germinal	ADJ
aji-147	579	18	centers	center	NOUN
aji-147	579	19	in	in	ADP
aji-147	579	20	covid-19	covid-19	PROPN
aji-147	579	21	.	.	PUNCT
aji-147	579	22	cell	cell	NOUN
aji-147	579	23	.	.	PUNCT
aji-147	580	1	2020;183(1	2020;183(1	X
aji-147	580	2	):	):	PUNCT
aji-147	580	3	143	143	NUM
aji-147	580	4	-	-	SYM
aji-147	580	5	57.e13	57.e13	NUM
aji-147	580	6	.	.	PUNCT
aji-147	581	1	46	46	NUM
aji-147	581	2	.	.	PUNCT
aji-147	582	1	juno	juno	PROPN
aji-147	582	2	ja	ja	PROPN
aji-147	582	3	,	,	PUNCT
aji-147	582	4	et	et	PROPN
aji-147	582	5	al	al	PROPN
aji-147	582	6	.	.	PROPN
aji-147	583	1	humoral	humoral	ADJ
aji-147	583	2	and	and	CCONJ
aji-147	583	3	circulating	circulate	VERB
aji-147	583	4	follicular	follicular	ADJ
aji-147	583	5	helper	helper	NOUN
aji-147	583	6	t	t	NOUN
aji-147	583	7	cell	cell	NOUN
aji-147	583	8	responses	response	NOUN
aji-147	583	9	in	in	ADP
aji-147	583	10	recovered	recovered	ADJ
aji-147	583	11	patients	patient	NOUN
aji-147	583	12	with	with	ADP
aji-147	583	13	covid-19	covid-19	PROPN
aji-147	583	14	.	.	PUNCT
aji-147	584	1	nat	nat	PROPN
aji-147	584	2	med	me	VERB
aji-147	584	3	.	.	PUNCT
aji-147	585	1	2020;26(9):1428	2020;26(9):1428	X
aji-147	585	2	-	-	SYM
aji-147	585	3	34	34	NUM
aji-147	585	4	.	.	PUNCT
aji-147	585	5	47	47	NUM
aji-147	585	6	.	.	PUNCT
aji-147	586	1	reiss	reiss	PROPN
aji-147	586	2	s	s	PROPN
aji-147	586	3	,	,	PUNCT
aji-147	586	4	et	et	PROPN
aji-147	586	5	al	al	PROPN
aji-147	586	6	.	.	PROPN
aji-147	587	1	comparative	comparative	ADJ
aji-147	587	2	analysis	analysis	NOUN
aji-147	587	3	of	of	ADP
aji-147	587	4	activation	activation	NOUN
aji-147	587	5	induced	induce	VERB
aji-147	587	6	marker	marker	NOUN
aji-147	587	7	(	(	PUNCT
aji-147	587	8	aim	aim	NOUN
aji-147	587	9	)	)	PUNCT
aji-147	587	10	assays	assay	NOUN
aji-147	587	11	for	for	ADP
aji-147	587	12	sensitive	sensitive	ADJ
aji-147	587	13	identification	identification	NOUN
aji-147	587	14	of	of	ADP
aji-147	587	15	antigen	antigen	NOUN
aji-147	587	16	-	-	PUNCT
aji-147	587	17	specific	specific	ADJ
aji-147	587	18	cd4	cd4	PROPN
aji-147	587	19	t	t	NOUN
aji-147	587	20	cells	cell	NOUN
aji-147	587	21	.	.	PUNCT
aji-147	588	1	plos	plos	PROPN
aji-147	588	2	one	one	NUM
aji-147	588	3	.	.	PUNCT
aji-147	589	1	2017;12(10	2017;12(10	NUM
aji-147	589	2	):	):	PUNCT
aji-147	590	1	e0186998	e0186998	PROPN
aji-147	590	2	.	.	PUNCT
aji-147	591	1	48	48	NUM
aji-147	591	2	.	.	PUNCT
aji-147	592	1	rodda	rodda	NOUN
aji-147	592	2	lb	lb	PROPN
aji-147	592	3	,	,	PUNCT
aji-147	592	4	et	et	PROPN
aji-147	592	5	al	al	PROPN
aji-147	592	6	.	.	PUNCT
aji-147	593	1	functional	functional	ADJ
aji-147	593	2	sars	sar	NOUN
aji-147	593	3	-	-	PUNCT
aji-147	593	4	cov-2specific	cov-2specific	ADJ
aji-147	593	5	immune	immune	ADJ
aji-147	593	6	memory	memory	NOUN
aji-147	593	7	persists	persist	VERB
aji-147	593	8	after	after	ADP
aji-147	593	9	mild	mild	ADJ
aji-147	593	10	covid-19	covid-19	PROPN
aji-147	593	11	.	.	PUNCT
aji-147	593	12	cell	cell	NOUN
aji-147	593	13	.	.	PUNCT
aji-147	594	1	2021;184(1):16983.e17	2021;184(1):16983.e17	NUM
aji-147	594	2	.	.	X
aji-147	595	1	49	49	NUM
aji-147	595	2	.	.	PUNCT
aji-147	596	1	dan	dan	PROPN
aji-147	596	2	jm	jm	PROPN
aji-147	596	3	,	,	PUNCT
aji-147	596	4	et	et	PROPN
aji-147	596	5	al	al	PROPN
aji-147	596	6	.	.	PUNCT
aji-147	597	1	immunological	immunological	ADJ
aji-147	597	2	memory	memory	NOUN
aji-147	597	3	to	to	ADP
aji-147	597	4	sars	sar	NOUN
aji-147	597	5	-	-	PUNCT
aji-147	597	6	cov-2	cov-2	NOUN
aji-147	597	7	assessed	assess	VERB
aji-147	597	8	for	for	ADP
aji-147	597	9	up	up	ADP
aji-147	597	10	to	to	PART
aji-147	597	11	8	8	NUM
aji-147	597	12	months	month	NOUN
aji-147	597	13	after	after	ADP
aji-147	597	14	infection	infection	NOUN
aji-147	597	15	.	.	PUNCT
aji-147	598	1	science	science	NOUN
aji-147	598	2	.	.	PUNCT
aji-147	599	1	2021;371(6529	2021;371(6529	ADV
aji-147	599	2	):	):	PUNCT
aji-147	600	1	eabf4063	eabf4063	PROPN
aji-147	600	2	.	.	PUNCT
aji-147	601	1	shukla	shukla	PROPN
aji-147	601	2	et	et	PROPN
aji-147	601	3	al	al	PROPN
aji-147	601	4	.	.	PROPN
aji-147	601	5	;	;	PUNCT
aji-147	601	6	asian	asian	PROPN
aji-147	601	7	j.	j.	PROPN
aji-147	601	8	immunol	immunol	PROPN
aji-147	601	9	.	.	PROPN
aji-147	601	10	,	,	PUNCT
aji-147	601	11	vol	vol	NOUN
aji-147	601	12	.	.	PROPN
aji-147	602	1	7	7	NUM
aji-147	602	2	,	,	PUNCT
aji-147	602	3	no	no	INTJ
aji-147	602	4	.	.	NOUN
aji-147	602	5	1	1	NUM
aji-147	602	6	,	,	PUNCT
aji-147	602	7	pp	pp	ADJ
aji-147	602	8	.	.	PUNCT
aji-147	603	1	228	228	NUM
aji-147	603	2	-	-	SYM
aji-147	603	3	246	246	NUM
aji-147	603	4	,	,	PUNCT
aji-147	603	5	2024	2024	NUM
aji-147	603	6	;	;	PUNCT
aji-147	604	1	article	article	NOUN
aji-147	604	2	no.aji.125387	no.aji.125387	VERB
aji-147	604	3	243	243	NUM
aji-147	604	4	50	50	NUM
aji-147	604	5	.	.	PUNCT
aji-147	605	1	wheatley	wheatley	PROPN
aji-147	605	2	ak	ak	PROPN
aji-147	605	3	,	,	PUNCT
aji-147	605	4	et	et	PROPN
aji-147	605	5	al	al	PROPN
aji-147	605	6	.	.	PROPN
aji-147	605	7	evolution	evolution	NOUN
aji-147	605	8	of	of	ADP
aji-147	605	9	immune	immune	ADJ
aji-147	605	10	responses	response	NOUN
aji-147	605	11	to	to	ADP
aji-147	605	12	sars	sar	NOUN
aji-147	605	13	-	-	PUNCT
aji-147	605	14	cov-2	cov-2	NOUN
aji-147	605	15	in	in	ADP
aji-147	605	16	mildmoderate	mildmoderate	PROPN
aji-147	605	17	covid-19	covid-19	PROPN
aji-147	605	18	.	.	PUNCT
aji-147	606	1	nat	nat	PROPN
aji-147	606	2	commun	commun	PROPN
aji-147	606	3	.	.	PUNCT
aji-147	606	4	2021	2021	NUM
aji-147	606	5	;	;	PUNCT
aji-147	606	6	12(1):1	12(1):1	NUM
aji-147	606	7	-	-	SYM
aji-147	606	8	11	11	NUM
aji-147	606	9	.	.	PUNCT
aji-147	607	1	51	51	NUM
aji-147	607	2	.	.	PUNCT
aji-147	607	3	ranasinghe	ranasinghe	PROPN
aji-147	607	4	s	s	PROPN
aji-147	607	5	,	,	PUNCT
aji-147	607	6	et	et	PROPN
aji-147	607	7	al	al	PROPN
aji-147	607	8	.	.	PROPN
aji-147	607	9	hiv-1	hiv-1	X
aji-147	607	10	antibody	antibody	NOUN
aji-147	607	11	neutralization	neutralization	NOUN
aji-147	607	12	breadth	breadth	NOUN
aji-147	607	13	is	be	AUX
aji-147	607	14	associated	associate	VERB
aji-147	607	15	with	with	ADP
aji-147	607	16	enhanced	enhance	VERB
aji-147	607	17	hiv	hiv	PROPN
aji-147	607	18	-	-	PUNCT
aji-147	607	19	specific	specific	ADJ
aji-147	607	20	cd4	cd4	PROPN
aji-147	607	21	+	+	PROPN
aji-147	607	22	t	t	NOUN
aji-147	607	23	cell	cell	NOUN
aji-147	607	24	responses	response	NOUN
aji-147	607	25	.	.	PUNCT
aji-147	608	1	j	j	PROPN
aji-147	608	2	virol	virol	NOUN
aji-147	608	3	.	.	PUNCT
aji-147	609	1	2015;90(5):2208	2015;90(5):2208	NUM
aji-147	609	2	-	-	SYM
aji-147	609	3	20	20	NUM
aji-147	609	4	.	.	PUNCT
aji-147	610	1	52	52	NUM
aji-147	610	2	.	.	PUNCT
aji-147	611	1	genannt	genannt	NOUN
aji-147	611	2	bonsmann	bonsmann	VERB
aji-147	611	3	ms	ms	PROPN
aji-147	611	4	,	,	PUNCT
aji-147	611	5	et	et	PROPN
aji-147	611	6	al	al	PROPN
aji-147	611	7	.	.	PUNCT
aji-147	612	1	enhancing	enhance	VERB
aji-147	612	2	the	the	DET
aji-147	612	3	quality	quality	NOUN
aji-147	612	4	of	of	ADP
aji-147	612	5	antibodies	antibody	NOUN
aji-147	612	6	to	to	ADP
aji-147	612	7	hiv-1	hiv-1	PUNCT
aji-147	612	8	envelope	envelope	VERB
aji-147	612	9	by	by	ADP
aji-147	612	10	gagpol	gagpol	NOUN
aji-147	612	11	-	-	PUNCT
aji-147	612	12	specific	specific	ADJ
aji-147	612	13	th	th	NOUN
aji-147	612	14	cells	cell	NOUN
aji-147	612	15	.	.	PUNCT
aji-147	613	1	j	j	PROPN
aji-147	613	2	immunol	immunol	NOUN
aji-147	613	3	.	.	PUNCT
aji-147	614	1	2015;195(10):4861	2015;195(10):4861	NUM
aji-147	614	2	-	-	SYM
aji-147	614	3	72	72	NUM
aji-147	614	4	.	.	PUNCT
aji-147	615	1	53	53	NUM
aji-147	615	2	.	.	PUNCT
aji-147	616	1	boppana	boppana	PROPN
aji-147	616	2	s	s	PROPN
aji-147	616	3	,	,	PUNCT
aji-147	616	4	et	et	PROPN
aji-147	616	5	al	al	PROPN
aji-147	616	6	.	.	PUNCT
aji-147	617	1	sars	sars	PROPN
aji-147	617	2	-	-	PUNCT
aji-147	617	3	cov-2	cov-2	NOUN
aji-147	617	4	-	-	PUNCT
aji-147	617	5	specific	specific	ADJ
aji-147	617	6	circulating	circulating	NOUN
aji-147	617	7	t	t	NOUN
aji-147	617	8	follicular	follicular	ADJ
aji-147	617	9	helper	helper	NOUN
aji-147	617	10	cells	cell	NOUN
aji-147	617	11	correlate	correlate	VERB
aji-147	617	12	with	with	ADP
aji-147	617	13	neutralizing	neutralize	VERB
aji-147	617	14	antibodies	antibody	NOUN
aji-147	617	15	and	and	CCONJ
aji-147	617	16	increase	increase	VERB
aji-147	617	17	during	during	ADP
aji-147	617	18	early	early	ADJ
aji-147	617	19	convalescence	convalescence	NOUN
aji-147	617	20	.	.	PUNCT
aji-147	618	1	plos	plos	PROPN
aji-147	618	2	pathog	pathog	PROPN
aji-147	618	3	.	.	PUNCT
aji-147	619	1	2021;17(7):e1009761	2021;17(7):e1009761	X
aji-147	619	2	.	.	PROPN
aji-147	619	3	54	54	NUM
aji-147	619	4	.	.	PUNCT
aji-147	619	5	luo	luo	PROPN
aji-147	619	6	w	w	PROPN
aji-147	619	7	,	,	PUNCT
aji-147	619	8	yin	yin	PROPN
aji-147	619	9	q.	q.	PROPN
aji-147	619	10	b	b	PROPN
aji-147	619	11	cell	cell	NOUN
aji-147	619	12	response	response	NOUN
aji-147	619	13	to	to	ADP
aji-147	619	14	vaccination	vaccination	NOUN
aji-147	619	15	.	.	PUNCT
aji-147	620	1	immunol	immunol	NOUN
aji-147	620	2	invest	invest	PROPN
aji-147	620	3	.	.	PUNCT
aji-147	621	1	2021;50(7	2021;50(7	NUM
aji-147	621	2	):	):	PUNCT
aji-147	621	3	780	780	NUM
aji-147	621	4	-	-	SYM
aji-147	621	5	801	801	NUM
aji-147	621	6	.	.	PUNCT
aji-147	622	1	55	55	NUM
aji-147	622	2	.	.	PUNCT
aji-147	622	3	vella	vella	PROPN
aji-147	622	4	la	la	PROPN
aji-147	622	5	,	,	PUNCT
aji-147	622	6	herati	herati	NOUN
aji-147	622	7	rs	rs	PROPN
aji-147	622	8	,	,	PUNCT
aji-147	622	9	wherry	wherry	PROPN
aji-147	622	10	ej	ej	PROPN
aji-147	622	11	.	.	PROPN
aji-147	623	1	cd4	cd4	PROPN
aji-147	623	2	+	+	PROPN
aji-147	623	3	t	t	NOUN
aji-147	623	4	cell	cell	NOUN
aji-147	623	5	differentiation	differentiation	NOUN
aji-147	623	6	in	in	ADP
aji-147	623	7	chronic	chronic	ADJ
aji-147	623	8	viral	viral	ADJ
aji-147	623	9	infections	infection	NOUN
aji-147	623	10	:	:	PUNCT
aji-147	623	11	the	the	DET
aji-147	623	12	tfh	tfh	PROPN
aji-147	623	13	perspective	perspective	NOUN
aji-147	623	14	.	.	PUNCT
aji-147	624	1	trends	trend	NOUN
aji-147	624	2	mol	mol	ADP
aji-147	624	3	med	med	PROPN
aji-147	624	4	.	.	PUNCT
aji-147	625	1	2017;23(12):1072	2017;23(12):1072	NUM
aji-147	625	2	-	-	SYM
aji-147	625	3	87	87	NUM
aji-147	625	4	.	.	PUNCT
aji-147	626	1	56	56	NUM
aji-147	626	2	.	.	PUNCT
aji-147	626	3	vinuesa	vinuesa	PROPN
aji-147	626	4	cg	cg	PROPN
aji-147	626	5	,	,	PUNCT
aji-147	626	6	et	et	PROPN
aji-147	626	7	al	al	PROPN
aji-147	626	8	.	.	PUNCT
aji-147	627	1	follicular	follicular	ADJ
aji-147	627	2	helper	helper	NOUN
aji-147	627	3	t	t	PROPN
aji-147	627	4	cells	cell	NOUN
aji-147	627	5	.	.	PUNCT
aji-147	628	1	annu	annu	PROPN
aji-147	628	2	rev	rev	VERB
aji-147	628	3	immunol	immunol	NOUN
aji-147	628	4	.	.	PUNCT
aji-147	629	1	2016;34:335	2016;34:335	X
aji-147	629	2	-	-	SYM
aji-147	629	3	68	68	NUM
aji-147	629	4	.	.	PUNCT
aji-147	630	1	57	57	NUM
aji-147	630	2	.	.	PUNCT
aji-147	631	1	xu	xu	PROPN
aji-147	632	1	l	l	PROPN
aji-147	632	2	,	,	PUNCT
aji-147	632	3	et	et	PROPN
aji-147	632	4	al	al	PROPN
aji-147	632	5	.	.	PUNCT
aji-147	633	1	the	the	DET
aji-147	633	2	kinase	kinase	PROPN
aji-147	633	3	mtorc1	mtorc1	NOUN
aji-147	633	4	promotes	promote	VERB
aji-147	633	5	the	the	DET
aji-147	633	6	generation	generation	NOUN
aji-147	633	7	and	and	CCONJ
aji-147	633	8	suppressive	suppressive	ADJ
aji-147	633	9	function	function	NOUN
aji-147	633	10	of	of	ADP
aji-147	633	11	follicular	follicular	ADJ
aji-147	633	12	regulatory	regulatory	ADJ
aji-147	633	13	t	t	NOUN
aji-147	633	14	cells	cell	NOUN
aji-147	633	15	.	.	PUNCT
aji-147	634	1	immunity	immunity	NOUN
aji-147	634	2	.	.	PUNCT
aji-147	635	1	2017;47(3):538	2017;47(3):538	NUM
aji-147	635	2	-	-	SYM
aji-147	635	3	51.e5	51.e5	NUM
aji-147	635	4	.	.	PUNCT
aji-147	636	1	58	58	NUM
aji-147	636	2	.	.	PUNCT
aji-147	637	1	crotty	crotty	PROPN
aji-147	637	2	s.	s.	PROPN
aji-147	637	3	t	t	PROPN
aji-147	637	4	follicular	follicular	ADJ
aji-147	637	5	helper	helper	NOUN
aji-147	637	6	cell	cell	NOUN
aji-147	637	7	biology	biology	NOUN
aji-147	637	8	:	:	PUNCT
aji-147	637	9	a	a	DET
aji-147	637	10	decade	decade	NOUN
aji-147	637	11	of	of	ADP
aji-147	637	12	discovery	discovery	NOUN
aji-147	637	13	and	and	CCONJ
aji-147	637	14	diseases	disease	NOUN
aji-147	637	15	.	.	PUNCT
aji-147	638	1	immunity	immunity	NOUN
aji-147	638	2	.	.	PUNCT
aji-147	639	1	2019;50(5):1132	2019;50(5):1132	PROPN
aji-147	639	2	-	-	SYM
aji-147	639	3	48	48	NUM
aji-147	639	4	.	.	PUNCT
aji-147	640	1	59	59	NUM
aji-147	640	2	.	.	PUNCT
aji-147	641	1	xiao	xiao	PROPN
aji-147	641	2	f	f	PROPN
aji-147	641	3	,	,	PUNCT
aji-147	641	4	et	et	PROPN
aji-147	641	5	al	al	PROPN
aji-147	641	6	.	.	PUNCT
aji-147	642	1	new	new	ADJ
aji-147	642	2	insights	insight	NOUN
aji-147	642	3	into	into	ADP
aji-147	642	4	follicular	follicular	ADJ
aji-147	642	5	helper	helper	NOUN
aji-147	642	6	t	t	NOUN
aji-147	642	7	cell	cell	NOUN
aji-147	642	8	response	response	NOUN
aji-147	642	9	and	and	CCONJ
aji-147	642	10	regulation	regulation	NOUN
aji-147	642	11	in	in	ADP
aji-147	642	12	autoimmune	autoimmune	ADJ
aji-147	642	13	pathogenesis	pathogenesis	NOUN
aji-147	642	14	.	.	PUNCT
aji-147	643	1	cell	cell	NOUN
aji-147	643	2	mol	mol	ADP
aji-147	643	3	immunol	immunol	NOUN
aji-147	643	4	.	.	PUNCT
aji-147	644	1	2021;18(6):1610	2021;18(6):1610	NUM
aji-147	644	2	-	-	SYM
aji-147	644	3	2	2	NUM
aji-147	644	4	.	.	NOUN
aji-147	644	5	60	60	NUM
aji-147	644	6	.	.	PUNCT
aji-147	645	1	qi	qi	PROPN
aji-147	645	2	h.	h.	PROPN
aji-147	645	3	t	t	PROPN
aji-147	645	4	follicular	follicular	ADJ
aji-147	645	5	helper	helper	NOUN
aji-147	645	6	cells	cell	NOUN
aji-147	645	7	in	in	ADP
aji-147	645	8	space	space	NOUN
aji-147	645	9	-	-	PUNCT
aji-147	645	10	time	time	NOUN
aji-147	645	11	.	.	PUNCT
aji-147	646	1	nat	nat	PROPN
aji-147	646	2	rev	rev	PROPN
aji-147	646	3	immunol	immunol	NOUN
aji-147	646	4	.	.	PUNCT
aji-147	647	1	2016;16(10):612	2016;16(10):612	NUM
aji-147	647	2	-	-	SYM
aji-147	647	3	25	25	NUM
aji-147	647	4	.	.	NOUN
aji-147	647	5	61	61	NUM
aji-147	647	6	.	.	PUNCT
aji-147	648	1	song	song	PROPN
aji-147	648	2	w	w	PROPN
aji-147	648	3	,	,	PUNCT
aji-147	648	4	craft	craft	PROPN
aji-147	648	5	j.	j.	PROPN
aji-147	648	6	t	t	PROPN
aji-147	648	7	follicular	follicular	ADJ
aji-147	648	8	helper	helper	NOUN
aji-147	648	9	cell	cell	NOUN
aji-147	648	10	heterogeneity	heterogeneity	NOUN
aji-147	648	11	:	:	PUNCT
aji-147	648	12	time	time	NOUN
aji-147	648	13	,	,	PUNCT
aji-147	648	14	space	space	NOUN
aji-147	648	15	,	,	PUNCT
aji-147	648	16	and	and	CCONJ
aji-147	648	17	function	function	NOUN
aji-147	648	18	.	.	PUNCT
aji-147	649	1	immunol	immunol	PROPN
aji-147	649	2	rev	rev	PROPN
aji-147	649	3	.	.	PROPN
aji-147	650	1	2019;288(1):85	2019;288(1):85	PROPN
aji-147	650	2	-	-	SYM
aji-147	650	3	96	96	NUM
aji-147	650	4	.	.	PUNCT
aji-147	651	1	62	62	NUM
aji-147	651	2	.	.	PUNCT
aji-147	652	1	deng	deng	PROPN
aji-147	652	2	j	j	PROPN
aji-147	652	3	,	,	PUNCT
aji-147	652	4	et	et	PROPN
aji-147	652	5	al	al	PROPN
aji-147	652	6	.	.	PROPN
aji-147	652	7	t	t	PROPN
aji-147	652	8	follicular	follicular	ADJ
aji-147	652	9	helper	helper	NOUN
aji-147	652	10	cells	cell	NOUN
aji-147	652	11	and	and	CCONJ
aji-147	652	12	t	t	X
aji-147	652	13	follicular	follicular	ADJ
aji-147	652	14	regulatory	regulatory	ADJ
aji-147	652	15	cells	cell	NOUN
aji-147	652	16	in	in	ADP
aji-147	652	17	rheumatic	rheumatic	ADJ
aji-147	652	18	diseases	disease	NOUN
aji-147	652	19	.	.	PUNCT
aji-147	653	1	nat	nat	PROPN
aji-147	653	2	rev	rev	PROPN
aji-147	653	3	rheumatol	rheumatol	NOUN
aji-147	653	4	.	.	PUNCT
aji-147	654	1	2019;15(8	2019;15(8	NUM
aji-147	654	2	):	):	PUNCT
aji-147	654	3	475	475	NUM
aji-147	654	4	-	-	SYM
aji-147	654	5	90	90	NUM
aji-147	654	6	.	.	PUNCT
aji-147	655	1	63	63	NUM
aji-147	655	2	.	.	PUNCT
aji-147	656	1	shao	shao	PROPN
aji-147	656	2	f	f	PROPN
aji-147	656	3	,	,	PUNCT
aji-147	656	4	et	et	PROPN
aji-147	656	5	al	al	PROPN
aji-147	656	6	.	.	PUNCT
aji-147	656	7	follicular	follicular	ADJ
aji-147	656	8	helper	helper	NOUN
aji-147	656	9	t	t	NOUN
aji-147	656	10	cells	cell	NOUN
aji-147	656	11	in	in	ADP
aji-147	656	12	type	type	NOUN
aji-147	656	13	1	1	NUM
aji-147	656	14	diabetes	diabetes	NOUN
aji-147	656	15	.	.	PUNCT
aji-147	657	1	faseb	faseb	PROPN
aji-147	657	2	j.	j.	PROPN
aji-147	657	3	2020;34(1):3040	2020;34(1):3040	PROPN
aji-147	657	4	.	.	PUNCT
aji-147	658	1	64	64	NUM
aji-147	658	2	.	.	PUNCT
aji-147	659	1	kroenke	kroenke	PROPN
aji-147	659	2	ma	ma	PROPN
aji-147	659	3	,	,	PUNCT
aji-147	659	4	et	et	PROPN
aji-147	659	5	al	al	PROPN
aji-147	659	6	.	.	PROPN
aji-147	659	7	bcl6	bcl6	PROPN
aji-147	659	8	and	and	CCONJ
aji-147	659	9	maf	maf	PROPN
aji-147	659	10	cooperate	cooperate	VERB
aji-147	659	11	to	to	PART
aji-147	659	12	instruct	instruct	VERB
aji-147	659	13	human	human	ADJ
aji-147	659	14	follicular	follicular	ADJ
aji-147	659	15	helper	helper	NOUN
aji-147	659	16	cd4	cd4	PROPN
aji-147	659	17	t	t	PROPN
aji-147	659	18	cell	cell	NOUN
aji-147	659	19	differentiation	differentiation	NOUN
aji-147	659	20	.	.	PUNCT
aji-147	660	1	j	j	PROPN
aji-147	660	2	immunol	immunol	NOUN
aji-147	660	3	.	.	PUNCT
aji-147	661	1	2012	2012	NUM
aji-147	661	2	;	;	PUNCT
aji-147	661	3	188(8):3734	188(8):3734	NUM
aji-147	661	4	-	-	SYM
aji-147	661	5	44	44	NUM
aji-147	661	6	.	.	PUNCT
aji-147	662	1	65	65	NUM
aji-147	662	2	.	.	PUNCT
aji-147	662	3	yu	yu	PROPN
aji-147	663	1	d	d	PROPN
aji-147	663	2	,	,	PUNCT
aji-147	663	3	et	et	PROPN
aji-147	663	4	al	al	PROPN
aji-147	663	5	.	.	PUNCT
aji-147	664	1	the	the	DET
aji-147	664	2	transcriptional	transcriptional	ADJ
aji-147	664	3	repressor	repressor	NOUN
aji-147	664	4	bcl-6	bcl-6	PUNCT
aji-147	664	5	directs	direct	VERB
aji-147	664	6	t	t	PROPN
aji-147	664	7	follicular	follicular	ADJ
aji-147	664	8	helper	helper	NOUN
aji-147	664	9	cell	cell	NOUN
aji-147	664	10	lineage	lineage	NOUN
aji-147	664	11	commitment	commitment	NOUN
aji-147	664	12	.	.	PUNCT
aji-147	665	1	immunity	immunity	NOUN
aji-147	665	2	.	.	PUNCT
aji-147	666	1	2009;31(3):457	2009;31(3):457	NUM
aji-147	666	2	-	-	SYM
aji-147	666	3	68	68	NUM
aji-147	666	4	.	.	PUNCT
aji-147	667	1	66	66	NUM
aji-147	667	2	.	.	PUNCT
aji-147	668	1	fernández	fernández	PROPN
aji-147	668	2	-	-	PUNCT
aji-147	668	3	barat	barat	PROPN
aji-147	668	4	l	l	PROPN
aji-147	668	5	,	,	PUNCT
aji-147	668	6	lópez	lópez	NOUN
aji-147	668	7	-	-	PUNCT
aji-147	668	8	aladid	aladid	VERB
aji-147	668	9	r	r	NOUN
aji-147	668	10	,	,	PUNCT
aji-147	668	11	torres	torre	VERB
aji-147	668	12	a.	a.	NOUN
aji-147	668	13	the	the	DET
aji-147	668	14	value	value	NOUN
aji-147	668	15	of	of	ADP
aji-147	668	16	serology	serology	NOUN
aji-147	668	17	testing	testing	NOUN
aji-147	668	18	to	to	PART
aji-147	668	19	manage	manage	VERB
aji-147	668	20	sars	sar	NOUN
aji-147	668	21	-	-	PUNCT
aji-147	668	22	cov-2	cov-2	NOUN
aji-147	668	23	infections	infection	NOUN
aji-147	668	24	.	.	PUNCT
aji-147	669	1	eur	eur	ADJ
aji-147	669	2	respiratory	respiratory	ADJ
aji-147	669	3	soc	soc	NOUN
aji-147	669	4	.	.	PUNCT
aji-147	670	1	2020	2020	NUM
aji-147	670	2	.	.	PUNCT
aji-147	671	1	67	67	NUM
aji-147	671	2	.	.	PUNCT
aji-147	672	1	ueno	ueno	PROPN
aji-147	672	2	h	h	PROPN
aji-147	672	3	,	,	PUNCT
aji-147	672	4	banchereau	banchereau	PROPN
aji-147	672	5	j	j	PROPN
aji-147	672	6	,	,	PUNCT
aji-147	672	7	vinuesa	vinuesa	PROPN
aji-147	672	8	cg	cg	PROPN
aji-147	672	9	.	.	PUNCT
aji-147	673	1	pathophysiology	pathophysiology	PROPN
aji-147	673	2	of	of	ADP
aji-147	673	3	t	t	PROPN
aji-147	673	4	follicular	follicular	ADJ
aji-147	673	5	helper	helper	NOUN
aji-147	673	6	cells	cell	NOUN
aji-147	673	7	in	in	ADP
aji-147	673	8	humans	human	NOUN
aji-147	673	9	and	and	CCONJ
aji-147	673	10	mice	mouse	NOUN
aji-147	673	11	.	.	PUNCT
aji-147	674	1	nat	nat	PROPN
aji-147	674	2	immunol	immunol	NOUN
aji-147	674	3	.	.	PUNCT
aji-147	675	1	2015;16(2):142	2015;16(2):142	PROPN
aji-147	675	2	-	-	PUNCT
aji-147	675	3	52	52	NUM
aji-147	675	4	.	.	PUNCT
aji-147	676	1	68	68	NUM
aji-147	676	2	.	.	PUNCT
aji-147	677	1	linterman	linterman	PROPN
aji-147	677	2	ma	ma	PROPN
aji-147	677	3	,	,	PUNCT
aji-147	677	4	et	et	PROPN
aji-147	677	5	al	al	PROPN
aji-147	677	6	.	.	PUNCT
aji-147	678	1	il-21	il-21	PRON
aji-147	678	2	acts	act	VERB
aji-147	678	3	directly	directly	ADV
aji-147	678	4	on	on	ADP
aji-147	678	5	b	b	PROPN
aji-147	678	6	cells	cell	NOUN
aji-147	678	7	to	to	PART
aji-147	678	8	regulate	regulate	VERB
aji-147	678	9	bcl-6	bcl-6	X
aji-147	678	10	expression	expression	NOUN
aji-147	678	11	and	and	CCONJ
aji-147	678	12	germinal	germinal	ADJ
aji-147	678	13	center	center	NOUN
aji-147	678	14	responses	response	NOUN
aji-147	678	15	.	.	PUNCT
aji-147	679	1	j	j	PROPN
aji-147	679	2	exp	exp	NOUN
aji-147	679	3	med	med	PROPN
aji-147	679	4	.	.	PUNCT
aji-147	680	1	2010;207(2):353	2010;207(2):353	X
aji-147	680	2	-	-	SYM
aji-147	680	3	63	63	NUM
aji-147	680	4	.	.	PUNCT
aji-147	681	1	69	69	NUM
aji-147	681	2	.	.	PUNCT
aji-147	682	1	akiyama	akiyama	PROPN
aji-147	682	2	m	m	PROPN
aji-147	682	3	,	,	PUNCT
aji-147	682	4	et	et	PROPN
aji-147	682	5	al	al	PROPN
aji-147	682	6	.	.	PUNCT
aji-147	683	1	peripheral	peripheral	ADJ
aji-147	683	2	tigit^+^	tigit^+^	PROPN
aji-147	683	3	t	t	PROPN
aji-147	683	4	follicular	follicular	ADJ
aji-147	683	5	helper	helper	NOUN
aji-147	683	6	cells	cell	NOUN
aji-147	683	7	that	that	PRON
aji-147	683	8	produce	produce	VERB
aji-147	683	9	high	high	ADJ
aji-147	683	10	levels	level	NOUN
aji-147	683	11	of	of	ADP
aji-147	683	12	interleukin-21	interleukin-21	PROPN
aji-147	683	13	via	via	ADP
aji-147	683	14	ox40	ox40	PROPN
aji-147	683	15	represent	represent	VERB
aji-147	683	16	disease	disease	NOUN
aji-147	683	17	activity	activity	NOUN
aji-147	683	18	in	in	ADP
aji-147	683	19	igg4	igg4	NOUN
aji-147	683	20	-	-	PUNCT
aji-147	683	21	related	relate	VERB
aji-147	683	22	disease	disease	NOUN
aji-147	683	23	.	.	PUNCT
aji-147	684	1	front	front	ADJ
aji-147	684	2	immunol	immunol	NOUN
aji-147	684	3	.	.	PUNCT
aji-147	685	1	2021;12:1232	2021;12:1232	X
aji-147	685	2	.	.	PROPN
aji-147	685	3	70	70	NUM
aji-147	685	4	.	.	PUNCT
aji-147	686	1	yang	yang	PROPN
aji-147	686	2	j	j	PROPN
aji-147	686	3	,	,	PUNCT
aji-147	686	4	et	et	PROPN
aji-147	686	5	al	al	PROPN
aji-147	686	6	.	.	PROPN
aji-147	686	7	slams	slam	VERB
aji-147	686	8	negatively	negatively	ADV
aji-147	686	9	regulate	regulate	VERB
aji-147	686	10	il-21	il-21	ADJ
aji-147	686	11	production	production	NOUN
aji-147	686	12	in	in	ADP
aji-147	686	13	tfh	tfh	PROPN
aji-147	686	14	-	-	PUNCT
aji-147	686	15	like	like	ADJ
aji-147	686	16	cells	cell	NOUN
aji-147	686	17	from	from	ADP
aji-147	686	18	allergic	allergic	ADJ
aji-147	686	19	rhinitis	rhinitis	NOUN
aji-147	686	20	patients	patient	NOUN
aji-147	686	21	.	.	PUNCT
aji-147	687	1	j	j	PROPN
aji-147	687	2	asthma	asthma	PROPN
aji-147	687	3	allergy	allergy	PROPN
aji-147	687	4	.	.	PUNCT
aji-147	688	1	2021;14:361	2021;14:361	NOUN
aji-147	688	2	.	.	X
aji-147	689	1	71	71	NUM
aji-147	689	2	.	.	PUNCT
aji-147	690	1	pontarini	pontarini	PROPN
aji-147	690	2	e	e	PROPN
aji-147	690	3	,	,	PUNCT
aji-147	690	4	et	et	PROPN
aji-147	690	5	al	al	PROPN
aji-147	690	6	.	.	PROPN
aji-147	690	7	unique	unique	ADJ
aji-147	690	8	expansion	expansion	NOUN
aji-147	690	9	of	of	ADP
aji-147	690	10	il21^+^	il21^+^	PROPN
aji-147	690	11	tfh	tfh	PROPN
aji-147	690	12	and	and	CCONJ
aji-147	690	13	tph	tph	PROPN
aji-147	690	14	cells	cell	NOUN
aji-147	690	15	under	under	ADP
aji-147	690	16	control	control	NOUN
aji-147	690	17	of	of	ADP
aji-147	690	18	icos	icos	PROPN
aji-147	690	19	identifies	identify	VERB
aji-147	690	20	sjögren	sjögren	PROPN
aji-147	690	21	’s	’s	PART
aji-147	690	22	syndrome	syndrome	NOUN
aji-147	690	23	with	with	ADP
aji-147	690	24	ectopic	ectopic	ADJ
aji-147	690	25	germinal	germinal	ADJ
aji-147	690	26	centres	centre	NOUN
aji-147	690	27	and	and	CCONJ
aji-147	690	28	malt	malt	NOUN
aji-147	690	29	lymphoma	lymphoma	NOUN
aji-147	690	30	.	.	PUNCT
aji-147	691	1	ann	ann	PROPN
aji-147	691	2	rheum	rheum	PROPN
aji-147	691	3	dis	dis	PROPN
aji-147	691	4	.	.	PUNCT
aji-147	692	1	2020;79(12	2020;79(12	NUM
aji-147	692	2	):	):	PUNCT
aji-147	692	3	1588	1588	NUM
aji-147	692	4	-	-	SYM
aji-147	692	5	99	99	NUM
aji-147	692	6	.	.	PUNCT
aji-147	693	1	72	72	NUM
aji-147	693	2	.	.	PUNCT
aji-147	693	3	olatunde	olatunde	PROPN
aji-147	693	4	ac	ac	PROPN
aji-147	693	5	,	,	PUNCT
aji-147	693	6	hale	hale	PROPN
aji-147	693	7	js	js	PROPN
aji-147	693	8	,	,	PUNCT
aji-147	693	9	lamb	lamb	PROPN
aji-147	693	10	tj	tj	PROPN
aji-147	693	11	.	.	PROPN
aji-147	693	12	cytokineskewed	cytokineskewe	VERB
aji-147	693	13	tfh	tfh	NOUN
aji-147	693	14	cells	cell	NOUN
aji-147	693	15	:	:	PUNCT
aji-147	693	16	functional	functional	ADJ
aji-147	693	17	consequences	consequence	NOUN
aji-147	693	18	for	for	ADP
aji-147	693	19	b	b	NOUN
aji-147	693	20	cell	cell	NOUN
aji-147	693	21	help	help	NOUN
aji-147	693	22	.	.	PUNCT
aji-147	694	1	trends	trend	NOUN
aji-147	694	2	immunol	immunol	NOUN
aji-147	694	3	.	.	PUNCT
aji-147	695	1	2021	2021	NUM
aji-147	695	2	;	;	PUNCT
aji-147	696	1	42(6):536	42(6):536	NOUN
aji-147	696	2	-	-	SYM
aji-147	696	3	50	50	NUM
aji-147	696	4	.	.	PUNCT
aji-147	696	5	73	73	NUM
aji-147	696	6	.	.	PUNCT
aji-147	697	1	crotty	crotty	PROPN
aji-147	697	2	s.	s.	PROPN
aji-147	697	3	t	t	PROPN
aji-147	697	4	follicular	follicular	ADJ
aji-147	697	5	helper	helper	NOUN
aji-147	697	6	cell	cell	NOUN
aji-147	697	7	differentiation	differentiation	NOUN
aji-147	697	8	,	,	PUNCT
aji-147	697	9	function	function	NOUN
aji-147	697	10	,	,	PUNCT
aji-147	697	11	and	and	CCONJ
aji-147	697	12	roles	role	NOUN
aji-147	697	13	in	in	ADP
aji-147	697	14	disease	disease	NOUN
aji-147	697	15	.	.	PUNCT
aji-147	698	1	immunity	immunity	NOUN
aji-147	698	2	.	.	PUNCT
aji-147	699	1	2014;41(4):529	2014;41(4):529	NUM
aji-147	699	2	-	-	SYM
aji-147	699	3	42	42	NUM
aji-147	699	4	.	.	PUNCT
aji-147	700	1	74	74	NUM
aji-147	700	2	.	.	PUNCT
aji-147	700	3	bauquet	bauquet	NOUN
aji-147	700	4	at	at	ADP
aji-147	700	5	,	,	PUNCT
aji-147	700	6	et	et	PROPN
aji-147	700	7	al	al	PROPN
aji-147	700	8	.	.	PUNCT
aji-147	701	1	the	the	DET
aji-147	701	2	costimulatory	costimulatory	PROPN
aji-147	701	3	molecule	molecule	PROPN
aji-147	701	4	icos	icos	PROPN
aji-147	701	5	regulates	regulate	VERB
aji-147	701	6	the	the	DET
aji-147	701	7	expression	expression	NOUN
aji-147	701	8	of	of	ADP
aji-147	701	9	c	c	NOUN
aji-147	701	10	-	-	PUNCT
aji-147	701	11	maf	maf	NOUN
aji-147	701	12	and	and	CCONJ
aji-147	701	13	il-21	il-21	NOUN
aji-147	701	14	in	in	ADP
aji-147	701	15	the	the	DET
aji-147	701	16	development	development	NOUN
aji-147	701	17	of	of	ADP
aji-147	701	18	follicular	follicular	ADJ
aji-147	701	19	t	t	PROPN
aji-147	701	20	helper	helper	NOUN
aji-147	701	21	cells	cell	NOUN
aji-147	701	22	and	and	CCONJ
aji-147	701	23	th-17	th-17	NOUN
aji-147	701	24	cells	cell	NOUN
aji-147	701	25	.	.	PUNCT
aji-147	702	1	nat	nat	PROPN
aji-147	702	2	immunol	immunol	NOUN
aji-147	702	3	.	.	PUNCT
aji-147	703	1	2009;10(2):167	2009;10(2):167	NUM
aji-147	703	2	-	-	SYM
aji-147	703	3	75	75	NUM
aji-147	703	4	.	.	PUNCT
aji-147	704	1	75	75	NUM
aji-147	704	2	.	.	PUNCT
aji-147	705	1	panneton	panneton	PROPN
aji-147	705	2	v	v	PROPN
aji-147	705	3	,	,	PUNCT
aji-147	705	4	et	et	PROPN
aji-147	705	5	al	al	PROPN
aji-147	705	6	.	.	PROPN
aji-147	705	7	inducible	inducible	ADJ
aji-147	705	8	t	t	NOUN
aji-147	705	9	-	-	PUNCT
aji-147	705	10	cell	cell	NOUN
aji-147	705	11	costimulator	costimulator	NOUN
aji-147	705	12	:	:	PUNCT
aji-147	705	13	signaling	signal	VERB
aji-147	705	14	mechanisms	mechanism	NOUN
aji-147	705	15	in	in	ADP
aji-147	705	16	t	t	PROPN
aji-147	705	17	follicular	follicular	ADJ
aji-147	705	18	helper	helper	NOUN
aji-147	705	19	cells	cell	NOUN
aji-147	705	20	and	and	CCONJ
aji-147	705	21	beyond	beyond	ADP
aji-147	705	22	.	.	PUNCT
aji-147	706	1	immunol	immunol	PROPN
aji-147	706	2	rev	rev	PROPN
aji-147	706	3	.	.	PROPN
aji-147	707	1	2019;291(1):91	2019;291(1):91	PROPN
aji-147	707	2	-	-	PUNCT
aji-147	707	3	103	103	NUM
aji-147	707	4	.	.	PUNCT
aji-147	708	1	76	76	NUM
aji-147	708	2	.	.	PUNCT
aji-147	709	1	aoki	aoki	PROPN
aji-147	709	2	n	n	PROPN
aji-147	709	3	,	,	PUNCT
aji-147	709	4	et	et	PROPN
aji-147	709	5	al	al	PROPN
aji-147	709	6	.	.	PROPN
aji-147	709	7	dysregulated	dysregulated	ADJ
aji-147	709	8	generation	generation	NOUN
aji-147	709	9	of	of	ADP
aji-147	709	10	follicular	follicular	ADJ
aji-147	709	11	helper	helper	NOUN
aji-147	709	12	t	t	NOUN
aji-147	709	13	cells	cell	NOUN
aji-147	709	14	in	in	ADP
aji-147	709	15	the	the	DET
aji-147	709	16	spleen	spleen	NOUN
aji-147	709	17	triggers	trigger	NOUN
aji-147	709	18	fatal	fatal	ADJ
aji-147	709	19	autoimmune	autoimmune	ADJ
aji-147	709	20	hepatitis	hepatitis	NOUN
aji-147	709	21	in	in	ADP
aji-147	709	22	mice	mouse	NOUN
aji-147	709	23	.	.	PUNCT
aji-147	710	1	gastroenterology	gastroenterology	NOUN
aji-147	710	2	.	.	PUNCT
aji-147	711	1	2011;140(4):1322	2011;140(4):1322	PROPN
aji-147	711	2	-	-	PUNCT
aji-147	711	3	33.e5	33.e5	NUM
aji-147	711	4	.	.	PUNCT
aji-147	712	1	77	77	NUM
aji-147	712	2	.	.	PUNCT
aji-147	713	1	linterman	linterman	PROPN
aji-147	713	2	ma	ma	PROPN
aji-147	713	3	,	,	PUNCT
aji-147	713	4	et	et	PROPN
aji-147	713	5	al	al	PROPN
aji-147	713	6	.	.	PUNCT
aji-147	714	1	follicular	follicular	ADJ
aji-147	714	2	helper	helper	NOUN
aji-147	714	3	t	t	NOUN
aji-147	714	4	cells	cell	NOUN
aji-147	714	5	are	be	AUX
aji-147	714	6	required	require	VERB
aji-147	714	7	for	for	ADP
aji-147	714	8	systemic	systemic	ADJ
aji-147	714	9	autoimmunity	autoimmunity	NOUN
aji-147	714	10	.	.	PUNCT
aji-147	715	1	j	j	PROPN
aji-147	715	2	exp	exp	NOUN
aji-147	715	3	med	med	PROPN
aji-147	715	4	.	.	PUNCT
aji-147	715	5	2009;206(3	2009;206(3	PROPN
aji-147	715	6	):	):	PUNCT
aji-147	715	7	561	561	NUM
aji-147	715	8	-	-	SYM
aji-147	715	9	76	76	NUM
aji-147	715	10	.	.	PUNCT
aji-147	716	1	78	78	NUM
aji-147	716	2	.	.	PUNCT
aji-147	717	1	shi	shi	PROPN
aji-147	717	2	j	j	PROPN
aji-147	717	3	,	,	PUNCT
aji-147	717	4	et	et	PROPN
aji-147	717	5	al	al	PROPN
aji-147	717	6	.	.	PROPN
aji-147	717	7	pd-1	pd-1	ADP
aji-147	717	8	controls	control	NOUN
aji-147	717	9	follicular	follicular	ADJ
aji-147	717	10	t	t	NOUN
aji-147	717	11	helper	helper	NOUN
aji-147	717	12	cell	cell	NOUN
aji-147	717	13	positioning	positioning	NOUN
aji-147	717	14	and	and	CCONJ
aji-147	717	15	function	function	NOUN
aji-147	717	16	.	.	PUNCT
aji-147	718	1	immunity	immunity	NOUN
aji-147	718	2	.	.	PUNCT
aji-147	719	1	2018;49(2):264	2018;49(2):264	NUM
aji-147	719	2	-	-	SYM
aji-147	719	3	74.e4	74.e4	NUM
aji-147	719	4	.	.	NOUN
aji-147	719	5	79	79	NUM
aji-147	719	6	.	.	PUNCT
aji-147	720	1	curran	curran	PROPN
aji-147	720	2	cs	cs	PROPN
aji-147	720	3	,	,	PUNCT
aji-147	720	4	et	et	PROPN
aji-147	720	5	al	al	PROPN
aji-147	720	6	.	.	PROPN
aji-147	720	7	pd-1	pd-1	ADP
aji-147	720	8	immunobiology	immunobiology	NOUN
aji-147	720	9	in	in	ADP
aji-147	720	10	systemic	systemic	ADJ
aji-147	720	11	lupus	lupus	PROPN
aji-147	720	12	erythematosus	erythematosus	PROPN
aji-147	720	13	.	.	PUNCT
aji-147	721	1	j	j	PROPN
aji-147	721	2	autoimmun	autoimmun	PROPN
aji-147	721	3	.	.	PUNCT
aji-147	722	1	2019;97:1	2019;97:1	NUM
aji-147	722	2	-	-	SYM
aji-147	722	3	9	9	NUM
aji-147	722	4	.	.	PUNCT
aji-147	723	1	shukla	shukla	NOUN
aji-147	723	2	et	et	PROPN
aji-147	723	3	al	al	PROPN
aji-147	723	4	.	.	PROPN
aji-147	723	5	;	;	PUNCT
aji-147	723	6	asian	asian	PROPN
aji-147	723	7	j.	j.	PROPN
aji-147	723	8	immunol	immunol	PROPN
aji-147	723	9	.	.	PROPN
aji-147	723	10	,	,	PUNCT
aji-147	723	11	vol	vol	NOUN
aji-147	723	12	.	.	PROPN
aji-147	723	13	7	7	NUM
aji-147	723	14	,	,	PUNCT
aji-147	723	15	no	no	INTJ
aji-147	723	16	.	.	NOUN
aji-147	723	17	1	1	NUM
aji-147	723	18	,	,	PUNCT
aji-147	723	19	pp	pp	ADJ
aji-147	723	20	.	.	PUNCT
aji-147	724	1	228	228	NUM
aji-147	724	2	-	-	SYM
aji-147	724	3	246	246	NUM
aji-147	724	4	,	,	PUNCT
aji-147	724	5	2024	2024	NUM
aji-147	724	6	;	;	PUNCT
aji-147	725	1	article	article	NOUN
aji-147	725	2	no.aji.125387	no.aji.125387	NOUN
aji-147	725	3	244	244	NUM
aji-147	725	4	80	80	NUM
aji-147	725	5	.	.	PUNCT
aji-147	726	1	wan	wan	PROPN
aji-147	726	2	z	z	PROPN
aji-147	726	3	,	,	PUNCT
aji-147	726	4	et	et	PROPN
aji-147	726	5	al	al	PROPN
aji-147	726	6	.	.	PUNCT
aji-147	726	7	tfh	tfh	PROPN
aji-147	726	8	cells	cell	NOUN
aji-147	726	9	in	in	ADP
aji-147	726	10	bystander	bystander	NOUN
aji-147	726	11	and	and	CCONJ
aji-147	726	12	cognate	cognate	VERB
aji-147	726	13	interactions	interaction	NOUN
aji-147	726	14	with	with	ADP
aji-147	726	15	b	b	NOUN
aji-147	726	16	cells	cell	NOUN
aji-147	726	17	.	.	PUNCT
aji-147	727	1	immunol	immunol	PROPN
aji-147	727	2	rev	rev	PROPN
aji-147	727	3	.	.	PROPN
aji-147	727	4	2019;288(1):28	2019;288(1):28	PROPN
aji-147	727	5	-	-	SYM
aji-147	727	6	36	36	NUM
aji-147	727	7	.	.	PUNCT
aji-147	727	8	81	81	NUM
aji-147	727	9	.	.	PUNCT
aji-147	728	1	liang	liang	PROPN
aji-147	728	2	k	k	PROPN
aji-147	728	3	,	,	PUNCT
aji-147	728	4	et	et	PROPN
aji-147	728	5	al	al	PROPN
aji-147	728	6	.	.	PROPN
aji-147	728	7	sustained	sustain	VERB
aji-147	728	8	low	low	ADV
aji-147	728	9	-	-	PUNCT
aji-147	728	10	dose	dose	NOUN
aji-147	728	11	interleukin-2	interleukin-2	NOUN
aji-147	728	12	therapy	therapy	NOUN
aji-147	728	13	alleviates	alleviate	VERB
aji-147	728	14	pathogenic	pathogenic	ADJ
aji-147	728	15	humoral	humoral	ADJ
aji-147	728	16	immunity	immunity	NOUN
aji-147	728	17	via	via	ADP
aji-147	728	18	elevating	elevate	VERB
aji-147	728	19	the	the	DET
aji-147	728	20	tfr	tfr	PROPN
aji-147	728	21	/	/	SYM
aji-147	728	22	tfh	tfh	PROPN
aji-147	728	23	ratio	ratio	NOUN
aji-147	728	24	in	in	ADP
aji-147	728	25	lupus	lupus	PROPN
aji-147	728	26	.	.	PUNCT
aji-147	729	1	clin	clin	PROPN
aji-147	729	2	transl	transl	PROPN
aji-147	729	3	immunol	immunol	NOUN
aji-147	729	4	.	.	PUNCT
aji-147	729	5	2021	2021	NUM
aji-147	729	6	;	;	PUNCT
aji-147	730	1	10(6):e1293	10(6):e1293	X
aji-147	730	2	.	.	X
aji-147	731	1	82	82	NUM
aji-147	731	2	.	.	PUNCT
aji-147	732	1	chen	chen	PROPN
aji-147	732	2	w	w	PROPN
aji-147	732	3	,	,	PUNCT
aji-147	732	4	et	et	PROPN
aji-147	732	5	al	al	PROPN
aji-147	732	6	.	.	PUNCT
aji-147	732	7	follicular	follicular	ADJ
aji-147	732	8	helper	helper	NOUN
aji-147	732	9	t	t	NOUN
aji-147	732	10	cells	cell	NOUN
aji-147	732	11	and	and	CCONJ
aji-147	732	12	follicular	follicular	ADJ
aji-147	732	13	regulatory	regulatory	ADJ
aji-147	732	14	t	t	NOUN
aji-147	732	15	cells	cell	NOUN
aji-147	732	16	in	in	ADP
aji-147	732	17	the	the	DET
aji-147	732	18	immunopathology	immunopathology	NOUN
aji-147	732	19	of	of	ADP
aji-147	732	20	primary	primary	ADJ
aji-147	732	21	sjögren	sjögren	PROPN
aji-147	732	22	's	's	PART
aji-147	732	23	syndrome	syndrome	NOUN
aji-147	732	24	.	.	PUNCT
aji-147	733	1	j	j	PROPN
aji-147	733	2	leukoc	leukoc	VERB
aji-147	733	3	biol	biol	PROPN
aji-147	733	4	.	.	PUNCT
aji-147	734	1	2021;109(2):43747	2021;109(2):43747	NUM
aji-147	734	2	.	.	X
aji-147	734	3	83	83	NUM
aji-147	734	4	.	.	PUNCT
aji-147	735	1	fazilleau	fazilleau	PROPN
aji-147	735	2	n	n	CCONJ
aji-147	735	3	,	,	PUNCT
aji-147	735	4	et	et	PROPN
aji-147	735	5	al	al	PROPN
aji-147	735	6	.	.	PUNCT
aji-147	736	1	follicular	follicular	ADJ
aji-147	736	2	helper	helper	NOUN
aji-147	736	3	t	t	PROPN
aji-147	736	4	cells	cell	NOUN
aji-147	736	5	:	:	PUNCT
aji-147	736	6	lineage	lineage	NOUN
aji-147	736	7	and	and	CCONJ
aji-147	736	8	location	location	NOUN
aji-147	736	9	.	.	PUNCT
aji-147	737	1	immunity	immunity	NOUN
aji-147	737	2	.	.	PUNCT
aji-147	738	1	2009;30(3	2009;30(3	NUM
aji-147	738	2	):	):	PUNCT
aji-147	738	3	324	324	NUM
aji-147	738	4	-	-	SYM
aji-147	738	5	35	35	NUM
aji-147	738	6	.	.	PUNCT
aji-147	739	1	84	84	NUM
aji-147	739	2	.	.	PUNCT
aji-147	740	1	shekhar	shekhar	PROPN
aji-147	740	2	s	s	PROPN
aji-147	740	3	,	,	PUNCT
aji-147	740	4	yang	yang	PROPN
aji-147	740	5	x.	x.	PROPN
aji-147	741	1	the	the	DET
aji-147	741	2	darker	dark	ADJ
aji-147	741	3	side	side	NOUN
aji-147	741	4	of	of	ADP
aji-147	741	5	follicular	follicular	ADJ
aji-147	741	6	helper	helper	NOUN
aji-147	741	7	t	t	PROPN
aji-147	741	8	cells	cell	NOUN
aji-147	741	9	:	:	PUNCT
aji-147	741	10	from	from	ADP
aji-147	741	11	autoimmunity	autoimmunity	NOUN
aji-147	741	12	to	to	ADP
aji-147	741	13	immunodeficiency	immunodeficiency	NOUN
aji-147	741	14	.	.	PUNCT
aji-147	742	1	cell	cell	NOUN
aji-147	742	2	mol	mol	ADP
aji-147	742	3	immunol	immunol	NOUN
aji-147	742	4	.	.	PUNCT
aji-147	743	1	2012;9(5):380	2012;9(5):380	X
aji-147	743	2	-	-	SYM
aji-147	743	3	5	5	NUM
aji-147	743	4	.	.	NOUN
aji-147	743	5	85	85	NUM
aji-147	743	6	.	.	PUNCT
aji-147	744	1	mintz	mintz	PROPN
aji-147	744	2	ma	ma	PROPN
aji-147	744	3	,	,	PUNCT
aji-147	744	4	cyster	cyster	NOUN
aji-147	744	5	jg	jg	PROPN
aji-147	744	6	.	.	PROPN
aji-147	745	1	t	t	PROPN
aji-147	745	2	follicular	follicular	ADJ
aji-147	745	3	helper	helper	NOUN
aji-147	745	4	cells	cell	NOUN
aji-147	745	5	in	in	ADP
aji-147	745	6	germinal	germinal	ADJ
aji-147	745	7	center	center	NOUN
aji-147	745	8	b	b	NOUN
aji-147	745	9	cell	cell	NOUN
aji-147	745	10	selection	selection	NOUN
aji-147	745	11	and	and	CCONJ
aji-147	745	12	lymphomagenesis	lymphomagenesis	NOUN
aji-147	745	13	.	.	PUNCT
aji-147	746	1	immunol	immunol	PROPN
aji-147	746	2	rev	rev	PROPN
aji-147	746	3	.	.	PROPN
aji-147	746	4	2020	2020	NUM
aji-147	746	5	;	;	PUNCT
aji-147	746	6	296(1):48	296(1):48	NUM
aji-147	746	7	-	-	SYM
aji-147	746	8	61	61	NUM
aji-147	746	9	.	.	PUNCT
aji-147	746	10	86	86	NUM
aji-147	746	11	.	.	PUNCT
aji-147	747	1	wu	wu	PROPN
aji-147	747	2	h	h	PROPN
aji-147	747	3	,	,	PUNCT
aji-147	747	4	et	et	PROPN
aji-147	747	5	al	al	PROPN
aji-147	747	6	.	.	PUNCT
aji-147	748	1	molecular	molecular	ADJ
aji-147	748	2	control	control	NOUN
aji-147	748	3	of	of	ADP
aji-147	748	4	follicular	follicular	ADJ
aji-147	748	5	helper	helper	NOUN
aji-147	748	6	t	t	PROPN
aji-147	748	7	cell	cell	NOUN
aji-147	748	8	development	development	NOUN
aji-147	748	9	and	and	CCONJ
aji-147	748	10	differentiation	differentiation	NOUN
aji-147	748	11	.	.	PUNCT
aji-147	749	1	front	front	ADJ
aji-147	749	2	immunol	immunol	NOUN
aji-147	749	3	.	.	PUNCT
aji-147	750	1	2018;9	2018;9	NUM
aji-147	750	2	:	:	PUNCT
aji-147	750	3	2470	2470	NUM
aji-147	750	4	.	.	PUNCT
aji-147	751	1	87	87	NUM
aji-147	751	2	.	.	PUNCT
aji-147	752	1	bettelli	bettelli	PROPN
aji-147	752	2	e	e	PROPN
aji-147	752	3	,	,	PUNCT
aji-147	752	4	campbell	campbell	PROPN
aji-147	752	5	dj	dj	PROPN
aji-147	752	6	.	.	PUNCT
aji-147	752	7	circulating	circulate	VERB
aji-147	752	8	tfh	tfh	PROPN
aji-147	752	9	cells	cell	NOUN
aji-147	752	10	as	as	ADP
aji-147	752	11	a	a	DET
aji-147	752	12	marker	marker	NOUN
aji-147	752	13	for	for	ADP
aji-147	752	14	early	early	ADJ
aji-147	752	15	therapeutic	therapeutic	ADJ
aji-147	752	16	intervention	intervention	NOUN
aji-147	752	17	in	in	ADP
aji-147	752	18	t1d	t1d	PROPN
aji-147	752	19	.	.	PUNCT
aji-147	753	1	nat	nat	PROPN
aji-147	753	2	immunol	immunol	NOUN
aji-147	753	3	.	.	PUNCT
aji-147	754	1	2020;21(10):1141	2020;21(10):1141	NUM
aji-147	754	2	-	-	SYM
aji-147	754	3	2	2	NUM
aji-147	754	4	.	.	NUM
aji-147	754	5	88	88	NUM
aji-147	754	6	.	.	PUNCT
aji-147	755	1	choi	choi	PROPN
aji-147	755	2	jy	jy	PROPN
aji-147	755	3	,	,	PUNCT
aji-147	755	4	et	et	PROPN
aji-147	755	5	al	al	PROPN
aji-147	755	6	.	.	PUNCT
aji-147	755	7	circulating	circulate	VERB
aji-147	755	8	follicular	follicular	ADJ
aji-147	755	9	helperlike	helperlike	ADJ
aji-147	755	10	t	t	NOUN
aji-147	755	11	cells	cell	NOUN
aji-147	755	12	in	in	ADP
aji-147	755	13	systemic	systemic	ADJ
aji-147	755	14	lupus	lupus	PROPN
aji-147	755	15	erythematosus	erythematosus	NOUN
aji-147	755	16	:	:	PUNCT
aji-147	755	17	association	association	NOUN
aji-147	755	18	with	with	ADP
aji-147	755	19	disease	disease	NOUN
aji-147	755	20	activity	activity	NOUN
aji-147	755	21	.	.	PUNCT
aji-147	756	1	arthritis	arthritis	NOUN
aji-147	756	2	rheumatol	rheumatol	NOUN
aji-147	756	3	.	.	PUNCT
aji-147	757	1	2015;67(4	2015;67(4	NUM
aji-147	757	2	):	):	PUNCT
aji-147	757	3	988	988	NUM
aji-147	757	4	-	-	SYM
aji-147	757	5	99	99	NUM
aji-147	757	6	.	.	PUNCT
aji-147	757	7	89	89	NUM
aji-147	757	8	.	.	PUNCT
aji-147	758	1	huang	huang	PROPN
aji-147	758	2	q	q	PROPN
aji-147	758	3	,	,	PUNCT
aji-147	758	4	xu	xu	PROPN
aji-147	759	1	l	l	NOUN
aji-147	759	2	,	,	PUNCT
aji-147	759	3	ye	ye	PROPN
aji-147	759	4	l.	l.	PROPN
aji-147	759	5	t	t	PROPN
aji-147	759	6	cell	cell	NOUN
aji-147	759	7	immune	immune	ADJ
aji-147	759	8	response	response	NOUN
aji-147	759	9	within	within	ADP
aji-147	759	10	b	b	NOUN
aji-147	759	11	-	-	PUNCT
aji-147	759	12	cell	cell	NOUN
aji-147	759	13	follicles	follicle	NOUN
aji-147	759	14	.	.	PUNCT
aji-147	760	1	adv	adv	PROPN
aji-147	760	2	immunol	immunol	NOUN
aji-147	760	3	.	.	PUNCT
aji-147	761	1	2019;144:155	2019;144:155	NUM
aji-147	761	2	-	-	SYM
aji-147	761	3	71	71	NUM
aji-147	761	4	.	.	PUNCT
aji-147	762	1	90	90	NUM
aji-147	762	2	.	.	PUNCT
aji-147	763	1	velu	velu	PROPN
aji-147	763	2	v	v	PROPN
aji-147	763	3	,	,	PUNCT
aji-147	763	4	et	et	PROPN
aji-147	763	5	al	al	PROPN
aji-147	763	6	.	.	PROPN
aji-147	763	7	induction	induction	NOUN
aji-147	763	8	of	of	ADP
aji-147	763	9	th1	th1	PROPN
aji-147	763	10	-	-	PUNCT
aji-147	763	11	biased	bias	VERB
aji-147	763	12	t	t	PROPN
aji-147	763	13	follicular	follicular	ADJ
aji-147	763	14	helper	helper	NOUN
aji-147	763	15	(	(	PUNCT
aji-147	763	16	tfh	tfh	NOUN
aji-147	763	17	)	)	PUNCT
aji-147	763	18	cells	cell	NOUN
aji-147	763	19	in	in	ADP
aji-147	763	20	lymphoid	lymphoid	ADJ
aji-147	763	21	tissues	tissue	NOUN
aji-147	763	22	during	during	ADP
aji-147	763	23	chronic	chronic	ADJ
aji-147	763	24	simian	simian	ADJ
aji-147	763	25	immunodeficiency	immunodeficiency	NOUN
aji-147	763	26	virus	virus	NOUN
aji-147	763	27	infection	infection	NOUN
aji-147	763	28	defines	define	VERB
aji-147	763	29	functionally	functionally	ADV
aji-147	763	30	distinct	distinct	ADJ
aji-147	763	31	germinal	germinal	ADJ
aji-147	763	32	center	center	NOUN
aji-147	763	33	tfh	tfh	PROPN
aji-147	763	34	cells	cell	NOUN
aji-147	763	35	.	.	PUNCT
aji-147	764	1	j	j	PROPN
aji-147	764	2	immunol	immunol	NOUN
aji-147	764	3	.	.	PUNCT
aji-147	765	1	2016;197(5):1832	2016;197(5):1832	NUM
aji-147	765	2	-	-	SYM
aji-147	765	3	42	42	NUM
aji-147	765	4	.	.	PUNCT
aji-147	766	1	91	91	NUM
aji-147	766	2	.	.	PUNCT
aji-147	767	1	velu	velu	PROPN
aji-147	767	2	v	v	PROPN
aji-147	767	3	,	,	PUNCT
aji-147	767	4	et	et	PROPN
aji-147	767	5	al	al	PROPN
aji-147	767	6	.	.	PUNCT
aji-147	768	1	tfh1	tfh1	NOUN
aji-147	768	2	cells	cell	NOUN
aji-147	768	3	in	in	ADP
aji-147	768	4	germinal	germinal	ADJ
aji-147	768	5	centers	center	NOUN
aji-147	768	6	during	during	ADP
aji-147	768	7	chronic	chronic	ADJ
aji-147	768	8	hiv	hiv	PROPN
aji-147	768	9	/	/	SYM
aji-147	768	10	siv	siv	PROPN
aji-147	768	11	infection	infection	NOUN
aji-147	768	12	.	.	PUNCT
aji-147	769	1	front	front	ADJ
aji-147	769	2	immunol	immunol	NOUN
aji-147	769	3	.	.	PUNCT
aji-147	770	1	2018;9:1272	2018;9:1272	NUM
aji-147	770	2	.	.	PUNCT
aji-147	771	1	92	92	NUM
aji-147	771	2	.	.	PUNCT
aji-147	772	1	schmitt	schmitt	PROPN
aji-147	772	2	n	n	CCONJ
aji-147	772	3	,	,	PUNCT
aji-147	772	4	bentebibel	bentebibel	PROPN
aji-147	772	5	se	se	PROPN
aji-147	772	6	,	,	PUNCT
aji-147	772	7	ueno	ueno	PROPN
aji-147	772	8	h.	h.	PROPN
aji-147	772	9	phenotype	phenotype	PROPN
aji-147	772	10	and	and	CCONJ
aji-147	772	11	functions	function	NOUN
aji-147	772	12	of	of	ADP
aji-147	772	13	memory	memory	NOUN
aji-147	772	14	tfh	tfh	PROPN
aji-147	772	15	cells	cell	NOUN
aji-147	772	16	in	in	ADP
aji-147	772	17	human	human	ADJ
aji-147	772	18	blood	blood	NOUN
aji-147	772	19	.	.	PUNCT
aji-147	773	1	trends	trend	NOUN
aji-147	773	2	immunol	immunol	NOUN
aji-147	773	3	.	.	PUNCT
aji-147	774	1	2014;35(9):436	2014;35(9):436	NUM
aji-147	774	2	-	-	PUNCT
aji-147	774	3	42	42	NUM
aji-147	774	4	.	.	PUNCT
aji-147	775	1	93	93	NUM
aji-147	775	2	.	.	PUNCT
aji-147	776	1	yao	yao	PROPN
aji-147	776	2	y	y	PROPN
aji-147	776	3	,	,	PUNCT
aji-147	776	4	et	et	PROPN
aji-147	776	5	al	al	PROPN
aji-147	776	6	.	.	PROPN
aji-147	776	7	roles	role	NOUN
aji-147	776	8	of	of	ADP
aji-147	776	9	follicular	follicular	ADJ
aji-147	776	10	helper	helper	NOUN
aji-147	776	11	and	and	CCONJ
aji-147	776	12	regulatory	regulatory	ADJ
aji-147	776	13	t	t	NOUN
aji-147	776	14	cells	cell	NOUN
aji-147	776	15	in	in	ADP
aji-147	776	16	allergic	allergic	ADJ
aji-147	776	17	diseases	disease	NOUN
aji-147	776	18	and	and	CCONJ
aji-147	776	19	allergen	allergen	VERB
aji-147	776	20	immunotherapy	immunotherapy	NOUN
aji-147	776	21	.	.	PUNCT
aji-147	777	1	allergy	allergy	NOUN
aji-147	777	2	.	.	PUNCT
aji-147	778	1	2021	2021	NUM
aji-147	778	2	;	;	PUNCT
aji-147	779	1	76(2):456	76(2):456	NOUN
aji-147	779	2	-	-	SYM
aji-147	779	3	70	70	NUM
aji-147	779	4	.	.	PUNCT
aji-147	780	1	94	94	NUM
aji-147	780	2	.	.	PUNCT
aji-147	781	1	nakayamada	nakayamada	PROPN
aji-147	781	2	s	s	PROPN
aji-147	781	3	,	,	PUNCT
aji-147	781	4	et	et	PROPN
aji-147	781	5	al	al	PROPN
aji-147	781	6	.	.	PROPN
aji-147	782	1	early	early	ADJ
aji-147	782	2	th1	th1	PROPN
aji-147	782	3	cell	cell	NOUN
aji-147	782	4	differentiation	differentiation	NOUN
aji-147	782	5	is	be	AUX
aji-147	782	6	marked	mark	VERB
aji-147	782	7	by	by	ADP
aji-147	782	8	a	a	DET
aji-147	782	9	tfh	tfh	PROPN
aji-147	782	10	cell	cell	NOUN
aji-147	782	11	-	-	PUNCT
aji-147	782	12	like	like	ADJ
aji-147	782	13	transition	transition	NOUN
aji-147	782	14	.	.	PUNCT
aji-147	783	1	immunity	immunity	NOUN
aji-147	783	2	.	.	PUNCT
aji-147	784	1	2011;35(6):919	2011;35(6):919	NUM
aji-147	784	2	-	-	SYM
aji-147	784	3	31	31	NUM
aji-147	784	4	.	.	PUNCT
aji-147	785	1	95	95	NUM
aji-147	785	2	.	.	PUNCT
aji-147	786	1	liang	liang	PROPN
aji-147	786	2	h	h	PROPN
aji-147	786	3	,	,	PUNCT
aji-147	786	4	et	et	PROPN
aji-147	786	5	al	al	PROPN
aji-147	786	6	.	.	PROPN
aji-147	787	1	zikv	zikv	PROPN
aji-147	787	2	infection	infection	NOUN
aji-147	787	3	induces	induce	VERB
aji-147	787	4	robust	robust	ADJ
aji-147	787	5	th1	th1	NOUN
aji-147	787	6	-	-	PUNCT
aji-147	787	7	like	like	ADJ
aji-147	787	8	tfh	tfh	PROPN
aji-147	787	9	cell	cell	NOUN
aji-147	787	10	and	and	CCONJ
aji-147	787	11	long	long	ADJ
aji-147	787	12	-	-	PUNCT
aji-147	787	13	term	term	NOUN
aji-147	787	14	protective	protective	ADJ
aji-147	787	15	antibody	antibody	NOUN
aji-147	787	16	responses	response	NOUN
aji-147	787	17	in	in	ADP
aji-147	787	18	immunocompetent	immunocompetent	ADJ
aji-147	787	19	mice	mouse	NOUN
aji-147	787	20	.	.	PUNCT
aji-147	788	1	nat	nat	PROPN
aji-147	788	2	commun	commun	PROPN
aji-147	788	3	.	.	PUNCT
aji-147	789	1	2019;10(1):1	2019;10(1):1	NUM
aji-147	789	2	-	-	SYM
aji-147	789	3	16	16	NUM
aji-147	789	4	.	.	PUNCT
aji-147	790	1	96	96	NUM
aji-147	790	2	.	.	PUNCT
aji-147	791	1	fonseca	fonseca	PROPN
aji-147	791	2	vr	vr	PROPN
aji-147	791	3	,	,	PUNCT
aji-147	791	4	et	et	PROPN
aji-147	791	5	al	al	PROPN
aji-147	791	6	.	.	PUNCT
aji-147	792	1	the	the	DET
aji-147	792	2	ratio	ratio	NOUN
aji-147	792	3	of	of	ADP
aji-147	792	4	blood	blood	NOUN
aji-147	792	5	t	t	PROPN
aji-147	792	6	follicular	follicular	ADJ
aji-147	792	7	regulatory	regulatory	ADJ
aji-147	792	8	cells	cell	NOUN
aji-147	792	9	to	to	ADP
aji-147	792	10	t	t	PROPN
aji-147	792	11	follicular	follicular	ADJ
aji-147	792	12	helper	helper	NOUN
aji-147	792	13	cells	cell	NOUN
aji-147	792	14	marks	mark	VERB
aji-147	792	15	ectopic	ectopic	ADJ
aji-147	792	16	lymphoid	lymphoid	ADJ
aji-147	792	17	structure	structure	NOUN
aji-147	792	18	formation	formation	NOUN
aji-147	792	19	while	while	SCONJ
aji-147	792	20	activated	activate	VERB
aji-147	792	21	follicular	follicular	ADJ
aji-147	792	22	helper	helper	NOUN
aji-147	792	23	t	t	NOUN
aji-147	792	24	cells	cell	NOUN
aji-147	792	25	indicate	indicate	VERB
aji-147	792	26	disease	disease	NOUN
aji-147	792	27	activity	activity	NOUN
aji-147	792	28	in	in	ADP
aji-147	792	29	primary	primary	ADJ
aji-147	792	30	sjögren	sjögren	PROPN
aji-147	792	31	's	's	PART
aji-147	792	32	syndrome	syndrome	NOUN
aji-147	792	33	.	.	PUNCT
aji-147	793	1	arthritis	arthritis	NOUN
aji-147	793	2	rheumatol	rheumatol	NOUN
aji-147	793	3	.	.	PUNCT
aji-147	794	1	2018;70(5):774	2018;70(5):774	NUM
aji-147	794	2	-	-	PUNCT
aji-147	794	3	84	84	NUM
aji-147	794	4	.	.	PUNCT
aji-147	795	1	97	97	NUM
aji-147	795	2	.	.	PUNCT
aji-147	795	3	rao	rao	PROPN
aji-147	795	4	da	da	PROPN
aji-147	795	5	,	,	PUNCT
aji-147	795	6	et	et	PROPN
aji-147	795	7	al	al	PROPN
aji-147	795	8	.	.	PROPN
aji-147	795	9	pathologically	pathologically	ADV
aji-147	795	10	expanded	expand	VERB
aji-147	795	11	peripheral	peripheral	ADJ
aji-147	795	12	t	t	PROPN
aji-147	795	13	helper	helper	NOUN
aji-147	795	14	cell	cell	NOUN
aji-147	795	15	subset	subset	NOUN
aji-147	795	16	drives	drive	VERB
aji-147	795	17	b	b	PROPN
aji-147	795	18	cells	cell	NOUN
aji-147	795	19	in	in	ADP
aji-147	795	20	rheumatoid	rheumatoid	NOUN
aji-147	795	21	arthritis	arthritis	NOUN
aji-147	795	22	.	.	PUNCT
aji-147	796	1	nature	nature	NOUN
aji-147	796	2	.	.	PUNCT
aji-147	797	1	2017;542(7639):110	2017;542(7639):110	NUM
aji-147	797	2	-	-	SYM
aji-147	797	3	4	4	NUM
aji-147	797	4	.	.	NOUN
aji-147	797	5	98	98	NUM
aji-147	797	6	.	.	PUNCT
aji-147	797	7	hutloff	hutloff	PROPN
aji-147	797	8	a.	a.	PROPN
aji-147	797	9	t	t	PROPN
aji-147	797	10	follicular	follicular	ADJ
aji-147	797	11	helper	helper	NOUN
aji-147	797	12	-	-	PUNCT
aji-147	797	13	like	like	ADJ
aji-147	797	14	cells	cell	NOUN
aji-147	797	15	in	in	ADP
aji-147	797	16	inflamed	inflame	VERB
aji-147	797	17	non	non	ADJ
aji-147	797	18	-	-	ADJ
aji-147	797	19	lymphoid	lymphoid	ADJ
aji-147	797	20	tissues	tissue	NOUN
aji-147	797	21	.	.	PUNCT
aji-147	798	1	front	front	ADJ
aji-147	798	2	immunol	immunol	NOUN
aji-147	798	3	.	.	PUNCT
aji-147	799	1	2018;9:1707	2018;9:1707	NUM
aji-147	799	2	.	.	PUNCT
aji-147	800	1	99	99	NUM
aji-147	800	2	.	.	PUNCT
aji-147	800	3	yoshitomi	yoshitomi	PROPN
aji-147	800	4	h	h	PROPN
aji-147	800	5	,	,	PUNCT
aji-147	800	6	ueno	ueno	PROPN
aji-147	800	7	h.	h.	PROPN
aji-147	800	8	shared	share	VERB
aji-147	800	9	and	and	CCONJ
aji-147	800	10	distinct	distinct	ADJ
aji-147	800	11	roles	role	NOUN
aji-147	800	12	of	of	ADP
aji-147	800	13	t	t	NOUN
aji-147	800	14	peripheral	peripheral	ADJ
aji-147	800	15	helper	helper	NOUN
aji-147	800	16	and	and	CCONJ
aji-147	800	17	t	t	PROPN
aji-147	800	18	follicular	follicular	ADJ
aji-147	800	19	helper	helper	NOUN
aji-147	800	20	cells	cell	NOUN
aji-147	800	21	in	in	ADP
aji-147	800	22	human	human	ADJ
aji-147	800	23	diseases	disease	NOUN
aji-147	800	24	.	.	PUNCT
aji-147	801	1	cell	cell	NOUN
aji-147	801	2	mol	mol	ADP
aji-147	801	3	immunol	immunol	NOUN
aji-147	801	4	.	.	PUNCT
aji-147	802	1	2021;18(3):523	2021;18(3):523	NUM
aji-147	802	2	-	-	PUNCT
aji-147	802	3	7	7	NUM
aji-147	802	4	.	.	NOUN
aji-147	802	5	100	100	NUM
aji-147	802	6	.	.	PUNCT
aji-147	803	1	zhang	zhang	PROPN
aji-147	803	2	yn	yn	PROPN
aji-147	803	3	,	,	PUNCT
aji-147	803	4	et	et	PROPN
aji-147	803	5	al	al	PROPN
aji-147	803	6	.	.	PROPN
aji-147	803	7	nasal	nasal	PROPN
aji-147	803	8	il-4	il-4	PROPN
aji-147	803	9	+	+	PROPN
aji-147	803	10	cxcr5	cxcr5	PROPN
aji-147	803	11	+	+	CCONJ
aji-147	803	12	cd4	cd4	PROPN
aji-147	803	13	+	+	PROPN
aji-147	803	14	t	t	PROPN
aji-147	803	15	follicular	follicular	ADJ
aji-147	803	16	helper	helper	NOUN
aji-147	803	17	cell	cell	NOUN
aji-147	803	18	counts	count	NOUN
aji-147	803	19	correlate	correlate	VERB
aji-147	803	20	with	with	ADP
aji-147	803	21	local	local	ADJ
aji-147	803	22	ige	ige	NOUN
aji-147	803	23	production	production	NOUN
aji-147	803	24	in	in	ADP
aji-147	803	25	eosinophilic	eosinophilic	ADJ
aji-147	803	26	nasal	nasal	PROPN
aji-147	803	27	polyps	polyp	NOUN
aji-147	803	28	.	.	PUNCT
aji-147	804	1	j	j	PROPN
aji-147	804	2	allergy	allergy	PROPN
aji-147	804	3	clin	clin	PROPN
aji-147	804	4	immunol	immunol	NOUN
aji-147	804	5	.	.	PUNCT
aji-147	805	1	2016;137(2):462	2016;137(2):462	NUM
aji-147	805	2	-	-	SYM
aji-147	805	3	73	73	NUM
aji-147	805	4	.	.	PUNCT
aji-147	806	1	101	101	NUM
aji-147	806	2	.	.	PUNCT
aji-147	806	3	gowthaman	gowthaman	PROPN
aji-147	806	4	u	u	PROPN
aji-147	806	5	,	,	PUNCT
aji-147	806	6	et	et	PROPN
aji-147	806	7	al	al	PROPN
aji-147	806	8	.	.	PUNCT
aji-147	806	9	identification	identification	NOUN
aji-147	806	10	of	of	ADP
aji-147	806	11	a	a	DET
aji-147	806	12	t	t	NOUN
aji-147	806	13	follicular	follicular	ADJ
aji-147	806	14	helper	helper	NOUN
aji-147	806	15	cell	cell	NOUN
aji-147	806	16	subset	subset	VERB
aji-147	806	17	that	that	SCONJ
aji-147	806	18	drives	drive	VERB
aji-147	806	19	anaphylactic	anaphylactic	ADJ
aji-147	806	20	ige	ige	PROPN
aji-147	806	21	.	.	PUNCT
aji-147	807	1	science	science	PROPN
aji-147	807	2	.	.	PUNCT
aji-147	808	1	2019	2019	NUM
aji-147	808	2	;	;	PUNCT
aji-147	809	1	365(6456):eaaw6433	365(6456):eaaw6433	PROPN
aji-147	809	2	.	.	PUNCT
aji-147	810	1	102	102	NUM
aji-147	810	2	.	.	PUNCT
aji-147	811	1	chen	chen	PROPN
aji-147	811	2	js	js	PROPN
aji-147	811	3	,	,	PUNCT
aji-147	811	4	et	et	PROPN
aji-147	811	5	al	al	PROPN
aji-147	811	6	.	.	PROPN
aji-147	811	7	flow	flow	PROPN
aji-147	811	8	cytometric	cytometric	ADJ
aji-147	811	9	identification	identification	NOUN
aji-147	811	10	of	of	ADP
aji-147	811	11	tfh13	tfh13	NOUN
aji-147	811	12	cells	cell	NOUN
aji-147	811	13	in	in	ADP
aji-147	811	14	mouse	mouse	NOUN
aji-147	811	15	and	and	CCONJ
aji-147	811	16	human	human	NOUN
aji-147	811	17	.	.	PUNCT
aji-147	812	1	j	j	PROPN
aji-147	812	2	allergy	allergy	PROPN
aji-147	812	3	clin	clin	PROPN
aji-147	812	4	immunol	immunol	PROPN
aji-147	812	5	.	.	PUNCT
aji-147	812	6	2021	2021	NUM
aji-147	812	7	;	;	PUNCT
aji-147	812	8	147(2):470	147(2):470	NUM
aji-147	812	9	-	-	SYM
aji-147	812	10	83	83	NUM
aji-147	812	11	.	.	PUNCT
aji-147	812	12	103	103	NUM
aji-147	812	13	.	.	PUNCT
aji-147	813	1	wang	wang	PROPN
aji-147	813	2	w	w	PROPN
aji-147	813	3	,	,	PUNCT
aji-147	813	4	et	et	PROPN
aji-147	813	5	al	al	PROPN
aji-147	813	6	.	.	PUNCT
aji-147	813	7	transcriptional	transcriptional	ADJ
aji-147	813	8	changes	change	NOUN
aji-147	813	9	in	in	ADP
aji-147	813	10	peanut	peanut	NOUN
aji-147	813	11	-	-	PUNCT
aji-147	813	12	specific	specific	NOUN
aji-147	813	13	cd4	cd4	PROPN
aji-147	813	14	+	+	PROPN
aji-147	813	15	t	t	NOUN
aji-147	813	16	cells	cell	NOUN
aji-147	813	17	over	over	ADP
aji-147	813	18	the	the	DET
aji-147	813	19	course	course	NOUN
aji-147	813	20	of	of	ADP
aji-147	813	21	oral	oral	ADJ
aji-147	813	22	immunotherapy	immunotherapy	NOUN
aji-147	813	23	.	.	PUNCT
aji-147	814	1	clin	clin	PROPN
aji-147	814	2	immunol	immunol	NOUN
aji-147	814	3	.	.	PUNCT
aji-147	815	1	2020;219:108568	2020;219:108568	NUM
aji-147	815	2	.	.	PUNCT
aji-147	816	1	104	104	NUM
aji-147	816	2	.	.	PUNCT
aji-147	817	1	chung	chung	PROPN
aji-147	817	2	y	y	PROPN
aji-147	817	3	,	,	PUNCT
aji-147	817	4	et	et	PROPN
aji-147	817	5	al	al	PROPN
aji-147	817	6	.	.	PUNCT
aji-147	818	1	follicular	follicular	ADJ
aji-147	818	2	regulatory	regulatory	ADJ
aji-147	818	3	t	t	NOUN
aji-147	818	4	cells	cell	NOUN
aji-147	818	5	expressing	express	VERB
aji-147	818	6	foxp3	foxp3	NOUN
aji-147	818	7	and	and	CCONJ
aji-147	818	8	bcl-6	bcl-6	ADV
aji-147	818	9	suppress	suppress	VERB
aji-147	818	10	germinal	germinal	ADJ
aji-147	818	11	center	center	NOUN
aji-147	818	12	reactions	reaction	NOUN
aji-147	818	13	.	.	PUNCT
aji-147	819	1	nat	nat	PROPN
aji-147	819	2	med	med	PROPN
aji-147	819	3	.	.	PUNCT
aji-147	820	1	2011;17(8):983	2011;17(8):983	NUM
aji-147	820	2	-	-	SYM
aji-147	820	3	8	8	NUM
aji-147	820	4	.	.	X
aji-147	820	5	105	105	NUM
aji-147	820	6	.	.	PUNCT
aji-147	821	1	linterman	linterman	PROPN
aji-147	821	2	ma	ma	PROPN
aji-147	821	3	,	,	PUNCT
aji-147	821	4	et	et	PROPN
aji-147	821	5	al	al	PROPN
aji-147	821	6	.	.	PUNCT
aji-147	822	1	foxp3	foxp3	PROPN
aji-147	823	1	+	+	ADP
aji-147	823	2	follicular	follicular	ADJ
aji-147	823	3	regulatory	regulatory	ADJ
aji-147	823	4	t	t	NOUN
aji-147	823	5	cells	cell	NOUN
aji-147	823	6	control	control	VERB
aji-147	823	7	the	the	DET
aji-147	823	8	germinal	germinal	ADJ
aji-147	823	9	center	center	NOUN
aji-147	823	10	response	response	NOUN
aji-147	823	11	.	.	PUNCT
aji-147	824	1	nat	nat	PROPN
aji-147	824	2	med	med	PROPN
aji-147	824	3	.	.	PUNCT
aji-147	825	1	2011;17(8):97582	2011;17(8):97582	NUM
aji-147	825	2	.	.	PROPN
aji-147	826	1	106	106	NUM
aji-147	826	2	.	.	PUNCT
aji-147	827	1	aloulou	aloulou	PROPN
aji-147	827	2	m	m	PROPN
aji-147	827	3	,	,	PUNCT
aji-147	827	4	et	et	PROPN
aji-147	827	5	al	al	PROPN
aji-147	827	6	.	.	PUNCT
aji-147	827	7	follicular	follicular	ADJ
aji-147	827	8	regulatory	regulatory	ADJ
aji-147	827	9	t	t	NOUN
aji-147	827	10	cells	cell	NOUN
aji-147	827	11	can	can	AUX
aji-147	827	12	be	be	AUX
aji-147	827	13	specific	specific	ADJ
aji-147	827	14	for	for	ADP
aji-147	827	15	the	the	DET
aji-147	827	16	immunizing	immunize	VERB
aji-147	827	17	antigen	antigen	NOUN
aji-147	827	18	and	and	CCONJ
aji-147	827	19	derive	derive	ADJ
aji-147	827	20	from	from	ADP
aji-147	827	21	naive	naive	ADJ
aji-147	827	22	t	t	NOUN
aji-147	827	23	cells	cell	NOUN
aji-147	827	24	.	.	PUNCT
aji-147	828	1	nat	nat	PROPN
aji-147	828	2	commun	commun	PROPN
aji-147	828	3	.	.	PUNCT
aji-147	829	1	2016;7(1):1	2016;7(1):1	PROPN
aji-147	829	2	-	-	PUNCT
aji-147	829	3	10	10	NUM
aji-147	829	4	.	.	PUNCT
aji-147	830	1	107	107	NUM
aji-147	830	2	.	.	PUNCT
aji-147	831	1	sage	sage	NOUN
aji-147	831	2	pt	pt	PROPN
aji-147	831	3	,	,	PUNCT
aji-147	831	4	sharpe	sharpe	PROPN
aji-147	831	5	ah	ah	INTJ
aji-147	831	6	.	.	PUNCT
aji-147	832	1	t	t	PROPN
aji-147	832	2	follicular	follicular	ADJ
aji-147	832	3	regulatory	regulatory	ADJ
aji-147	832	4	cells	cell	NOUN
aji-147	832	5	.	.	PUNCT
aji-147	833	1	immunol	immunol	PROPN
aji-147	833	2	rev	rev	PROPN
aji-147	833	3	.	.	PUNCT
aji-147	834	1	2016;271(1):246	2016;271(1):246	NUM
aji-147	834	2	-	-	SYM
aji-147	834	3	59	59	NUM
aji-147	834	4	.	.	PUNCT
aji-147	835	1	shukla	shukla	NOUN
aji-147	835	2	et	et	PROPN
aji-147	835	3	al	al	PROPN
aji-147	835	4	.	.	PROPN
aji-147	835	5	;	;	PUNCT
aji-147	835	6	asian	asian	PROPN
aji-147	835	7	j.	j.	PROPN
aji-147	835	8	immunol	immunol	PROPN
aji-147	835	9	.	.	PROPN
aji-147	835	10	,	,	PUNCT
aji-147	835	11	vol	vol	NOUN
aji-147	835	12	.	.	PROPN
aji-147	836	1	7	7	NUM
aji-147	836	2	,	,	PUNCT
aji-147	836	3	no	no	INTJ
aji-147	836	4	.	.	NOUN
aji-147	836	5	1	1	NUM
aji-147	836	6	,	,	PUNCT
aji-147	836	7	pp	pp	ADJ
aji-147	836	8	.	.	PUNCT
aji-147	837	1	228	228	NUM
aji-147	837	2	-	-	SYM
aji-147	837	3	246	246	NUM
aji-147	837	4	,	,	PUNCT
aji-147	837	5	2024	2024	NUM
aji-147	837	6	;	;	PUNCT
aji-147	838	1	article	article	NOUN
aji-147	838	2	no.aji.125387	no.aji.125387	VERB
aji-147	838	3	245	245	NUM
aji-147	838	4	108	108	NUM
aji-147	838	5	.	.	PUNCT
aji-147	839	1	sage	sage	NOUN
aji-147	839	2	pt	pt	PROPN
aji-147	839	3	,	,	PUNCT
aji-147	839	4	sharpe	sharpe	PROPN
aji-147	839	5	ah	ah	INTJ
aji-147	839	6	.	.	PUNCT
aji-147	840	1	t	t	PROPN
aji-147	840	2	follicular	follicular	ADJ
aji-147	840	3	regulatory	regulatory	ADJ
aji-147	840	4	cells	cell	NOUN
aji-147	840	5	in	in	ADP
aji-147	840	6	the	the	DET
aji-147	840	7	regulation	regulation	NOUN
aji-147	840	8	of	of	ADP
aji-147	840	9	b	b	NOUN
aji-147	840	10	cell	cell	NOUN
aji-147	840	11	responses	response	NOUN
aji-147	840	12	.	.	PUNCT
aji-147	841	1	trends	trend	NOUN
aji-147	841	2	immunol	immunol	NOUN
aji-147	841	3	.	.	PUNCT
aji-147	842	1	2015;36(7):410	2015;36(7):410	NUM
aji-147	842	2	-	-	SYM
aji-147	842	3	8	8	NUM
aji-147	842	4	.	.	X
aji-147	842	5	109	109	NUM
aji-147	842	6	.	.	PUNCT
aji-147	843	1	ye	ye	PRON
aji-147	843	2	y	y	PROPN
aji-147	843	3	,	,	PUNCT
aji-147	843	4	wang	wang	PROPN
aji-147	843	5	m	m	PROPN
aji-147	843	6	,	,	PUNCT
aji-147	843	7	huang	huang	PROPN
aji-147	843	8	h.	h.	PROPN
aji-147	843	9	follicular	follicular	PROPN
aji-147	843	10	regulatory	regulatory	ADJ
aji-147	843	11	t	t	NOUN
aji-147	843	12	cell	cell	NOUN
aji-147	843	13	biology	biology	NOUN
aji-147	843	14	and	and	CCONJ
aji-147	843	15	its	its	PRON
aji-147	843	16	role	role	NOUN
aji-147	843	17	in	in	ADP
aji-147	843	18	immune	immune	NOUN
aji-147	843	19	-	-	PUNCT
aji-147	843	20	mediated	mediate	VERB
aji-147	843	21	diseases	disease	NOUN
aji-147	843	22	.	.	PUNCT
aji-147	844	1	j	j	PROPN
aji-147	844	2	leukoc	leukoc	VERB
aji-147	844	3	biol	biol	PROPN
aji-147	844	4	.	.	PUNCT
aji-147	845	1	2021;110(2):239	2021;110(2):239	NUM
aji-147	845	2	-	-	SYM
aji-147	845	3	55	55	NUM
aji-147	845	4	.	.	PUNCT
aji-147	846	1	110	110	NUM
aji-147	846	2	.	.	PUNCT
aji-147	847	1	gonzalez	gonzalez	PROPN
aji-147	847	2	-	-	PUNCT
aji-147	847	3	figueroa	figueroa	PROPN
aji-147	847	4	p	p	PROPN
aji-147	847	5	,	,	PUNCT
aji-147	847	6	et	et	PROPN
aji-147	847	7	al	al	PROPN
aji-147	847	8	.	.	PUNCT
aji-147	848	1	follicular	follicular	ADJ
aji-147	848	2	regulatory	regulatory	ADJ
aji-147	848	3	t	t	NOUN
aji-147	848	4	cells	cell	NOUN
aji-147	848	5	produce	produce	VERB
aji-147	848	6	neuritin	neuritin	NOUN
aji-147	848	7	to	to	PART
aji-147	848	8	regulate	regulate	VERB
aji-147	848	9	b	b	NOUN
aji-147	848	10	cells	cell	NOUN
aji-147	848	11	.	.	PUNCT
aji-147	849	1	cell	cell	NOUN
aji-147	849	2	.	.	PUNCT
aji-147	850	1	2021;184(7):177589.e19	2021;184(7):177589.e19	NUM
aji-147	850	2	.	.	X
aji-147	850	3	111	111	NUM
aji-147	850	4	.	.	PUNCT
aji-147	851	1	fonseca	fonseca	PROPN
aji-147	851	2	vr	vr	PROPN
aji-147	851	3	,	,	PUNCT
aji-147	851	4	ribeiro	ribeiro	PROPN
aji-147	851	5	f	f	PROPN
aji-147	851	6	,	,	PUNCT
aji-147	851	7	graca	graca	PROPN
aji-147	851	8	l.	l.	PROPN
aji-147	851	9	t	t	PROPN
aji-147	851	10	follicular	follicular	ADJ
aji-147	851	11	regulatory	regulatory	ADJ
aji-147	851	12	(	(	PUNCT
aji-147	851	13	tfr	tfr	NOUN
aji-147	851	14	)	)	PUNCT
aji-147	851	15	cells	cell	NOUN
aji-147	851	16	:	:	PUNCT
aji-147	851	17	dissecting	dissect	VERB
aji-147	851	18	the	the	DET
aji-147	851	19	complexity	complexity	NOUN
aji-147	851	20	of	of	ADP
aji-147	851	21	tfr	tfr	NOUN
aji-147	851	22	-	-	PUNCT
aji-147	851	23	cell	cell	NOUN
aji-147	851	24	compartments	compartment	NOUN
aji-147	851	25	.	.	PUNCT
aji-147	852	1	immunol	immunol	PROPN
aji-147	852	2	rev	rev	PROPN
aji-147	852	3	.	.	PUNCT
aji-147	853	1	2019;288(1):112	2019;288(1):112	NUM
aji-147	853	2	-	-	SYM
aji-147	853	3	27	27	NUM
aji-147	853	4	.	.	PUNCT
aji-147	854	1	112	112	NUM
aji-147	854	2	.	.	PUNCT
aji-147	855	1	wing	wing	NOUN
aji-147	855	2	jb	jb	PROPN
aji-147	855	3	,	,	PUNCT
aji-147	855	4	tekgüç	tekgüç	PROPN
aji-147	855	5	m	m	PROPN
aji-147	855	6	,	,	PUNCT
aji-147	855	7	sakaguchi	sakaguchi	PROPN
aji-147	855	8	s.	s.	PROPN
aji-147	855	9	control	control	PROPN
aji-147	855	10	of	of	ADP
aji-147	855	11	germinal	germinal	ADJ
aji-147	855	12	center	center	NOUN
aji-147	855	13	responses	response	NOUN
aji-147	855	14	by	by	ADP
aji-147	855	15	t	t	PROPN
aji-147	855	16	-	-	PUNCT
aji-147	855	17	follicular	follicular	ADJ
aji-147	855	18	regulatory	regulatory	ADJ
aji-147	855	19	cells	cell	NOUN
aji-147	855	20	.	.	PUNCT
aji-147	856	1	front	front	ADJ
aji-147	856	2	immunol	immunol	NOUN
aji-147	856	3	.	.	PUNCT
aji-147	857	1	2018;9:1910	2018;9:1910	NOUN
aji-147	857	2	.	.	PUNCT
aji-147	858	1	113	113	NUM
aji-147	858	2	.	.	PUNCT
aji-147	859	1	xie	xie	PROPN
aji-147	859	2	mm	mm	PROPN
aji-147	859	3	,	,	PUNCT
aji-147	859	4	dent	dent	PROPN
aji-147	859	5	al	al	PROPN
aji-147	859	6	.	.	PROPN
aji-147	859	7	unexpected	unexpected	ADJ
aji-147	859	8	help	help	NOUN
aji-147	859	9	:	:	PUNCT
aji-147	859	10	follicular	follicular	ADJ
aji-147	859	11	regulatory	regulatory	ADJ
aji-147	859	12	t	t	NOUN
aji-147	859	13	cells	cell	NOUN
aji-147	859	14	in	in	ADP
aji-147	859	15	the	the	DET
aji-147	859	16	germinal	germinal	ADJ
aji-147	859	17	center	center	NOUN
aji-147	859	18	.	.	PUNCT
aji-147	860	1	front	front	ADJ
aji-147	860	2	immunol	immunol	NOUN
aji-147	860	3	.	.	PUNCT
aji-147	861	1	2018;9:1536	2018;9:1536	NOUN
aji-147	861	2	.	.	PUNCT
aji-147	862	1	114	114	NUM
aji-147	862	2	.	.	PUNCT
aji-147	863	1	gong	gong	PROPN
aji-147	863	2	y	y	PROPN
aji-147	863	3	,	,	PUNCT
aji-147	863	4	tong	tong	PROPN
aji-147	863	5	j	j	PROPN
aji-147	863	6	,	,	PUNCT
aji-147	863	7	wang	wang	PROPN
aji-147	863	8	s.	s.	PROPN
aji-147	863	9	are	be	AUX
aji-147	863	10	follicular	follicular	ADJ
aji-147	863	11	regulatory	regulatory	ADJ
aji-147	863	12	t	t	NOUN
aji-147	863	13	cells	cell	NOUN
aji-147	863	14	involved	involve	VERB
aji-147	863	15	in	in	ADP
aji-147	863	16	autoimmune	autoimmune	ADJ
aji-147	863	17	diseases	disease	NOUN
aji-147	863	18	?	?	PUNCT
aji-147	864	1	front	front	ADJ
aji-147	864	2	immunol	immunol	NOUN
aji-147	864	3	.	.	PUNCT
aji-147	865	1	2017;8:1790	2017;8:1790	NOUN
aji-147	865	2	.	.	PUNCT
aji-147	866	1	115	115	NUM
aji-147	866	2	.	.	PUNCT
aji-147	867	1	greczmiel	greczmiel	PROPN
aji-147	867	2	u	u	PROPN
aji-147	867	3	,	,	PUNCT
aji-147	867	4	oxenius	oxenius	PROPN
aji-147	867	5	a.	a.	NOUN
aji-147	867	6	the	the	DET
aji-147	867	7	janus	janus	PROPN
aji-147	867	8	face	face	NOUN
aji-147	867	9	of	of	ADP
aji-147	867	10	follicular	follicular	ADJ
aji-147	867	11	t	t	NOUN
aji-147	867	12	helper	helper	NOUN
aji-147	867	13	cells	cell	NOUN
aji-147	867	14	in	in	ADP
aji-147	867	15	chronic	chronic	ADJ
aji-147	867	16	viral	viral	ADJ
aji-147	867	17	infections	infection	NOUN
aji-147	867	18	.	.	PUNCT
aji-147	868	1	front	front	ADJ
aji-147	868	2	immunol	immunol	NOUN
aji-147	868	3	.	.	PUNCT
aji-147	869	1	2018;9:1162	2018;9:1162	NUM
aji-147	869	2	.	.	PUNCT
aji-147	870	1	116	116	NUM
aji-147	870	2	.	.	PUNCT
aji-147	871	1	kervevan	kervevan	PROPN
aji-147	871	2	j	j	PROPN
aji-147	871	3	,	,	PUNCT
aji-147	871	4	chakrabarti	chakrabarti	PROPN
aji-147	871	5	la	la	PROPN
aji-147	871	6	.	.	PUNCT
aji-147	871	7	role	role	NOUN
aji-147	871	8	of	of	ADP
aji-147	871	9	cd4	cd4	PROPN
aji-147	871	10	+	+	PROPN
aji-147	871	11	t	t	NOUN
aji-147	871	12	cells	cell	NOUN
aji-147	871	13	in	in	ADP
aji-147	871	14	the	the	DET
aji-147	871	15	control	control	NOUN
aji-147	871	16	of	of	ADP
aji-147	871	17	viral	viral	ADJ
aji-147	871	18	infections	infection	NOUN
aji-147	871	19	:	:	PUNCT
aji-147	871	20	recent	recent	ADJ
aji-147	871	21	advances	advance	NOUN
aji-147	871	22	and	and	CCONJ
aji-147	871	23	open	open	ADJ
aji-147	871	24	questions	question	NOUN
aji-147	871	25	.	.	PUNCT
aji-147	872	1	int	int	PROPN
aji-147	872	2	j	j	PROPN
aji-147	872	3	mol	mol	ADP
aji-147	872	4	sci	sci	PROPN
aji-147	872	5	.	.	PUNCT
aji-147	872	6	2021;22(2):523	2021;22(2):523	NUM
aji-147	872	7	.	.	PUNCT
aji-147	873	1	117	117	NUM
aji-147	873	2	.	.	PUNCT
aji-147	874	1	ma	ma	PROPN
aji-147	874	2	cs	cs	PROPN
aji-147	874	3	,	,	PUNCT
aji-147	874	4	deenick	deenick	PROPN
aji-147	874	5	ek	ek	PROPN
aji-147	874	6	.	.	PROPN
aji-147	874	7	human	human	PROPN
aji-147	874	8	t	t	PROPN
aji-147	874	9	follicular	follicular	ADJ
aji-147	874	10	helper	helper	NOUN
aji-147	874	11	(	(	PUNCT
aji-147	874	12	tfh	tfh	NOUN
aji-147	874	13	)	)	PUNCT
aji-147	874	14	cells	cell	NOUN
aji-147	874	15	and	and	CCONJ
aji-147	874	16	disease	disease	NOUN
aji-147	874	17	.	.	PUNCT
aji-147	875	1	immunol	immunol	NOUN
aji-147	875	2	cell	cell	NOUN
aji-147	875	3	biol	biol	NOUN
aji-147	875	4	.	.	PUNCT
aji-147	876	1	2014;92(1):64	2014;92(1):64	PROPN
aji-147	876	2	-	-	SYM
aji-147	876	3	71	71	NUM
aji-147	876	4	.	.	PUNCT
aji-147	877	1	118	118	NUM
aji-147	877	2	.	.	PUNCT
aji-147	878	1	chen	chen	PROPN
aji-147	878	2	x	x	PROPN
aji-147	878	3	,	,	PUNCT
aji-147	878	4	et	et	PROPN
aji-147	878	5	al	al	PROPN
aji-147	878	6	.	.	PUNCT
aji-147	879	1	the	the	DET
aji-147	879	2	histone	histone	NOUN
aji-147	879	3	methyltransferase	methyltransferase	NOUN
aji-147	879	4	ezh2	ezh2	NOUN
aji-147	879	5	primes	prime	VERB
aji-147	879	6	the	the	DET
aji-147	879	7	early	early	ADJ
aji-147	879	8	differentiation	differentiation	NOUN
aji-147	879	9	of	of	ADP
aji-147	879	10	follicular	follicular	ADJ
aji-147	879	11	helper	helper	NOUN
aji-147	879	12	t	t	NOUN
aji-147	879	13	cells	cell	NOUN
aji-147	879	14	during	during	ADP
aji-147	879	15	acute	acute	ADJ
aji-147	879	16	viral	viral	ADJ
aji-147	879	17	infection	infection	NOUN
aji-147	879	18	.	.	PUNCT
aji-147	880	1	cell	cell	NOUN
aji-147	880	2	mol	mol	ADP
aji-147	880	3	immunol	immunol	NOUN
aji-147	880	4	.	.	PUNCT
aji-147	881	1	2020;17(3):247	2020;17(3):247	NUM
aji-147	881	2	-	-	SYM
aji-147	881	3	60	60	NUM
aji-147	881	4	.	.	PUNCT
aji-147	882	1	119	119	NUM
aji-147	882	2	.	.	PUNCT
aji-147	883	1	deng	deng	PROPN
aji-147	883	2	j	j	PROPN
aji-147	883	3	,	,	PUNCT
aji-147	883	4	et	et	PROPN
aji-147	883	5	al	al	PROPN
aji-147	883	6	.	.	PUNCT
aji-147	884	1	the	the	DET
aji-147	884	2	metabolic	metabolic	NOUN
aji-147	884	3	hormone	hormone	NOUN
aji-147	884	4	leptin	leptin	NOUN
aji-147	884	5	promotes	promote	VERB
aji-147	884	6	the	the	DET
aji-147	884	7	function	function	NOUN
aji-147	884	8	of	of	ADP
aji-147	884	9	tfh	tfh	PROPN
aji-147	884	10	cells	cell	NOUN
aji-147	884	11	and	and	CCONJ
aji-147	884	12	supports	support	VERB
aji-147	884	13	vaccine	vaccine	NOUN
aji-147	884	14	responses	response	NOUN
aji-147	884	15	.	.	PUNCT
aji-147	885	1	nat	nat	PROPN
aji-147	885	2	commun	commun	PROPN
aji-147	885	3	.	.	PUNCT
aji-147	886	1	2021;12(1):1	2021;12(1):1	NUM
aji-147	886	2	-	-	SYM
aji-147	886	3	15	15	NUM
aji-147	886	4	.	.	PUNCT
aji-147	887	1	120	120	NUM
aji-147	887	2	.	.	PUNCT
aji-147	888	1	baumjohann	baumjohann	PROPN
aji-147	888	2	d	d	PROPN
aji-147	888	3	,	,	PUNCT
aji-147	888	4	fazilleau	fazilleau	PROPN
aji-147	888	5	n.	n.	PROPN
aji-147	888	6	antigendependent	antigendependent	PROPN
aji-147	888	7	multistep	multistep	ADJ
aji-147	888	8	differentiation	differentiation	NOUN
aji-147	888	9	of	of	ADP
aji-147	888	10	t	t	PROPN
aji-147	888	11	follicular	follicular	ADJ
aji-147	888	12	helper	helper	NOUN
aji-147	888	13	cells	cell	NOUN
aji-147	888	14	and	and	CCONJ
aji-147	888	15	its	its	PRON
aji-147	888	16	role	role	NOUN
aji-147	888	17	in	in	ADP
aji-147	888	18	sarscov-2	sarscov-2	NUM
aji-147	888	19	infection	infection	NOUN
aji-147	888	20	and	and	CCONJ
aji-147	888	21	vaccination	vaccination	NOUN
aji-147	888	22	.	.	PUNCT
aji-147	889	1	eur	eur	PROPN
aji-147	889	2	j	j	PROPN
aji-147	889	3	immunol	immunol	NOUN
aji-147	889	4	.	.	PUNCT
aji-147	890	1	2021;51(6):1325	2021;51(6):1325	PROPN
aji-147	890	2	-	-	SYM
aji-147	890	3	33	33	NUM
aji-147	890	4	.	.	NOUN
aji-147	890	5	121	121	NUM
aji-147	890	6	.	.	PUNCT
aji-147	891	1	schultheiß	schultheiß	PROPN
aji-147	891	2	c	c	PROPN
aji-147	891	3	,	,	PUNCT
aji-147	891	4	et	et	PROPN
aji-147	891	5	al	al	PROPN
aji-147	891	6	.	.	PROPN
aji-147	892	1	next	next	ADJ
aji-147	892	2	-	-	PUNCT
aji-147	892	3	generation	generation	NOUN
aji-147	892	4	sequencing	sequencing	NOUN
aji-147	892	5	of	of	ADP
aji-147	892	6	t	t	PROPN
aji-147	892	7	and	and	CCONJ
aji-147	892	8	b	b	PROPN
aji-147	892	9	cell	cell	NOUN
aji-147	892	10	receptor	receptor	NOUN
aji-147	892	11	repertoires	repertoire	NOUN
aji-147	892	12	from	from	ADP
aji-147	892	13	covid-19	covid-19	PROPN
aji-147	892	14	patients	patient	NOUN
aji-147	892	15	showed	show	VERB
aji-147	892	16	signatures	signature	NOUN
aji-147	892	17	associated	associate	VERB
aji-147	892	18	with	with	ADP
aji-147	892	19	severity	severity	NOUN
aji-147	892	20	of	of	ADP
aji-147	892	21	disease	disease	NOUN
aji-147	892	22	.	.	PUNCT
aji-147	893	1	immunity	immunity	NOUN
aji-147	893	2	.	.	PUNCT
aji-147	894	1	2020;53(2	2020;53(2	NUM
aji-147	894	2	):	):	PUNCT
aji-147	894	3	442	442	NUM
aji-147	894	4	-	-	SYM
aji-147	894	5	55.e4	55.e4	NUM
aji-147	894	6	.	.	PUNCT
aji-147	894	7	122	122	NUM
aji-147	894	8	.	.	PUNCT
aji-147	895	1	huber	huber	PROPN
aji-147	895	2	je	je	PROPN
aji-147	895	3	,	,	PUNCT
aji-147	895	4	et	et	PROPN
aji-147	895	5	al	al	PROPN
aji-147	895	6	.	.	PUNCT
aji-147	896	1	dynamic	dynamic	ADJ
aji-147	896	2	changes	change	NOUN
aji-147	896	3	in	in	ADP
aji-147	896	4	circulating	circulate	VERB
aji-147	896	5	t	t	PROPN
aji-147	896	6	follicular	follicular	ADJ
aji-147	896	7	helper	helper	NOUN
aji-147	896	8	cell	cell	NOUN
aji-147	896	9	composition	composition	NOUN
aji-147	896	10	predict	predict	VERB
aji-147	896	11	neutralising	neutralise	VERB
aji-147	896	12	antibody	antibody	NOUN
aji-147	896	13	responses	response	NOUN
aji-147	896	14	after	after	ADP
aji-147	896	15	yellow	yellow	ADJ
aji-147	896	16	fever	fever	NOUN
aji-147	896	17	vaccination	vaccination	NOUN
aji-147	896	18	.	.	PUNCT
aji-147	897	1	clin	clin	PROPN
aji-147	897	2	transl	transl	PROPN
aji-147	897	3	immunol	immunol	NOUN
aji-147	897	4	.	.	PUNCT
aji-147	898	1	2020;9(5	2020;9(5	NUM
aji-147	898	2	)	)	PUNCT
aji-147	898	3	.	.	PUNCT
aji-147	899	1	123	123	NUM
aji-147	899	2	.	.	PUNCT
aji-147	900	1	sadarangani	sadarangani	PROPN
aji-147	900	2	m	m	PROPN
aji-147	900	3	,	,	PUNCT
aji-147	900	4	marchant	marchant	PROPN
aji-147	900	5	a	a	PRON
aji-147	900	6	,	,	PUNCT
aji-147	900	7	kollmann	kollmann	PROPN
aji-147	900	8	tr	tr	VERB
aji-147	900	9	.	.	NOUN
aji-147	900	10	immunological	immunological	ADJ
aji-147	900	11	mechanisms	mechanism	NOUN
aji-147	900	12	of	of	ADP
aji-147	900	13	vaccineinduced	vaccineinduce	VERB
aji-147	900	14	protection	protection	NOUN
aji-147	900	15	against	against	ADP
aji-147	900	16	covid-19	covid-19	PROPN
aji-147	900	17	in	in	ADP
aji-147	900	18	humans	human	NOUN
aji-147	900	19	.	.	PUNCT
aji-147	901	1	nat	nat	PROPN
aji-147	901	2	rev	rev	PROPN
aji-147	901	3	immunol	immunol	NOUN
aji-147	901	4	.	.	PUNCT
aji-147	902	1	2021;21(8	2021;21(8	NUM
aji-147	902	2	):	):	PUNCT
aji-147	902	3	475	475	NUM
aji-147	902	4	-	-	SYM
aji-147	902	5	84	84	NUM
aji-147	902	6	.	.	PUNCT
aji-147	903	1	124	124	NUM
aji-147	903	2	.	.	PUNCT
aji-147	904	1	lederer	lederer	PROPN
aji-147	904	2	k	k	PROPN
aji-147	904	3	,	,	PUNCT
aji-147	904	4	et	et	PROPN
aji-147	904	5	al	al	PROPN
aji-147	904	6	.	.	PUNCT
aji-147	905	1	sars	sars	PROPN
aji-147	905	2	-	-	PUNCT
aji-147	905	3	cov-2	cov-2	NOUN
aji-147	905	4	mrna	mrna	PROPN
aji-147	905	5	vaccines	vaccine	NOUN
aji-147	905	6	foster	foster	VERB
aji-147	905	7	potent	potent	ADJ
aji-147	905	8	antigen	antigen	NOUN
aji-147	905	9	-	-	PUNCT
aji-147	905	10	specific	specific	ADJ
aji-147	905	11	germinal	germinal	ADJ
aji-147	905	12	center	center	NOUN
aji-147	905	13	responses	response	NOUN
aji-147	905	14	associated	associate	VERB
aji-147	905	15	with	with	ADP
aji-147	905	16	neutralizing	neutralize	VERB
aji-147	905	17	antibody	antibody	NOUN
aji-147	905	18	generation	generation	NOUN
aji-147	905	19	.	.	PUNCT
aji-147	906	1	immunity	immunity	NOUN
aji-147	906	2	.	.	PUNCT
aji-147	907	1	2020;53(6):1281	2020;53(6):1281	NUM
aji-147	907	2	-	-	SYM
aji-147	907	3	95.e5	95.e5	NUM
aji-147	907	4	.	.	PROPN
aji-147	907	5	125	125	NUM
aji-147	907	6	.	.	PUNCT
aji-147	908	1	tian	tian	PROPN
aji-147	908	2	j	j	PROPN
aji-147	908	3	-	-	PROPN
aji-147	908	4	h	h	PROPN
aji-147	908	5	,	,	PUNCT
aji-147	908	6	et	et	PROPN
aji-147	908	7	al	al	PROPN
aji-147	908	8	.	.	PUNCT
aji-147	909	1	sars	sars	PROPN
aji-147	909	2	-	-	PUNCT
aji-147	909	3	cov-2	cov-2	NOUN
aji-147	909	4	spike	spike	ADJ
aji-147	909	5	glycoprotein	glycoprotein	NOUN
aji-147	909	6	vaccine	vaccine	NOUN
aji-147	909	7	candidate	candidate	NOUN
aji-147	909	8	nvxcov2373	nvxcov2373	VERB
aji-147	909	9	immunogenicity	immunogenicity	NOUN
aji-147	909	10	in	in	ADP
aji-147	909	11	baboons	baboon	NOUN
aji-147	909	12	and	and	CCONJ
aji-147	909	13	protection	protection	NOUN
aji-147	909	14	in	in	ADP
aji-147	909	15	mice	mouse	NOUN
aji-147	909	16	.	.	PUNCT
aji-147	910	1	nat	nat	PROPN
aji-147	910	2	commun	commun	PROPN
aji-147	910	3	.	.	PUNCT
aji-147	910	4	2021	2021	NUM
aji-147	910	5	;	;	PUNCT
aji-147	910	6	12(1):1	12(1):1	NUM
aji-147	910	7	-	-	SYM
aji-147	910	8	14	14	NUM
aji-147	910	9	.	.	PUNCT
aji-147	911	1	126	126	NUM
aji-147	911	2	.	.	PUNCT
aji-147	912	1	tan	tan	PROPN
aji-147	912	2	h	h	NOUN
aji-147	912	3	-	-	PUNCT
aji-147	912	4	x	x	NOUN
aji-147	912	5	,	,	PUNCT
aji-147	912	6	et	et	PROPN
aji-147	912	7	al	al	PROPN
aji-147	912	8	.	.	PUNCT
aji-147	913	1	immunogenicity	immunogenicity	NOUN
aji-147	913	2	of	of	ADP
aji-147	913	3	primeboost	primeboost	NOUN
aji-147	913	4	protein	protein	NOUN
aji-147	913	5	subunit	subunit	NOUN
aji-147	913	6	vaccine	vaccine	NOUN
aji-147	913	7	strategies	strategy	NOUN
aji-147	913	8	against	against	ADP
aji-147	913	9	sars	sar	NOUN
aji-147	913	10	-	-	PUNCT
aji-147	913	11	cov-2	cov-2	NOUN
aji-147	913	12	in	in	ADP
aji-147	913	13	mice	mouse	NOUN
aji-147	913	14	and	and	CCONJ
aji-147	913	15	macaques	macaque	NOUN
aji-147	913	16	.	.	PUNCT
aji-147	914	1	nat	nat	PROPN
aji-147	914	2	commun	commun	PROPN
aji-147	914	3	.	.	PUNCT
aji-147	915	1	2021;12(1):1	2021;12(1):1	NUM
aji-147	915	2	-	-	SYM
aji-147	915	3	10	10	NUM
aji-147	915	4	.	.	PUNCT
aji-147	916	1	127	127	NUM
aji-147	916	2	.	.	PUNCT
aji-147	917	1	wu	wu	PROPN
aji-147	917	2	z	z	PROPN
aji-147	917	3	,	,	PUNCT
aji-147	917	4	et	et	PROPN
aji-147	917	5	al	al	PROPN
aji-147	917	6	.	.	PROPN
aji-147	917	7	safety	safety	PROPN
aji-147	917	8	,	,	PUNCT
aji-147	917	9	tolerability	tolerability	NOUN
aji-147	917	10	,	,	PUNCT
aji-147	917	11	and	and	CCONJ
aji-147	917	12	immunogenicity	immunogenicity	NOUN
aji-147	917	13	of	of	ADP
aji-147	917	14	an	an	DET
aji-147	917	15	inactivated	inactivated	ADJ
aji-147	917	16	sarscov-2	sarscov-2	NUM
aji-147	917	17	vaccine	vaccine	NOUN
aji-147	917	18	(	(	PUNCT
aji-147	917	19	coronavac	coronavac	PROPN
aji-147	917	20	)	)	PUNCT
aji-147	917	21	in	in	ADP
aji-147	917	22	healthy	healthy	ADJ
aji-147	917	23	adults	adult	NOUN
aji-147	917	24	aged	age	VERB
aji-147	917	25	60	60	NUM
aji-147	917	26	years	year	NOUN
aji-147	917	27	and	and	CCONJ
aji-147	917	28	older	old	ADJ
aji-147	917	29	:	:	PUNCT
aji-147	917	30	a	a	DET
aji-147	917	31	randomised	randomised	ADJ
aji-147	917	32	,	,	PUNCT
aji-147	917	33	double	double	ADJ
aji-147	917	34	-	-	PUNCT
aji-147	917	35	blind	blind	ADJ
aji-147	917	36	,	,	PUNCT
aji-147	917	37	placebocontrolled	placebocontrolle	VERB
aji-147	917	38	,	,	PUNCT
aji-147	917	39	phase	phase	NOUN
aji-147	917	40	1/2	1/2	NUM
aji-147	917	41	clinical	clinical	ADJ
aji-147	917	42	trial	trial	NOUN
aji-147	917	43	.	.	PUNCT
aji-147	918	1	lancet	lancet	PROPN
aji-147	918	2	infect	infect	PROPN
aji-147	918	3	dis	dis	PROPN
aji-147	918	4	.	.	PUNCT
aji-147	919	1	2021;21(6):803	2021;21(6):803	NOUN
aji-147	919	2	-	-	SYM
aji-147	919	3	12	12	NUM
aji-147	919	4	.	.	PUNCT
aji-147	919	5	128	128	NUM
aji-147	919	6	.	.	PUNCT
aji-147	920	1	xia	xia	PROPN
aji-147	920	2	s	s	PROPN
aji-147	920	3	,	,	PUNCT
aji-147	920	4	et	et	PROPN
aji-147	920	5	al	al	PROPN
aji-147	920	6	.	.	PROPN
aji-147	920	7	safety	safety	NOUN
aji-147	920	8	and	and	CCONJ
aji-147	920	9	immunogenicity	immunogenicity	NOUN
aji-147	920	10	of	of	ADP
aji-147	920	11	an	an	DET
aji-147	920	12	inactivated	inactivated	ADJ
aji-147	920	13	sars	sar	NOUN
aji-147	920	14	-	-	PUNCT
aji-147	920	15	cov-2	cov-2	PART
aji-147	920	16	vaccine	vaccine	NOUN
aji-147	920	17	,	,	PUNCT
aji-147	920	18	bbibp	bbibp	NOUN
aji-147	920	19	-	-	PUNCT
aji-147	920	20	corv	corv	NOUN
aji-147	920	21	:	:	PUNCT
aji-147	920	22	a	a	DET
aji-147	920	23	randomised	randomised	ADJ
aji-147	920	24	,	,	PUNCT
aji-147	920	25	double	double	ADJ
aji-147	920	26	-	-	PUNCT
aji-147	920	27	blind	blind	ADJ
aji-147	920	28	,	,	PUNCT
aji-147	920	29	placebo	placebo	NOUN
aji-147	920	30	-	-	PUNCT
aji-147	920	31	controlled	control	VERB
aji-147	920	32	,	,	PUNCT
aji-147	920	33	phase	phase	NOUN
aji-147	920	34	1/2	1/2	NUM
aji-147	920	35	trial	trial	NOUN
aji-147	920	36	.	.	PUNCT
aji-147	921	1	lancet	lancet	PROPN
aji-147	921	2	infect	infect	PROPN
aji-147	921	3	dis	dis	PROPN
aji-147	921	4	.	.	PUNCT
aji-147	922	1	2021;21(1):39	2021;21(1):39	PROPN
aji-147	922	2	-	-	SYM
aji-147	922	3	51	51	NUM
aji-147	922	4	.	.	PUNCT
aji-147	922	5	129	129	NUM
aji-147	922	6	.	.	PUNCT
aji-147	923	1	zhang	zhang	PROPN
aji-147	923	2	y	y	PROPN
aji-147	923	3	,	,	PUNCT
aji-147	923	4	et	et	PROPN
aji-147	923	5	al	al	PROPN
aji-147	923	6	.	.	PROPN
aji-147	923	7	safety	safety	PROPN
aji-147	923	8	,	,	PUNCT
aji-147	923	9	tolerability	tolerability	NOUN
aji-147	923	10	,	,	PUNCT
aji-147	923	11	and	and	CCONJ
aji-147	923	12	immunogenicity	immunogenicity	NOUN
aji-147	923	13	of	of	ADP
aji-147	923	14	an	an	DET
aji-147	923	15	inactivated	inactivated	ADJ
aji-147	923	16	sars	sar	NOUN
aji-147	923	17	-	-	PUNCT
aji-147	923	18	cov-2	cov-2	NOUN
aji-147	923	19	vaccine	vaccine	NOUN
aji-147	923	20	in	in	ADP
aji-147	923	21	healthy	healthy	ADJ
aji-147	923	22	adults	adult	NOUN
aji-147	923	23	aged	age	VERB
aji-147	923	24	18–59	18–59	NUM
aji-147	923	25	years	year	NOUN
aji-147	923	26	:	:	PUNCT
aji-147	923	27	a	a	DET
aji-147	923	28	randomised	randomised	ADJ
aji-147	923	29	,	,	PUNCT
aji-147	923	30	doubleblind	doubleblind	NOUN
aji-147	923	31	,	,	PUNCT
aji-147	923	32	placebo	placebo	NOUN
aji-147	923	33	-	-	PUNCT
aji-147	923	34	controlled	control	VERB
aji-147	923	35	,	,	PUNCT
aji-147	923	36	phase	phase	NOUN
aji-147	923	37	1/2	1/2	NUM
aji-147	923	38	clinical	clinical	ADJ
aji-147	923	39	trial	trial	NOUN
aji-147	923	40	.	.	PUNCT
aji-147	924	1	lancet	lancet	PROPN
aji-147	924	2	infect	infect	PROPN
aji-147	924	3	dis	dis	PROPN
aji-147	924	4	.	.	PUNCT
aji-147	925	1	2021;21(2	2021;21(2	NUM
aji-147	925	2	):	):	PUNCT
aji-147	925	3	181	181	NUM
aji-147	925	4	-	-	SYM
aji-147	925	5	92	92	NUM
aji-147	925	6	.	.	PUNCT
aji-147	925	7	130	130	NUM
aji-147	925	8	.	.	PUNCT
aji-147	926	1	corbett	corbett	PROPN
aji-147	926	2	ks	ks	PROPN
aji-147	926	3	,	,	PUNCT
aji-147	926	4	et	et	PROPN
aji-147	926	5	al	al	PROPN
aji-147	926	6	.	.	PUNCT
aji-147	926	7	evaluation	evaluation	NOUN
aji-147	926	8	of	of	ADP
aji-147	926	9	the	the	DET
aji-147	926	10	mrna1273	mrna1273	PROPN
aji-147	926	11	vaccine	vaccine	NOUN
aji-147	926	12	against	against	ADP
aji-147	926	13	sars	sar	NOUN
aji-147	926	14	-	-	PUNCT
aji-147	926	15	cov-2	cov-2	NOUN
aji-147	926	16	in	in	ADP
aji-147	926	17	nonhuman	nonhuman	ADJ
aji-147	926	18	primates	primate	NOUN
aji-147	926	19	.	.	PUNCT
aji-147	927	1	n	n	CCONJ
aji-147	927	2	engl	engl	PROPN
aji-147	927	3	j	j	PROPN
aji-147	927	4	med	med	PROPN
aji-147	927	5	.	.	PUNCT
aji-147	928	1	2020;383(16):1544	2020;383(16):1544	NUM
aji-147	928	2	-	-	SYM
aji-147	928	3	55	55	NUM
aji-147	928	4	.	.	PUNCT
aji-147	929	1	131	131	NUM
aji-147	929	2	.	.	PUNCT
aji-147	930	1	cui	cui	PROPN
aji-147	930	2	d	d	PROPN
aji-147	930	3	,	,	PUNCT
aji-147	930	4	et	et	PROPN
aji-147	930	5	al	al	PROPN
aji-147	930	6	.	.	PUNCT
aji-147	931	1	follicular	follicular	ADJ
aji-147	931	2	helper	helper	NOUN
aji-147	931	3	t	t	NOUN
aji-147	931	4	cells	cell	NOUN
aji-147	931	5	in	in	ADP
aji-147	931	6	the	the	DET
aji-147	931	7	immunopathogenesis	immunopathogenesis	NOUN
aji-147	931	8	of	of	ADP
aji-147	931	9	sars	sar	NOUN
aji-147	931	10	-	-	PUNCT
aji-147	931	11	cov-2	cov-2	NOUN
aji-147	931	12	infection	infection	NOUN
aji-147	931	13	.	.	PUNCT
aji-147	932	1	front	front	ADJ
aji-147	932	2	immunol	immunol	NOUN
aji-147	932	3	.	.	PUNCT
aji-147	933	1	2021;12:3806	2021;12:3806	NUM
aji-147	933	2	.	.	NOUN
aji-147	933	3	132	132	NUM
aji-147	933	4	.	.	PUNCT
aji-147	934	1	koutsakos	koutsakos	PROPN
aji-147	934	2	m	m	PROPN
aji-147	934	3	,	,	PUNCT
aji-147	934	4	et	et	PROPN
aji-147	934	5	al	al	PROPN
aji-147	934	6	.	.	PROPN
aji-147	934	7	integrated	integrate	VERB
aji-147	934	8	immune	immune	ADJ
aji-147	934	9	dynamics	dynamic	NOUN
aji-147	934	10	define	define	VERB
aji-147	934	11	correlates	correlate	NOUN
aji-147	934	12	of	of	ADP
aji-147	934	13	covid-19	covid-19	PROPN
aji-147	934	14	severity	severity	NOUN
aji-147	934	15	and	and	CCONJ
aji-147	934	16	antibody	antibody	NOUN
aji-147	934	17	responses	response	NOUN
aji-147	934	18	.	.	PUNCT
aji-147	935	1	cell	cell	NOUN
aji-147	935	2	rep	rep	PROPN
aji-147	935	3	med	med	PROPN
aji-147	935	4	.	.	PUNCT
aji-147	936	1	2021;2(3):100208	2021;2(3):100208	NUM
aji-147	936	2	.	.	PROPN
aji-147	936	3	133	133	NUM
aji-147	936	4	.	.	PUNCT
aji-147	937	1	zhang	zhang	PROPN
aji-147	937	2	j	j	PROPN
aji-147	937	3	,	,	PUNCT
aji-147	937	4	et	et	PROPN
aji-147	937	5	al	al	PROPN
aji-147	937	6	.	.	PROPN
aji-147	937	7	spike	spike	ADJ
aji-147	937	8	-	-	PUNCT
aji-147	937	9	specific	specific	ADJ
aji-147	937	10	circulating	circulating	NOUN
aji-147	937	11	t	t	NOUN
aji-147	937	12	follicular	follicular	ADJ
aji-147	937	13	helper	helper	NOUN
aji-147	937	14	cell	cell	NOUN
aji-147	937	15	and	and	CCONJ
aji-147	937	16	cross	cross	ADJ
aji-147	937	17	-	-	ADJ
aji-147	937	18	neutralizing	neutralizing	ADJ
aji-147	937	19	antibody	antibody	NOUN
aji-147	937	20	responses	response	NOUN
aji-147	937	21	in	in	ADP
aji-147	937	22	covid-19convalescent	covid-19convalescent	NOUN
aji-147	937	23	individuals	individual	NOUN
aji-147	937	24	.	.	PUNCT
aji-147	938	1	nat	nat	PROPN
aji-147	938	2	microbiol	microbiol	PROPN
aji-147	938	3	.	.	PUNCT
aji-147	939	1	2021;6(1):51	2021;6(1):51	NUM
aji-147	939	2	-	-	SYM
aji-147	939	3	8	8	NUM
aji-147	939	4	.	.	PUNCT
aji-147	940	1	shukla	shukla	NOUN
aji-147	940	2	et	et	PROPN
aji-147	940	3	al	al	PROPN
aji-147	940	4	.	.	PROPN
aji-147	940	5	;	;	PUNCT
aji-147	940	6	asian	asian	PROPN
aji-147	940	7	j.	j.	PROPN
aji-147	940	8	immunol	immunol	PROPN
aji-147	940	9	.	.	PROPN
aji-147	940	10	,	,	PUNCT
aji-147	940	11	vol	vol	NOUN
aji-147	940	12	.	.	PROPN
aji-147	941	1	7	7	NUM
aji-147	941	2	,	,	PUNCT
aji-147	941	3	no	no	INTJ
aji-147	941	4	.	.	NOUN
aji-147	941	5	1	1	NUM
aji-147	941	6	,	,	PUNCT
aji-147	941	7	pp	pp	ADJ
aji-147	941	8	.	.	PUNCT
aji-147	942	1	228	228	NUM
aji-147	942	2	-	-	SYM
aji-147	942	3	246	246	NUM
aji-147	942	4	,	,	PUNCT
aji-147	942	5	2024	2024	NUM
aji-147	942	6	;	;	PUNCT
aji-147	943	1	article	article	NOUN
aji-147	943	2	no.aji.125387	no.aji.125387	VERB
aji-147	943	3	246	246	NUM
aji-147	943	4	134	134	NUM
aji-147	943	5	.	.	PUNCT
aji-147	944	1	sandberg	sandberg	PROPN
aji-147	944	2	jt	jt	PROPN
aji-147	944	3	,	,	PUNCT
aji-147	944	4	et	et	PROPN
aji-147	944	5	al	al	PROPN
aji-147	944	6	.	.	PUNCT
aji-147	945	1	sars	sars	PROPN
aji-147	945	2	-	-	PUNCT
aji-147	945	3	cov-2	cov-2	ADV
aji-147	945	4	-	-	PUNCT
aji-147	945	5	specific	specific	ADJ
aji-147	945	6	humoral	humoral	ADJ
aji-147	945	7	and	and	CCONJ
aji-147	945	8	cellular	cellular	ADJ
aji-147	945	9	immunity	immunity	NOUN
aji-147	945	10	persists	persist	VERB
aji-147	945	11	through	through	ADP
aji-147	945	12	9	9	NUM
aji-147	945	13	months	month	NOUN
aji-147	945	14	irrespective	irrespective	ADV
aji-147	945	15	of	of	ADP
aji-147	945	16	covid19	covid19	NOUN
aji-147	945	17	severity	severity	NOUN
aji-147	945	18	at	at	ADP
aji-147	945	19	hospitalisation	hospitalisation	NOUN
aji-147	945	20	.	.	PUNCT
aji-147	946	1	clin	clin	PROPN
aji-147	946	2	transl	transl	PROPN
aji-147	946	3	immunol	immunol	NOUN
aji-147	946	4	.	.	PUNCT
aji-147	947	1	2021;10(7	2021;10(7	NUM
aji-147	947	2	)	)	PUNCT
aji-147	947	3	.	.	PUNCT
aji-147	948	1	135	135	NUM
aji-147	948	2	.	.	PUNCT
aji-147	949	1	koutsakos	koutsakos	PROPN
aji-147	949	2	m	m	PROPN
aji-147	949	3	,	,	PUNCT
aji-147	949	4	et	et	PROPN
aji-147	949	5	al	al	PROPN
aji-147	949	6	.	.	PROPN
aji-147	950	1	t	t	PROPN
aji-147	950	2	follicular	follicular	ADJ
aji-147	950	3	helper	helper	NOUN
aji-147	950	4	cells	cell	NOUN
aji-147	950	5	in	in	ADP
aji-147	950	6	the	the	DET
aji-147	950	7	humoral	humoral	ADJ
aji-147	950	8	immune	immune	ADJ
aji-147	950	9	response	response	NOUN
aji-147	950	10	to	to	ADP
aji-147	950	11	sars	sar	NOUN
aji-147	950	12	-	-	PUNCT
aji-147	950	13	cov-2	cov-2	PART
aji-147	950	14	infection	infection	NOUN
aji-147	950	15	and	and	CCONJ
aji-147	950	16	vaccination	vaccination	NOUN
aji-147	950	17	.	.	PUNCT
aji-147	951	1	j	j	PROPN
aji-147	951	2	leukoc	leukoc	VERB
aji-147	951	3	biol	biol	PROPN
aji-147	951	4	.	.	PUNCT
aji-147	952	1	2022;111(2	2022;111(2	NUM
aji-147	952	2	):	):	PUNCT
aji-147	952	3	355	355	NUM
aji-147	952	4	-	-	SYM
aji-147	952	5	65	65	NUM
aji-147	952	6	.	.	PUNCT
aji-147	953	1	136	136	NUM
aji-147	953	2	.	.	PUNCT
aji-147	954	1	moderbacher	moderbacher	PROPN
aji-147	954	2	cr	cr	PROPN
aji-147	954	3	,	,	PUNCT
aji-147	954	4	et	et	PROPN
aji-147	954	5	al	al	PROPN
aji-147	954	6	.	.	PUNCT
aji-147	955	1	antigen	antigen	NOUN
aji-147	955	2	-	-	PUNCT
aji-147	955	3	specific	specific	ADJ
aji-147	955	4	adaptive	adaptive	ADJ
aji-147	955	5	immunity	immunity	NOUN
aji-147	955	6	to	to	ADP
aji-147	955	7	sars	sar	NOUN
aji-147	955	8	-	-	PUNCT
aji-147	955	9	cov-2	cov-2	NOUN
aji-147	955	10	in	in	ADP
aji-147	955	11	acute	acute	NOUN
aji-147	955	12	covid-19	covid-19	PROPN
aji-147	955	13	and	and	CCONJ
aji-147	955	14	associations	association	NOUN
aji-147	955	15	with	with	ADP
aji-147	955	16	age	age	NOUN
aji-147	955	17	and	and	CCONJ
aji-147	955	18	disease	disease	NOUN
aji-147	955	19	severity	severity	NOUN
aji-147	955	20	.	.	PUNCT
aji-147	956	1	cell	cell	NOUN
aji-147	956	2	.	.	PUNCT
aji-147	957	1	2020;183(4):9961012.e19	2020;183(4):9961012.e19	NUM
aji-147	957	2	.	.	X
aji-147	957	3	137	137	NUM
aji-147	957	4	.	.	PUNCT
aji-147	958	1	nguyen	nguyen	PROPN
aji-147	958	2	th	th	PROPN
aji-147	958	3	,	,	PUNCT
aji-147	958	4	et	et	PROPN
aji-147	958	5	al	al	PROPN
aji-147	958	6	.	.	PROPN
aji-147	958	7	immune	immune	ADJ
aji-147	958	8	cellular	cellular	ADJ
aji-147	958	9	networks	network	NOUN
aji-147	958	10	underlying	underlie	VERB
aji-147	958	11	recovery	recovery	NOUN
aji-147	958	12	from	from	ADP
aji-147	958	13	influenza	influenza	NOUN
aji-147	958	14	virus	virus	NOUN
aji-147	958	15	infection	infection	NOUN
aji-147	958	16	in	in	ADP
aji-147	958	17	acute	acute	ADJ
aji-147	958	18	hospitalized	hospitalize	VERB
aji-147	958	19	patients	patient	NOUN
aji-147	958	20	.	.	PUNCT
aji-147	959	1	nat	nat	PROPN
aji-147	959	2	commun	commun	PROPN
aji-147	959	3	.	.	PROPN
aji-147	959	4	2021	2021	NUM
aji-147	959	5	;	;	PUNCT
aji-147	959	6	12(1):1	12(1):1	NUM
aji-147	959	7	-	-	SYM
aji-147	959	8	17	17	NUM
aji-147	959	9	.	.	PUNCT
aji-147	959	10	138	138	NUM
aji-147	959	11	.	.	PUNCT
aji-147	959	12	sekine	sekine	PROPN
aji-147	959	13	t	t	PROPN
aji-147	959	14	,	,	PUNCT
aji-147	959	15	et	et	PROPN
aji-147	959	16	al	al	PROPN
aji-147	959	17	.	.	PROPN
aji-147	959	18	robust	robust	PROPN
aji-147	959	19	t	t	PROPN
aji-147	959	20	cell	cell	NOUN
aji-147	959	21	immunity	immunity	NOUN
aji-147	959	22	in	in	ADP
aji-147	959	23	convalescent	convalescent	NOUN
aji-147	959	24	individuals	individual	NOUN
aji-147	959	25	with	with	ADP
aji-147	959	26	asymptomatic	asymptomatic	ADJ
aji-147	959	27	or	or	CCONJ
aji-147	959	28	mild	mild	ADJ
aji-147	959	29	covid-19	covid-19	PROPN
aji-147	959	30	.	.	PUNCT
aji-147	959	31	cell	cell	NOUN
aji-147	959	32	.	.	PUNCT
aji-147	960	1	2020;183(1):158	2020;183(1):158	NUM
aji-147	960	2	-	-	SYM
aji-147	960	3	68.e14	68.e14	NUM
aji-147	960	4	.	.	PUNCT
aji-147	961	1	139	139	NUM
aji-147	961	2	.	.	PUNCT
aji-147	962	1	meckiff	meckiff	ADJ
aji-147	962	2	bj	bj	PROPN
aji-147	962	3	,	,	PUNCT
aji-147	962	4	et	et	PROPN
aji-147	962	5	al	al	PROPN
aji-147	962	6	.	.	PROPN
aji-147	962	7	imbalance	imbalance	NOUN
aji-147	962	8	of	of	ADP
aji-147	962	9	regulatory	regulatory	ADJ
aji-147	962	10	and	and	CCONJ
aji-147	962	11	cytotoxic	cytotoxic	ADJ
aji-147	962	12	sars	sar	NOUN
aji-147	962	13	-	-	PUNCT
aji-147	962	14	cov-2	cov-2	NOUN
aji-147	962	15	-	-	PUNCT
aji-147	962	16	reactive	reactive	ADJ
aji-147	962	17	cd4	cd4	PROPN
aji-147	962	18	+	+	PROPN
aji-147	962	19	t	t	NOUN
aji-147	962	20	cells	cell	NOUN
aji-147	962	21	in	in	ADP
aji-147	962	22	covid-19	covid-19	PROPN
aji-147	962	23	.	.	PUNCT
aji-147	962	24	cell	cell	NOUN
aji-147	962	25	.	.	PUNCT
aji-147	963	1	2020;183(5	2020;183(5	X
aji-147	963	2	):	):	PUNCT
aji-147	963	3	1340	1340	NUM
aji-147	963	4	-	-	SYM
aji-147	963	5	53.e16	53.e16	NUM
aji-147	963	6	.	.	PUNCT
aji-147	964	1	140	140	NUM
aji-147	964	2	.	.	PUNCT
aji-147	965	1	turner	turner	PROPN
aji-147	965	2	js	js	PROPN
aji-147	965	3	,	,	PUNCT
aji-147	965	4	et	et	PROPN
aji-147	965	5	al	al	PROPN
aji-147	965	6	.	.	PUNCT
aji-147	966	1	sars	sars	PROPN
aji-147	966	2	-	-	PUNCT
aji-147	966	3	cov-2	cov-2	NOUN
aji-147	966	4	mrna	mrna	PROPN
aji-147	966	5	vaccines	vaccine	NOUN
aji-147	966	6	induce	induce	VERB
aji-147	966	7	persistent	persistent	ADJ
aji-147	966	8	human	human	ADJ
aji-147	966	9	germinal	germinal	ADJ
aji-147	966	10	centre	centre	NOUN
aji-147	966	11	responses	response	NOUN
aji-147	966	12	.	.	PUNCT
aji-147	967	1	nature	nature	NOUN
aji-147	967	2	.	.	PUNCT
aji-147	968	1	2021	2021	NUM
aji-147	968	2	;	;	PUNCT
aji-147	968	3	596(7870):109	596(7870):109	NUM
aji-147	968	4	-	-	SYM
aji-147	968	5	13	13	NUM
aji-147	968	6	.	.	PUNCT
aji-147	969	1	141	141	NUM
aji-147	969	2	.	.	PUNCT
aji-147	970	1	mudd	mudd	PROPN
aji-147	970	2	pa	pa	PROPN
aji-147	970	3	,	,	PUNCT
aji-147	970	4	et	et	PROPN
aji-147	970	5	al	al	PROPN
aji-147	970	6	.	.	PUNCT
aji-147	971	1	sars	sars	PROPN
aji-147	971	2	-	-	PUNCT
aji-147	971	3	cov-2	cov-2	NOUN
aji-147	971	4	mrna	mrna	NOUN
aji-147	971	5	vaccination	vaccination	NOUN
aji-147	971	6	elicits	elicit	VERB
aji-147	971	7	a	a	DET
aji-147	971	8	robust	robust	ADJ
aji-147	971	9	and	and	CCONJ
aji-147	971	10	persistent	persistent	ADJ
aji-147	971	11	t	t	PROPN
aji-147	971	12	follicular	follicular	ADJ
aji-147	971	13	helper	helper	NOUN
aji-147	971	14	cell	cell	NOUN
aji-147	971	15	response	response	NOUN
aji-147	971	16	in	in	ADP
aji-147	971	17	humans	human	NOUN
aji-147	971	18	.	.	PUNCT
aji-147	972	1	cell	cell	NOUN
aji-147	972	2	.	.	PUNCT
aji-147	973	1	2022;185(4):603	2022;185(4):603	X
aji-147	973	2	-	-	SYM
aji-147	973	3	13.e15	13.e15	NUM
aji-147	973	4	.	.	PUNCT
aji-147	974	1	142	142	NUM
aji-147	974	2	.	.	PUNCT
aji-147	975	1	apostolidis	apostolidis	PROPN
aji-147	975	2	sa	sa	PROPN
aji-147	975	3	,	,	PUNCT
aji-147	975	4	et	et	PROPN
aji-147	975	5	al	al	PROPN
aji-147	975	6	.	.	PUNCT
aji-147	975	7	cellular	cellular	ADJ
aji-147	975	8	and	and	CCONJ
aji-147	975	9	humoral	humoral	ADJ
aji-147	975	10	immune	immune	ADJ
aji-147	975	11	responses	response	NOUN
aji-147	975	12	following	follow	VERB
aji-147	975	13	sars	sar	NOUN
aji-147	975	14	-	-	PUNCT
aji-147	975	15	cov-2	cov-2	NOUN
aji-147	975	16	mrna	mrna	NOUN
aji-147	975	17	vaccination	vaccination	NOUN
aji-147	975	18	in	in	ADP
aji-147	975	19	patients	patient	NOUN
aji-147	975	20	with	with	ADP
aji-147	975	21	multiple	multiple	ADJ
aji-147	975	22	sclerosis	sclerosis	NOUN
aji-147	975	23	on	on	ADP
aji-147	975	24	anti	anti	ADJ
aji-147	975	25	-	-	ADJ
aji-147	975	26	cd20	cd20	ADJ
aji-147	975	27	therapy	therapy	NOUN
aji-147	975	28	.	.	PUNCT
aji-147	976	1	nat	nat	PROPN
aji-147	976	2	med	med	PROPN
aji-147	976	3	.	.	PUNCT
aji-147	977	1	2021;27(11):1990	2021;27(11):1990	NUM
aji-147	977	2	-	-	PROPN
aji-147	977	3	2001	2001	NUM
aji-147	977	4	.	.	PUNCT
aji-147	978	1	143	143	NUM
aji-147	978	2	.	.	PUNCT
aji-147	979	1	kuthuru	kuthuru	PROPN
aji-147	979	2	o	o	PROPN
aji-147	979	3	,	,	PUNCT
aji-147	979	4	et	et	PROPN
aji-147	979	5	al	al	PROPN
aji-147	979	6	.	.	PROPN
aji-147	979	7	rapid	rapid	ADJ
aji-147	979	8	induction	induction	NOUN
aji-147	979	9	of	of	ADP
aji-147	979	10	antigen	antigen	NOUN
aji-147	979	11	-	-	PUNCT
aji-147	979	12	specific	specific	NOUN
aji-147	979	13	cd4	cd4	PROPN
aji-147	979	14	t	t	PROPN
aji-147	979	15	cells	cell	NOUN
aji-147	979	16	is	be	AUX
aji-147	979	17	associated	associate	VERB
aji-147	979	18	with	with	ADP
aji-147	979	19	coordinated	coordinate	VERB
aji-147	979	20	humoral	humoral	ADJ
aji-147	979	21	and	and	CCONJ
aji-147	979	22	cellular	cellular	ADJ
aji-147	979	23	immunity	immunity	NOUN
aji-147	979	24	to	to	ADP
aji-147	979	25	sars	sars	PROPN
aji-147	979	26	-	-	PUNCT
aji-147	979	27	cov-2	cov-2	NOUN
aji-147	979	28	mrna	mrna	NOUN
aji-147	979	29	vaccination	vaccination	NOUN
aji-147	979	30	.	.	PUNCT
aji-147	980	1	immunity	immunity	NOUN
aji-147	980	2	.	.	PUNCT
aji-147	981	1	2021;54:2133	2021;54:2133	NUM
aji-147	981	2	-	-	SYM
aji-147	981	3	42	42	NUM
aji-147	981	4	.	.	PUNCT
aji-147	982	1	144	144	NUM
aji-147	982	2	.	.	PUNCT
aji-147	983	1	goel	goel	PROPN
aji-147	983	2	rr	rr	PROPN
aji-147	983	3	,	,	PUNCT
aji-147	983	4	et	et	PROPN
aji-147	983	5	al	al	PROPN
aji-147	983	6	.	.	PUNCT
aji-147	984	1	mrna	mrna	PROPN
aji-147	984	2	vaccination	vaccination	NOUN
aji-147	984	3	induces	induce	VERB
aji-147	984	4	durable	durable	ADJ
aji-147	984	5	immune	immune	ADJ
aji-147	984	6	memory	memory	NOUN
aji-147	984	7	to	to	ADP
aji-147	984	8	sars	sar	NOUN
aji-147	984	9	-	-	PUNCT
aji-147	984	10	cov-2	cov-2	NOUN
aji-147	984	11	with	with	ADP
aji-147	984	12	continued	continue	VERB
aji-147	984	13	evolution	evolution	NOUN
aji-147	984	14	to	to	ADP
aji-147	984	15	variants	variant	NOUN
aji-147	984	16	of	of	ADP
aji-147	984	17	concern	concern	NOUN
aji-147	984	18	.	.	PUNCT
aji-147	985	1	biorxiv	biorxiv	NOUN
aji-147	985	2	.	.	PUNCT
aji-147	986	1	2021	2021	NUM
aji-147	986	2	.	.	PUNCT
aji-147	987	1	145	145	NUM
aji-147	987	2	.	.	PUNCT
aji-147	987	3	marfe	marfe	NOUN
aji-147	987	4	g	g	PROPN
aji-147	987	5	,	,	PUNCT
aji-147	987	6	et	et	PROPN
aji-147	987	7	al	al	PROPN
aji-147	987	8	.	.	PROPN
aji-147	987	9	viral	viral	ADJ
aji-147	987	10	shedding	shedding	NOUN
aji-147	987	11	and	and	CCONJ
aji-147	987	12	long	long	ADJ
aji-147	987	13	covid-19	covid-19	PROPN
aji-147	987	14	disease	disease	NOUN
aji-147	987	15	in	in	ADP
aji-147	987	16	cancer	cancer	NOUN
aji-147	987	17	patients	patient	NOUN
aji-147	987	18	.	.	PUNCT
aji-147	988	1	in	in	ADP
aji-147	988	2	:	:	PUNCT
aji-147	988	3	oncology	oncology	NOUN
aji-147	988	4	and	and	CCONJ
aji-147	988	5	covid-19	covid-19	PROPN
aji-147	988	6	.	.	PUNCT
aji-147	988	7	crc	crc	PROPN
aji-147	988	8	press	press	PROPN
aji-147	988	9	;	;	PUNCT
aji-147	988	10	2023	2023	NUM
aji-147	988	11	.	.	PUNCT
aji-147	989	1	p.	p.	NOUN
aji-147	989	2	83	83	NUM
aji-147	989	3	-	-	SYM
aji-147	989	4	99	99	NUM
aji-147	989	5	.	.	PUNCT
aji-147	989	6	146	146	NUM
aji-147	989	7	.	.	PUNCT
aji-147	989	8	marfe	marfe	NOUN
aji-147	989	9	g	g	PROPN
aji-147	989	10	,	,	PUNCT
aji-147	989	11	et	et	PROPN
aji-147	989	12	al	al	PROPN
aji-147	989	13	.	.	PROPN
aji-147	990	1	possible	possible	ADJ
aji-147	990	2	interaction	interaction	NOUN
aji-147	990	3	between	between	ADP
aji-147	990	4	drugs	drug	NOUN
aji-147	990	5	for	for	ADP
aji-147	990	6	covid-19	covid-19	PROPN
aji-147	990	7	and	and	CCONJ
aji-147	990	8	cancer	cancer	NOUN
aji-147	990	9	therapy	therapy	NOUN
aji-147	990	10	.	.	PUNCT
aji-147	991	1	clin	clin	PROPN
aji-147	991	2	med	med	PROPN
aji-147	991	3	health	health	PROPN
aji-147	991	4	res	re	NOUN
aji-147	991	5	j.	j.	PROPN
aji-147	991	6	2024;4(2):839	2024;4(2):839	PROPN
aji-147	991	7	-	-	SYM
aji-147	991	8	57	57	NUM
aji-147	991	9	.	.	PUNCT
aji-147	992	1	147	147	NUM
aji-147	992	2	.	.	PUNCT
aji-147	992	3	marfe	marfe	NOUN
aji-147	992	4	g	g	PROPN
aji-147	992	5	,	,	PUNCT
aji-147	992	6	et	et	PROPN
aji-147	992	7	al	al	PROPN
aji-147	992	8	.	.	PROPN
aji-147	992	9	effectiveness	effectiveness	NOUN
aji-147	992	10	of	of	ADP
aji-147	992	11	covid-19	covid-19	PROPN
aji-147	992	12	vaccines	vaccine	NOUN
aji-147	992	13	and	and	CCONJ
aji-147	992	14	their	their	PRON
aji-147	992	15	challenges	challenge	NOUN
aji-147	992	16	.	.	PUNCT
aji-147	993	1	exp	exp	NOUN
aji-147	993	2	ther	ther	PROPN
aji-147	993	3	med	me	VERB
aji-147	993	4	.	.	PUNCT
aji-147	994	1	2021;22(6):1	2021;22(6):1	NUM
aji-147	994	2	-	-	SYM
aji-147	994	3	19	19	NUM
aji-147	994	4	.	.	NOUN
aji-147	994	5	148	148	NUM
aji-147	994	6	.	.	PUNCT
aji-147	995	1	cui	cui	PROPN
aji-147	995	2	d	d	PROPN
aji-147	995	3	,	,	PUNCT
aji-147	995	4	et	et	PROPN
aji-147	995	5	al	al	PROPN
aji-147	995	6	.	.	PUNCT
aji-147	996	1	follicular	follicular	ADJ
aji-147	996	2	helper	helper	NOUN
aji-147	996	3	t	t	NOUN
aji-147	996	4	cells	cell	NOUN
aji-147	996	5	in	in	ADP
aji-147	996	6	the	the	DET
aji-147	996	7	immunopathogenesis	immunopathogenesis	NOUN
aji-147	996	8	of	of	ADP
aji-147	996	9	sars	sar	NOUN
aji-147	996	10	-	-	PUNCT
aji-147	996	11	cov-2	cov-2	NOUN
aji-147	996	12	infection	infection	NOUN
aji-147	996	13	.	.	PUNCT
aji-147	997	1	front	front	ADJ
aji-147	997	2	immunol	immunol	NOUN
aji-147	997	3	.	.	PUNCT
aji-147	998	1	2021;12:731100	2021;12:731100	NUM
aji-147	998	2	.	.	PUNCT
aji-147	998	3	disclaimer	disclaimer	ADJ
aji-147	998	4	/	/	SYM
aji-147	998	5	publisher	publisher	NOUN
aji-147	998	6	’s	’s	PART
aji-147	998	7	note	note	NOUN
aji-147	998	8	:	:	PUNCT
aji-147	998	9	the	the	DET
aji-147	998	10	statements	statement	NOUN
aji-147	998	11	,	,	PUNCT
aji-147	998	12	opinions	opinion	NOUN
aji-147	998	13	and	and	CCONJ
aji-147	998	14	data	datum	NOUN
aji-147	998	15	contained	contain	VERB
aji-147	998	16	in	in	ADP
aji-147	998	17	all	all	DET
aji-147	998	18	publications	publication	NOUN
aji-147	998	19	are	be	AUX
aji-147	998	20	solely	solely	ADV
aji-147	998	21	those	those	PRON
aji-147	998	22	of	of	ADP
aji-147	998	23	the	the	DET
aji-147	998	24	individual	individual	ADJ
aji-147	998	25	author(s	author(s	PROPN
aji-147	998	26	)	)	PUNCT
aji-147	998	27	and	and	CCONJ
aji-147	998	28	contributor(s	contributor(s	NOUN
aji-147	998	29	)	)	PUNCT
aji-147	998	30	and	and	CCONJ
aji-147	998	31	not	not	PART
aji-147	998	32	of	of	ADP
aji-147	998	33	the	the	DET
aji-147	998	34	publisher	publisher	NOUN
aji-147	998	35	and/or	and/or	CCONJ
aji-147	998	36	the	the	DET
aji-147	998	37	editor(s	editor(s	NOUN
aji-147	998	38	)	)	PUNCT
aji-147	998	39	.	.	PUNCT
aji-147	999	1	this	this	DET
aji-147	999	2	publisher	publisher	NOUN
aji-147	999	3	and/or	and/or	CCONJ
aji-147	999	4	the	the	DET
aji-147	999	5	editor(s	editor(s	NOUN
aji-147	999	6	)	)	PUNCT
aji-147	999	7	disclaim	disclaim	VERB
aji-147	999	8	responsibility	responsibility	NOUN
aji-147	999	9	for	for	ADP
aji-147	999	10	any	any	DET
aji-147	999	11	injury	injury	NOUN
aji-147	999	12	to	to	ADP
aji-147	999	13	people	people	NOUN
aji-147	999	14	or	or	CCONJ
aji-147	999	15	property	property	NOUN
aji-147	999	16	resulting	result	VERB
aji-147	999	17	from	from	ADP
aji-147	999	18	any	any	DET
aji-147	999	19	ideas	idea	NOUN
aji-147	999	20	,	,	PUNCT
aji-147	999	21	methods	method	NOUN
aji-147	999	22	,	,	PUNCT
aji-147	999	23	instructions	instruction	NOUN
aji-147	999	24	or	or	CCONJ
aji-147	999	25	products	product	NOUN
aji-147	999	26	referred	refer	VERB
aji-147	999	27	to	to	ADP
aji-147	999	28	in	in	ADP
aji-147	999	29	the	the	DET
aji-147	999	30	content	content	NOUN
aji-147	999	31	.	.	PUNCT
aji-147	1000	1	_	_	PUNCT
aji-147	1001	1	_	_	PUNCT
aji-147	1002	1	_	_	PUNCT
aji-147	1003	1	_	_	PUNCT
aji-147	1004	1	_	_	PUNCT
aji-147	1005	1	_	_	PUNCT
aji-147	1006	1	_	_	PUNCT
aji-147	1007	1	_	_	PUNCT
aji-147	1008	1	_	_	PUNCT
aji-147	1009	1	_	_	PUNCT
aji-147	1010	1	_	_	PUNCT
aji-147	1011	1	_	_	PUNCT
aji-147	1012	1	_	_	PUNCT
aji-147	1013	1	_	_	PUNCT
aji-147	1014	1	_	_	PUNCT
aji-147	1015	1	_	_	PUNCT
aji-147	1016	1	_	_	PUNCT
aji-147	1017	1	_	_	PUNCT
aji-147	1018	1	_	_	PUNCT
aji-147	1019	1	_	_	PUNCT
aji-147	1020	1	_	_	PUNCT
aji-147	1021	1	_	_	PUNCT
aji-147	1022	1	_	_	PUNCT
aji-147	1023	1	_	_	PUNCT
aji-147	1024	1	_	_	PUNCT
aji-147	1025	1	_	_	PUNCT
aji-147	1026	1	_	_	PUNCT
aji-147	1027	1	_	_	PUNCT
aji-147	1028	1	_	_	PUNCT
aji-147	1029	1	_	_	PUNCT
aji-147	1030	1	_	_	PUNCT
aji-147	1031	1	_	_	PUNCT
aji-147	1032	1	_	_	PUNCT
aji-147	1033	1	_	_	PUNCT
aji-147	1034	1	_	_	PUNCT
aji-147	1035	1	_	_	PUNCT
aji-147	1036	1	_	_	PUNCT
aji-147	1037	1	_	_	PUNCT
aji-147	1038	1	_	_	PUNCT
aji-147	1039	1	_	_	PUNCT
aji-147	1040	1	_	_	PUNCT
aji-147	1041	1	_	_	PUNCT
aji-147	1042	1	_	_	PUNCT
aji-147	1043	1	_	_	PUNCT
aji-147	1044	1	_	_	PUNCT
aji-147	1045	1	_	_	PUNCT
aji-147	1046	1	_	_	PUNCT
aji-147	1047	1	_	_	PUNCT
aji-147	1048	1	_	_	PUNCT
aji-147	1049	1	_	_	PUNCT
aji-147	1050	1	_	_	PUNCT
aji-147	1051	1	_	_	PUNCT
aji-147	1052	1	_	_	PUNCT
aji-147	1053	1	_	_	PUNCT
aji-147	1054	1	_	_	PUNCT
aji-147	1055	1	_	_	PUNCT
aji-147	1056	1	_	_	PUNCT
aji-147	1057	1	_	_	PUNCT
aji-147	1058	1	_	_	PUNCT
aji-147	1059	1	_	_	PUNCT
aji-147	1060	1	_	_	PUNCT
aji-147	1061	1	_	_	PUNCT
aji-147	1062	1	_	_	PUNCT
aji-147	1063	1	_	_	PUNCT
aji-147	1064	1	_	_	PUNCT
aji-147	1065	1	_	_	PUNCT
aji-147	1066	1	_	_	PUNCT
aji-147	1067	1	_	_	PUNCT
aji-147	1068	1	_	_	PUNCT
aji-147	1069	1	_	_	PUNCT
aji-147	1070	1	_	_	PUNCT
aji-147	1071	1	_	_	PUNCT
aji-147	1072	1	_	_	PUNCT
aji-147	1073	1	_	_	PUNCT
aji-147	1074	1	_	_	PUNCT
aji-147	1075	1	_	_	PUNCT
aji-147	1076	1	_	_	PUNCT
aji-147	1077	1	_	_	PUNCT
aji-147	1078	1	_	_	PUNCT
aji-147	1079	1	_	_	PUNCT
aji-147	1080	1	_	_	PUNCT
aji-147	1081	1	©	©	PRON
aji-147	1081	2	copyright	copyright	NOUN
aji-147	1081	3	(	(	PUNCT
aji-147	1081	4	2024	2024	NUM
aji-147	1081	5	):	):	PUNCT
aji-147	1081	6	author(s	author(s	NOUN
aji-147	1081	7	)	)	PUNCT
aji-147	1081	8	.	.	PUNCT
aji-147	1082	1	the	the	DET
aji-147	1082	2	licensee	licensee	NOUN
aji-147	1082	3	is	be	AUX
aji-147	1082	4	the	the	DET
aji-147	1082	5	journal	journal	PROPN
aji-147	1082	6	publisher	publisher	NOUN
aji-147	1082	7	.	.	PUNCT
aji-147	1083	1	this	this	PRON
aji-147	1083	2	is	be	AUX
aji-147	1083	3	an	an	DET
aji-147	1083	4	open	open	ADJ
aji-147	1083	5	access	access	NOUN
aji-147	1083	6	article	article	NOUN
aji-147	1083	7	distributed	distribute	VERB
aji-147	1083	8	under	under	ADP
aji-147	1083	9	the	the	DET
aji-147	1083	10	terms	term	NOUN
aji-147	1083	11	of	of	ADP
aji-147	1083	12	the	the	DET
aji-147	1083	13	creative	creative	ADJ
aji-147	1083	14	commons	common	NOUN
aji-147	1083	15	attribution	attribution	NOUN
aji-147	1083	16	license	license	NOUN
aji-147	1083	17	(	(	PUNCT
aji-147	1083	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-147	1083	19	)	)	PUNCT
aji-147	1083	20	,	,	PUNCT
aji-147	1083	21	which	which	PRON
aji-147	1083	22	permits	permit	VERB
aji-147	1083	23	unrestricted	unrestricted	ADJ
aji-147	1083	24	use	use	NOUN
aji-147	1083	25	,	,	PUNCT
aji-147	1083	26	distribution	distribution	NOUN
aji-147	1083	27	,	,	PUNCT
aji-147	1083	28	and	and	CCONJ
aji-147	1083	29	reproduction	reproduction	NOUN
aji-147	1083	30	in	in	ADP
aji-147	1083	31	any	any	DET
aji-147	1083	32	medium	medium	NOUN
aji-147	1083	33	,	,	PUNCT
aji-147	1083	34	provided	provide	VERB
aji-147	1083	35	the	the	DET
aji-147	1083	36	original	original	ADJ
aji-147	1083	37	work	work	NOUN
aji-147	1083	38	is	be	AUX
aji-147	1083	39	properly	properly	ADV
aji-147	1083	40	cited	cite	VERB
aji-147	1083	41	.	.	PUNCT
aji-147	1084	1	peer	peer	NOUN
aji-147	1084	2	-	-	PUNCT
aji-147	1084	3	review	review	NOUN
aji-147	1084	4	history	history	NOUN
aji-147	1084	5	:	:	PUNCT
aji-147	1084	6	the	the	DET
aji-147	1084	7	peer	peer	NOUN
aji-147	1084	8	review	review	NOUN
aji-147	1084	9	history	history	NOUN
aji-147	1084	10	for	for	ADP
aji-147	1084	11	this	this	DET
aji-147	1084	12	paper	paper	NOUN
aji-147	1084	13	can	can	AUX
aji-147	1084	14	be	be	AUX
aji-147	1084	15	accessed	access	VERB
aji-147	1084	16	here	here	ADV
aji-147	1084	17	:	:	PUNCT
aji-147	1084	18	https://www.sdiarticle5.com/review-history/125387	https://www.sdiarticle5.com/review-history/125387	PROPN
aji-147	1084	19	https://www.sdiarticle5.com/review-history/125387	https://www.sdiarticle5.com/review-history/125387	PROPN